<4D F736F F D20F4E8F0E8E9ED20372E303820ECE4E3F4F1E420F1E5F4E9FA2E646F63>

7/2008 י"ב/התשס"ט רשומות ISRAEL STATE RECORDS November 26, 2008 כ"ח בחשוון התשס"ט יומן הפטנטים והמדגמים PATENTS AND DESIGNS JOURNAL PATENTS Applications filed Applications accepted Patents granted Patents renewed Patents not in force Patents renewed for 20 years Notices Changes in particulars entered in register Changes in proprietorship Country codes Indices of applications accepted DESIGNS Designs registered Designs renewed Designs void עמוד Page 2504 2614 2829 2830 2832 2833 2834 2835 2836 2837 i 2839 2848 2849 פטנטים בקשות שהוגשו בקשות שקובלו פטנטים שניתנו פטנטים שחודשו פטנטים שתוקפם פקעו פטנטים שחודשו לעשרים שנה הודעות שינויים בפרטים רשומים בפנקס שינויי בעלות קודים למדינות מפתחות לבקשות שקובלו מדגמים מדגמים שנרשמו מדגמים שחודשו מדגמים שבוטלו 2503

ידיעות כלליות מכתבים, מסמכים, וכו' בענייני פטנטים ומדגמים יש לשלוח אל: רשם הפטנטים והמדגמים, רח' הסדנא 4, ירושלים לשכת הפטנטים נמצאת ברח' הסדנא 4, תלפיות, ירושלים והיא פתוחה לציבור בימי חול שאינם ערבי שבת או מועד בין השעות 8:30 ו- 12:30. לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של 2.50 שקלים בעד כל עמוד או חלק ממנו. אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס' 0-24145-2. יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה שולמה. GENERAL INFORMATION Letters, documents, etc. concerning Patents and Designs should be addressed to: The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs. The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50 per page or part thereof. Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together with the application for the action for which the fee has been paid. Copyright by the State of Israel. No Extracts may be published except with the permission of the Patent Office. Price per single issue (incl. VAT) : NIS 96. Annual subscription (incl. VAT): NIS 1,152. Available at the Distribution Service of Government Publications, 29 B-Street, Hakirya, Tel-Aviv. זכות היוצרים בתקצירים אלה שמורה למדינת ישראל, אין להעתיק מת קצירים אלה אלא ברשות לשכת הפטנטים. מחיר: לכל חוברת בודדת (כולל מ.ע.מ.). 96 דמי חתימה לשנה (כולל מ.ע.מ.). 1,152 אפשר להשיג אצל: שרות ההפצה של פרסומי הממשלה, רחוב ב' מס' 29, הקריה, תל-אביב. 2504

NOTICE UNDER SECTION 16 OF THE PATENTS LAW, 5727-1967 In the following there are listed new Applications complying with the Provisions of rule 32(a) of the Patent Regulations, 5728-1968 Particulars of the applications are given in the following order: Number and date of application And the first four symbols of the International Classification Title of invention (as proposed by applicant) Applicant הודעה לפי סעיף 16 לחוק הפטנטים תשכ"ז - 1967 להלן רשימת בקשות חדשות הממלאות אחר הדרישות שנקבעו בתקנה 32 א( ( לתקנות הפטנטים, תשכ"ח 1968 : פרטי הבקשות מובאים לפי סדר זה: מספר הבקשה ותאריך הגשתה וארבעה הסמנים הראשונים של הסיווג הבינלאומי שם האמצאה (כפי שהוצע ע"י המבקש) המבקש Priority right: Convention country Number and date of Foreign application דין קדימה: מדינת האיגוד תאריך ומספר בקשת החוץ International Application Number International Publication Number מספר בקשה בינלאומית מס' פרסום בינלאומי 2505

15/11/2007 ALARM SYSTEM DOV BARAK, MARKETING DIVISION NUCLEAR RESEARCH CENTER NEGEV 187394 G08B מערכת אזעקה דב ברק, אגף שיווק הקריה למחקר גרעיני 26/05/2006 GENE VECTOR FONDAZIONE TELETHON US 60/684954 27/05/2005 PCT/IB/2006/002266 WO/2007/000668 187679 C12N וקטור גני 31/05/2006 AUTOMATED CELL THERAPY SYSTEM KWALATA TRADING LIMITED US 60/687115 02/06/2005 PCT/IL/2006/000633 WO/2006/129312 187697 A61K מערכת אוטומטית לטיפול תאי 22/06/2006 USE OF CMP FOR ALUMINUM MIRROR AND SOLAR CELL FABRICATION CABOT MICROELECTRONICS CORPORATION US 11/173518 30/06/2005 PCT/US/2006/024789 WO/2007/120163 187706 B24B שימוש בליטוש כימי מכני ליצור מראות אלומינום ותאים סולריים 2506

31/05/2006 TRAFFIC PREEMPTION SYSTEM COMMUNICATION METHOD GLOBAL TRAFFIC TECHNOLOGIES, LLC US 11/142019 01/06/2005 PCT/US/2006/021013 WO/2006/130633 187817 G08G שיטת תקשורת למערכת זכות קדימה תעבורתית 11/12/2007 A TOOTHBRUSH OREN CHARCHI 188065 A46B מברשת שיניים לידיה חיה פיטרו ישראל 12/12/2007 BIT GENERATOR 188089 G06F מחולל ביטים 18/12/2007 COATED CEMENTED CARBIDE CUTTING TOOL INSERTS AND METHODS OF MAKING THE SAME SANDVIK INTELLECTUAL PROPERTY AB SE 0602815-3 27/12/2006 188208 B23C תותבות מקארביד מודבק מצופה עבור מכשיר חיתוך ושיטות להכנתן 18/12/2007 MULTILAYERED COATED CUTTING TOOL SANDVIK INTELLECTUAL PROPERTY AB SE 0602814-6 27/12/2006 188210 B23G מכשיר חיתוך מצופה רב שכבתי 2507

18/12/2007 CEMENTED CARBIDE COATED CUTTING TOOL INSERTS WITH TOUGHNESS SANDVIK INTELLECTUAL PROPERTY AB SE 0602812-0 27/12/2006 188212 B23H תותבות מצופות מקארביד מודבק עבור מכשיר חיתוך בעלי חוזק 20/12/2007 FLEXIBLE ELECTRIC HEATERS A.H.T. ADVANCED HEATING TECHNOLOGIES LTD. 188303 F24H מחממים חשמליים גמישים אי.איצ'.טי. אדוונסד היטינג טכנולוג'יז בע"מ 20/12/2007 SYSTEM AND METHOD FOR JOINING NON-TRANSPARENT PARTS BY MEANS OF A RADIATION CURABLE ADHESIVE EROWA AG SE 00088/07 22/01/2007 188311 E06B מערכת ושיטה לחיבור חלקים לא שקופים באמצעי קרינת ריפוי מדביקה 24/12/2007 ADDING INCENTIVES TO PEER-TO- PEER SYSTEMS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 188377 G06F הוספת תמריצים למערכות עמית לעמית PEER TO PEER) ( יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים 08/01/2008 188669 LOW-DRAG SWEPT WINGS ISRAEL AEROSPACE INDUSTRIES LTD. US 60/879028 08/01/2007 B64D כנפיים משוכות בעלות גרר נמוך התעשייה האוירית לישראל בע"מ 2508

15/01/2008 METHOD AND SYSTEM FOR THE ACQUISITION OF DATA AND FOR THE DISPLAY OF DATA ISRAEL AEROSPACE INDUSTRIES LTD. US 11/657118 24/01/2007 188775 G06F שיטה ומערכת לרכישת מידע ולהצגת מידע התעשייה האוירית לישראל בע"מ 25/07/2006 METHOD OF TREATING ISCHEMIA- REPERFUSION INJURY BIOREST LTD. US 11/190787 26/07/2005 PCT/IB/2006/002028 WO/2007/012947 189041 A61K שיטה לטיפול בנזק איסכמיה רפרפוזיה ביורסט בע"מ 28/01/2008 A COMMUNICATIONS GATEWAY BETWEEN TWO ENTITIES HISPANO-SUIZA FR 0752939 29/01/2007 189085 H04B שער לחיבור תקשורתי בין שתי ישויות 01/08/2006 USE OF LIPID CONJUGATES IN CYSTIC FIBROSIS AND APPLICATIONS THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM US 60/704874 03/08/2005 US 60/780379 09/03/2006 PCT/US/2006/029893 WO/2007/019131 189171 A61K שימוש בתצמידים שומנים לציסטיק פיברוזיס ויישומם יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים 2509

04/02/2008 THREAT DETECTION SYSTEM INMANTICA LTD. 189268 G08B מערכת לזיהוי סיכונים אינמנטיקה בע"מ 06/02/2008 SYSTEM AND METHOD FOR FOR LOW COMPLEXITY SPHERE DECODING FOR SPATIAL MULTIPLEXING MIMO RUNCOM TECHNOLOGIES LTD 189328 H04L מערכת ושיטה למפענח SPHERE DECODING בעל סיבוכיות נמוכה עבור ריבוב מרחבי MIMO רנקום טכנולוגיות בע"מ 13/02/2008 A SYSTEM AND METHODS FOR POSITIONING INFORMATION FROM A PLURALITY OF USERS ISHAI, RON 189505 G08G מערכת ושיטות למיקום מידע אודות מספר משתמשים רון ישי 14/02/2008 LAMP WITH HEAT-RESPONSIVE DECORATION SHLOMO AVITAL 189529 B29C מנורה עם קישוט המגיב לחום שלמה אביטל 14/02/2008 ULTRASONIC SPRAYER SYSTEM AND METHOD U.S. DRYER LTD 189548 B06B מרסס אולטראסוני מערכת ושיטה מייבש אולטרסוני בע"מ 2510

17/02/2008 FRAMELESS TUBE SEMI-TRAILER FOR FLUID TRANSPORTATION ENERGTEK PRODUCTS LTD 189549 B62D גרור ללא מסגרת להובלת נוזל אנרגטק מוצרים בע"מ 17/02/2008 A BUILDING METHOD AND BUILDINGS ISRAEL HIRSHBERG 189554 E04G שיטת בנייה ובניינים ישראל הירשברג 18/02/2008 REPORTING CAMERA LIOR ARANYA US 60/985238 13/11/2007 189565 G08B מצלמת דיווח ליאור ארניה 18/02/2008 189566 COMPACTING TRASHCAN LIOR ARANYA US 60/985239 13/11/2007 A47J פח דחיסה ליאור ארניה 18/02/2008 A LIQUID DISPENSER ROZENBAUM NAFTALI 189567 B65D מנפק נוזלים 18/02/2008 189568 METHOD AND DEVICE TO TRANSFER DIGITAL DATA UZI EZRA HAVOSHA US 60/902032 20/02/2007 US 60/928198 09/05/2007 2511 G06F שיטה ומתקן להעברת מידע דיגיטלי עוזי חבושה, עו"ד

18/02/2008 APPARATUS AND METHOD FOR INDEPENDENT AXIAL POSITIONAL CONTROL OF MULTIPLE MOTORS REDLER COMPUTERS LTD. 189570 B25J התקן ושיטה לבקרה של הכוונת ציר עצמאית במערכת בה מנועים מרובים רדלר מחשבים בע"מ 18/02/2008 MECHANICAL DEVICE THAT PROTECTS BABIES BEN-ZION VIDER 189575 A47D התקן מכני אשר מגן על תינוקות דר' בן-ציון וידר 18/02/2008 MULTIPURPOSE AQUEOUS PARTS WASHER SAFETY-KLEEN SYSTEMS, INC. US 11/681652 02/03/2007 US 11/766643 21/06/2007 189577 A47L מכשיר רב תכליתי לשטיפת רכיבים על בסיס מים 18/02/2008 METHOD FOR DETECTING DUPLICATED INSTANCES OF A SOFTWARE LICENSE ALADDIN KNOWLEDGE SYSTEMS LTD US 11/677953 22/02/2007 189588 H04K שיטה לזיהוי מקרים של שכפול רשיון תוכנה אלדין מערכות ידע בע"מ 18/02/2008 SELF-DEFENSIVE PROTECTED SOFTWARE WITH SUSPENDED LATENT LICENSE ENFORCEMENT ALADDIN KNOWLEDGE SYSTEMS LTD US 11/710281 22/02/2007 189592 H04K תוכנה מוגנת המגנה על עצמה עם אכיפת רשיון סמויה מושהית אלדין מערכות ידע בע"מ 2512

18/02/2008 METHOD FOR DETECTING THAT A PROTECTED SOFTWARE PROGRAM IS CRACKED ALADDIN KNOWLEDGE SYSTEMS LTD US 11/710282 22/02/2007 189593 G06F שיטה לגילוי שתוכנה מוגנת נפרצה אלדין מערכות ידע בע"מ 20/02/2008 METHOD AND APPARATUS FOR IDENTIFYING REDUNDANT SCAN ELEMENTS MARVELL ISRAEL (M.I.S.L) LTD US 60/890918 21/02/2007 US 12/018410 23/01/2008 189636 G06F שיטה והתקן לזיהוי של אלמנטים עודפים של סריקה מארוול ישראל (אמ.איי.אס.אל) בע"מ 20/02/2008 SYSTEM AND METHOD FOR SELF- VERIFICATION OF SAFE STORAGE WITHIN HERMETICALLY SEALED CONTAINERS GRAINPRO, INC. US 11/677636 22/02/2007 189637 B65D מערכת ושיטה לאימות עצמית של אחסון ביטוחי בתוך מיכלים אטומים הרמטיים 20/02/2008 METHOD AND SYSTEM FOR RECOGNITION AND SPOTTING STOLEN CARS, VEHICLES ARE MOVING AS OPPOSED TO THE LEW, PROOF EVIDENCE SUPPLY OF TRANSGRESSION MAKING AND GIVING ABILITY OF IMMEDIATE ENFORCEMENT GUY WOLF 189639 G08B שיטה ומערכת לזיהוי ואיתור מכוניות גנובות ומכוניות הנעות בדרכים בניגוד לחוק, אספקת ראיות והוכחות לביצוע העבירות ומתן יכולת אכיפה מיידית גיא וולף 2513

21/02/2008 "THE KEEPER" NISIM TURGEMAN 189641 B65B "השומר" ניסים תורג'מן 21/02/2008 COFFEE MAKER ARGO LTD. 189645 A47J התקן להכנת קפה ארגו בע"מ 21/02/2008 COMMUNICATION SYSTEM, TERMINATING APPARATUS, AND PON VIRTUALIZATION METHOD FOR USE THEREIN NEC CORPORATION 2007- JP 14/03/2007 064275 189647 G06F מערכת תקשורת, התקן סיום, ושיטות וירטואליזצית PON לשימוש בה 21/02/2008 DEVICE FOR MAKING GLASS, BOWEL OR HOLDER FOR CANDLE MADE OF ICE TAMAR GARMIZO 189652 A47J מיתקן להכנת כוס, קערית או מחזיק לנר מקרח תמר גרמיזו 21/02/2008 WORD ISOLATING EDUCATIONAL TOOL DWIGHT J. LOCKETT 189653 G09B כלי חינוכי לבידוד מילים 2514

21/02/2008 A METHOD AND SYSTEM FOR DETECTING AND BLOCKING PHISHING ATTACKS POSTALGUARD LTD. 189654 H04K שיטה ומערכת לאיתור וחסימה של התקפת פישינג פוסטלגארד בע"מ 21/02/2008 PROCESS OF MAKING COMPOSITE MEMBRANES BASED ON ALUMINUM FOR MICRO FILTRATION C-FILTERS LTD 189656 B01D תהליך לייצור ממברנות מרוכבות למיקרו סינון המבוססות על אלומיניום סי פילטרס בע"מ 21/02/2008 189682 SECURE INTERNET E-COMMERCE P.C.S.M. LTD. US 60/709831 22/08/2005 WO IL2006/000948 16/08/2006 G06Q מערכת אינטרנט בטוח למסחר אלקטרוני פי.סי.אס.אמ. בע"מ 24/02/2008 DIGITAL ASSETS INTERNET TIMELINE AGGREGATION AND SHARING PLATFORM ALLOFME LTD. 189695 H04N ליקוט נכסים דיגיטליים של קו הזמן באינטרנט ופלטפורמה משותפת אול אוף מי בע"מ 24/02/2008 A METHOD AND APPARATUS FOR FORWARDING MEDIA OBJECTS TO A CELLULAR TELEPHONE USER PAPERLNX LTD. 189701 H04M שיטה ומכשיר לשליחת אוביקטיי מדיה למשתמש טלפון סלולרי פייפרלנקס בע"מ 2515

24/02/2008 HANDLING MANIPULATOR ASSEMBLY EROWA AG CH 00587/07 10/04/2007 189704 G06F טיפול במניפולטורים שלשפת סף 25/02/2008 APPARATUS AND METHOD FOR USING A MOBILE TELEPHONE UNIT AS A STANDARD LAND LINE TELEPHONE UNIT FOR AN EXISTING WIRED TELEPHONE LAND LINE ZVI HAY BEN-YISHAY 189722 H04Q מנגנון ושיטה לשימוש בטלפון נייד כמכשיר טלפון קווי סטנדרטי על גבי קו טלפון חוטי קיים שי ששון 25/02/2008 189723 METHOD SYSTEM AND DEVICE FOR A FIRST AID CONTAINER UZI EZRA HAVOSHA US 60903037 26/02/2007 A47K שיטה מערכת ומתקן לקופסת עזרה ראשונה עוזי חבושה, עו"ד 25/08/2006 MODIFIED ANTIGEN BINDING MOLECULES WITH ALTERED CELL SIGNALING ACTIVITY GLYCART BIOTECHNOLOGY AG US 60/711454 26/08/2005 PCT/IB/2006/003294 WO/2007/031875 189756 C07K מולקולות קושרות אנטיגן מותאמות עם פעילות איתות תאי שונה 2516

25/02/2008 A BUFFER SYSTEM FOR A LONG- LASTING PRECAST ELECTROPHORESIS GEL GENE BIO-APPLICATION LTD. 189759 G01N מערכת בופר לג'ל יצוק מראש לאלקטרופורזה עמיד לטווח ארוך גן יישומים בביולוגיה בע"מ 25/02/2008 ANTI-EFFRACTION SAFETY SYSTEM FOR DOOR AND WINDOW FRAMES SAVIO S.P.A. IT TO2007A000780 05/11/2007 189761 G08B מערכת בטיחות נגד פריצות עבור דלת ומסגרות של חלונות 26/02/2008 HYDRAULIC WIND FARMS FOR GRID ELECTRICITY AND DESLINATION AVI EFRATY 189765 F03D חוות רוח הידראוליות לחשמל רשת ולהתפלה אבי אפרתי 26/02/2008 189778 DEVICE FOR LABELING CONTENT OF CONTAINERS DROR ELI B67D התקן לסימון תכולה, לכלי קיבול דרור אלי 26/02/2008 189791 A47B SLIDE-IN FOLDER FOR RING BINDER תיקיה הניתנת להשחלה לקלסר טבעות ODED GOLAN עודד גולן US 60/903318 26/02/2007 2517

27/02/2008 ARMORED MODULES TEXAR TECHNOLOGIES LTD 189806 B32B מדולות משוריינות טקסר טכנולוגיות בע"מ 27/02/2008 NON-LEAKING FOLDABLE POLYGONAL CONTAINER ELI LEVIS 189807 B65D מיכל מצולע מתקפל חסין בפני נזילות אלי לויס 27/02/2008 SYSTEM AND METHOD FOR OPTIMIZING HEAD-UP DISPLAY UNIFORMITY HONEYWELL INTERNATIONAL INC. US 11/680216 28/02/2007 189808 G06K מערכת ושיטה לייעול אחידות תצוגה של אלמנטים גרפיים בממשק משתמש 28/02/2008 A METHOD AND AN APPARATUS FOR ALLOWING BROWSING USERS TO COMMUNICATE WITH ONE ANOTHER OVER A COMPUTER NETWORK TWOJUMPS CORP. US 60/904172 01/03/2007 189831 G06F שיטה ומכשיר לאפשר למשתמשי רשת מחשב לתקשר ביניהם באמצעות הרשת 28/02/2008 WATER JUG ACCESSORY AND METHOD OF MITIGATING TAMPERING WITH A WATER JUG ADRIEN HADDAD 189838 A47J אביזר לקנקן מים ושיטה למניעת חדירה לקנקן אדריאן חדד 2518

28/02/2008 189848 TURBO DECODER MARVELL ISRAEL (MISL) LTD. US 60/893274 06/03/2007 US 12/037573 26/02/2008 H03M מפענח טורבו מרבל ישראל MISL) ( בע"מ 28/02/2008 SYSTEM AND METHOD FOR PREMISES MONITORING USING WEIGHT DETECTION OPTIMAL INNOVATIONS, INC. US 11/683308 07/03/2007 189859 G08B מערכת ושיטה לבקרת איזורים על ידי שימוש בגלאי משקל 28/02/2008 LIGHT SWITCH USED AS A COMMUNICATION DEVICE OPTIMAL INNOVATIONS, INC. US 11/683298 07/03/2007 189860 H04M מתג אור המשמש כמכשיר תקשורת 28/02/2008 SYSTEMS AND METHODS FOR LINKING UTILITY CONTROL DEVICES OPTIMAL INNOVATIONS, INC. US 11/683304 07/03/2007 189861 H04M שיטות ומערכות לחיבור מכשירי שליטה 28/02/2008 ANTICIPATORY UTILITY CONTROL DEVICE OPTIMAL INNOVATIONS, INC. US 11/683335 07/03/2007 189862 H04M התקן לשליטה במכשיר מנבא 2519

28/02/2008 SYSTEMS AND METHODS FOR INFRASTRUCTURE REPORTING OPTIMAL INNOVATIONS, INC. US 11/683327 07/03/2007 189867 G08B מערכות ושיטות לדיווחי תשתית 28/02/2008 ANTICIPATORY UTILITY CONTROL DEVICE OPTIMAL INNOVATIONS, INC. US 11/683326 07/03/2007 189868 G09F התקן לשליטה במכשיר מנבא 02/03/2008 HOT GREETIUGS PILLOW HAMAMIT LTD. 189873 G09F לב ברכה שמחממת את הלב חממית מן הטבע בע"מ 02/03/2008 NAPKIN RING AND SAIT AND PEPPER DISPENSER ORON MARKUS 189874 A47J מחזיק מפיות ומלחיה אורון מרקוס 02/03/2008 A METHOD FOR DIGITALLY SIGNING AN EMAIL MESSAGE POSTALGUARD LTD. 189875 H04L שיטה לחתימה דיגיטאלית של דבר דואר אלקטרוני פוסטלגארד בע"מ 03/03/2008 VENEER CONTAINER TZUR ADAR 189889 B65D מיכלים מפורניר צור אדר 2520

03/03/2008 BOOK STAND ELI NEUMAN 189890 A47F מתקן קריאה לספרים אלי ניומן 03/03/2008 COMMUNICATION DEVICE, COMMUNICATION CONTROL SYSTEM, COMMUNICATION CONTROL METHOD AND RECORDING MEDIUM RECORDING COMMUNICATION CONTROL PROGRAM NEC CORPORATION 2007- JP 26/03/2007 078752 189896 H04M התקן תקשורת, מערכת בקרת תקשורת, שיטה לבקרת תקשורת ותווך הקלטה, ותוכנית להקלטת בקרת תקשורת 03/03/2008 INDEXABLE INSERT AND DRILL USING THE SAME SUMITOMO ELECTRIC HARDMETAL CORP. 2007- JP 07/03/2007 057038 189902 B23C שימת הניתן לסימון ומקדח המתשמש בו 03/03/2008 189903 FINANCIAL AUTHORIZATION APPARATUS C.O.D. RAMI COMMUNICATION LTD G07B מכשיר לאישור כספי ק.ו.ד. רמי תקשורת בע"מ 04/03/2008 189907 E04H PERSONAL ARTIFLICIAL SHELTER THAT SURROUNDS THE PERSON(S). מחסה אישי/קבוצתי מלאכותי ניד המקיף, את האדם/אנשים. DR. HAIM AMRAM BEN-SIMHON ד"ר חיים עמרם בן שמחון 2521

04/03/2008 ARM WATER CARRIER SARIT COHEN 189908 A47K מתקן מים זרועי שרית כהן 04/03/2008 INSERT FOR STABILIZING MEN'S HATS YOSEF FARCKASH 189912 A47D תותב מייצב צורת כובע של גבר יוסף פרקש 04/03/2008 189917 H04L A MULTI-LEVEL MULTI-PIN DIFFERENTIAL INTERFACE ממשק דיפרנציאלי רב שלבים רב שבבים MARVELL ISRAEL (MISL) LTD. מרבל ישראל MISL) ( בע"מ US 60/893009 05/03/2007 04/03/2008 DIGITAL RANDOM NUMBER GENERATOR BASED ON DIGITALLY- CONTROLLED OSCILLATORS SANDISK IL LTD. 189921 G06F מחולל מספרים אקראיים ספרתי המבוסס על מתנדים נשלטים ספרתית סנדיסק אייאל בע"מ 04/03/2008 NON-LEAKING FOLDABLE POLYGONAL CONTAINER ELI LEVIS 189925 B67C מיכל מצולע מתקפל חסין בפני נזילות אלי לויס 2522

28/11/2006 IL-21 ANTAGONISTS ZYMOGENETICS INC. US 60/740154 PCT/US/2006/061277 WO/2007/111714 28/11/2005 189949 C07K אנטגוניסטים IL 21 05/03/2008 DEVICE, SYSTEM, AND METHOD OF ELECTRONIC COMMUNICATION UTILIZING AUDIOVISUAL CLIPS MY HOLLYWOOD LTD. US 60/905847 09/03/2007 189955 H04M מכשיר, מערכת ושיטה לתקשורת אלקטרונית באמצעות קליפים אודיו ויזואלים 06/03/2008 A METHOD OF MANUFACTURING A CERAMIC CUTTING INSERT SANDVIK INTELLECTUAL PROPERTY AB SE 0700624-0 12/03/2007 189968 B23P שיטה ליצור תותבת חיתוך קרמית 26/09/2006 COMBINED VENTILATOR INEXSUFFLATOR INNOVENT MEDICAL SOLUTIONS, INC. US 60/720042 26/09/2005 US 60/830741 13/07/2006 PCT/IB/2006/003897 WO/2007/054829 190117 A61M התקן המסייע לנשימה המשולב עם מאוורר 2523

15/09/2006 FLEXIBLE ADVERTISING SYSTEM WHICH ALLOWS ADVERTISERS WITH DIFFERENT VALUE PROPOSITIONS TO EXPRESS SUCH VALUE PROPOSITIONS TO THE ADVERTISING SYSTEM GOOGLE, INC. US 11/228583 16/09/2005 PCT/US/2006/036062 WO/2007/035499 190132 G09F מערכת פרסום גמישה המאפשרת למפרסמים בעלי הנחות עריכות שונות לבטא הנחות ערכיות כאלה במערכת הפרסום 27/09/2006 MODULATION OF TLR-MEDIATED IMMUNE RESPONSES USING ADAPTOR OLIGONUCLEOTIDES COLEY PHARMACEUTICAL GROUP, INC. US 60/720981 27/09/2005 PCT/US/2006/037987 WO/2007/038720 190392 A61K אפנון של תגובות אימוניות מתווכות TLR תוך שימוש במתאם אוליגונוקלאוטידים 26/09/2006 PDGF AMPHIPHILIC POLYMER COMPLEX ADOCIA FR 05/09803 26/09/2005 PCT/IB/2006/002666 WO/2007/034320 190400 A61K קומפלס אמפיפילי של פולימר PDGF 2524

01/11/2006 COMPOSITIONS, REAGENTS AND KITS FOR AND METHODS OF DIAGNOSING, MONITORING AND TREATING HORMONAL IMBALANCE 191000 C07K תכשירים, מגיבים וערכות עבור ושיטה לאבחון, מעקב וטיפול בחוסר איזון הורמונלי LIAT MINTZ US 60/733090 PCT/US/2006/042606 WO/2007/055996 03/11/2005 ליאת מינץ 20/10/2006 VERSATILE ROBOTIC CONTROL MODULE IROBOT CORPORATION US 60/729388 21/10/2005 US 60/729445 21/10/2005 US 60/780389 08/03/2006 US 60/838704 18/08/2006 PCT/US/2006/041177 WO/2007/048003 191001 G05B מודול רב גווני לבקרה רובוטית 28/12/2005 191002 NON-PLASMA METHOD OF REMOVING PHOTORESIST FROM A SUBSTRATE THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA US 11/255695 21/10/2005 PCT/US/2005/047106 WO/2007/046835 C03C שיטה להסרת חומר רגיש אור ממצע ללא שימוש בפלסמה 2525

27/10/2006 NOVEL INDOLE-CONTAINING BETA AGONISTS, METHOD FOR PRODUCING THEM AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH DE 102005052127.4 28/10/2005 PCT/EP/2006/067872 WO/2007/048841 191003 C07D בתא אגוניסטים חדשים המכילים אינדול, שיטה לייצורם ושימושם כתרופות 11/12/2006 ANTIBODIES AGAINST AMYLOID BETA 4 WITH GLYCOSYLATED ASN IN THE VARIABLE REGION F. HOFFMANN-LA ROCHE AG EP 05027090.9 12/12/2005 PCT/EP/2006/011914 WO/2007/068429 191004 C07K נוגדנים נגד אמילויד בתא 4 עם Asn מותמר בגליקוציד באיזור המשתנה 19/10/2006 IMPROVED AIRFLOW DISTRIBUTION TO A LOW EMISSION COMBUSTOR POWER SYSTEMS MFG. LLC US 11/262447 28/10/2005 PCT/US/2006/040903 WO/2007/053323 191006 F02C חלוקה משופרת של זרם אויר לתא שריפה בעל פליטה נמוכה 26/10/2006 COUPLING HAVING ANGULARLY ORIENTED CAVITY VICTAULIC COMPANY US 60/730305 26/10/2005 PCT/US/2006/041626 WO/2008/008088 191007 F16L מחבר בעל חלל עם כיווניות זויתית 2526

14/11/2006 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. 2005- JP 15/11/2005 330590 PCT/JP/2006/323066 WO/2007/058338 191008 C07D תרכובת אוקסאזול ותכשיר רוקחות 30/11/2006 PURINE DERIVATIVES AND METHODS OF USE THEREOF INOTEK PHARMACEUTICALS CORPORATION US 60/740795 30/11/2005 PCT/US/2006/045845 WO/2007/064795 191009 A01N תולדות פורין ושיטות לשימוש בהן 09/11/2006 SILICON NANOPARTICLE PHOTOVOLTAIC DEVICES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, US 60/736139 10/11/2005 PCT/US/2006/043808 WO/2008/051235 191011 H01L התקנים פוטוולוטאיים המבוססים על חלקיקי סיליקון זעירים 2527

02/11/2006 WASTEWATER TREATMENT METHOD COMPRISING DECANTATION AND FINE SCREENING STAGES AND DEVICE FOR CARRYING OUT SAID METHOD OTV SA FR 0511525 14/11/2005 PCT/EP/2006/068046 WO/2007/054461 191012 C02F שיטה לטיפול במי שפכים הכוללת שפיתה ושלבי סריקה מדוקדקת והתקן לביצוע שיטה זו 08/11/2006 THERAPEUTIC VACCINES TARGETING HMGB1 PHARMEXA A/S DK PA200501556 US 60/734747 PCT/DK/2006/000614 WO/2007/054090 191013 C07K חיסונים רפואיים הממוענים ל HMGB1 09/11/2005 09/11/2005 07/11/2006 LIQUID CONTAINER AND LIQUID FILLING METHOD SEIKO EPSON CORPORATION JP 2005-323977 08/11/2005 JP 2005-347091 30/11/2005 JP 2005-353111 07/12/2005 JP 2006-215220 08/08/2006 PCT/JP/2006/322519 WO/2007/055344 191014 B41J מיכל לנוזלים ושיטה למילוי נוזלים 2528

25/10/2006 191015 (HETERO) ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH EP 05110014.7 26/10/2005 PCT/EP/2006/067750 WO/2007/048802 C07D תרכובות (הטרו) אריל בעלות פעילות אנטגוניסטית ל MCH ותרופות המכילות תרכובות אלו 24/10/2006 PIPERIDIN-4-YL-PYRIDAZIN-3- YLAMINE DERIVATIVES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. EP 05110028.7 26/10/2005 EP 06100209.3 10/01/2006 EP 06101545.9 10/02/2006 PCT/EP/2006/067696 WO/2007/048779 191016 C07D תולדות פיפרידין 4 יל פירידאזין 3 ילאמיניות כמפרידות במהירות אנטגוניסטים של קולטן דופאמין 2 21/11/2006 CARBAMATE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. US 60/738702 22/11/2005 PCT/US/2006/045099 WO/2007/062058 191017 C07D תרכובות קרבאמאט כאגוניסטים של קולטן HT 54 2529

24/10/2006 ELECTROMAGNETIC WAVE SENSOR WITH TETRAHERTZ BANDWIDTH THALES FR 0510875 25/10/2005 PCT/EP/2006/067695 WO/2007/048778 191019 G01N חיישן גל אלקטרומגנטי עם רוחב פס טטרה הרצי 24/10/2006 OVULATION CYCLE MONITORING AND MANAGEMENT MANAWATU BIOTECH INVESTMENTS LTD. US 60/729554 24/10/2005 PCT/IB/2006/003925 WO/2007/049157 191020 G01N ניטור וניהול של מחזור ביוץ 16/10/2006 CAN FOR BEVERAGES COMPRISING A PROTECTIVE LID JULIEN SAVINO OF FR 0510816 24/10/2005 FR 0601896 03/03/2006 FR 0601898 03/03/2006 PCT/FR/2006/002335 WO/2007/048897 191021 B65D פחית עבור משקאות המכילה מכסה מגן 09/10/2006 METHOD FOR MODIFYING INSULATING OR SEMI-CONDUCTIVE SURFACES, AND RESULTING PRODUCTS ALCHIMER FR 0510914 26/10/2005 PCT/FR/2006/002260 WO/2007/048894 191022 C08J שיטה לשינוי משטחים מבודדים או מוליכים למחצה והתוצרים המתקבלים 2530

02/10/2006 METHOD FOR TREATING/CONTROLLING/KILLING FUNGI AND BACTERIA STAVAL PHARMA, LTD. US 60/729624 24/10/2005 PCT/US/2006/038490 WO/2007/050242 191023 A01N שיטה לטיפול/בקרה/קטילה של פטריות ובקטריות 06/11/2006 2-(BENZIMIDAZOL-1-YL)-N-(4- PHENYLTHIAZOL-2-YL)ACETAMIDE DERIVATIVES USEFUL IN TREATMENT OF TRPV1 RELATED DISORDERS N.V. ORGANON EP 05110450.3 08/11/2005 PCT/EP/2006/068109 WO/2007/054474 191025 C07D תולדות 2 (בנזימידאזול 1 יל) N (4 פנילתיזול 2 יל)אצטאמידיות המשמשות לטיפול באי סדרים הקשורים ל TRPV1 10/11/2006 PROCESS FOR THE PREPARATION OF OLANZAPINE EGIS GYOGYSZERGYAR Nyilvanosan Mukodo Reszvenytarsasag HU P0501046 11/11/2005 PCT/HU/2006/000096 WO/2007/054750 191026 C07D תהליך להכנת אולאנזאפין 2531

02/11/2006 BIOCIDAL STRUCTURAL BARRIER (BSB) SEP INNOVATERM, FR 0511115 02/11/2005 FR 0607122 03/08/2006 PCT/EP/2006/068030 WO/2007/051814 191028 C04B חסמים מבניים של חומרים קוטלי יצורים חיים 06/11/2006 FUNGICIDAL MIXTURES BASF SE US 60/735194 PCT/EP/2006/068098 WO/2007/054469 10/11/2005 191030 A01N תערובות קוטלות פטריות 06/11/2006 NOVEL PYRROLIDINE DERIVATIVES AS INHIBITORS OF COAGULATION FACTOR XA F. HOFFMANN-LA ROCHE AG EP 05110818.1 16/11/2005 PCT/EP/2006/068138 WO/2007/057317 191031 C07D תולדות פירולידיניות חדשות כמעכבות פקטור הקרשה XA 03/11/2006 PROCESS FOR THE PREPARATION OF A LEUKOTRIENE ANTAGONIST AND INTERMEDIATES THEREOF ESTEVE QUIMICA, S.A. EP 05110348.9 04/11/2005 US 60/733533 04/11/2005 PCT/EP/2006/068052 WO/2007/051828 191032 C07D תהליך להכנת אנטגוניסט של לוקוטריאן וחומרי ביניים עבורו 2532

01/11/2006 USES OF ANTI-CD40 ANTIBODIES XOMA TECHNOLOGY LTD. US 60/732730 01/11/2005 PCT/US/2006/042929 WO/2007/053767 191033 A61K שימושים בנוגדנים אנטי CD40 24/10/2006 APPARATUS AND METHOD FOR MEASURING BIOLOGIC PARAMETERS MARCIO MARC ABREU US 60/729232 24/10/2005 US 60/802503 23/05/2006 PCT/US/2006/041238 WO/2007/050487 191039 A61B התקן ושיטה למדידה של נתונים ביולוגיים 02/08/2006 A HYDROPHILIC POLYMER SPONGE HEMCON, INC. US 11/261351 28/10/2005 PCT/US/2006/030283 WO/2007/055761 191042 A61F ספוג מפולימר הידרופילי 23/10/2006 ANTIBODIES WITH ENHANCED ANTIBODY-DEPENDENT CELLULAR CYTOXICITY ACTIVITY, METHODS OF THEIR PRODUCTION AND USE GTC BIOTHERAPEUTICS, INC. US 60/729054 21/10/2005 PCT/US/2006/041656 WO/2007/048077 191095 C07K נוגדנים עם פעילות ציטוטקסית תאית תלוית נוגדן מוגברת, שיטות להפקתם ולשימוש בהם 2533

27/10/2006 RESOURCE ALLOCATION FOR SHARED SIGNALING CHANNELS IN OFDM QUALCOMM INCORPORATED US 11/261158 27/10/2005 US 11/370640 07/03/2006 PCT/US/2006/060332 WO/2007/051186 191096 H04Q אמצעי מינון לערוצי שידור משותפים ב OFDM 26/10/2006 A METHOD AND APPARATUS FOR PRE-CODING FREQUENCY DIVISION DUPLEXING SYSTEM QUALCOMM INCORPORATED US 11/261064 27/10/2005 PCT/US/2006/060286 WO/2007/051154 191097 H04B שיטה והתקן עבור מערכת כפולת תדר קדם קידודי 27/10/2006 SEAMLESS INTER-FREQUENCY HANDOFF IN WIRELESS COMMUNICATION NETWORKS QUALCOMM INCORPORATED US 11/261804 27/10/2005 PCT/US/2006/060331 WO/2007/051185 191098 H04Q מעבר בין תדרי בין רשתות תקשורת אלחוטיות ללא תפר 2534

20/10/2006 VIDEO ERROR CONTROL BASED ON REVERSE LINK INFORMATION QUALCOMM INCORPORATED US 60/729017 21/10/2005 US 11/315399 21/12/2005 US 11/454475 15/06/2006 PCT/US/2006/060141 WO/2007/048138 191099 H04N בקרת שגיאת וידאו מבוססת על קישור מידע מהופך 27/10/2006 PRECODING FOR SEGMENT SENSITIVE SCHEDULING IN WIRELESS COMMUNICATION SYSTEMS QUALCOMM INCORPORATED US 60/731558 27/10/2005 PCT/US/2006/042058 WO/2007/050924 191100 H04L קידוד מקדים למקטע רגיש לתזמון ברשתות תקשורת אלחוטיות 26/10/2006 PILOT SYMBOL TRANSMISSION IN WIRELESS COMMUNICATION SYSTEMS QUALCOMM INCORPORATED US 60/731111 27/10/2005 US 11/511735 28/08/2006 PCT/US/2006/060287 WO/2007/051155 191101 H04J שידור סמל ניסיוני במערכות תקשורת אלחוטיות 2535

20/10/2006 POINTER COMPUTATION METHOD AND SYSTEM FOR A SCALABLE, PROGRAMMABLE CIRCULAR BUFFER QUALCOMM INCORPORATED US 11/255434 20/10/2005 PCT/US/2006/060133 WO/2007/048133 191102 G06F שיטה לחישוב מחוון ומערכת למקום לאכסון זמני בזיכרון מדיד, בר תכנות מעגלי 20/10/2006 METHOD AND SYSTEM FOR ADAPTIVE ENCODING OF REAL- TIME INFORMATION IN WIRELESS NETWORKS QUALCOMM INCORPORATED US 60/729017 21/10/2005 US 11/315399 21/12/2005 PCT/US/2006/060139 WO/2007/073508 191103 H04N שיטה ומערכת לקידוד מתואם לאנפורמצייה בזמן אמת ברשתות אלחוטיות 20/10/2006 BACKGROUND THREAD PROCESSING IN A MULTITHREAD DIGITAL SIGNAL PROCESSOR QUALCOMM INCORPORATED US 11/256350 20/10/2005 PCT/US/2006/060132 WO/2007/048132 191105 G06F עיבוד ביצוע ברקע מעבד אות דיגיטלי רב ביצועים בהליך 2536

10/11/2006 METHOD FOR DIAGNOSTICATING HEPATIC DISEASES AND FOR SCREENING MOLECULES FOR TREATING SAID DISEASES SANOFI-AVENTIS FR 0511432 10/11/2005 PCT/FR/2006/002503 WO/2007/057548 191106 G01N שיטה לאבחון של מחלות כבד ולסריקה של מולקולות לטיפול במחלות אלה 27/10/2006 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED 2005- JP 28/10/2005 315267 PCT/JP/2006/322043 WO/2007/049820 191108 C07D תרכובת אמיד הטרוציקלית ושימושיה 09/11/2006 DECREASING OR PREVENTING SUB- SURFACE GEOLOGICAL MATTER CONTAMINATION BY AGROCHEMICALS YEDA RESEARCH AND DEVELOPMENT CO. LTD US 60/735167 10/11/2005 US 60/750333 15/12/2005 PCT/IL/2006/001293 WO/2007/054937 191109 A01N הפחתת או מניעת זיהום של אגרוכימיקלים בחומר גיאולוגי תת קרקעי ידע חברה למחקר ופיתוח בע"מ 2537

25/10/2005 CHESS PLAYING METHOD AND DEVICE FOR CARRYING OUT SAID METHOD VYACHESLAV ALEKSANDROVICH FETISOV 191111 A63F שיטה למשחק בשח ומכשיר לביצועה PCT/RU/2005/000521 WO/2007/049985 31/10/2006 METHODS FOR CHLORINATING SUCROSE-6-ESTER HEALTHY BRANDS, LLC US 60/732421 31/10/2005 US 11/554398 30/10/2006 PCT/US/2006/042448 WO/2007/053604 191112 C08K שיטות להפיכה לכלור של סוקרוז 6 אסטר 04/01/2007 TREATMENT OF STRESSED PATIENTS NESTEC S.A. US 60/757835 09/01/2006 PCT/EP/2007/050098 WO/2007/080149 191113 A23L טיפול בחולים תחת לחץ 27/09/2006 APPLIANCE FOR LOWERING AND TRACKING AN UNDERWATER VESSEL ATLAS ELEKTRONIK GMBH DE 102005058475.6 07/12/2005 PCT/EP/2006/009371 WO/2007/065495 191114 B63G מכשיר להורדה ועקיבה אחרי כלי שייט תת ימי 2538

10/11/2005 DEVICE FOR DETERMINING THE GLUCOSE LEVEL IN BODY TISSUE SOLIANIS HOLDING AG PCT/CH/2005/000666 WO/2007/053963 191177 A61B מכשיר לקביעת רמת הסוכר ברקמת גוף 03/11/2006 A CONCENTRATE DERIVED FROM A MILK PRODUCT ENRICHED IN NATURALLY OCCURRING SIALYLLACTOSE AND PROCESS FOR PREPARATION THEREOF ARLA FOODS AMBA US 60/733204 04/11/2005 PCT/DK/2006/000607 WO/2007/051475 191179 A23C תרכיז הנגזר ממוצר חלבי המועשר בסיאליללקטוז טבעי ותהליך להכנתו 02/11/2006 EXTRACTING DEVICE FOR SURGICAL FASTENERS ENDOGUN MEDICAL SYSTEMS LTD. US 60/732101 02/11/2005 PCT/IL/2006/001273 WO/2007/052276 191180 A61B התקן שליפה עבור מהדקים כירורגיים אנדוגן מערכות רפואיות בע"מ 20/07/2006 MOVABLE PULLEY HEADS FOR A LATERAL SPREADER MOVEMENT MAERSK ESPANA S.A. ES P200502752 03/11/2005 PCT/ES/2006/000422 WO/2007/051874 191181 B66C ראשי גלגלת ניידים עבור תנועה צדדית של מפזר 2539

19/12/2006 USE OF CO-GRINDING AGENTS IN A METHOD FOR PRODUCING NATURAL CALCIUM CARBONATES, OBTAINED CO-GROUND PRECIPITATIONS, SUSPENSIONS AND DRY PIGMENTS AND THE USE THEREOF COATEX S.A.S. FR 0513504 30/12/2005 PCT/IB/2006/003806 WO/2007/077484 191182 C09C שיטה לשימוש בגורמי עזר טחינה בשיטה ליצור קלציום קרבונאט טבעי המתקבל ממשקעים שעברו טחינת עזר, סוספנסיות ופיגמנטים ושימוש בהם 02/06/2006 WIPER FOR USE WITH DISINFECTANTS KIMBERLY-CLARK WORLDWIDE, INC. US 11/300751 15/12/2005 PCT/US/2006/021362 WO/2007/070090 191183 C11D מגב לשימוש עם מחטאים 28/11/2006 PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN LABELED ORGANIC COMPOUND NIHON MEDI-PHYSICS CO., LTD. 2005- JP 29/11/2005 343653 PCT/JP/2006/323659 WO/2007/063824 191184 C07C תרכובת פרקרסורית של תרכובת אורגנית המתוייגת עם הלוגן רדיואקטיבי 2540

08/12/2006 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL INTERMEDIATE EGIS GYOGYSZERGYAR Nyilvanosan Mukodo Reszvenytarsasag HU P0501138 08/12/2005 PCT/HU/2006/000108 WO/2007/066162 191185 C07D תהליך להכנת חומר ביניים רוקחי 08/12/2006 OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES EGIS GYOGYSZERGYAR Nyilvanosan Mukodo Reszvenytarsasag HU P0501139 08/12/2005 PCT/HU/2006/000109 WO/2007/066163 191186 C07D קרבאמאטים פעילים אופטית, תהליך להכנתם ושימוש בהם כחומר ביניים רוקחי 02/11/2006 REINFORCEMENT FOR CONCRETE ELEMENTS AND SYSTEM AND METHOD FOR PRODUCING REINFORCED CONCRETE ELEMENTS BBA BLACKBULL AS NO 20055188 04/11/2005 PCT/NO/2006/000395 WO/2007/053038 191187 E04C חיזוק לאלמנטים מביטון ומערכת ושיטה ליצור אלמנטים מביטון מחוזקים 2541

13/11/2006 INDOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME PHARMA MAR, S.A. GB 0523098.2 14/11/2005 PCT/GB/2006/050386 WO/2007/054748 191189 C07D תולדות אינדול ותכשירי רוקחות המכילים אותן 02/11/2006 sirna MOLECULES AND USE THEREOF TO PREPARE PHARMACEUTICAL COMPOSITIONS PROTIVA BIOTHERAPEUTICS, INC. US 60/732964 02/11/2005 US 60/817933 30/06/2006 PCT/CA/2006/001801 WO/2007/051303 191192 C07H מולקולות sirna ושימוש בהן להכנת תכשירי רוקחות 03/11/2006 QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME PORTOLA PHARMACEUTICALS, INC. US 60/733650 03/11/2005 PCT/US/2006/043093 WO/2007/056219 191193 C07D תולדות קווינאזולין ותכשירי רוקחות במכילים אותן 2542

03/11/2005 METHOD OF SOLIDIFYING SUGAR SOLUTIONS OBTAINED FROM GRAPES AND FROM MUST APPLIED PROCESSES, CONCENTRATED RECTIFIED MUST, CONCENTRATED RECTIFIED JUICE AND TRANSFORMATION PRODUCTS OF VEGETABLE ORIGIN AND THEIR DERIVATIVES PIRRONE, LUIGI PCT/IT/2005/000639 WO/2007/052314 191195 C12G שיטה לגיבוש תמיסות סוכר המתקבלות מתהליכי הפקת מיצים מענבים, מיץ פירות מרוכז ומזוקק וטרנספורמציה של מוצרים ממקור צמחי ונגזרותיהם 20/11/2006 PYRIDO-,PYRAZO-AND PYRIMIDO- PYRIMIDINE DERIVATIVES AS mtor INHIBITORS KUDOS PHARMACEUTICALS LIMITED US 60/738902 22/11/2005 GB 0524047.8 25/11/2005 US 60/823308 23/08/2006 US 60/823309 23/08/2006 PCT/GB/2006/004327 WO/2007/060404 191196 C07D נגזרות פירידו,פיראזו ופירימידו פירימידין כמעכבי mtor 02/11/2006 HUMAN GROWTH HORMONE PATCH FORMULATIONS TRANSPHARMA MEDICAL LTD. US 60/733005 02/11/2005 US 60/739288 22/11/2005 PCT/US/2006/042894 WO/2007/056105 191197 A61K פורמולציות לרטיות של הורמון גדילה של אדם טרנספארמה מדיקל בע"מ 2543

01/11/2006 COMPOSITIONS AND METHODS FOR CELL KILLING SURE INTERNATIONAL VENTURES B.V. US 60/732130 02/11/2005 PCT/IL/2006/001263 WO/2007/052270 191198 A01N הרכבים ושיטה להריגת תאים שור אינטרנשיונל ונטשר 23/10/2006 CATION-EXCHANGE DISPLACEMENT CHROMATOGRAPHY PROCESS AND CATIONIC ORGANIC COMPOUNDS FOR USE AS DISPLACER COMPOUNDS IN CATION- EXCHANGE DISPLACEMENT CHROMATOGRAPHY PROCESS SACHEM INC. US 11/267823 04/11/2005 PCT/US/2006/041328 WO/2007/055896 191200 G01N שיטה לכרומטוגרפיה באמצעות חומרים אורגניים קטיוניים 08/11/2006 PROCESS FOR PREPARATION OF (3R,5R)-7-[2-(4-FLUOROPHENYL)-5- ISOPROPYL-3-PHENYL-4-[(4-HYDROXY METHYL PHENYL AMINO)CARBONYL]-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID HEMI CALCIUM SALT RANBAXY LABORATORIES LIMITED IN 2964/DEL/2005 08/11/2005 IN DEL/2005/2967 08/11/2005 IN DEL/2005/3033 14/11/2005 PCT/IB/2006/003153 WO/2007/054790 191201 C07D תהליך להכנת מלח המי קלציום של ( R3 R5) 7 [2 (4 פלואורופניל) 5 איזופרופיל 3 פניל 4)] 4 הידרוקסי מתיל פניל אמינו) קרבוניל] פירול 1 איל] 3, 5 דיהידרוקסי חומצה הפטונאית 2544

07/11/2006 PROCESS FOR (3R,5R)-7-[2-(4- FLUOROPHENYL)-5-ISOPROPYL-3- PHENYL-4-[(4-HYDROXY METHYL PHENYL AMINO) CARBONYL]- PYRROL-1-YL]-3,5-DIHYDROXY- HEPTANOIC ACID HEMI CALCIUM SALT RANBAXY LABORATORIES LIMITED IN 2964/DEL/2005 08/11/2005 IN DEL/2005/2967 08/11/2005 IN DEL/2005/3033 14/11/2005 PCT/IB/2006/054154 WO/2007/054896 191202 C07D תהליך לייצור מלח המי קלציום של ( R3,R5) 7 [2 (4 פלואורופניל) 5 איזופרופיל 3 פניל 4)] 4 הידרוקסי מתיל פניל אמינו) קרבוניל] פירול 1 איל] 3, 5 דיהידרוקסי חומצה הפטנואית 07/11/2006 COMBINATION GRIP FOR AN EXERCISE DEVICE FITNESS ANYWHERE, INC US 60/734145 07/11/2005 US 11/557050 06/11/2006 PCT/US/2006/060596 WO/2007/079281 191205 A63B ידית משולבת למתקן התעלמות 13/11/2006 ANTI-PROLIFERATIVE COMBINATION THERAPY COMPRISING A PLATINUM-BASED CHEMOTHERAPEUTIC AGENT AND EGFR INHIBITORS OR PYRIMIDINE ANALOGUES GPC BIOTECH AG EP 05024701.4 11/11/2005 PCT/EP/2006/068381 WO/2007/054573 191206 A61K טיפול משולב נוגד פרוליפירציה הכולל תכשיר כימותרפי מבוסס פלטינה ומעכבי EGFR או אנלוגים פירימידינים 2545

23/11/2006 F,G,H,I AND K CRYSTAL FORMS OF IMATINIB MESYLATE NOVARTIS AG GB 0524061.9 25/11/2005 GB 0524062.7 25/11/2005 US 60/740016 28/11/2005 US 60/740017 28/11/2005 US 60/740018 28/11/2005 PCT/EP/2006/011240 WO/2007/059963 191207 של אימאטיניב C07D צורות גביש F,G,H,I ו K מזילאט 08/11/2006 AZAINDOLE-2-CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG EP 05110949.4 18/11/2005 PCT/EP/2006/068206 WO/2007/057329 191209 C07D תולדות אזאינדול 2 קרבוקסאמיד 03/11/2006 CONTINUOUSLY SEALING ONE WAY VALVE ASSEMBLY AND FLUID DELIVERY SYSTEM FORMULATIONS FOR USE THEREIN RESEAL INTERNATIONAL LIMITED PARTNERSHIP US 11/267868 03/11/2005 US 60/823462 24/08/2006 PCT/US/2006/042940 WO/2007/056131 191210 B65D הרכבת שסתום חד כיוונית רצופת איטום ומערכת לחלוקת פורמולת נוזל לשימוש בהן 2546

03/11/2006 ONE WAY VALVE ASSEMBLY RESEAL INTERNATIONAL LIMITED PARTNERSHIP US 11/267868 03/11/2005 US 60/783451 17/03/2006 US 60/783569 17/03/2006 US 60/840377 24/08/2006 PCT/US/2006/043113 WO/2007/056233 191211 B65D הרכבת שסתום חד כיוונית 24/10/2006 ONE WAY VALVE ASSEMBLY RESEAL INTERNATIONAL LIMITED PARTNERSHIP US 11/267868 03/11/2005 PCT/US/2006/041840 WO/2007/055922 191212 B65D הרכבת שסתום חד כיוונית 21/11/2006 SUBSTITUTED BICYCLIC PYRIMIDONE DERIVATIVES SANOFI-AVENTIS EP 05292457.8 21/11/2005 PCT/IB/2006/004046 WO/2007/057790 191213 C07D נגזרות מותמרות ביציקליות של פירימידון 2547

22/11/2006 ISOQUINOLINE AND BENZO[H]ISOQUINOLINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF AS ANTAGONISTS OF HISTAMINE H3 RECEPTOR SANOFI-AVENTIS EP 05111248.0 24/11/2005 PCT/EP/2006/012246 WO/2007/060027 191214 C07D נגזרות של איזוקוינולין ובנזו( H )איזוקוינולין, הכנה ושימוש רפואי שלהם כאנטגוניסטים של רצפטור H3 היסטמין 17/11/2006 INHIBITORS OF DIACYGLYCEROL ACYLTRANSFERASE (DGAT) F. HOFFMANN-LA ROCHE AG US 60/740578 28/11/2005 US 60/849352 04/10/2006 PCT/EP/2006/068611 WO/2007/060140 191215 C07D מעכבים של דיאצילגליצרול אצילטרנספראז (DGAT) 03/11/2006 FABRIC SUPPORT FRAME SECTION NEWMAT S.A. FR 0511199 03/11/2005 PCT/FR/2006/002453 WO/2007/051927 191216 E04B מקטע מסגרת לתמיכה בבד 05/12/2006 ANTI-IL -17 ANTIBODIES ELI LILLY AND COMPANY US 60/749953 13/12/2005 US 60/801948 19/05/2006 PCT/US/2006/061586 WO/2007/070750 191217 C07K נוגדנים כנגד IL 17 2548

14/11/2006 BIOMARKERS FOR ANTI-NOGO-A ANTIBODY TREATMENT IN SPINAL CORD INJURY UNIVERSITY OF ZURICH US 60/737410 16/11/2005 PCT/EP/2006/068457 WO/2007/057395 191218 G01N סמנים ביולוגיים לטיפול עם נוגדן כנגד A NOGO בפגיעות בחוט השידרה 27/10/2006 MORPHOLINE TYPE CINNAMIDE COMPOUND EISAI R&D MANAGEMENT CO., LTD. 2005- JP 24/11/2005 337952 JP 2006-205591 28/07/2006 PCT/JP/2006/321473 WO/2007/060810 191219 C07D תרכובת סינאמיד מסוג מורפולין 20/11/2006 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA ASTRAZENECA AB US 60/738650 21/11/2005 US 60/815746 22/06/2006 PCT/SE/2006/001317 WO/2007/058602 191220 C07D תרכובות חדשות של 2 אמינו אימידאזול 4 און ושימושן בייצור תרופה לשימוש בטיפול בליקוי קוגניטיבי, מחלת אלצהיימר, נוירודגנרציה ודימנציה 2549

01/11/2006 BIODEGRABLE COMPOSITE FOR INTERNAL LOCAL RADIOTHERAPY YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM US 60/731872 01/11/2005 PCT/IL/2006/001259 WO/2007/052267 191221 A61K תכשיר מתכלה לרדיוטרפיה יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים 03/11/2006 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. US 60/734030 04/11/2005 US 60/747174 12/05/2006 US 60/823344 23/08/2006 PCT/US/2006/043108 WO/2007/056228 191222 C07K מעכבי חלבון משפעל 5 ליפוקסיגנאז (FLAP) 03/11/2006 MANDREL USED FOR DIGITAL PRINTING ON CAN MEMBERS BALL PACKAGING EUROPE HOLDING GMBH & CO. KG EP 05110323.2 03/11/2005 PCT/EP/2006/068090 WO/2007/051848 191223 B41F סרן המשמש להדפסה דיגיטלית על גבי פחיות 2550

13/11/2006 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. US 60/736564 14/11/2005 US 60/845291 18/09/2006 US 60/845331 18/09/2006 PCT/US/2006/043920 WO/2007/070201 191224 C07D מעכבי אספרטיק פרוטאז 02/11/2006 191225 FLEXIBLE MULTICAST AND/OR BROADCAST LISTENING INTERVALS NOKIA CORPORATION US 60/733739 04/11/2005 PCT/IB/2006/003093 WO/2007/052137 G06F מרווחי האזנה גמישים להעברת מידע לנמענים רבים ו/או שידור 02/11/2006 MECHANISM FOR MULTICAST AND/OR BRODCAST ACKNOWLEDGEMENTS NOKIA CORPORATION US 60/733998 04/11/2005 PCT/IB/2006/003105 WO/2007/052143 191226 H04L מנגנון אישור העברת מידע לנמענים רבים ו/או שידור 2551

02/11/2006 LIQUID CONCENTRATE/EXTRACT BEVERAGE DISPENSER WITH REPLACEABLE CONCENTRATE/EXTRACT CARTRIDGE INTELLIGENT COFFEE COMPANY. L.L.C. US 11/266695 03/11/2005 US 60/794777 25/04/2006 US 60/845310 18/09/2006 PCT/US/2006/042878 WO/2007/056097 191227 B65D מנפק תרכיז/תמצית משקה נוזליים עם מיכל תרכיז/ תמצית הניתן להחלפה 27/10/2006 REAGENTS, METHODS AND SYSTEMS FOR SELECTING A CYTOTOXIC ANTIBODY OR VARIANT THEREOF THE ROCKEFELLER UNIVERSITY US 60/734196 07/11/2005 PCT/US/2006/041791 WO/2007/055916 191228 A61K מגיבים, שיטות ומערכות לברירת נוגדן ציטוטוקסי או וריאנט שלו 24/10/2006 METHOD AND APPARATUS OF EXCHANGING MESSAGES VIA A WIRELESS DISTRIBUTION SYSTEM BETWEEN GROUPS OPERATING IN DIFFERENT FREQUENCIES INTERDIGITAL TECHNOLOGY CORPORATION US 60/733292 03/11/2005 US 11/537161 29/09/2006 PCT/US/2006/041365 WO/2007/055898 191229 H04L שיטה ומערכת להחלפת הודעות באמצעות מערכת הפצה אלחוטית בין קבוצות הפועלות בתדירויות שונות 2552

08/12/2006 A BETA 1-42 SPECIFIC MONOCLONAL ANTIBODIES WITH THERAPEUTIC PROPERTIES AC IMMUNE S.A. EP 05027092.5 12/12/2005 EP 06014729.5 14/07/2006 EP 06020766.9 02/10/2006 PCT/EP/2006/011862 WO/2007/068412 191230 A61K נוגדנים חד שבטיים בררניים לבטא 42 1 בעלי תכונות רפואיות 10/11/2006 METHOD AND APPARATUS FOR COMPUTER MODELING THE HUMAN BRAIN FOR PREDICTING DRUG EFFECTS IN SILICO BIOSCIENCES, INC. US 60/735618 10/11/2005 PCT/US/2006/043887 WO/2007/094830 191233 G06F שיטה והתקן להדמיית המוח של בן אדם באמצעות מחשב עבור חיזוי ההשפעה של סמים 13/11/2006 QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME VERTEX PHARMACEUTICALS INCORPORATED US 60/737330 14/11/2005 PCT/US/2006/043895 WO/2007/058989 191234 C07D תולדות קווינאזולין ותכשירי רוקחות המכילים אותן 2553

01/11/2006 191235 METHOD AND SYSTEM FOR PERFORMING PEER-TO-PEER COMMUNICATION BETWEEN STATIONS WITHIN A BASIC SERVICE SET INTERDIGITAL TECHNOLOGY CORPORATION US 60/733217 03/11/2005 PCT/US/2006/042594 WO/2007/055993 H04L שיטה ומערכת לביצוע תקשורת PEER TO PEER בין תחנות בתוך מערכת שרות בסיסית 30/10/2006 METHOD AND SYSTEM FOR AUTONOMOUS CHANNEL COORDINATION FOR A WIRELESS DISTRIBUTION SYSTEM INTERDIGITAL TECHNOLOGY CORPORATION US 60/732779 02/11/2005 PCT/US/2006/042597 WO/2007/055994 191236 H04L שיטה ומערכת עבור קואורדינצית ערוץ אוטונומי עבור מערכת הפצה אלחוטית 21/11/2006 SKIN REPAIR ACCELERATING THERAPEUTIC AGENT CONTAINING DESACYL GHERLIN AND DERIVATIVES THEREOF AS ACTIVE AGENTS UNIVERSITY OF MIYAZAKI 2005- JP 21/11/2005 336420 PCT/JP/2006/323231 WO/2007/058360 191238 A61K חומר תרפויטי לזירוז שיקום העור המכיל דסאציל גהרלין ונגזרות שלו כחומרים פעילים 2554

21/11/2006 191239 A61K חומר תרפויטי לזירוז שיקום העור המכיל גהרלין ונגזרות שלו או חומר הפועל על RLa GHS כמרכיב פעיל 03/11/2006 SEMI-AUTOMATIC MULTIPLEXING SYSTEM FOR AUTOMATED SEMICONDUCTOR WAFER TESTING QUALITAU, INC. US 11/270371 08/11/2005 PCT/US/2006/043148 WO/2007/056257 191240 G01R מערכת ריבוב חצי אוטומאטית עבור בדיקה אוטומאטית של שבבים מוליכים למחצה 30/10/2006 SKIN REPAIR ACCELERATING THERAPEUTIC AGENT CONTAINING GHRELIN AND DERIVATIVES THEREOF OR SUBSTANCE ACTING ON GHS-RLa AS ACTIVE INGREDIENT UNIVERSITY OF MIYAZAKI 2005- JP 21/11/2005 336418 PCT/JP/2006/323226 WO/2007/058359 INDEXABLE INSERT SUMITOMO ELECTRIC HARDMETAL CORP. 2005- JP 21/11/2005 336125 PCT/JP/2006/321645 WO/2007/058065 191241 B23B שימת הניתן לסימון 2555

07/11/2006 AEROSOL FORMULATION FOR INHALATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH EP 05110552.6 09/11/2005 PCT/EP/2006/068191 WO/2007/054498 191244 A61K פורמולציה בצורת תרסיס עבור אינהלציה 09/11/2005 IDENTIFICATION AND CHARACTERIZATION OF FUNCTION- BLOCKING ANTI-ED-B- FIBRONECTIN ANTIBODIES MORPHOSYS AG 191246 C12N זיהוי ואפיון של נוגדנים אנטי ED B פיברונקטין בעלי פונקציה חוסמת PCT/EP/2005/012185 WO/2007/054120 06/11/2006 IMAGING SYSTEM AND METHOD FOR A STENCIL PRINTER SPEEDLINE TECHNOLOGIES, INC. US 11/272192 10/11/2005 PCT/US/2006/043166 WO/2007/056268 191247 H05K מערכת הדמיה ושיטה למדפסת סטנסיל 06/11/2006 SOL-GEL PROCESS FOR THE MANUFACTURE OF MOULDS FOR PHOTOCATALYTIC PROCESSES P.C.R S.r.l OF IT 2005A002333 06/12/2005 PCT/EP/2006/068139 WO/2007/065766 191248 B29C תהליך סול ג'ל ליצור תבניות לתהליכים פוטוקטליטים 2556

15/11/2006 INDANYL-AND TETRAHYDRONAPHTHYL-AMINO- AZOLINE COMPOUNDS FOR COMBATING ANIMAL PESTS BASF SE US 60/739730 25/11/2005 PCT/EP/2006/068482 WO/2007/060121 191249 C07D תרכובות אינדאניל וטטרהידרונפתיל אמינו אזולין לטיפול במטרדי חיות 16/11/2006 SHAPED BODIES BASED ON A CROSS- LINKED GELATINOUS MATERIAL, METHOD FOR PRODUCING THE SAME AND THEIR USE GELITA AG DE 102005054938.1 17/11/2005 PCT/EP/2006/010973 WO/2007/057176 191252 A61L גופים מעוצבים המבוססים על חומר גלטיני מוצלב, שיטה לייצורם ושימושיהם 06/11/2006 RECOMBINANT EXPRESSION OF MULTIPROTEIN COMPLEXES USING POLYGENES ETH ZURICH EP 05024271.8 08/11/2005 PCT/EP/2006/010608 WO/2007/054250 191253 C12N ביטוי רקומביננטי של קומפלקסים רבי חלבון תוך שימוש בפוליגנים 20/11/2006 3-AMINO-2-ARYLPROPYL AZAINDOLES AND USES THEREOF F. HOFFMANN-LA ROCHE AG US 60/741272 30/11/2005 PCT/EP/2006/068650 WO/2007/062998 191254 C07D 3 אמינו 2 ארילפרופיל אזאינדולים ושימושיהם 2557

29/11/2006 2-PHENYLETHYLAMINO DERIVATIVES AS CALCIUM AND/OR SODIUM CHANNEL MODULATORS NEWRON PHARMACEUTICALS S.P.A. EP 05028147.6 22/12/2005 PCT/EP/2006/011443 WO/2007/071311 191255 C07D תולדות 2 פנילאתילאמינו כמאפננים של תעלת סידן ו/או נתרן 09/11/2006 EPOXY BASED COATINGS SIGMAKALON B.V. EP 05024529.9 10/11/2005 PCT/EP/2006/010748 WO/2007/054304 191259 C09D ציפויים מבוססי אפוקסי 08/11/2006 USE OF PYRROLOQUINOLINE COMPOUNDS TO KILL CLINICALLY LATENT MICROORGANISMS HELPERBY THERAPEUTICS LIMITED GB 0522715.2 08/11/2005 PCT/GB/2006/004178 WO/2007/054693 191260 C07D שימוש בתרכובות פירולוקווינולין להריגת מיקרואורגניזמים רדומים מבחינה קלינית 19/12/2005 191261 GLOVE WITH HAND-FRIENDLY COATING AND METHOD OF MAKING ANSELL HEALTHCARE PRODUCTS LLC US 11/291227 01/12/2005 PCT/US/2005/046014 WO/2007/064343 A41D כפפה עם ציפוי ידידותי ליד ושיטה להכנה 2558

23/11/2006 SPIROCYCLIC QUINAZOLINE DERIVATIVES AS PDE7 INHIBITORS PFIZER LIMITED US 60/741854 02/12/2005 US 60/791186 10/04/2006 PCT/IB/2006/003388 WO/2007/063391 191262 C07D נגזרות של קווינאזולין ספירוציקלי כמעכבי PDE7 07/12/2006 CTLA-4 ANTIBODY DOSAGE ESCALATION REGIMENS MEDAREX, INC. US 60/748688 07/12/2005 PCT/US/2006/061753 WO/2007/067959 191263 A61K משטרי הגברת מינון של נוגדן כנגד 4 CTLA 17/11/2006 ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES GLENMARK PHARMACEUTICALS S.A. US 60/738303 18/11/2005 PCT/CA/2006/001876 WO/2007/056858 191264 C12N נוגדנים כנגד אינטגרין אלפא 2 ושימושיהם 15/11/2005 DIGITAL VIDEO ZOOMING SYSTEM NDS LIMITED 191265 H04N מערכת זום לוידיאו דיגיטאלי PCT/IL/2005/001205 WO/2007/057875 2559

11/12/2006 ESTROGEN MODULATORS PFIZER PRODUCTS INC. US 60/752780 22/12/2005 US 60/805233 20/06/2006 PCT/IB/2006/003671 WO/2007/072164 191266 C07D מודולטורים של אסטרוגן 13/11/2006 191267 HEPATITIS C VIRUS POLYNUCLEOTIDES, VARIENTS AND PROTEASES VERTEX PHARMACEUTICALS INCORPORATED US 60/735577 11/11/2005 US 60/854598 25/10/2006 PCT/US/2006/044363 WO/2007/059221 C07K פולינוקלאוטידים, וריאנטים ופרוטאזים של נגיף הפאטיטוס C 03/11/2006 PROCESS FOR THE PREPARATION OF LIVER CELLS FOR CRYOPRESERVATION CYTONET GMBH &CO. KG DE 102005057106.9 25/11/2005 PCT/EP/2006/010549 WO/2007/059855 191268 A01N שיטה להכנת תאי כבד לשמירה על ידי הקפאה 29/11/2006 THERAPEUTIC USES OF A3 ADENOSINE RECEPTOR ANTIBODIES CAN-FITE BIOPHARMA LTD. US 60/740630 30/11/2005 PCT/IL/2006/001375 WO/2007/063539 191270 A61K שימושים טיפוליים של נוגדנים של קולטן אדנוסין A3 כן-פייט ביופארמה בע"מ 2560

21/11/2006 IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS WYETH US 60/739271 22/11/2005 PCT/US/2006/045059 WO/2007/062040 191272 A61K הרכבים של חלבון אימונוגלובולין מאוחה 08/11/2006 METHOD AND SYSTEM FOR MEDIA INDEPENDENT HANDOVER USING OPERATION, ADMINISTRATION AND MAINTENANCE PROTOCOL INTERDIGITAL TECHNOLOGY CORPORATION US 60/735275 10/11/2005 PCT/US/2006/043723 WO/2007/058916 191274 H04Q שיטה ומערכת להעברה בלתי תלויה של מדיה באמצעות שימוש בפרוטוקול הפעלה, אדמיניסטרציה ותחזוקה 31/10/2006 METHODS FOR PRODUCTION OF RECEPTOR AND LIGAND ISOFORMS RECEPTOR BIOLOGIX, INC. US 60/736134 10/11/2005 PCT/US/2006/042680 WO/2007/064437 191275 C07K שיטות ליצור קולטן וליגנד שווי צורות 28/11/2006 PROCESS FOR THE PREPARATION OF FERRI-SUCCINYLCASEIN VIFOR (INTERNATIONAL) AG. EP 05111733.1 06/12/2005 PCT/EP/2006/068994 WO/2007/065812 191276 C07K תהליך להכנת פרי סוקסיניל קזאין 2561

24/10/2006 COMPOSITIONS AND METHODS OF VASCULAR INJURY REPAIR AMORCYTE, INC. US 60/734151 07/11/2005 PCT/US/2006/041536 WO/2007/055905 191277 C12N תכשירים ושיטות לטיפול בפציעה וסקולרית 07/11/2006 COMBINATION OF GLYCOISOFORMS FOR THE TREATMENT OR PREVENTION OF SEPTICEMIA, TRANSGENIC CELL LINE THAT PRODUCES ERYTHROPOIETIN GLYCOISOFORMS, PHARMACEUTICAL COMPOSITION COMPRISING SAID COMBINATION PROTECH PHARMA, S.A. AR P050104712 10/11/2005 PCT/ES/2006/070171 WO/2007/054600 191279 C07K שילוב של גליקואיזופורמים לטיפול או מניעה של הרעלת דם, תאים טרנסגנים שמייצרים גליקואיזופורמים של אריתרופואיטין, תכשיר רפואי המשלב את הקומבינציה האמורה לעיל 23/10/2006 BROMINATED BUTADIENE/VINYL AROMATIC COPOLYMERS, BLENDS OF SUCH COPOLYMERS WITH A VINYL AROMATIC POLYMER, AND POLYMERIC FOAMS FORMED FROM SUCH BLENDS DOW GLOBAL TECHNOLOGIES INC. US 60/735361 12/11/2005 PCT/US/2006/041295 WO/2007/058736 191282 C08F קופולימרים ארומטיים של בוטאדיאן/ויניל מותמרים בברום, תערובות של קופולימרים כאלה עם פולימר ויניל ארומטי, וקצפים שנוצרו מתערובות אלו 2562

08/11/2006 METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS COMBINATORX, INC. US 60/735989 09/11/2005 PCT/US/2006/043493 WO/2007/056457 191283 A61K שיטות, הרכבים וערכות לטיפול במצבים רפואיים 03/11/2006 PROCESS FOR ELIMINATING HYDROGEN SULPHIDE AND ODOURS FROM WASTEWATER SYSTEMS ROMOLD GMBH DE 102005053300.0 09/11/2005 PCT/EP/2006/010544 WO/2007/054236 191284 B01D תהליך לסילוק מימן גפריתי וצחנה ממערכות מי שפכים 02/11/2006 PROCESS FOR THE PRODUCTION OF OLIGOSACCHARIDES CLASADO INC. GB 0522740.4 08/11/2005 PCT/EP/2006/068029 WO/2007/054459 191285 C12P תהליך לייצור אוליגוסכרידים 15/11/2006 METHODS FOR ISOLATING PROPARGYLATED AMINOINDANS TEVA PHARMACEUTICAL INDUSTRIES LTD. US 60/738163 17/11/2005 PCT/US/2006/044327 WO/2007/061717 191288 C07C דרכים לבודד פרופארג'יל אמינואינדאנים טבע תעשיות פרמצבטיות בע"מ 2563

13/11/2006 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS BOARD SUPERVISORS OF LOUISIANA STATE UNIVERSITY & AGRICULTURAL & MECHANICAL COLLEGE US 60/735507 10/11/2005 US 60/764727 02/02/2006 PCT/US/2006/044126 WO/2007/056618 191289 A61K הרכבים ושיטות לטיפול בהתמכרות והפרעות נאורופסיכיאטריות אחרות 07/11/2006 IMAGE ENHANCEMENT IN THE MOSAIC DOMAIN D-BLUR TECHNOLOGIES LTD. US 60/735520 10/11/2005 PCT/IL/2006/001284 WO/2007/054931 191290 G06T שיפור תמונה בתחום המוזאיקה ד-בלור טכנולוגיות בע"מ 05/05/2006 BOLT-A-BLOK-A SYSTEM FOR UNITIZED, POST-TENSIONED MASONRY STRUCTURES ROGER F. MARSH US 11/271703 10/11/2005 PCT/US/2006/017364 WO/2007/061443 191292 E04C BLOK A BOLT מערכת ליצירת מבנים מלוחות בנייה מאוחדים לאחר שחרור מאמצים 2564

10/11/2006 AZA-SUBSTITUTED SPIRO DERIVATIVE BANYU PHARMACEUTICAL CO. LTD 2005- JP 10/11/2005 325808 JP 2006-060814 07/03/2006 PCT/JP/2006/322911 WO/2007/055418 191295 C07D נגזרת ספיראלית המותמרת בקבוצת AZA 21/11/2006 4-OXADIAZOLYL-PIPERIDINE COMPOUNDS AND USE THEREOF PURDUE PHARMA L.P. US 60/739107 21/11/2005 PCT/EP/2006/011150 WO/2007/057229 191296 C07D תרכובות 4 אוקסדיאזוליל פיפרידין ושימוש שלהן 22/11/2006 BISACYLOXYPROPYLCYSTEINE CONJUGATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME HELMHOLTZ-ZENTRUM FUR INFEKTIONS-FORSCHUNG GMBH EP 05025431.7 22/11/2005 PCT/EP/2006/011182 WO/2007/059931 191300 A61K מוצמדי ביסאצילאוקסיפרופילציסטאין ותכשירי רוקחות המכילים אותם 2565

08/11/2006 SELF-PROTECTION SYSTEM FOR COMBAT VEHICLES OR OTHER OBJECTS TO BE PROTECTED RHEINMETALL WAFFE MUNITION GMBH DE 102005054275.1 11/11/2005 PCT/EP/2006/010692 WO/2007/054278 191301 F41H מערכת הגנה עצמית לרכבים קרביים או עצמים אחרים שיש להגן עליהם 15/11/2006 GAN CRYSTAL SHEET MOSAIC CRYSTALS LTD. US 60/737786 PCT/IL/2006/001319 WO/2007/057892 17/11/2005 191302 C30B משטח גביש של גליום ניטריד מוזאיק קריסטלס בע"מ 09/11/2006 DEVICE PROVIDING A SECURE WORK ENVIRONMENT AND UTILIZING A VIRTUAL INTERFACE ELECTRONIC PLASTICS, LLC US 60/734793 09/11/2005 PCT/US/2006/043541 WO/2007/056476 191304 G06F התקן המספק סביבת עבודה מאובטחת המשתמש בממשק וירטואלי 12/11/2006 METHOD FOR NON-AUTOLOGOUS CARTILAGE REGENERATION CARTICURE LTD US 60/735204 10/11/2005 US 60/813690 15/06/2006 PCT/IL/2006/001295 WO/2007/054939 191306 C12N שיטה לרגנרציה לא עצמונית של סחוס קרטיקיור בע"מ 2566

27/11/2006 CHEMICAL PROCESS FOR THE PREPARATION OF AN AMIDO- PHENOXYBENZOIC ACID COMPOUND 191307 C07D תהליך כימי להכנת תרכובת של חומצה אמידו פנוקסיבנזואית ASTRAZENECA AB US 60/740042 PCT/GB/2006/004399 WO/2007/060448 28/11/2005 08/11/2006 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED 2005- JP 01/12/2005 347646 JP 2006-146381 26/05/2006 PCT/JP/2006/322698 WO/2007/063702 191308 C07D תרכובת אימינופרופן ושימוש מזה 09/11/2006 COMPOSITION AND METHOD FOR RECYCLING SEMICONDUCTOR WAFERS HAVING LOW-K DIELECTRIC MATERIALS THEREON ADVANCED TECHNOLOGY MATERIALS, INC. US 60/735225 09/11/2005 US 60/760969 20/01/2006 US 60/805826 26/06/2006 US 60/821631 07/08/2006 PCT/US/2006/060696 WO/2007/111694 191309 H01L תרכובת ושיטה למחזור פרוסות מוליכות למחצה בעלות חומרי K נמוך שאינם מוליכי חשמל מזה 2567

15/11/2006 COMPOSITIONS AND METHODS FOR MODULATING HEMOSTASIS THE CHILDREN'S HOSPITAL OF PHILADELPHIA US 60/736680 15/11/2005 PCT/US/2006/060927 WO/2007/059513 191310 C07K תרכובות ושיטות לאפנן המוסטאזיס 10/10/2006 TRANSDERMAL THERAPEUTIC SYSTEM NOVARTIS AG US 60/741511 01/12/2005 PCT/US/2006/039557 WO/2007/064407 191311 A61K מערכת רפואית תת עורית 23/11/2006 IMPROVED SEMI-CONTINUOUS TWO-COMPONENT METHOD FOR OBTAINING A COMPOSITE EXPLOSIVE CHARGE WITH POLYURETHANE MATRIX EURENCO FRANCE FR 0511892 24/11/2005 PCT/FR/2006/051213 WO/2007/060365 191313 C06B שיטה משופרת חצי המשכית דו שלבית להשגת מטען נפץ מרוכב עם מטריקס של פוליאורתאן 20/11/2006 1,5-SUBSTITUTED INDOL-2-YL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG EP 05111478.3 30/11/2005 PCT/EP/2006/068655 WO/2007/062999 191314 C07D תולדות אינדול 2 יל אמיד המותמר בעמדה 1,5 2568

03/11/2006 METHOD AND APPARATUS FOR ENHANCED DETECTION OF TOXIC AGENTS UT-BATTELLE, LLC US 11/271643 10/11/2005 PCT/US/2006/042984 WO/2008/054394 191315 C12Q שיטה ומכשיר לזיהוי מוגבר של מרכיבים רעילים 30/05/2006 A STABLE FORMULATION FOR TREATMENT OF RESPIRATORY DISORDER CENTURY BIOLOGICALS PRIVATE LIMITED IN 1642/CHE/2005 10/11/2005 PCT/IN/2006/000184 WO/2007/054958 191316 A61K פורמולציה יציבה לטיפול באי סדר נשימתי 08/12/2006 PROCESS FOR THE PREPARATION OF 2-CHLOROETHOXY-ACETIC ACID-N,N-DIMETHYLAMIDE EGIS GYOGYSZERGYAR Nyilvanosan Mukodo Reszvenytarsasag HU P0501140 08/12/2005 PCT/HU/2006/000110 WO/2007/066164 191318 C07C תהליך להכנת 2 כלורואתוקסי חומצה אצטית N,N דימתילאמיד 15/11/2006 METHODS USING PORES ISIS INNOVATION LIMITED GB 0523282.2 15/11/2005 PCT/GB/2006/004265 WO/2007/057668 191319 C12Q שיטות המשתמשות בפורים 2569

31/10/2006 HEPATOCYTE GROWTH FACTOR INTRON FUSION PROTEINS RECEPTOR BIOLOGIX, INC. US 60/735609 10/11/2005 PCT/US/2006/042607 WO/2007/058776 191320 C07K חלבונים מאוחים המכילים גורם גדילה אינטרוני הפטוציטי 06/11/2006 COMPOSITIONS AND METHODS FOR CONTROLLING TISSUE FACTOR SIGNALING SPECIFICITY THE SCRIPPS RESEARCH INSTITUTE US 60/734149 07/11/2005 PCT/US/2006/043313 WO/2007/056352 191321 A61K תכשירים ושיטות לשליטה בסימון יחודיות של גורם רקמה 01/11/2006 AGENT FOR TREATING OIL-POLLUTED GROUND AND FOR CLEANING OIL- CONTAMINATED SURFACES AND CONTAINERS SWISSTECH HOLDING AG CH 1779/05 07/11/2005 CH PCT/CH05/000658 08/11/2005 CH 1473/06 15/09/2006 CH 1474/06 15/09/2006 PCT/CH/2006/000613 WO/2007/051337 191322 B09C גורם לטיפול בקרקע מזוהמת בשמן ולניקוי משטחים מוזהמים בשמן ומיכלים 2570

01/11/2006 COMPOSITION AND BIOREMEDIATION METHOD FOR WATER POLLUTED BY HYDROCARBONS SWISSTECH HOLDING AG CH 1779/05 07/11/2005 CH PCT/CH05/000658 08/11/2005 CH 1473/06 15/09/2006 PCT/CH/2006/000614 WO/2007/051338 191323 C02F תכשיר ושיטה לטיפול ביולוגי במים המזוהמים על ידי פחמימנים 28/11/2006 MACHINE FOR PRODUCING WATER FROM WIND ENERGY MARC HUGUES PARENT FR 0512052 29/11/2005 PCT/FR/2006/002602 WO/2007/063208 191324 E03B מכונה ליצור מים מאנרגית רוח 23/02/2006 PRESSURE FLUCTUATION ADSORPTION METHOD AND APPARATUS TAIYO NIPPON SANSO CORPORATION 2005- JP 14/11/2005 328582 PCT/JP/2006/303306 WO/2007/055035 191325 B01D שיטה ומערכת לספיחה תנודתית תחת לחץ 2571 19/12/2006 NEW COMPOUNDS RICHTER GEDEON NYRT. HU P0501171 HU P0600920 PCT/HU/2006/000123 WO/2007/072095 20/12/2005 18/12/2006 191326 C07D תרכובות חדשות

08/11/2006 PRODUCTIVITY AUGMENTING PROTEIN FACTOR, NOVEL CELL LINES AND USES THEREOF PROBIOGEN AG, EP 05110453.7 08/11/2005 US 60/750156 14/12/2005 PCT/EP/2006/068234 WO/2007/054516 191327 C12N פרודוקטיביות המגדילה גורם חלבוני, סוגי תאים חדשים ושימושיהם 10/11/2006 MARKING IMAGES OF TEXT WITH SPECKLE PATTERNS IBM CORPORATION US 11/282912 18/11/2005 PCT/EP/2006/068359 WO/2007/057363 191328 H04N סימון דמויות טקסט ע"י תבניות מוכתמות 26/10/2006 SENDING ROUTING DATA BASED ON TIMES THAT SERVERS JOINED A CLUSTER IBM CORPORATION US 11/282029 17/11/2005 PCT/EP/2006/067819 WO/2007/057284 191329 H04L שליחת מידע של ניתוב המבוסס על זמן הצטרפות השרתים לאשכול 2572

23/03/2007 ANTIBODIES SELECTIVE FOR HUMAN AB PROTOFIBRILS AND COMPOSITIONS CONTANING THE SAME BIOARCTIC NEUROSCIENCE AB SE 0600662-1 23/03/2006 SE 0602591-0 30/11/2006 PCT/SE/2007/000292 WO/2007/108756 191331 C07K נוגדנים בריירניים עבור פרוטופיבריליים אנושיים ותכשירים המכילים אותם 09/11/2006 BRAZING MATERIAL WITH CONTINUOUS LENGTH LAYER OF ELASTOMER CONTAINING A FLUX WOLVERINE TUBE, INC. US 60/735323 10/11/2005 PCT/US/2006/043856 WO/2007/058969 191332 B23K חומר הלחמה המכיל תלחים במוכל בתוך שכבה אלסטומרית רציפה 09/11/2006 MULTIFUNCTIONAL MEDICAL DEVICE ASSEMBLY ALLEGIANCE CORPORATION US 60/735165 10/11/2005 PCT/US/2006/043828 WO/2007/056585 191335 A61M מכשיר רפואי רב שימושי לאיסוף 2573

09/11/2006 AUTOMATED CHEMICAL SYNTHESIZER AND METHOD FOR SYNTHESIS USING SAME DAVID Y PHELPS, US 60/735276 11/11/2005 US 11/372818 10/03/2006 US 11/469571 01/09/2006 PCT/US/2006/060706 WO/2007/059403 191336 B01J סינתיסיזר כימי אוטומטי ושיטה לסינתיזה המשתמשת בו 09/11/2006 SELECTION, PROPAGATION AND USE OF MOSAIC ANEUPLOID STEM CELLS THE SCRIPPS RESEARCH INSTITUTE US 60/735715 09/11/2005 PCT/US/2006/043794 WO/2007/056572 191337 A01N בחירה, התרבות ושימוש של פסיפס תאי גזע בעלי סטייה במספר הכרומוזומים 09/11/2006 INSULATED CUP SEDA S.P.A. EP 05024667.7 PCT/EP/2006/010767 WO/2007/054318 11/11/2005 191338 B65D מכסה בודד 14/11/2006 N-SULFAMOYL-N- BENZOPYRANPIPERIDINES AS INHBITORS OF CARBONIC ANHYDRASES SOLVAY PHARMACEUTICALS GMBH EP 05110724.1 14/11/2005 PCT/EP/2006/068416 WO/2007/054580 191339 C07D N סולפמואיל N ' בנזופיראנפיפרידינים כמעכבי אנהידרזים קרבוניים 2574

08/12/2006 HUMAN MONOCLONAL ANTIBODIES TO O8E MEDAREX, INC. US 60/748914 US 60/824593 PCT/US/2006/061816 WO/2007/067991 08/12/2005 05/09/2006 191340 C07K נוגדנים מונוקלונליים כנגד E8O 08/11/2006 APPARATUS AND METHODS FOR USE IN FLASH DETECTION GENERAL ATOMICS US 60/734906 08/11/2005 US 11/557830 08/11/2006 PCT/US/2006/060683 WO/2007/056753 191341 G01T התקן ושיטות לשימוש בגילוי הבזקים 13/11/2006 ENGRAVED GEMSTONE VIEWER GEMEX SYSTEMS, INC. US 60/735339 12/11/2005 US 60/783635 17/03/2006 US 60/847040 25/09/2006 PCT/US/2006/044108 WO/2007/059090 191342 G01N מתקן צפייה באבני חן חרוטות 07/11/2006 VEHICLE WITH LOW, FLAT FLOOR AND RAMP FOR PERSONS WITH DISABILITIES OR FOR OTHER USES STANDARD VEHICLES GROUP, LLC US 60/734284 08/11/2005 US 11/521587 15/09/2006 PCT/US/2006/043441 WO/2007/056431 191343 B60P רכב בעל תחתית נמוכה ושטוחה עבור בעלי מוגבלויות ולשימושים אחרים 2575

09/11/2006 COMPOUNDS FOR ENZYME INHIBITION PROTEOLIX, INC. US 60/736118 09/11/2005 US 60/842582 05/09/2006 PCT/US/2006/043503 WO/2007/056464 191344 C07K תרכובות לעיכוב אנזים 10/11/2006 LUNG CANCER DIAGNOSTIC ASSAY UNIVERSITY OF KENTUCKY US 60/735555 10/11/2005 US 60/735418 10/11/2005 US 60/806778 08/07/2006 PCT/US/2006/060796 WO/2007/079284 191345 G01N בדיקה לאבחון סרטן ריאות 30/06/2006 METHOD OF CONVERTING WATER- SOLUBLE ACTIVE PROTEINS INTO HYDROPHOBIC ACTIVE PROTEIN, THE USE OF THE SAME FOR THE PREPARATION OF MONOMOLECULAR LAYERS OF ORIENTED ACTIVE PROTEINS, AND DEVICES COMPRISING OF THE SAME PROTEOGEN BIO S.R.L. WO PCT/EP2005/55901 11/11/2005 PCT/IB/2006/052203 WO/2007/054839 191346 C12N שיטה להתמרת חלבונים פעילים מסיסי מים לחלבונים פעילים דוחי מים להכנת שכבות חד פרודתיות של חלבונים פעילים מוכוונים והתקנים המורכבים כאמור 2576

21/11/2006 PHARMACEUTICAL COMPOSITIONS COMPRISING AZD2171, PROCESSES FOR THEIR MANUFACTURE AND USE THEREOF IN THE MANUFACTURE OF MEDICAMENTS AND AS MEDICAMENTS FOR PRODUCING AN ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY REDUCING EFFECT ASTRAZENECA AB GB 0523810.0 23/11/2005 PCT/GB/2006/004320 WO/2007/060402 191347 A61K תכשירי רוקחות המכילים,AZD171 תהליכים להכנתם ושימוש בהם בייצור תרופות וכתרופות ליצירת אפקט נוגד היווצרות כלי דם ו/או מפחית חדירות כלי דם 17/11/2006 SPIROCYCLIC COMPOUNDS AS HDAC INHIBITORS MERCK & CO., INC. US 60/739324 23/11/2005 PCT/US/2006/044948 WO/2007/061978 191349 C07D תרכובות ספירוציקליות כמעכבים ל HDAC 21/11/2006 2-(PHENYL OR HETEROCYCLIC)-1H- PHENANTRHO[9,10-D]IMIDAZOLES AS MPGES-1 INHIBITORS MERCK FROSST CANADA LTD US 11/374288 23/11/2005 PCT/CA/2006/001904 WO/2007/059611 191351 C07D 2 (פניל או הטרוציקיל) H1 פננטרו [10,9 אימידזולים כמעכבים ל MPGES 1 D] 2577

16/11/2006 DRINK DISPENSING VALVE AND DISPENSING VALVE-DRINK RESERVOIR ASSEMBLY BRAVILOR HOLDING B.V. NL 1030454 17/11/2005 PCT/NL/2006/050290 WO/2007/058537 191353 B67D שסתום מזיגת משקה והתקן הכולל שסתום מזיגה מיכל משקה 17/11/2006 LONGITUDINALLY REINFORCED CURED IN PLACE LINER AND REINFORCED COATING INA ACQUISITION CORP. US 11/283196 18/11/2005 PCT/US/2006/044736 WO/2007/061875 191354 F16L ציפוי פנימי מוקשה במקום בעל חיזוקים אורכיים וציפויים מחוזקים 10/11/2006 NEEDLE FOR PUNCTURING POWDER CAPSULES FOR INHALATION BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG DE 102005054383.9 15/11/2005 PCT/EP/2006/068356 WO/2007/057362 191355 A61M מחט לניקוב קפסולות המכילות אבקה עבור אינהלציה 2578

16/11/2006 17-ALLYLAMINO-17- DEMETHOXYGELDANAMYCIN POLYMORPHS AND FORMULATIONS KOSAN BIOSCIENCES, INC. US 60/739225 23/11/2005 US 60/809527 30/05/2006 US 11/595005 08/11/2006 PCT/US/2006/044746 WO/2007/061878 191357 C07D הרכבים ופולימורפים של 17 אלילאמינו 17 דמתוקסי גלדאנאמיצין 25/10/2006 SUBSTITUTED 5-PHENYL-3,6- DIHYDRO-2-OXO-6H- [1,3,4]THIADIAZINES MERCK PATENT GMBH DE 102005055354.0 21/11/2005 PCT/EP/2006/010285 WO/2007/057092 191360 C07D 5 פניל 6,3 דיהידרו 2 אוקסו H6 1,3,4 ]]תיאדיאזינים מותמרים 25/10/2006 3,6-DIHYDRO-2-OXO-6H- (1,3,4)THIADIAZINE DERIVATIVES MERCK PATENT GMBH DE 102005055355.9 21/11/2005 PCT/EP/2006/010286 WO/2007/057093 191361 C07D תולדות של 6,3 דיהידרו 2 אוקסו H6 [1,3,4 ]תיאדיאזינים 2579

15/11/2006 AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE PRO NATURA GESELLSCHAFT FUR GESUNDE ERNAHRUNG MBH DE 102005055081.9 16/11/2005 DE 102005056169.1 23/11/2005 DE 102005060768.3 16/12/2005 DE 102005060769.1 16/12/2005 DE 102006000873.1 04/01/2006 DE 102006000881.2 04/01/2006 DE 102006001015.9 05/01/2006 US 60/757414 10/01/2006 US 60/757424 10/01/2006 DE 102006012244.5 15/03/2006 DE 102006013624.1 22/03/2006 DE 102006014423.6 27/03/2006 US 60/831050 17/07/2006 US 60/831174 17/07/2006 PCT/IB/2006/003223 WO/2007/057749 191363 A61K תכשיר לשימוש במקרה של אי סבילות פרוקטוזה 23/11/2006 AGENT FOR REDUCING THE USEABLE CALORIE CONTENT OF FOOD AND FOR THERAPEUTIC REUDCTION OF WEIGHT, IN PARTICULAR FOR USE IN THE CASE OF ADIPOSITY (OBESITY) PRO NATURA GESELLSCHAFT FUR GESUNDE ERNAHRUNG MBH DE 102005056170.5 23/11/2005 DE 102005060767.5 16/12/2005 DE 102005061330.6 20/12/2005 DE 102005063194.0 30/12/2005 DE 102006001016.7 05/01/2006 US 60/757413 10/01/2006 DE 102006013623.3 22/03/2006 DE 102006014420.1 27/03/2006 US 60/831173 17/07/2006 PCT/EP/2006/011231 WO/2007/059955 191364 A23L תכשיר עבור הקטנת כמות הקלוריות השימושית באוכל ועבור הורדת משקל תראפיוטית, במיוחד לשימוש במקרה של שומן (שמנות) 2580

23/11/2006 AGENT FOR USE IN THE CASE OF DISORDERS OF BLOOD SUGAR METABOLISM, INCLUDING DIABETES PRO NATURA GESELLSCHAFT FUR GESUNDE ERNAHRUNG MBH DE 102005056103.9 23/11/2005 DE 102005061329.2 20/12/2005 DE 102006001017.5 05/01/2006 US 60/757425 10/01/2006 DE 102006014424.4 23/03/2006 US 60/831175 17/07/2006 PCT/EP/2006/011232 WO/2007/059956 191365 A21D תכשיר לשימוש במקרה של מחלות של מטבוליזם של סובר בדם, כולל סכרת 15/11/2006 METHOD FOR TRAINING NEURAL NETWORKS BERNADETTE GARNER UA 2005906330 15/11/2005 PCT/AU/2006/001708 WO/2007/056803 191366 G06N שיטה לסיגול רשתות נוירונים 13/11/2006 SUBSTITUTED PHENYLPIPERIDINES WITH SEROTONINERGIC ACTIVITY AND ENHANCED THERAPEUTIC PROPERTIES AUSPEX PHARMACEUTICALS, INC. US 60/736581 14/11/2005 US 60/741530 01/12/2005 PCT/US/2006/043917 WO/2007/058998 191367 C07D פנילפיפרידינים מותמרים עם פעילות סרוטונינרגטית ותכונות טיפוליות מוגברות 2581

22/11/2006 IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES COLEY PHARMACEUTICAL GROUP, INC. US 60/739529 25/11/2005 US 60/778989 03/03/2006 PCT/US/2006/045183 WO/2007/062107 191369 C12N אוליגוריבונוקליאוטידים ממריצים של מערכת החיסון 20/11/2006 3-AMINO-1-ARYLPROPYL INDOLES AND AZA-SUBSTITUTED INDOLES F. HOFFMANN-LA ROCHE AG US 60/741266 30/11/2005 PCT/EP/2006/068646 WO/2007/062996 191370 C07D 3 אמינו 1 ארילפרופיל אינדולים ואינדולים מותמרים ב AZA 22/11/2006 OIL-IN-WATER EMULSION AND ITS USE FOR THE DELIVERY OF FUNCTIONALITY NESTEC S.A. EP 05025439.0 22/11/2005 PCT/EP/2006/068761 WO/2007/060177 191372 A61K אמולסית שמן בתוך מים ושימושה לשחרור תפקודיות 22/11/2006 EASILY DISPERSIBLE LIPIDIC PHASE NESTEC S.A. EP 05025405.1 22/11/2005 PCT/EP/2006/068739 WO/2007/060171 191373 A23D חלוקה של שלב ליפידי בקלות 2582

22/11/2006 OIL-IN-WATER EMULSION FOR CREATING NEW PRODUCT CONSISTENCIES NESTEC S.A. EP 05025526.4 23/11/2005 PCT/EP/2006/068753 WO/2007/060174 191375 B01F אמולסית שמן בתוך שמן עבור ייצור עקבי של מוצר חדש 14/11/2006 PRESSURE EXCHANGER ROVEX LIMITED GB 0523265.7 PCT/GB/2006/004236 WO/2007/057650 15/11/2005 191376 F04F חלפן לחץ 16/11/2006 COMPOSITIONS AND METHODS OF TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS WITH REDUCED NON-TOXIN PROTEINS REVANCE THERAPEUTICS, INC. US 60/738144 17/11/2005 PCT/US/2006/060979 WO/2007/059528 191378 A61K הרכבים ושיטות לאפליקציה חיצונית ולהעברה דרך העור של רעלני בוטולינום עם הפחתה בחלבונים שאינם רעלנים 17/11/2006 SEWAGE TREATMENT AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION AU 2005906407 17/11/2005 PCT/AU/2006/001728 WO/2007/056818 191379 C02F טיפול בשפכים 2583

13/11/2006 IRRIGATION EMITTER STAKE NETAFIM LTD FR 0511529 14/11/2005 PCT/IL/2006/001300 WO/2007/054943 191381 A01G מוט להחזקת צינור השקייה נטפים בע"מ 23/11/2006 PATCH ANTENNA ELEMENT AND APPALICATION THEREOF IN A PHASED ARRAY ANTENNA ELTA SYSTEMS LTD. US 11/296569 08/12/2005 PCT/IL/2006/001354 WO/2007/066322 191382 H01Q גורם מוסף לאנטנה וישומו במערך אנטנות בעל מספר מופעים אלתא מערכות בע"מ 27/11/2006 WASHING DEVICE CREAHOLIC S.A. CH 1890/05 PCT/CH/2006/000660 WO/2007/062536 29/11/2005 191383 E03C התקן לשטיפה 27/11/2006 PRODRUG ER?-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS BAYER SCHERING PHARMA AG DE 102005057224.3 29/11/2005 PCT/EP/2006/011729 WO/2007/062877 191384 C07J מטרימי תרופות של חומרים הסלקטיבים ל?,ER שיטות לייצורם ותכשירי רוקחות המכילים את התרכובות הללו 2584

17/11/2006 PROCESS FOR OBTAINING A TRIGLYCERIDE-RICH REFINED AVOCADO OIL, AND OIL WHICH CAN BE OBTAINED BY MEANS OF SUCH A PROCESS LABORATOIRES EXPANSCIENCE US 60/737745 18/11/2005 FR 0511702 18/11/2005 PCT/EP/2006/068607 WO/2007/057439 191385 C11B תהליך לקבלת שמן אבוקדו מזוקק עשיר בטריגליצריד, ושמן שניתן להפיק באמצעות תהליך כזה 22/11/2006 COMPOSITIONS AND METHODS FOR MODULATING GATED ION CHANNELS PAINCEPTOR PHARMA CORPORATION US 60/739600 23/11/2005 PCT/CA/2006/001897 WO/2007/059608 191386 C07D תכשירים ושיטות לאפנון תעלות יונים בעלות שערים 11/08/2006 WATERING SYSTEM FOR WATERING PLANTS PLANTCARE AG. CH 1866/05 23/11/2005 PCT/CH/2006/000426 WO/2007/059636 191387 A01G מערכת השקיה להשקיית צמחים 2585

30/11/2006 NONCOMPETITIVE DOMAIN ANTIBODY FORMATS THAT BIND INTERLEUKIN 1 RECEPTOR TYPE 1 DOMANTIS LIMITED US 60/742062 01/12/2005 PCT/GB/2006/004471 WO/2007/063308 191388 C07K צורות נוגדנים שאינם מכילים תחום תחרותי ואשר קושרים קולטן אינטרלוקין מטיפוס 1 20/12/2005 METHOD AND SYSTEM FOR DELIVERING MESSAGES IN A COMMUNICATION SYSTEM SKYPE LIMITED US 11/285396 23/11/2005 PCT/EP/2005/013924 WO/2007/059796 191389 H04L שיטה ומערכת להעברת הודעות במערכת תקשורת 13/10/2006 DEVICE FOR PRODUCING A STACKING PROJECTION AND CONTAINER WITH SAME SEDA S.P.A. EP 05024836.8 14/11/2005 PCT/EP/2006/009933 WO/2007/054179 191390 B31B התקן ליצור היטל ערימה ומיכל המכיל התקן זה 21/11/2006 MICROBIAL OXYGEN ABSORBER CHR. HANSEN A/S DK PA200501623 21/11/2005 US 60/738031 21/11/2005 PCT/DK/2006/000648 WO/2007/057026 191391 A23L סופח חמצן חיידקי 2586

22/11/2006 OXADIAZOLE DERIVATIVES WITH CRTH2 RECEPTOR ACTIVITY 7TM PHARMA A/S GB 0524428.0 30/11/2005 PCT/EP/2006/011216 WO/2007/062773 191392 C07D תולדות אוקסאדיאזול בעלות פעילות קולטן CRTH 2 16/11/2006 IR-ABSORBING INTAGLIO INK SICPA HOLDING S.A. EP 05111295.1 25/11/2005 PCT/EP/2006/068586 WO/2007/060133 191393 C09D דיו ליציקות הסופג קרינת IR 23/11/2006 METHOD FOR PRODUCING 5-FLUORO- 1,3-DIALKYL-1H-PYRAZOL-4- CARBOXYLIC ACID CHLORIDES BAYER CROPSCIENCE AG DE 102005057180.8 01/12/2005 PCT/EP/2006/011228 WO/2007/062776 191394 C07D שיטה להכנת כלורידים של 5 פלואורו 3,1 דיאלקיל H1 פיראזול 4 חומצה קרבוקסילית 30/11/2006 COMPETITIVE DOMAIN ANTIBODY FORMATS THAT BIND INTERLEUKIN 1 RECEPTOR TYPE 1 DOMANTIS LIMITED US 60/742218 01/12/2005 PCT/GB/2006/004474 WO/2007/063311 191395 C07K צורות נוגדנים בעלות איזורים תחרותיים ואשר קושרים אינטרלוקין 1 לקולטן מטיפוס 1 2587

08/12/2006 THERAPEUTIC VACCINE AC IMMUNE S.A. EP 05027091.7 EP 06009098.2 PCT/EP/2006/011861 WO/2007/068411 12/12/2005 02/05/2006 191397 C07K חיסון טיפולי 19/04/2006 ENANTIOSELECTIVE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND THEIR SALTS RATIOPHARM GMBH DE 102005061720.4 22/12/2005 PCT/EP/2006/003587 WO/2007/079784 191398 C07D הכנה אננטיובררנית של תולדות בנזאימידזול ומלחיהן 12/12/2006 TRANSMISSION CONTROL PROTOCOL WITH PERFORMANCE ENHANCING PROXY FOR DEGRADED COMMUNICATION CHANNELS VIASAT INC. US 11/298612 12/12/2005 PCT/US/2006/046988 WO/2007/070411 191400 H04L פרוטוקול בקרת שידור הכולל מתווך עבור ערוצי תיקשורת בעלי התדרדרות בביצועיהם 22/12/2005 PROVISIONING OF USER INFORMATION TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) PCT/SE/2005/002005 WO/2007/073252 191401 H04M הפצת מידע משתמש 2588

15/11/2006 NEW DIAMOND USES/APPLICATIONS BASED ON SINGLE-CRYSTAL CVD DIAMOND PRODUCED AT HIGH GROWTH RATE CARNEGIE INSTITUTION OF WASHINGTON US 60/721584 15/11/2005 PCT/US/2006/044421 WO/2007/059251 191402 C30B שימושים ויישומים חדשים של יהלומים המבוססים על יהלום בעל גביש יחידי המיוצר על ידי שיקוע אדים כימיים( CVD ( בקצב גידול גבוה 30/10/2006 A HIGH STRENGTH MARTENSITIC STEEL ALLOY CRS HOLDINGS, INC. US 11/283084 18/11/2005 PCT/US/2006/042205 WO/2007/058759 191403 C22C סגסוגת פלדה מרטינסיטיק בעלת חוזק רב 11/12/2006 FUEL CELLS AND ELECTRODE MEMBRANE ASSEMBLIES CONTAINING A PROTEIN EXCHANGE MEMBRANE GEORGIA TECH RESEARCH CORPORATION US 60/749382 12/12/2005 PCT/US/2006/046962 WO/2007/070399 191406 H01M תאי דלק והרכבים של אלקטרודות קרומיות המכילים קרומים להחלפת חלבונים 2589

17/11/2006 DESLORATADINE CRYSTALLINE FORMS MIXTURES HAVING A LOW LEVEL OF RESIDUAL SOLVENTS TEVA PHARMACEUTICAL INDUSTRIES LTD. US 60/737964 17/11/2005 PCT/IB/2006/004266 WO/2008/056202 191410 C07D תערובות של צורות קריסטליניות של דסלורטדין המכילות רמה נמוכה של ממסים שייריים טבע תעשיות פרמצבטיות בע"מ 17/11/2006 MALODOR REDUCING COMPOSITIONS AND METHODS COLGATE-PALMOLIVE COMPANY US 60/737644 17/11/2005 PCT/US/2006/061034 WO/2007/059532 191412 C11D הרכבים ושיטות להפחתת סרחון 17/11/2006 OIL-IN-WATER FORMULATION OF AVERMECTINS CHEMINOVA A/S DK PA200501619 18/11/2005 US 60/738072 21/11/2005 PCT/DK/2006/050068 WO/2007/057028 191413 A01N תערובת שמן במים של אוורמקטינים 2590

16/11/2006 PHARMACEUTICAL COMPOSITION AND METHOD FOR REGULATING ABNORMAL CELLULAR PROLIFERATION THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH OFFICE OF US 60/737384 17/11/2005 PCT/IL/2006/001324 WO/2007/057897 191416 A61K תכשירים ושיטות לבקרה של ריבוי תאים אבנורמלי תל השומר-מחקרים,תשתית ושירותים רפואיים בע"מ 16/11/2006 PHARMACEUTICAL COMPOSITIONS COMPRISING BUPRENORPHINE SCHERING-PLOUGH LTD. US 60/738524 21/11/2005 PCT/US/2006/044464 WO/2007/061739 191418 A61K תכשירים רוקחיים המכילים בופרנורפין 18/10/2006 TIMING OF A Q-SWITCH TO SUPPRESS PRE-LASING OF THE LASER SELEX SENSORS AND AIRBORNE SYSTEMS LIMITED GB 0523128.7 14/11/2005 EP 05270080.4 14/11/2005 PCT/GB/2006/050336 WO/2007/054737 191419 H01S תזמון של מפסק Q להנחתת פרה ליסינג של לייזר 2591

14/11/2006 SALMONELLA BASED ORAL VACCINES FOR ANTHRAX UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE US 60/736457 14/11/2005 PCT/US/2006/044037 WO/2008/048289 191420 A61K חיסון מבוסס סלמונלה נגד אנטרקס למתן דרך הפה 14/11/2006 TOUCH-SAFE SOCKET POULSEN, CARSTEN, HORNSHOJ DK PA200501590 15/11/2005 PCT/DK/2006/000629 WO/2007/057010 191421 H01R שקע מוגן מנגיעה 28/11/2006 DEVICE, SYSTEM AND METHOD OF PERFORMING AN ADMINISTRATIVE OPERATION ON A SECURITY TOKEN K.K. ATHENA SMARTCARD SOLUTIONS US 60/740247 29/11/2005 PCT/IL/2006/001367 WO/2007/063536 191422 G06F התקן, מערכת ושיטה לביצוע פעולה אדמיניסטרטיבית על טוקן אבטחה 16/11/2006 MEDICAL FLUID INJECTION SYSTEM ACIST MEDICAL SYSTEMS, INC. US 60/738829 21/11/2005 PCT/US/2006/060983 WO/2007/062315 191423 A61M מערכת להזרקת נוזל רפואי 2592

28/11/2006 RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR PRODUCTION THEREOF GENMAB A/S US 60/740403 28/11/2005 US 60/852479 17/10/2006 US 60/852611 18/10/2006 PCT/DK/2006/000669 WO/2007/059782 191424 C07K נוגדנים מונוולנטים רקומביננטים ושיטות לייצורם 01/12/2006 FUSED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED 2005- JP 02/12/2005 349858 JP 2006-060648 07/03/2006 PCT/JP/2006/324499 WO/2007/064045 191425 C07D תרכובות הטרוציקליות מאוחות 23/11/2006 ERYTHROPOIETIN POLYPEPTIDES, THEIR PREPARATION AND USES THEREOF LABORATOIRES SERONO SA EP 05111262.1 24/11/2005 EP 05111265.4 24/11/2005 US 60/753668 22/12/2005 US 60/753706 22/12/2005 PCT/EP/2006/068859 WO/2007/060213 191426 C07K אריתרופויאטין פוליפפטידים, הכנתם ושימושים שלהם 2593

21/11/2006 HYBRID ANTIGEN BINDING MOLECULES, THEIR PREPARATION AND USE LABORATOIRES SERONO SA US 60/738647 21/11/2005 PCT/US/2006/045056 WO/2007/062037 191427 C07K מולקולות היברידיות הקשורות אנטיגנים, הכנתן ושימושיהן 16/11/2006 INTERFERON IN INFLUENZA ARES TRADING S.A. EP 05110965.0 18/11/2005 US 60/738483 21/11/2005 PCT/EP/2006/068588 WO/2007/057436 191428 A61K אינטרפרון בשפעת 21/11/2006 DEVICES AND METHODS FOR HIGH- PRESSURE REFOLDING OF PROTEINS BAROFOLD, INC. US 60/739094 21/11/2005 PCT/US/2006/045297 WO/2007/062174 191429 B01L התקנים ושיטות להחזקת דוגמאות של חלבונים תחת לחץ גבוה 29/11/2006 ELECTROCHEMICAL TREATMENT OF SOLUTIONS CONTAINING HEXAVALENT CHROMIUM INDUSTRIE DE NORA S.P.A IT MI2005A002297 30/11/2005 PCT/EP/2006/069080 WO/2007/063082 191430 C02F טיפול אלקטרוכימי של תמיסות המכילות כרום הקסאוולנטי 2594

13/12/2006 COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES AMBRX, INC. US 60/743041 14/12/2005 US 60/743040 14/12/2005 PCT/US/2006/047822 WO/2007/070659 191431 A61K תכשירים המכילים חומצות אמיניות ופוליפפטידים שאינם טבעיים, שיטות הנוגעות לחומרים הללו ושימושים בהם 07/12/2006 PYRIMIDINE DERIVATIVES PFIZER LIMITED US 60/752612 20/12/2005 PCT/IB/2006/003668 WO/2007/072163 191432 C07D תולדות פירימידין 14/11/2006 METHODS FOR PREDICTION AND PROGNOSIS OF CANCER, AND MONITORING CANCER THERAPY BAYER HEALTHCARE LLC US 60/735854 14/11/2005 PCT/US/2006/044117 WO/2007/059094 191433 G01N שיטות לחיזוי וניבוי של סרטן, וניטור טיפול בסרטן 09/10/2006 SOLDERING DEVICE WITH COMPUTER- BASED SENSOR SYSTEM THOMAS ALLETZHAEUSER DE 102005054521.1 14/11/2005 PCT/DE/2006/001769 WO/2007/054045 191439 B23K מכשיר הלחמה עם מערכת חישן מבוססת מחשב 2595

15/11/2006 PUMP APPARATUS AND METHODS FOR USING SAME FOAM IN PLACE CO. LTD. US 60/736801 15/11/2005 US 60/746177 02/05/2006 PCT/IB/2006/054277 WO/2007/057848 191440 F04C התקן משאבה ושיטות לשימוש בה 14/11/2006 RAPID NON-EQUILIBRIUM DECOMPRESSION OF MICROORGANISM-CONTAINING WASTE STREAMS SHEPHERD, SAMUEL, L. US 11/274935 15/11/2005 PCT/US/2006/060876 WO/2007/059487 191441 C12H הסרת לחץ מהירה שלא בשיווי משקל של מי שפכים המכילים מיקרו אורגניזמים 26/11/2006 FLEXIBLE ELECTRIC LOAD MANAGEMENT SYSTEM AND METHOD THEREFOR COMPUTERIZED ELECTRICITY SYSTEMS LTD. US 60/739355 25/11/2005 PCT/IL/2006/001360 WO/2007/060669 191442 G06F מערכת גמישה לניהול עומסים חשמליים ושיטה עבורה 2596

14/11/2006 IMPROVED SYNTHESES AND PREPARATIONS OF INTERMEDIATES AND NEW POLYMORPHS THEREOF USEFUL FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE MEDICHEM S.A. US 60/735838 14/11/2005 PCT/IB/2006/004254 WO/2007/119118 191444 C07D סינתיזה משופרת של חומרי ביניים ופולימורפים חדשים לשימוש בהכנת דונפזיל הידרוכלוריד 14/09/2006 METHOD OF INCREASING THE RANGE OF A SUBCALIBRE SHELL AND SUBCALIBRE SHELLS WITH LONG RANGE BAE SYSTEMS BOFORS AB SE 0502509-3 15/11/2005 PCT/SE/2006/001047 WO/2007/058573 191446 F42B שיטה להגדלת טווח פגז תת קוטר ופגזי תת קוטר ארוכי טווח 15/11/2006 N4-PHENYL-QUINAZ0LINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES ARRAY BIOPHARMA INC. US 60/736289 15/11/2005 US 60/817019 28/06/2006 PCT/US/2006/044431 WO/2007/059257 191448 C07D נגזרות N4 פניל קינאזולין 4 אמין ותרכובות קשורות כמעכבי טירוזין קינאז לרצפטור ERBB סוג I לטיפול במחלות הקשורות להתרבות מהירות של תאים 2597

08/08/2007 191449 B23B כלי חיתוך בעל פני שטח מצופה 08/08/2007 SURFACE -COATED CUTTING TOOL SUMITOMO ELECTRIC HARDMETAL CORP. 2006- JP 31/08/2006 236447 PCT/JP/2007/065526 WO/2008/026432 SURFACE-COATED CUTTING TOOL SUMITOMO ELECTRIC HARDMETAL CORP. 2006- JP 31/08/2006 236448 PCT/JP/2007/065527 WO/2008/026433 191450 B23B כלי חיתוך בעל פני שטח מצופה 08/12/2006 IMMUNOGENIC COMPOSITION BASED ON CONDITIONALLY LIVE VIRION AND METHOD FOR PRODUCING THE SAME KARP, Nelson, M. US 60/749007 09/12/2005 PCT/US/2006/047175 WO/2007/067808 191451 C12N תכשיר אימונוג'יני על בסיס ויריון חי בתנאי ושיטה לייצורו 2598

28/11/2006 POINT TO MULIPOINT DEVICE FOR COMMUNICATION WITH A PLURALITY OF TELECOMMUNICATIONS UNITS AIRSPAN NETWORKS INC. GB 0525161.6 09/12/2005 GB 0611227.0 07/06/2006 PCT/GB/2006/004446 WO/2007/066074 191452 H04B נקודה לאמצעי רב נקודתי לתקשורת עם יחידות טלקומוניקציה מגוונות 28/11/2006 POINT TO MULTIPOINT DEVICE FOR COMMUNICATION WITH A PLURALITY OF TELECOMMUNICATIONS UNITS AIRSPAN NETWORKS INC. GB 0525161.6 09/12/2005 GB 0611230.4 07/06/2006 PCT/GB/2006/004434 WO/2007/066073 191453 H04B נקודה לאמצעי רב נקודתי לתקשורת עם יחידות טלקומוניקציה מגוונות 07/11/2006 VPLS REMOTE FAILURE INDICATION CORRIGENT SYSTEMS LTD. US 60/737733 16/11/2005 PCT/IL/2006/001283 WO/2007/057884 191454 H04J אינדיקציית כשלון VPLS מרחוק קוריגנט מערכות בע"מ 2599

12/12/2006 SYSTEM AND METHOD FOR DELIVERING SHORT MESSAGES ON DO AND 1X NETWORKS QUALCOMM INCORPORATED US 60/750234 13/12/2005 US 11/550955 19/10/2006 PCT/US/2006/061959 WO/2007/102908 191455 H04Q מערכת ושיטה להעברת הודעות קצרות על רשתות DO ו X 1 26/10/2006 MESSAGE HANDLING IN AN IP MULTIMEDIA SUBSYSTEM TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) GB 0524036.1 25/11/2005 PCT/EP/2006/067789 WO/2007/060074 191456 H04L טיפול בהודעות בתת מערכת מולטימדיה IP 17/11/2006 FLUORESCENT MEMBRANE INTERCALATING PROBES AND METHODS FOR THEIR USE PHANOS TECHNOLOGIES, INC. AU 2005234696 18/11/2005 PCT/US/2006/044533 WO/2007/061768 191459 C07D בוחני ממברנה פלורוסנטיים ושיטות לשימוש בהם 2600

27/12/2006 COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES AMBRX, INC. US 60/755711 30/12/2005 US 60/755018 30/12/2005 US 60/755338 30/12/2005 PCT/US/2006/049397 WO/2007/079130 191461 A61K תכשירים המכילים חומצות אמיניות ופוליפפטידים שאינם טבעיים, שיטות המערבות חומרים אלו ושימושים בהם 05/12/2006 LIGANDS THAT HAVE BINDING SPECIFICITY FOR EGFR AND/OR VEGF AND METHODS OF USE THEREFOR DOMANTIS LIMITED US 60/742992 06/12/2005 US 60/758355 11/01/2006 PCT/GB/2006/004559 WO/2007/066106 191462 C07K ליגנדים בעלי בררנות קישור ל EGFR ו/או VEGF ושיטות לשימוש בהם 05/12/2006 BISPECIFIC LIGANDS WITH BINDING SPECIFICITY TO CELL SURFACE TARGETS AND METHODS OF USE THEREFOR DOMANTIS LIMITED US 60/742992 06/12/2005 PCT/GB/2006/004565 WO/2007/066109 191463 C07K ליגנדים בעלי בררנות כפולה עם בררנות לקישור למטרות על פני שטח התא ושיטות לשימוש בהם 2601

09/11/2006 LID FOR A CUP-SHAPED RECEPTACLE SEDA S.P.A. EP 05025264.2 PCT/EP/2006/010766 WO/2007/057123 18/11/2005 191464 B65D מכסה עבור כלי קיבול בצורת כוס 14/02/2006 A PROCESS AND A DEVICE FOR SURGICAL TREATMENT OF RECTAL AND HAEMORRHOIDAL PROLAPSE THD S.P.A. VIA DELL'INDUSTRIA PCT/IT/2006/000074 WO/2007/094016 191466 A61B תהליך והתקן לטיפול ניתוחי של טחורים ושל תמט רקטלי 18/11/2006 NEW PLEUROMUTILIN DERIVATIVE AND ITS USE GLAXO GROUP LIMITED US 60/738308 18/11/2005 PCT/US/2006/061066 WO/2007/062333 191467 C07D תולדת פליאורומוטילין חדשה ושימושה 22/11/2006 SEROTONIN TRANSPORTER (SERT) INHIBITORS F. HOFFMANN-LA ROCHE AG EP 05111565.7 01/12/2005 PCT/EP/2006/068740 WO/2007/063009 191468 C07D מעכבים של מוביל של סרוטונין (SERT) 2602

20/11/2006 METHODS FOR SYNTHESIS OF 3- AMINO-1-ARYLPROPYL INDOLES F. HOFFMANN-LA ROCHE AG US 60/741516 30/11/2005 PCT/EP/2006/068644 WO/2007/062994 191469 C07D שיטות לסינתזה של 3 אמינו 1 ארילפרופיל אינדולים 22/11/2006 2,4,5-TRIPHENYL IMIDAZOLINE DERIVATIVES AS INHIBITORS OF THE INTERACTION BETWEEN P53 AND MDM2 PROTEINS FOR USE AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG US 60/741223 01/12/2005 US 60/852747 19/10/2006 PCT/EP/2006/068748 WO/2007/063013 191470 C07D נגזרות של 5,4,2 טריפניל אימידאזולין כמעכבים של האינטראקציה בין חלבונים של P53 ו MDM2 לשימוש כחומרים נגד סרטן 22/11/2006 NOVEL VINYLOGOUS ACIDS DERIVATIVES F. HOFFMANN-LA ROCHE AG EP 05111598.8 01/12/2005 PCT/EP/2006/068741 WO/2007/063010 191472 C07D נגזרות חדשות של חומצות וינילוגיות 2603

30/11/2006 CONTAINER VERIFICATION SYSTEM FOR NON-INVASIVE DETECTION OF CONTENTS INNOVATIVE AMERICAN TECHNOLOGY, INC. US 11/291574 01/12/2005 US 60/759331 17/01/2006 US 60/759332 17/01/2006 US 60/759373 17/01/2006 US 60/759375 17/01/2006 US 11/363594 27/02/2006 PCT/US/2006/046255 WO/2007/065004 191473 G08B מערכת לאימות מיכל לשם זיהוי לא חודרני של תכולה 17/11/2006 MACHINE AND METHOD FOR PHARMACEUTICAL AND PHARAMACEUTICAL-LIKE PRODUCT ASSEMBLY GLAXO GROUP LIMITED US 60/738283 18/11/2005 PCT/US/2006/061032 WO/2007/062323 191474 A61K מכונה ושיטה להרכבת תוצר רוקחי ודמוי רוקחי 20/11/2006 NEUROENDOCRINE TUMOR TREATMENT USING MTOR INHIBITORS NOVARTIS AG GB 0523658.3 21/11/2005 GB 0601082.1 19/01/2006 GB 0602747.8 10/02/2006 GB 0607942.0 21/04/2006 GB 0609272.0 10/05/2006 GB 0609912.1 18/05/2006 EP 06120660.3 14/09/2006 PCT/EP/2006/068656 WO/2007/057457 191475 A61P טיפול בגידול נוירואנדוקריני תוך שימוש במעכבי MTOR 2604

22/11/2006 SUBSTITUTED ARYLOXYPROPYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY AUSPEX PHARMACEUTICALS, INC. US 60/739261 23/11/2005 US 60/837830 11/08/2006 PCT/US/2006/045202 WO/2007/062119 191476 C07B ארילאוקסיפרופילאמידים מותמרים עם פעילות סרוטונינרגית ו/או נוראפינפרינרגית 20/11/2006 5-SUBSTITUTED INDOLE-2- CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG EP 05111477.5 30/11/2005 PCT/EP/2006/068658 WO/2007/063000 191478 C07D נגזרות של אינדול 2 קרבוקסאמיד המותמרות בעמדה 5 20/11/2006 1,1-DIOXO-THIOMORPHOLINYL INDOLYL METHANONE DERIVATIVES FOR USE AS H3 MODULATORS F. HOFFMANN-LA ROCHE AG EP 05111479.1 30/11/2005 PCT/EP/2006/068649 WO/2007/062997 191479 C07D נגזרות של 1,1 דיאוקסו תיומורפוליניל אינדוליל מתאנון לשימוש כמודולטורים של H3 2605

22/11/2006 191480 HETEROARYL SUBSTITUTED PIPERIDINE DERIVATIVES AS L-CPT1 INHIBITORS F. HOFFMANN-LA ROCHE AG EP 05111560.8 01/12/2005 PCT/EP/2006/068745 WO/2007/063012 C07D תולדות פיפרידין מותמרות עם הטרואריל כמעכבי CPT L1 16/09/2007 ITEM OF TRANSFORMABLE FURNITURE ORT JOINT-STOCK COMPANY GB 109675 15/09/2006 PCT/IB/2007/002674 WO/2008/032199 191481 A47C פריט ריהוט משנה צורה 17/11/2006 COMMUNICATION SYSTEM AND METHOD XYNK PTY LTD AU 2005906435 18/11/2005 AU 2006903816 14/07/2006 PCT/AU/2006/001738 WO/2007/056824 191483 H04L מערכת תקשורת ושיטה 17/11/2006 SCRUBBER FOR CLEANING THE EXHAUST GASES OF A DIESEL ENGINE, METHOD OF OPERATING IT AND CORRESPONDING MARITIME VEHICLE LAB SA FR 0511704 18/11/2005 PCT/FR/2006/002537 WO/2007/057573 191484 F01N אמצעי קרצוף לניקוי גזי הפליטה של מנוע דיזל, שיטה לתפעולו וכלי ימי מקביל 2606

01/11/2006 BICYCLIC CINNAMIDE COMPOUND EISAI R&D MANAGEMENT CO., LTD. JP 2005-337963 24/11/2005 JP 2006-205538 28/07/2006 PCT/JP/2006/321877 WO/2007/060821 191485 C07D תרכובת סינאמיד ביציקלית 13/10/2006 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. US 11/282507 18/11/2005 PCT/US/2006/040197 WO/2007/061529 191489 A61K תהליך ליאופיליזציה ותוצריו 21/11/2006 IMPROVEMENTS TO DOPPLER RADAR SYSTEMS PLEXTEK LIMITED GB 0523676.5 21/11/2005 GB 0600682.9 13/01/2006 PCT/EP/2006/068731 WO/2007/057475 191490 G01S שיפורים במערכות רדאר דופלר 21/11/2006 FREQUENCY SCANNING ANTENNA PLEXTEK LIMITED GB 0523676.5 21/11/2005 GB 0600685.2 13/01/2006 PCT/EP/2006/068732 WO/2007/057476 191491 H01Q משושה סורקת תדרים 2607

21/11/2006 RADAR SYSTEM PLEXTEK LIMITED GB 0523676.5 GB 0600704.1 PCT/EP/2006/068730 WO/2007/057474 21/11/2005 13/01/2006 191492 G01S מערכת רדאר 17/10/2006 COLD-FORMABLE LAMINATE FOR BLISTER BASE PARTS ALCAN TECHNOLOGY & MANAGEMENT LTD. EP 05405644.5 17/11/2005 PCT/EP/2006/009984 WO/2007/057081 191493 B32B רבד לעיצוב קר עבור חלקים עם בסיס בועית 17/11/2006 INDUCIBLE EXPRESSION SYSTEMS STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN EP 05077623.6 17/11/2005 PCT/NL/2006/000575 WO/2007/058527 191494 C12N מערכת המאפשרת הסקת ביטוי 08/12/2006 ACYL TRANSFERASE USEFUL FOR DECONTAMINATION GENENCOR INTERNATIONAL, INC. US 60/748782 09/12/2005 US 10/581014 30/05/2006 PCT/US/2006/047022 WO/2007/133263 191497 C12P אציל טרנספראז המשמש לסילוק חומרים מזהמים 2608

13/11/2006 TRANSMIT-POWER CONTROL FOR WIRELESS MOBILE SERVICES TRUEPOSITION, INC US 11/280643 16/11/2005 PCT/US/2006/060837 WO/2007/059464 191498 H04B בקרת העברת כח עבור שירותים אלחוטיים ניידים 21/11/2006 THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INC. US 60/739339 23/11/2005 US 60/837653 14/08/2006 PCT/US/2006/045129 WO/2007/062078 191499 C07D תרכובות ושיטות לאפנון פעילות תרומבופואיטינית 05/12/2006 CONTAINER BEING PROVIDED WITH AN INNER BAG GREEN BOTTLE LIMITED GB 0524789.5 05/12/2005 GB 0611137.1 06/06/2006 PCT/GB/2006/004534 WO/2007/066090 191500 B65D מיכל המסופק יחד עם שקית פנימית 2609

15/12/2006 191501 PHARMACEUTICAL COMPOSITION CONTAINING DONEPEZIL HYDROCHLORIDE, TABLETS PRODUCED THEREFROM AND METHOD FOR PRODUCING THE SAME RATIOPHARM GMBH DE 102005060377.7 16/12/2005 EP PCT/EP06/007990 11/08/2006 PCT/EP/2006/012122 WO/2007/073888 A61K תכשיר רוקחות המכיל דונפזיל הידרוכלוריד, טבליות המיוצרות ממנו ושיטה לייצורן 18/12/2006 OPTIMIZING WRITE AND WEAR PREFORMANCE FOR A MEMORY MICROSOFT CORPORATION US 11/303382 16/12/2005 PCT/US/2006/048402 WO/2007/075668 191502 G06F אופטימיזציה של ביצועי כתיבה ומחיקה עבור זכרון 23/11/2006 METHOD FOR PRODUCING SULFONAMIDES BASF SE DE 102005057681.8 EP 06123569.3 PCT/EP/2006/068832 WO/2007/063028 01/12/2005 07/11/2006 191503 C07C שיטה ליצור סולפונאמידים 2610

27/11/2006 PRODRUGS OF ER-BETA-SELECTIVE SUBSTANCES METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME BAYER SCHERING PHARMA AG DE 102005057225.1 29/11/2005 PCT/EP/2006/011728 WO/2007/062876 191504 C07J מטרימי תרופות של ER בתא חומרים בררניים, שיטה לייצורם ותכשירי רוקחות המכילים אותם 17/11/2006 MAXILLOFACIAL BONE AUGMENTATION USING rhpdgf-bb AND A BIOCOMPATIBLE MATRIX BIOMIMETIC THERAPEUTICS, INC. US 60/738076 17/11/2005 PCT/US/2006/044766 WO/2007/061889 191505 A61L הגדלת עצם מקסילופציאלית על ידי שימוש ב BB rhdgf וטריצה ביוקומפטבילית 10/03/2006 SAFETY SYRINGE WITH PLUNGER LOCKING MEANS GLOBAL MEDISAFE HOLDINGS LIMITED AU 2005906318 15/11/2005 AU 2006900314 23/01/2006 PCT/AU/2006/000320 WO/2007/056792 191506 A61M מזרק בטיחותי עם אמצעי נעילת בוכנה 2611

18/11/2005 SEGMENTED PHARMACEUTICAL DOSAGE FORMS ACCU-BREAK TECHNOLOGIES, INC. 191507 A61K צורות מתן תכשיר מקוטעות PCT/US/2005/042120 WO/2007/058660 19/11/2006 MATERIALS AND METHODS FOR TREATING CHRONIC FIBROTIC DISEASE THE REGENTS OF THE UNIVERSITY OF MICHIGAN US 60/753647 23/12/2005 PCT/US/2006/048282 WO/2007/075592 191509 C12Q חומרים ושיטות לטיפול במחלת לייפת כרונית 19/12/2006 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LUTS COMPRISING A PDE5 INHIBITOR AND A MUSCARINIC ANTAGONIST PFIZER PRODUCTS INC. US 60/752625 20/12/2005 US 60/757720 09/01/2006 PCT/IB/2006/003683 WO/2007/072169 191511 A61K קומבינציות פרמצבטיות לטיפול בתסמינים של דרכי השתן התחתונות המכילים מעכב PDE5 2612

28/12/2006 ISOXAZOLINES FOR CONTROLLING INVERTEBRATE PESTS E.I. DU PONT DE NEMOURS AND COMPANY,INC. US 60/755247 30/12/2005 US 60/839988 23/08/2006 US 60/857307 07/11/2006 PCT/US/2006/049459 WO/2007/079162 191512 C07D איזוקסזולינים לריסון מזיקים חסרי חוליות 14/11/2006 APPARATUS AND TECHNIQUES FOR FREEZING AND THAWING OF AGRICULTURAL PRODUCE FRESH DEFROST LTD IL 172001 16/11/2005 PCT/IL/2006/001309 WO/2007/057888 191513 A23B מערכות וטכניקות להקפאה והפשרה של תוצרת חקלאית פרש דיפרוסט בע"מ 2613

NOTICE UNDER SECTION 26 OF THE PATENTS LAW, 5727-1967 The applications, particulars of which are set out below, have been accepted pursuant to Section 17 of the Patents Law. Any person wishing to oppose the grant of a patent on any of the applications published here, may, within three months from the date of this journal, give to the Commissioner of Patents notice under Section 30 of the Patents Law, in the manner prescribed in regulations 57 et seq of the Patents Regulations, 5728-1968 Particulars of the applications, where applicable, are given in the following order: [11] [21] Number of application Title of invention Application date [31] [32] [33] Number and date of foreign application convention country. * Int.Cl. [61] Application for patent of addition [62] Divisional application Applicant [72] Inventor [87] International Publication Number Address for service [57] Abridgement of invention (in the language in which the specification is drawn up) *Note: As from Patents and Designs Journal No.1/06, patent applications are classified according to the Eighth Edition of the International Patent Classification (2006) הודעה לפי סעיף 26 לחוק הפטנטים תשכ"ז - 1976 הבקשות שפרטיהן מתפרסמים להלן קובלו לפי סעיף 17 לחוק הפטנטים. כל המעונין להתנגד למתן פטנט על פי בקשה מהבקשות המתפרסמות רשאי, תוך שלושה חדשים מתאריך יומן זה, להגיש לרשם הפטנטים הודעת התנגדות לפי סעיף 30 לחוק הפטנטים בדרך הקבועה בתקנה 57 ואילך לתקנות הפטנטים, תשכ"ח 1968. פרטי הבקשות במידה ויישימים מובאים לפי סדר זה: מספר הבקשה שם האמצאה תאריך הבקשה מספר ותאריך של בקשות החוץ מדינת האגוד *סיווג בינלאומי מהדורה שביעית בקשה לפטנט מוסף בקשת חלוקה המבקש הממציא מס' פרסום של בקשה הבינלאומית מען למסירת מסמכים תקציר האמצאה (בשפה בה ערוך הפירוט) *הערה: החל מיומן הפטנטים והמדגמים מס' 1/06 ניתן ציון לבקשות פטנטים הסיווג לפי המהדורה השמינית של הסיווג הבינלאומי של פטנטים (משנה 2006) 2614

110669 ERYTHROPOIETIN ANALOGS אנלוגים לאריתרופיטן 15.08.1994 [31] 08/108016 [32] 17.08.1993 [33] US Int. Cl.8 A61K 038/18, A61P 007/06, C07K 014/505, C12N 005/10, 015/16 KIRIN-AMGEN INC., SWITZERLAND SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] An analog of human erythropoietin having at least one additional site for N-glycosylation at an asparagine residue at any one of amino acid positions 30, 51, 57, 88, 89, 136 and 138 and wherein at least one additional N-linked carbohydrate chain is attached at any one of said amino acid positions. Also claimed are an analog of human erythropoietin comprising a sites in human erythropoietin and an addition of an equal number of nonnaturally occurring glycosylation sites whereby the positions of carbohydrate chains are changed and an analog of human erythropoietin having an additional site for O-glycosylation at amino acid position 123 and wherein an additional O-linked carbohydrate chain is attached at said amino acid position. deletion of one or more glycosylation The applications for division from this application have not yet been published,192290,136189,136188 בקשות חלוקה מבקשה זו שטרם פורסמו. 2615

CONSTRUCT FOR INFECTING MAMMALIAN CELLS COMPRISING THE SV40 VP1 CAPSID PROTEIN AND A HISTONE - FREE CONSTITUENT, METHODS OF CONSTRUCTION AND USES THEREOF 115880 קונסטרוקט להדבקת תאי יונקים המכיל חלבון מעטפת VP1 של וירוס SV40 ורכיב נטול היסטונים, שיטות לבנייתו ושימושיו [72] 06.11.1995 Int. Cl.8 A61K 048/00, C07K 014/025, C12N 005/10, 015/37, 015/63, 015/87 YISSUM RESEARCH יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים, ירושלים DEVELOPMENT COMPANY OF הדסית שרותי מחקר רפואי ופיתוח בע"מ, THE HEBREW UNIVERSITY OF JERUSALEM ירושלים HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. ARIELLA OPPENHEIM, ZIV SANDALON, AMOS B. OPPENHEIM LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 אריאלה אופנהיים, זיו סנדלון, עמוס ב. אופנהיים לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] A construct capable of infecting a mammalian cell comprising: semi-purified or pure SV40 VP1 capsid protein or a mixture of SV40 VP1 capsid protein and at least one of semi-purified or pure VP2 and VP3; and a histone-free constituent selected from the group consisting of naked exogenous polynucleotide selected from: DNA encoding an exogenous protein or peptide product, or encoding therapeutic RNA, or itself a therapeutic product, a vector comprising DNA encoding an exogenous protein or peptide product, or encoding therapeutic RNA, or itself a therapeutic product, RNA encoding an exogenous protein or peptide product or itself a therapeutic product, a vector comprising RNA encoding an exogenous protein or peptide product or itself a therapeutic product, and antisense RNA, ribozyme RNA or any RNA or DNA which inhibits or prevents the expression of undesired protein(s) in said mammalian cell; and optionally further comprising operatively linked regulatory elements sufficient for the replication of said exogenous polynucleotide, and/or for the expression of a portion encoded by said polynucleotide, in a mammalian cell. 2616

MULTI-ARRAY, MULTI-SPECIFIC ELECTROCHEMILUMINESCENCE TESTING 117422 בדיקת אלקטרוכימילומיניסצנציה מולטי-ספציפית רב שורתית [31] 10.03.1996 08/402076 [32] 10.03.1995 08/402277 06.03.1996 Int. Cl.8 G01N 033/543 MESO SCALE TECHNOLOGIES, LLC, U.S.A. EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] US US איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] An apparatus for use in the detection of an analyte by electrochemiluminescence comprising a light detector and an electrode (16) having immobilized on a surface thereof a plurality of binding domains (14) comprising binding reagents capable of binding said analyte or capable of binding a binding partner of said analyte. 2617

ANTIBODY OR ITS FRAGMENT SPECIFIC TO THE ED-B ONCOFOETAL DOMAIN OF FIBRONECTIN, PROCESS FOR THEIR PRODUCTION AND THEIR USES 127216 נוגדן או קטעו ספציפיים לאזור אונקו עוברי B ED של פיברונקטין, תהליך להכנתם ושימושם [31] [87] 23.05.1997 9610967.3 [32] 24.05.1996 [33] GB Int. Cl.8 A61K 039/395, 051/10, C07K 016/18, C12N 001/21, 015/13, G01N 033/577, 033/68 PHILOGEN S.R.L., ITALY WO/1997/045544 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] An isolated antibody or antibody fragment which is specific for and binds directly to the ED-B oncofoetal domain of fibronectin (FN), having a dissociation constant (Kd) for ED-B FN of less than 6x10-8 M, when measured as a purified monomer. NUCLEAR TRANSFER WITH DIFFERENTIATED FETAL AND ADULT DONOR CELLS 130829 העברה גרעינית של תאי תורם מובחנים עובריים ובוגרים [31] [87] 05.01.1998 08/781752 [32] 10.01.1997 [33] US Int. Cl.8 A01K 067/027, A61K 035/12, 048/00, C12N 005/06, 015/00, 015/87 UNIVERSITY OF MASSACHUSETTS, U.S.A. WO/1998/030683 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A method of cloning a bovine, comprising: (i) inserting a desired propagating differentiated mammalian cell or cell nucleus into an enucleated mammalian oocyte of the same species as the differentiated cell or cell nucleus, under conditions suitable for the formation of a nuclear transfer (NT) unit; (ii) activating the resultant nuclear transfer 2618

unit; (iii) culturing said activated nuclear transfer unit until greater than the 2-cell developmental stage; and (iv) transferring said cultured NT unit to a bovine host mammal such that the NT unit develops into a fetus. HUMAN NEURTURIN RECEPTOR- A (NTNR A ) POLYPEPTIDES, ANTIBODIES TO NTNR A AND COMPOSITION COMPRISING THE SAME 130954 פוליפפטידים לקולטן נוירטורין אנושי ) a ( NTNR,נוגדנים ל a NTNR ותכשירים המכילים אותם [31] [87] 17.02.1998 08/802805 [32] 18.02.1997 [33] US 08/871913 09.06.1997 US 08/957063 24.10.1997 US Int. Cl.8 A01K 067/027, A61K 038/18, 039/395, C07K 014/71, 016/28, 019/00, C12N 005/10, 015/12, 015/85, G01N 033/53, 033/68 GENENTECH, INC., WO/1998/036072 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] An isolated polypeptide comprising a sequence selected from the group consisting of: (a) a human neurturin receptor-α (NTNRα) extracellular domain (ECD) amino acid sequence having the amino acid sequence set out in SEQ ID NO:3 between amino acid residues 23 and 447 inclusive; (b) an allelic variant or mammalian homolog of (a) having at least a 60% amino acid sequence identity with the NTNRα amino acid sequence set out in SEQ ID NO:3; (c) a sequence encoded by nucleic acid which hybridizes under stringent conditions (42 o C in 20% formamide) to a nucleic acid encoding (a) or (b), the sequence having the biological activity of binding neurturin (NTN); (d) a sequence derived from (a) by substitution, deletion, or addition of one or several amino acids in the amino acid sequence of (a), the sequence having at least 60% sequence identity with the NTNRα amino acid sequence set out in SEQ ID NO:3; and, (e) a sequence encoding at least 20 contiguous amino acids from (a). 2619

132661 AGONISTS SPECIFIC FOR THE PERIPHERAL CANNABINOID RECEPTOR אגוניסטים ספציפיים לקולטנים הקנבינואידיים הפריפרליים [72] 31.10.1999 Int. Cl.8 A61K 031/09, 031/216, A61P 009/12, C07C 043/23 YISSUM RESEARCH יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים, ירושלים DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF אהרון גרזון JERUSALEM AARON GARZON רפאל משולם, אסתר פריד, לומיר הנוס, RAPHAEL MECHOULAM, ESTER אביבה ברוייאר, סוסנה צ'יליבון, מיכל FRIDE, LUMIR HANUS, AVIVA BREUER, SUSANA TCHILIBON, הורוביץ MICHAL HOROWITZ WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121 ד"ר וב ושות', רח' פקריס, 2 ת.ד. 2189, רחובות [57] A pharmaceutical composition of matter for treating or preventing hypertension, inflammation, peripheral pain or gastrointestinal disorders, comprising as an active ingredient a compound of the formula having the (3S, 4S) configuration, and which is essentially free of the (3R, 4R) enantiomer, wherein A---B designates an optional double bond, R 1 designates a variety of organic moieties, G designates hydrogen, halogen or various ether groups, and R 3 designates various alkyl groups, ether groups, or combinations thereof. 2620

IMIDAZOLYL-CYCLIC ACETALS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM 133311 אסטלים אימידזוליל סיקליק, הכנתם, והרכבים פרמצבטיים שמכילים אותם [31] [87] 12.06.1998 9712270.9 [32] 12.06.1997 60/052185 10.07.1997 9724678.9 21.11.1997 60/085499 14.05.1998 Int. Cl.8 C07D 405/00 RHONE-POULENC RORER LIMITED, UNITED KINGDOM WO/1998/056788 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] GB US GB US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A compound of the formula wherein: R 1 is heteroaryl optionally substituted by one or more heteroaryl group substituents; R 2 is aryl optionally substituted by one or more aryl group substituents or R 2 is heteroaryl optionally substituted by one or more heteroaryl group substituents; R 3 represents a group L 1 -R 7 or L 2 -R 8 [where L 1 represents a straight-or branched-chain alkylene linkage containing from 1 to about 6 carbon atoms optionally substituted by halogen or oxo; R 7 is hydrogen, aryl, cyano, cycloalkyl, heteroaryl, heterocycloalkyl, nitro, - S(O) n R 9, (where R 9 is alkyl, aryl, arylalkyl, cycloalkyl, heteroaryl, heteroarylalkyl, or 2621 heterocycloalkyl and n is zero or an integer 1 or 2), -NHSO 2 R 9, -C(=Z)OR 10 (where Z is an oxygen or sulphur atom and R 10 is hydrogen or R 9 ), -C(=Z)R 10, -N(R 11 )- C(=Z)R 9 (where R 11 is hydrogen or alkyl), -NY 1 Y 2 {where Y 1 and Y 2 are independently hydrogen, alkenyl, alkyl, alkynyl, aryl, arylalkyl, cycloalkenyl cycloalkyl, heteroaryl or heteroarylalkyl, or the group NY 1 Y 2 may form a 5-7 membered cyclic amine which may optionally contain a further heteroatom selected from O, S, or NY 3 (where Y 3 is hydrogen, alkyl, aryl, arylalkyl, -CHO, - C(=Z)R 9 or SO 2 R 9 ), or which may also be fused to additional aryl, heteroaryl,

heterocycloalkyl or cycloalkyl rings to form a bicyclic or tricyclic ring system}, - SO 2 -NY 1 Y 2, -C(=Z)-NY 1 Y 2, -N(R 11 )- C(=Z) -NY 1 Y 2, -N(OR 10 ) C(=Z) -NY 1 Y 2, -N(OR 10 )-C(=Z)R 10, -C(=NOR 10 )R 10, - C(=Z)NR 10 OR 12 (where R 12 is hydrogen, alkyl, aryl or arylalkyl), -N(R 11 )-C(=NR 13 ) -NY 1 Y 2 (where R 13 is hydrogen, cyano, alkyl, cycloalkyl or aryl), or N(R 11 )- C(=Z)OR 11 ; L 2 represents a direct bond or a straight or branched-carbon chain comprising from 2 to about 6 carbon atoms and contains a double or triple carboncarbon bond; and R 8 is hydrogen, aryl, cycloalkenyl, cycloalkyl, heteroaryl or heterocycloalkyl]; R 4 represents a group L 3 -R 14 [where L 3 represents a direct bond or a straight-or branched-chain alkylene linkage containing from 1 to about 6 carbon atoms (optionally substituted by halogen, hydroxy, alkoxy or oxo); and R 14 is hydrogen, alkyl, azido, hydroxy, alkoxy, aryl, arylalkyloxy, aryloxy, carboxy (or an acid bioisostere), cycloalkyloxy, heteroaryl, heteroarylalkyloxy, heteroaryloxy, heterocycloalkyl, heterocycloalkyloxy, nitro, -NY 4 Y 5, {where Y 4 and Y 5 are independently hydrogen, aryl, cycloalkyl, heterocycloalkyl, heteroaryl or alkyl optionally substituted by alkoxy, aryl, cyano, cycloalkyl, heteroaryl, heterocycloalkyl, hydroxy, oxo-co 2 R 10, - CONY 1 Y 2 or -NY 1 Y 2, or the group NY 4 Y 5 may form a 5-7 membered cyclic amine which (i) may be optionally substituted with one or more substitutents selected from alkoxy, carboxamido, carboxy, hydroxy, oxo (or a 5, 6 or 7 membered cyclic acetal derivative thereof), R 9 or alkyl substituted by carboxy, carboxamido or hydroxy (ii) may also contain a further heteroatom selected from O, S, SO 2 or NY 6 (where Y 6 is hydrogen, alkyl, aryl, arylalkyl, -C(=Z)R 9, - C(=Z)OR 9 or SO 2 R 9 ) and (iii) may also be fused to additional aryl, heteroaryl, heterocycloalkyl or cycloalkyl ring to form a bicyclic or tricyclic ring system), - N(R 10 )-C(=Z)-R 15 (where R 15 is alkyl, alkoxy, aryl, arylalkyloxy, cycloalkyl, heteroaryl, heteroarylalkoxy or heterocycloalkyl); -N(R 10 )-C(=Z)-L 4 -R 16 (where R 16 is alkoxy, aryl, arylalkyloxy, arylalkyloxycarbonylamino, carboxy (or an acid bioisostere), cycloalkyl, cyano, halo, heteroaryl, heteroarylalkoxy, heterocycloalkyl, hydroxy or -NY 1 Y 2, and L 4 is a straight- or branched-chain alkylene linkage containing from 1 to about 6 carbon atoms), -NR-C(=Z)-NH-R 15, -NH- C(=Z)-NH-L 4 -R 16, -N(R 10 )-SO 2 -R 15, - N(R 10 )-SO 2 -L 4 -R 16, -S(O) n R 9, -C(=Z) NY 4 Y 5 or C(=Z)-OR 9 ]; R 5 represents hydrogen, alkyl or hydroxyalkyl; or R 4 and R 5, when attached to the same carbon atom, may form with the said carbon atom a cycloalkyl, cycloalkenyl or heterocycloalkyl ring or a group C=CH 2 ; R 6 represents hydrogen or alkyl; and m is zero or an integer 1 or 2; and wherein "heteroaryl group substituent" is a substituent selected from the group consisting of acyl, acylamino, alkoxycarbonyl, alkylenedioxy, aroyl, aroylamino, aryl, arylalkyloxycarbonyl, aryloxycarbonyl, carboxy, cyano, halo, heteroaroyl, heteroaryl, heteroaroylamino, hydroxy, nitro, trifluoromethyl, R 17 Z 3-, Y 4 Y 5 N -, Y 4 Y 5 N-CO-, Y 4 Y 5 NSO 2 -, alkyl SO 2 -Y 4 N - or alkyl optionally substituted with aryl, heteroaryl, hydroxy, oxo, - CO 2 R 10, -CONY 1 Y 2 and Y 4 Y 5 N-;and "aryl group substituent" is a substituent selected from the group consisting of acyl, acylamino, alkoxy, alkoxycarbonyl, alkylenedioxy, alkylsulphinyl, alkylsulphonyl, alkylthio, aroyl, aroylamino, aryl, arylalkyloxy, arylalkyloxycarbonyl, arylalkylthio, aryloxy, aryloxycarbonyl, arylsulphinyl, arylsulphonyl, arylthio, carboxy, cyano, halo, heteroaroyl, heteroaryl, heteroarylalkyloxy, heteroaroylamino, 2622

heteroaryloxy, hydroxy, nitro, trifluoromethyl, Y 7 Y 8 N-, -Y 7 Y 8 NCO-, Y 7 Y 8 NSO 2 -(wherein Y 7 and Y 8 are independently hydrogen, alkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl), Y 7 Y 8 N-C 2-6 alkylene-z 2 -(wherein Z 2 is O, NR 5 or S(O) n ), alkyl C(=O)-Y 7 N-, alkyl SO 2 -Y 7 N- or alkyl optionally substituted with aryl, heteroaryl, hydroxy, and Y 7 Y 8 N-;and N-oxides thereof, and their ester prodrugs; and pharmaceutically acceptable salts and solvates (e.g. hydrate of compounds of formula (l) and N-oxides thereof, and their ester prodrugs. HOLLOW FIBER CO-FLOW FILTRATION DEVICE 134202 מתקן מסיבים חלולים לסינון בזרימה מקבילה [31] [87] 24.07.1998 08/907307 [32] 06.08.1997 Int. Cl.8 B01D 063/02, 063/10, 069/10 GENENTECH, INC., U.S.A. WO/1999/007458 S. HOROWITZ & CO., ZION HOUSE, 41-45 ROTHSCHILD BLVD., TEL AVIV 65784 [33] US 41-45, תל, ש. הורוביץ ושות', בית ציון, שדרות רוטשילד אביב [57] A hollow fiber membrane filtration module useful for separating species of interest from a mixture, said filtration module comprising: (a) a filter cartridge shell; and (b) a hollow fiber filter element contained within said filter cartridge shell, said hollow fiber filter element comprising a mat of hollow fibers physically layered onto the surface of a flow-restricting screen, wherein the hollow fibers of said filter element are configured into a bundle and said flow-restricting screen occupies at least 5% of the void volume between said hollow fibers such that the flow of filtrate between said hollow fibers is restricted and the transmembrane pressure is substantially constant along the entire length of the hollow fibers in said module. 2623

PHARMACEUTICAL ANTI- NOCICEPTIVE ANALGESIC COMPOSITION COMPRISING NORIBOGAINE 134796 תכשיר רוקחי אנאלגזי נגד תופעות כאב הכולל נוריבוגיין [31] [87] 03.09.1998 60/057921 [32] 04.09.1997 [33] US Int. Cl.8 A61K 031/55, A61P 025/00, C07D 471/18 NOVONEURON INC., U.S.A. WO/1999/011250 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Use of an effective amount of noribogaine or its salt for the manufacture of a pharmaceutical composition for the alleviation or elimination of nociceptive pain in a patient in the absence of chemical dependence or drug abuse, substantially as described in the specification. SEEDLESS TOMATOES AND METHODS FOR MAKING THE SAME 135587 עגבניות ללא גרעינים ושיטות להכנתן [31] [87] 23.10.1998 08/957867 [32] 27.10.1997 Int. Cl.8 A01H 001/00, 001/04, 005/00 SEMINIS VEGETABLE SEEDS, INC., U.S.A. WO/1999/021411 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] US וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] A process for producing a hybrid Lycopersicon esculentum plant which produces fruit which is 100% seedless the process comprising the steps of: (a) selecting a Lycopersicon esculentum plant containing at least one parthenocarpic gene; (b) selecting a Lycopersicon esculentum plant which is cytoplasmically male sterile and contains at least one parthenocarpic gene; and (c) crossing the plants identified in steps (a) and (b); wherein parent plants identified in steps (a) and (b) are 2624

homozygous for the parthenocarpic gene(s), and wherein said gene(s) are identical. [31] [87] ADENOVIRUS VECTORS AND METHOD FOR REDUCING THE FREQUENCY OF INTRA- OR INTERMOLECULAR HOMOLOGOUS RECOMBINATION BETWEEN CHROMOSOMAL AND EXTRA- CHROMOSOMAL NUCLEIC ACID 17.11.1998 97/14383 [32] 17.11.1997 Int. Cl.8 C12N 005/10, 015/861 AVENTIS PHARMA S.A., FRANCE WO/1999/025861 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 135983 ווקטורים אדנ וויראליים ושיטה להפחתת תדירות רקומבינציה הומולוגית בין או תוך מולקולרית, בין חומצות גרעין כרומוזומליות לבין חומצות גרעין חוץ כרומוזומליות [33] FR לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] A method for reducing the frequency of intra-or intermolecular homologous recombination events between a chromosomal nucleic acid comprising the E1 region of an adenovirus genome, as well as a flanking region, and an extrachromosomal nucleic acid which comprises an adenovirus genome defective for the E1 region, wherein said method comprises introducing into the cell comprising said chromosomal nucleic acid, said extrachromosomal nucleic acid, wherein the sequence of at least one of the two nucleic acids is a coding sequence and is degenerated. 2625

CRYSTALLINE FORMS OF HYDRATED 1S-[ALPHA (2S*,3R*) 9ALPHA]- 6,10 DIOXO N (2 ETHOXY 5 OXO TETRAHYDRO 3 FURANYL) - 9[[(1-ISOQUINOLYL) CARBONYL]- AMINO] OCTAHYDRO 6H PYRIDAZINO [1, 2 A] [1,2] DIAZEPIN 1 CARBOXAMIDE 138818 צורות גבישיות של של הידראטים S1 1] אלפא,(R*,2S3*) 9 אלפא],6 10 דיאוקסו N 2) אתוקסי 5 אוקסו טטראהידרו 3 פורניל) 9 1)]] איזוקינוליל) קרבוניל] אמינו] אוקטאהידרו H6 פירידזינו 2,1] [A [2,1] דיאזפין 1 קרבוקסאמיד [31] [72] [87] 07.04.1999 98/04367 [32] 08.04.1998 Int. Cl.8 A61K 038/06, C07K 005/023 AVENTIS PHARMA S.A., FRANCE JEAN-YVES GODARD, VALERIE ROGNON WO/1999/052935 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] FR איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] Crystalline form of anhydrous 1S- [1α(2S*, 3R*), 9α]-6, 10-dioxo-N-(2- ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1- isoquinolyl) carbonyl]amino]-octahydro- 6H-pyridazino[1,2-a] [1,2] diazepine-1- carboxamide. The applications for division from this application have not yet been published,168047 בקשות חלוקה מבקשה זו שטרם פורסמו. 2626

MECHANISM FOR MATCHING A RECEIVER WITH A SECURITY MODULE 139364 מנגנון להתאמת מקלט עם מודולת אבטחה [31] [87] 06.05.1999 PCT/IB98/00681 [32] 07.05.1998 Int. Cl.8 H04N 007/16, 007/167 NAGRACARD S.A., SWITZERLAND WO/1999/057901 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] WO וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] A pay-tv reception system comprising a receiver connected to security means, this receiver receiving descrambling information from the security means, characterized in that at least a part of the information is encrypted, before being transmitted to the receiver by said security means, with a unique encryption key stored on the one hand in the receiver and, on the other hand, in the security means, said encryption key forming a matching between the security means and the receiver, the system further comprising a verification mechanism of the conformity of said matching. 2627

139569 [31] [87] COMPACT FINGERPRINT OPTICAL SENSOR 14.05.1999 98/06090 [32] 14.05.1998 Int. Cl.8 G06K 009/00 SAGEM DEFENSE SECURITE, FRANCE WO/1999/058057 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 חיישן אופטי קומפקטי לטביעת אצבעות [33] FR ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] Optical fingerprint sensor including an optical transmission body (1) having a reception surface (8) intended to receive a finger (100), an image of whose fingerprint is to be taken, illumination means (3) for the finger, imaging means (2) having a detection surface (4) for imaging the finger through the optical transmission body and thus sensing the fingerprint according to imaging angles corresponding to the incidences of light rays of the illumination means, directed onto the reception surface with total reflection onto the grooves of the fingerprint of the finger, the sensor being characterised by the fact that the optical transmission body comprises a surface (11) for determining the magnification between the fingerprint and its image, arranged in order to direct the light rays of the illumination means towards the fingerprint and in order to modify the optical paths of the light rays coming from the illumination means so that the light rays, which are reflected onto the grooves of the fingerprint of the finger, strike the detection surface of the imaging means, leaving the body without encountering an optical element. 2628

FLUOROPHENYL RESIN COMPOUNDS AND PROCESS FOR THEIR PREPARATION 140001 תרכובות שרף פלוארו פניל ותהליך להכנה [31] [87] 23.06.1999 60/090558 [32] 24.06.1998 Int. Cl.8 C08F 212/06, 212/36 AVENTIS PHARMACEUTICALS INC., U.S.A. WO/1999/067228 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A fluorophenyl resin compound of the formula wherein s is a solid support; A is selected from L is a chemical bond, 2629

m is 1 to 5; p is 0, 1, or 2; B is F, OW, or azaheterocyclenyl; R i is CH 2 R f, R 0, R 1 and SO2Z; D is CH or N; W is hydrogen, R 2 are a ring system substituent, or R 0 and tripyrrolidinophosphonium, C(O)V, R 1 taken together with the adjacent carbon C(O)R a, C(O)NR b R c, C(O)OR a or SO 2 R a atoms through which they are linked form V is Cl or imidazol-l-yl; Y is O or NR 3 ; Z a 6 membered aryl or 5 to 6 membered is Cl, -OH, OR a or NR a R i ; R a and R f are heteroaryl; R 3 is H or lower alkyl; and R 4, independently aliphatic or aromatic; R b R 5, R 6 and R 7 are independently ring and R c are independently H, aliphatic or system substituents, or R 4 and R 5 taken aromatic, or R b and R c, taken together with together with the carbon atoms through the N atom through which they are which they are linked form a 6 membered attached, form an azaheterocyclyl or aryl or 5 to 6 membered heteroaryl. USE OF FARNESYL PROTEIN TRANSFERASE INHIBITOR FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION HAVING RADIOSENSITIZING PROPERTIES 140721 שימוש במעכב חלבון פרנזיל טרנזיל טרנספרז להכנת תכשיר רוקחי בעל תכונות המגיברות רגישות לקרינה [31] [87] 30.06.1999 98202257.6 [32] 06.07.1998 [33] EP 98204330.9 18.12.1998 EP Int. Cl.8 A61K 031/47, A61P 035/00, 043/00, C07D 401/10, 401/14, 405/14, 413/14 JANSSEN PHARMACEUTICA N.V., BELGIUM WO/2000/001411 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Use of at least one farnesyl protein transferase inhibitor for the preparation of a pharmaceutical composition having radiosensitizing properties for administration before, during or after irradiation of a tumor for treating cancer in vivo, wherein the said farnesyl protein transferase inhibitor is a compound of formula (I), or a compound of formula (II) or (III) which is metabolized in vivo to a 2630

compound of formula (I), said compounds being represented by a stereoisomeric form thereof, a pharmaceutically acceptable acid or base addition salt thereof, wherein the dotted line represents an optional bond and X, R 1 - R 19, Alk 1, Ar 1, Ar 2, are as defined in the specification. 140732 SYNTHETIC PEPTIDES FOR DIAGNOSIS AND TREATMENT OF ANTIPHOSPHOLIPID SYNDROME פפטידים סינתטיים לאבחון וטיפול בסינדרום אנטי פוספוליפיד [31] [72] [87] 06.07.1999 125262 [32] 07.07.1998 [33] IL Int. Cl.8 A61P 043/00, C07K 007/06, 014/775, 017/02 YEDA RESEARCH AND ידע חברה למחקר ופיתוח בע"מ, רחובות DEVELOPMENT CO. LTD. CABILLY, MIRI BLANK, SHMUEL מירי בלנק, שמואל קבילי, יהודה שיינפלד YEHUDA SHOENFELD AND EPHRAIM KATCHALSKI-KATZIR ואפריים קצ'לסקי-קציר WO/2000/001729 PAULINA BEN-AMI, BEN-AMI & פאולינה בן-עמי, בן עמי ושות', ASSOCIATES, P.O.B. 94, ת.ד. 94, רחובות REHOVOT 76100 [57] A synthetic peptide selected from the group consisting (i) a peptide of SEQ ID NO:1 to SEQ ID NO:7, of the sequences; 2631 Leu Lys Thr Pro Arg Val (SEQ ID NO:1); Lys Thr- Pro Arg- Val Thr (SEQ ID NO:2);

Asn- Thr Leu Lys Thr Pro Arg Thr- Lys Leu Arg- Val Tyr (SEQ ID Val Gly Gly (SEQ ID NO:3); NO:6); and Lys Asp Lys Ala Thr Phe Gly- Cys Ala Thr Leu Arg Val Tyr Thr His Asp Gly (SEQ ID NO:4); Lys Gly Gly (SEQ ID NO: 7); and (ii) a peptide of (i) that is biotinylated. AZETIDINE DERIVATIVES, THEIR PREPARATION AND MEDICINES CONTAINING THEM 141769 נגזרות של אזטידין, הכנתן ותרופות המכילות אותן [31] [87] 09.09.1999 98/11342 [32] 11.09.1998 [33] FR 60/119929 12.02.1999 US Int. Cl.8 A61P 001/00, 003/04, 009/00, 011/06, 025/30, 037/00, C07D 205/06, 401/06, 401/12, 403/12, 405/12, 409/06, 413/12, 417/06 AVENTIS PHARMA S.A., FRANCE WO/2000/015609 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] Compounds of the formula: in which R represents a chain R1 represents a methyl or a ethyl radical, alkyl, alkoxy CO-alk, hydroxyl, -COOR 5, R 2 represents either an aromatic chosen formyl, trifluoromethyl, from phenyl, naphthyl or indenyl, these trifluoromethylsulphanyl, aromatics being nonsubstituted or trifluoromethoxy, nitro, - NR 6 R 7, -CO-NHsubstituted with one or more halogen, NR 6 -R 7, -N(alk)COOR 8, cyano, - 2632

CONHR 9, -CO-NR 16 R 17, alkylsulphanyl, hydroxyalkyl O-alk-NR 12 R 13 or alkylthioalkyl or a heteroaromatic chosen from the benzofuryl, benzothiazolyl, benzothienyl, benzoxazolyl, chromanyl, 2, 3-dihydrobenzofuryl, 2, 3- dihydrobenzothienyl, indolinyl, indolyl, isochromanyl, isoquinolyl, pyridyl, quinolyl, 1, 2, 3, 4-tetrahydroisoquinolyl, 1, 2, 3, 4-tetrahydroquinolyl, thiazolyl, or thienyl, rings, it being possible for these heteroaromatics to be nonsubstituted or substituted whith a halogen, alkyl, alkoxy, -COOR 5, trifluoromethyl, trifluoromethylsulphanyl, trifluoromethoxy, nitro, -NR 6 R 7, -CO-NH- NR 6 R 7, cyano, -CONHR 9, alkylsulphanyl, hydroxyalkyl or alkylthioalkyl, R 3 and R 4, which are identical or different, represent either an aromatic chosen from phenyl, naphthyl or indenyl, these aromatics being nonsubstituted or substituted with one or more halogen, alkyl, alkoxy, formyl, hydroxyl, trifluoromethyl, trifluoromethoxy, -CO-alk, cyano, - COOR 5, -CONR 10 R 11, -CO-NH-NR 6 R 7, alkylsulphanyl, hydroxyalkyl, -alk-nr 6 R 7 or alkylthioalkyl; or a heteroaromatic chosen from benzofuryl, benzothiazolyl, benzothienyl, benzoxazolyl, chromanyl, 2, 3-dihydrobenzofuryl, 2, 3- dihydrobenzothienyl, furyl, isochromanyl, isoquinolyl, pyrrolyl, quinolyl, 1, 2, 3, 4- tetrahydroisoquinolyl, thiazolyl or thienyl rings, it being possible for these heteroaromatics to be nonsubstituted or substituted with a halogen, alkyl, alkoxy, hydroxyl, trifluoromethyl, trifluoromethoxy, cyano, -COOR 5, -CO- NH-NR 6 R 7, - CONR 10 R 11, -alk-nr 6 R 7, alkylsulphanyl, hydroxyalkyl or alkylthioalkyl, R 5 is an alkyl or phenyl radical which is optionally substituted with one or more halogen atoms, R 6 and R 7, which are identical or different, represent a hydrogen atom or an alkyl, -COOalk, cycloalkyl, alkylcycloalkyl, -alk-o-alk or hydroxyalkyl radical or alternatively R 6 2633 and R 7 together form with the nitrogen atom to which they are attached a 3-to 10- membered saturated or unsaturated monoor bicyclic heterocycle optionally containing another heteroatom chosen from oxygen, sulphur and nitrogen and being optionally substituted with one or more alkyl, -COalk, -COOalk, -CO- NHalk, -CS- NHalk, -CO-alk-NR 14 R 15, oxo, hydroxyalkyl, -alk-o-alk or CO-NH 2 radicals, R 8 represents an alkyl radical, R 9 represents a hydrogen atom or an alkyl radical or an alkyl radical substituted with dialkylamino, phenyl, cycloalkyl, (optionally substituted with COOalk) or a 3- to 10-membered saturated or unsaturated mono- or bicyclic heterocycle containing one or more heteroatoms chosen from oxygen, sulphur and nitrogen and being optionally substituted with one or more alkyl radicals, R 10 and R 11, which are identical or different, represent a hydrogen atom or an alkyl radical or alternatively R 10 and R 11 together form with the nitrogen atom to which they are attached a 3- to 10-membered saturated mono-or bicyclic heterocycle optionally containing another heteroatom chosen from oxygen, sulphur and nitrogen and being optionally substituted with an alkyl radical, R 12 and R 13, which are identical or different, represents a hydrogen atom or an alkyl or cycloalkyl radical or alternatively R 12 and R 13 together form with the nitrogen atom to which they are attached a 3- to 10-membered saturated mono-or bicyclic heterocycle optionally containing another heteroatom chosen form oxygen, sulphur and nitrogen and being optionally substituted with an alkyl, -COalk, - COOalk, -CO-NHalk, -CS- NHalk or COalk-NR 14 R 15 radical or a 3- to 10- membered saturated mono-or bicyclic heterocycle containing a heteroatom chosen from oxygen, sulphur and nitrogen, R 14 and R 15, which are identical or different, represent a hydrogen atom or an alkyl or COOalkyl radical, R 16 and R 17

together form with the nitrogen atom to which they are attached a 3- to 10- membered saturated mono- or bicyclic heterocycle optionally containing another heteroatom chosen from oxygen, sulphur and nitrogen, R' represents a hydrogen atom or a CO-alk radical, alk represents an alkyl or alkylene radical, it being understood that the alkyl and alkylene radicals and portions and the alkoxy radicals and portions are in the form of a straight or branched chain and contain 1 to 6 carbon atoms, their optical isomers and their salts with an inorganic or organic acid. 141775 AGLYCO PRODUCTS AND USES THEREOF מוצרי אגליקו והשימוש בהם [31] [87] 30.08.1999 09/146755 [32] 04.09.1998 [33] US Int. Cl.8 A61K 031/7008, 038/10, A61P 031/18, 035/00, C07K 007/08, G01N 033/53 SAMUEL BOGOCH, U.S.A. ELENORE S. BOGOCH, U.S.A. WO/2000/018351 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] An isolated peptide having the amino acid sequence of SEQ ID NO:1, or SEQ ID NO: 2, or both. The applications for division from this application have not yet been published,192679 בקשות חלוקה מבקשה זו שטרם פורסמו. 2634

PROCESS FOR THE PREPARATION OF ALKYL MERCAPTO METHYL ERGOLINE DERIVATIVES AND SOME NOVEL INTERMEDIATES OBTAINED THEREWITH 141920 תהליך להכנת נגזרות של אלקיל מרקפטו מתיל ארגולין ומספר תרכובות ביניים חדשות המתקבלות במהלכו [31] [87] 31.12.1999 MI99A000146 [32] 27.01.1999 [33] IT Int. Cl.8 A61P 025/16, C07D 457/02, C12P 017/18 POLI INDUSTRIA CHIMICA SPA, ITALY WO/2000/044748 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A process for the preparation of a compound of the formula wherein R 4 is a saturated or unsaturated C 1-8 alkyl radical, comprising the following steps: (a) a compound of the formula 2635

wherein R 1 represents a saturated or unsaturated C 1-8 alkyl residue, is reacted with 3-halo- and/or 2-halo-propionyl chloride in an aprotic organic solvent in the presence of a proton acceptor; (b) the compound or mixture of compounds so obtained in step (a) is then reacted with calcium borohydride in tetrahydrofuran at a temperature between 10 and 65 o C; (c) the compound so obtained in step (b) is reacted in an aprotic organic solvent with an alkylsulphonyl chloride in the presence of a proton acceptor; (d) the compound so obtained in step (c) is then reacted in an aprotic organic solvent with a compound of formula R 4 SX, wherein R 4 has the meaning given above and X is an alkali metal; (e) the compound so obtained in step (d) is converted into compound VI by treatment with a reducing agent in an aprotic organic solvent. Also claimed as new are compounds of the formula wherein R 2 and R 3 are halogen and hydrogen, respectively, or are bonded to one another by a double bond and R 1 represents a saturated or unsaturated C 1-8 alkyl residue; 2636

wherein X is a halogen or a compound of the general formula R 5 SO 3 - and R 5 is selected from methyl, ethyl, p-tolyl and wherein R 4 is saturated or unsaturated C 1-4 alkyl residue. This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728-1968 פירוט זה נבחן בהתאם לתקנה 35 לתקנות הפטנטים, תשכ"ח 1968 2637

USE OF A PRO172 POLYPEPTIDE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR INHIBITING NEOPLASTIC CELL GROWTH 142088 שימוש בפוליפפטיד PRO172 להכנת תכשירים רוקחיים לעיכוב הגידול של תאים ניאופלסטיים [31] [87] 05.10.1999 60/104080 [32] 13.10.1998 [33] US Int. Cl.8 A61K 038/17, A61P 043/00, C07K 014/47, C12N 015/12, 015/62 GENENTECH, INC., U.S.A., WO/2000/021996 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Use of a PRO 172 polypeptide in the preparation of a pharmaceutical composition for inhibiting the growth of a tumor cell, wherein said PRO 172 polypeptide comprises at least about 80% amino acid sequence identity to (a) residues 1 or 22 to 723 of the PRO 172 polypeptide shown in Figure 8 as shown in the specification (SEQ ID NO:21), (b) X to 723 of the PRO 172 polypeptide shown in Figure 8 (SEQ ID NO:21), wherein X is any amino acid residue from 17 to 26 of Figure 8 (SEQ ID NO:21) or (c) 1 or 22 to X of Figure 8 (SEQ ID NO:21), wherein X is any amino acid from amino acid 543 to amino acid 552 of Figure 8 (SEQ ID NO:21). The applications for division from this application have not yet been published,189502 בקשות חלוקה מבקשה זו שטרם פורסמו. 2638

PROTEIN HAVING TOXIN ACTIVITY AGAINST A COLEOPTERAN INSECT, A POLYNUCLEOTIDE ENCODING THE PROTEIN AND METHODS USING THE PROTEIN 142170 חלבון בעל פעילות רעלן נגד חרק קשי כנפיים, פולינוקליוטיד המקודד לחלבון ושיטות המשתמשות בחלבון [31] [87] 21.08.2000 09/378088 [32] 20.08.1999 [33] US Int. Cl.8 A01N 063/00, C07K 014/325, C12N 001/21, 015/32, 015/82, C12R 001/07 MYCOGEN CORPORATION, U.S.A. WO/2001/014417 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] An isolated polynucleotide that encodes a protein having toxin activity against a coleopteran insect, wherein the complement of said polynucleotide hybridizes under stringent conditions with a nucleotide sequence selected from the group consisting of SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO: 53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO:61, SEQ ID NO:63, SEQ ID NO: 65, SEQ ID NO:67, SEQ ID NO:69, SEQ ID NO:71, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO: 77, SEQ ID NO:79, SEQ ID NO:81, SEQ ID NO:83, SEQ ID NO:85, SEQ ID NO:87, SEQ ID NO: 89, SEQ ID NO:91, SEQ ID NO:93, SEQ ID NO:95, SEQ ID NO:97, SEQ ID NO:99, SEQ ID NO: 101 SEQ ID NO:103, SEQ ID NO:105, SEQ ID NO:107, SEQ ID NO:109, SEQ ID NO:111, SEQ ID NO:113, SEQ ID NO:115, SEQ ID NO:117, SEQ ID NO: 119, SEQ ID NO:121, SEQ ID NO:123, SEQ ID NO:125, SEQ ID NO:131, SEQ ID NO:132, SEQ ID NO:133, SEQ ID NO:135, SEQ ID NO: 137, SEQ ID NO: 139, SEQ ID NO: 141, SEQ ID NO: 143, SEQ ID NO: 145, SEQ ID NO: 147, SEQ ID NO: 149, SEQ ID NO; 151, SEQ ID NO: 153, SEQ ID NO: 155, SEQ ID NO: 156, SEQ ID NO: 157, SEQ ID NO: 158, SEQ ID NO: 160, SEQ ID NO: 161, SEQ ID NO: 162, SEQ ID NO: 163, SEQ ID NO: 164, SEQ ID NO: 165 and SEQ ID NO: 166. 2639

142179 BIOCOMPATIBLE, BIODEGRADABLE, WATER- ABSORBENT MATERIAL AND METHODS FOR ITS PREPARATION 21.03.2001 חומר מתאים לחומר מן החי, מתכלה וסופג מים ושיטות להכנתו Int. Cl.8 A61F 013/00, A61K 047/00, A61L 015/22, C08F 210/00, 210/02, 218/00, 220/00, C08J 003/24, C08L 001/00, 003/00, 005/00, C09K 017/18 EXOTECH BIO SOLUTION LTD. אקסוטק ביו סולושין בע"מ, קרית גת SELIGSOHN GABRIELI & CO., זליגסון גבריאלי ושות', 31 YAVNE ST., רח' יבנה, 31 ת.ד. 1426, תל אביב P.O.B. 1426, TEL AVIV 61013 [57] A bio-compatible, biodegradable macromolecular water-absorbent polymeric matrial having a threedimensional configuration with intermolecular covalent bonds and containing free functional groups selected from OH, SH, NH 2, and COOH, said polymer being formed by polymerpolymer inter-coupling interaction between a natural water-soluble polymer A or its derivatives having a molecular weight between 20,000 and 500,000 Da, and a synthetic polymer B in a ratio of A:B of 15:85 to 85:15, wherein the natural watersoluble polymer A is selected from the group consisting of: (A1) a non-ionic natural, partially denatured or chemically modified polymer, that does not dissociate in water and which can undergo polymer-polymer intercoupling reactions, having only free hydroxyl groups in an amount of at least 5x10-3 moles OH/g, and optionally containing non-ionic groups, (A2) an anionic natural, partially denatured or chemically modified polymer, that dissociates in water to form anions and which can undergo polymer-polymer intercoupling reactions, said polymer optionally containing non-ionic groups, (A3) a cationic natural, partially denatured or chemically modified polymer, that dissociates in water to form cations and which can undergo polymer-polymer intercoupling reactions, said polymers optionally containing non-ionic groups, (A4) an amphoteric natural, partially denatured or chemically modified polymer, that dissociates in water to form both anions and cations and which can undergo polymer-polymer intercoupling reactions, and (A5) mixtures of A1-A4, polymer A being capable of undergoing polymer-polymer intercoupling, and wherein: the synthetic polymer B is a linear or branched reactive synthetic copolymer having a molecular weight of 10,000-500,000 Da derived from a vinyl monomer and an ethylenically unsaturated monomer, said copolymer having a backbone with polymeric subunits R n and R r wherein R represents a subunit covalently bonded to the polymer backbone, n represents non-reactive chemical functional groups and r represents reactive chemical functional groups. 2640

METHOD FOR DIAGNOSING AND IMPROVING VISION 142328 שיטה לאיבחון ושיפור הראיה [31] [87] 01.10.1999 60/102813 [32] 02.10.1998 Int. Cl.8 A61B 017/32 SCIENTIFIC OPTICS, INC., U.S.A. WO/2000/019918 EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120 [33] US קבוצת איתן מהולל, עורכי דין ועורכי פטנטים, שדרות אבא אבן, 10 ת.ד. 2081, הרצליה [57] A method for diagnosing, analyzing or planning the treatment of the cornea of an eye, said method being performed with the aid of a computer system running a topological modeling computer program which, making use of sampled points on the cornea for which the coordinates are known relative to a reference plane, produces a surface model of said cornea which closely represents the surface of the cornea, said method comprising the steps of: modifying the shape of the surface model enough to change the radius of curvature at a plurality of selected points to achieve a correction in vision indicated to be necessary by an eye test, without introducing substantial changes in shape that are not associated with changing the radius of curvature, to produce a corrected surface model; and at least one of: viewing the surface model or the corrected surface model on a display device; and utilizing the corrected surface model to produce information to control the laser ablation of the cornea. The applications for division from this application have not yet been published,176601 בקשות חלוקה מבקשה זו שטרם פורסמו. 2641

142366 CONVERSATIONAL BROWSER AND CONVERSATIONAL SYSTEMS מעלעל דיבורי ומערכות דיבוריות [31] [87] 01.10.1999 60/102957 [32] 02.10.1998 [33] US 60/117595 27.01.1999 US Int. Cl.8 G06F 003/16, 017/30, G10L 013/00, 015/00, H04M 003/487, 003/493, 003/50 LENOVO (SINGAPORE) PTE. LTD., SINGAPORE WO/2000/021232 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] A conversational browsing system, comprising: a conversational browser comprising: a command and control interface for converting an input command; and a CML (conversational markup language) processor for parsing and interpreting a CML file, the CML file comprising meta-information representing a conversational user interface for presentation to a user; a conversational engine for decoding input commands for interpretation by the command and control interface and decoding meta-information provided by the CML processor for generating synthesized audio output; and a communication stack for transmitting the navigation request to a content server and receiving a CML file from the content server based on the navigation request. 2642

142596 REPLICATION DEFICIENT BACULOVIRUS EXPRESSION SYSTEM מערכת ביטוי בקיולוירוס נטולת רפליקציה [31] [87] 14.08.2000 9919409.4 [32] 18.08.1999 [33] GB Int. Cl.8 C12N 001/19, 001/21, 005/10, 015/81, 015/866 NATURAL ENVIRONMENT RESEARCH COUNCIL, UNITED KINGDOM OXFORD BROOKES UNIVERSITY, UNITED KINGDOM WO/2001/012829 EITAN, PEARL, LATZER AND איתן, פרל, לצר וכהן צדק, COHEN ZEDEK, P.O.B. 12688, רחוב שנקר, 7 ת.ד. 12688, הרצליה HERZLIYA 46733 [57] Method for cloning a gene (a) a nucleic acid sequence which is comprising the steps of: capable of restoring replication in the (i) providing a replication-deficient replication-deficient baculovirus vector; baculovirus vector capable of being and maintained in an intermediate cell, wherein (b) at least one gene to be cloned; the intermediate cell is a yeast cell or a (iii) allowing the replication-deficient bacterial cell, the replication deficient baculovirus vector and rescue vector to baculovirus vector comprising one or more recombine in an insect cell to produce a nucleic acid sequences which enable the replication-enabled baculovirus vector vector to replicate within the intermediate comprising the at least one gene to be host; cloned; and (ii) providing a rescue vector encoding: (iv) growing the replication-enabled baculovirus vector within the insect cell. 2643

142699 SYSTEM AND METHOD FOR FREQUENCY UP-CONVERSION מערכת ושיטה להעלאת תדר [31] [87] 18.10.1999 09/176154 [32] 21.10.1998 09/176022 21.10.1998 09/293580 16.04.1999 09/293095 16.04.1999 09/293342 16.04.1999 Int. Cl.8 H03C 001/62 PARKERVISION, INC., U.S.A. WO/2000/024116 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] US US US US US וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] A method of up-converting, comprising: (1) gating a first reference signal under the control of a first modulated information signal to generate a first gated signal; and (2) isolating at least one harmonic of the first gated signal to generate a first upconverted information signal. 142766 IMAGING DEVICE התקן הדמייה [31] [87] 12.10.1999 9824276.1 [32] 05.11.1998 [33] GB Int. Cl.8 G01T 001/24, H01L 027/14, H04N 003/15, 005/32 IPL INTELLECTUAL PROPERTY LICENSING LIMITED, CYPRUS WO/2000/028729 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] An imaging device (6) for imaging radiation, the imaging device comprising an image cell array including an array of detector cells (11) for generating charge in response to incident radiation and a corresponding array of pixel circuits (12) comprising accumulation circuitry (53) for accumulating pixel image values corresponding to incident radiation on respective detector cells, each pixel circuit being associated with a respective detector cell, wherein said accumulation circuitry comprises counting circuitry for counting plural radiation hits incident on said associated detector cell, and said pixel image value comprises a count value of 2644

said hits, characterised in that: the imaging device is adapted for scan imaging radiation in a Time Delay Integration (TDI) mode, and each pixel circuit is controllable to transfer a pixel image value to an adjacent pixel circuit (49), said pixel circuit being operable to receive a pixel image value from an adjacent pixel circuit (48). USE OF AN ALIQUOT OF A MAMMAL'S BLOOD IN THE PREPARATION OF A MEDICAMENT FOR PREVENTING PROGRESSION OF ATHEROSCLEROSIS IN MAMMALS 143160 שימוש בקרטב של דם היונק בהכנת תרופה למניעת התקדמות של טרשת עורקים ביונקים [31] [87] 13.11.1999 09/190236 [32] 13.11.1998 09/304262 06.05.1999 Int. Cl.8 A61K 035/14 VASOGEN IRELAND LIMITED, IRELAND WO/2000/029003 SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013 [33] US US זליגסון גבריאלי ושות', רח' יבנה, 31 ת.ד. 1426, תל אביב [57] Use in preparation of a medicament for preventing progression of 2645 atherosclerosis in a mammal, of an aliquot of the mammal's blood which has been

subjected extracorporeally to an environment. electromagnetic emission and an oxidative 143276 DEVICE AND METHOD FOR DEPLOYMENT OF A MESH IN LAPAROSCOPIC HERNIA REPAIR 21.05.2001 Int. Cl.8 A61B 017/00, 017/11 ELIAHU ANTEBI ELIAHU ANTEBI, 102 ROTSCHILD BLVD., TEL AVIV התקן ושיטה לפרישת רשת בניתוח לפרוסקופי של הרניה אליהו ענתבי, תל אביב אליהו ענתבי, שד' רוטשילד 102, תל אביב [57] A device for inserting and internally deploying a mesh and for positioning the mesh over a hernia defect in a laparoscopic hernia repair, comprising: (a) a hollow tubular capsule (2) having a proximal end and distal end; (b) a central rod (8) extending along the central longitudinal axis of said tubular capsule; (c) a folded mesh (12) located inside the capsule, having a releasable connection to said rod, wherein said mesh is built with a mesh frame so constructed as an inverted closed umbrella (22, 23) and said mesh is extendable, in a manner similar to that of an umbrella, to an open planar configuration when pushed out from the distal end of said capsule and extended; (d) extending means for both pushing the mesh out of the capsule and for opening the mesh to the open planar configuration. 2646

PALLADIUM-SUBSTITUTED BACTERIOCHLOROPHYLL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM 143591 תולדות בקטריוכלורופיל המותמרות בפאלאדיום, הכנתן ותכשירי רוקחות המכילים אותן [31] [72] [87] 09.12.1999 98403110.4 [32] 09.12.1998 [33] EP Int. Cl.8 A61K 031/409, 038/38, A61P 035/00, C07D 487/22, C12P 017/18 YEDA RESEARCH AND ידע חברה למחקר ופיתוח בע"מ, רחובות DEVELOPMENT CO. LTD. YORAM SALOMON, HUGO SCHEER, ALEXANDER BRANDIS, AVIGDOR SCHERZ WO/2000/033833 PAULINA BEN-AMI, BEN-AMI & פאולינה בן-עמי, בן עמי ושות', ASSOCIATES, P.O.B. 94, ת.ד. 94, רחובות REHOVOT 76100 [57] A compound of the formulae 2647

2648

A represents OH, -O-R 1, -O-(CH 2 ) n -Y, -S-(CH 2 ) n -Y, -NH-(CH 2 ) n -Y, -O-(CH 2 ) 2 -OH, -NH-(CH 2 ) 2 -NH-BOC or -N-(CH 2 -CH=CH 2 ) 2 wherein R 1 represents Na +, K +, (Ca 2+ ) 0.5, (Mg 2+ ) 0.5, Li +, NH + 4, + NH 3 -C(CH 2 OH) 3, + NH 3 -CH 2 - (CHOH) 4 -CH 2 OH, + NH 2 (CH 3 )-CH 2 - (CHOH) 4 -CH 2 OH or + N(C n H 2n+1 ) 4 ; R 2 represents H, OH or COOR 4, wherein the compound is of formula I, wherein R 4 is C 1 -C 12 alkyl or C 3 -C 12 cycloalkyl, or R 2 represents H or C 1 -C 12 alkyl when the compound is of formula I'; R 3 represents H, OH or C 1 -C 12 alkyl or alkoxy when the compound is of formula l, or R 3 represents H or C 1 -C 12 alkyl when the compound is of formula l'; n is 1, 2, 3, 4, 5 or 6, Y is NR' 1 R' 2 or - + NR' 1 R' 2 R' 3, X - wherein R' 1, R' 2 and R' 3 independently from each other represent CH 3 or C 2 H 5 ; X is F, Cl, Br or I, N' is 1, 2, 3 or 4, and wherein * denotes an asymmetric carbon and --- represents a single saturated bond or a double unsaturated bond. 143604 [31] [72] [87] DISPERSIBLE CONCENTRATE FOR THE DELIVERY OF CYCLOSPORIN 30.12.1999 09/223378 [32] 30.12.1998 Int. Cl.8 A61K 009/00 DEXCEL LTD. ABRAHAM J. DOMB WO/2000/040219 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15 TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 [33] US תרכיז לעשיית תרחיף לאספקת סיקלוספורין דקסל בע"מ, חדרה אברהם י. דומב ג'י.אי.ארליך (1995) בע"מ, מגדל אילון, קומה 15,רחוב מנחם בגין 11, רמת גן [57] A composition for administering a cyclosporin compound, the composition comprising: (a) a dispersible concentrate characterized by being capable of forming, upon contact with an aqueous solution, particles of a size of less than about 100 nm, said dispersible concentrate comprising: (i) at least one surfactant; and (ii) an amphiphilic solvent comprising a lower alkyl hydroxy alkanoic acid ester or a lower alkyl ester of N-alkyl pyrrolidone; and (b) a pharmaceutically effective amount of the cyclosporin compound. 2649

HUMAN AKT-3, PHARMACEUTICAL COMPOSITION COMPRISING IT, USES THEREOF AND METHODS FOR IDENTIFYING AGENTS WHICH INFLUENCE ITS ACTIVITY 143862 AKT 3 ממקור אנושי, תכשירי רוקחות המכילים אותו, שימושים שלו ושיטות לזיהוי חומרים המשפיעים על פעילותו [31] 17.12.1999 9828375.7 [32] 22.12.1998 [33] GB Int. Cl.8 A61K 038/45, 039/395, 048/00, A61P 035/00, C07K 016/40, C12N 009/12, 015/10, 015/11, 015/54, 015/70, C12Q 001/48, G01N 033/566 JANSSEN PHARMACEUTICA N.V. [87] WO/2000/037613 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A nucleic acid molecule encoding human Akt-3 protein or a functional equivalent thereof, comprising the amino acid sequence set forth in SEQ ID No. 3, wherein a functional equivalent is an Akt-3 protein capable to phosphorylate histone H2B when expressed and purified as a recombinant GST fusion protein. SULFOALKYL ETHER CYCLODEXTRIN BASED CONTROLLED RELEASE SOLID PHARMACEUTICAL FORMULATIONS 143900 הרכבי רוקחות מוצקים לשחרור מבוקר המבוססים על סולפואלקילאתר ציקלודקסטרין [31] [87] 11.01.2000 09/229513 [32] 13.01.1999 [33] US Int. Cl.8 A61K 009/20, 009/28, 047/40, C08B 037/00, 037/16 CYDEX, INC., U.S.A. WO/2000/041704 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 2650

[57] A controlled release solid pharmaceutical formulation comprising: a core comprising a first composition comprising a physical mixture of a therapeutic agent and at least one sulfoalkyl ether cyclodextrin, wherein a major portion of the therapeutic agent is not complexed with the sulfoalkyl ether cyclodextrin; and a coating surrounding said core and consisting of a film forming agent; wherein, said therapeutic agent of the first composition is released from the core at a controlled rate in the absence of a pore forming agent in the coating. SELECTION OF PROTEINS USING RNA-PROTEIN FUSIONS 144518 בחירת חלבונים בשימוש מיזוגי RNA חלבון [31] [87] 01.02.2000 247190 [32] 09.02.1999 [33] US Int. Cl.8 C12N 015/00, 015/10, 015/62, C12Q 001/68, C40B 005/010000 G01N 033/68 THE GENERAL HOSPITAL CORPORATION, U.S.A. WO/2000/047775 SELIGSOHN GABRIELI & CO., זליגסון גבריאלי ושות', 31 YAVNE ST., P.O.B. 1426, רח' יבנה, 31 ת.ד. 1426, תל אביב TEL AVIV 61013 [57] A method for producing a protein library, comprising the steps of: (a) providing a population of RNA molecules, each of which comprises a translation initiation sequence and a start codon operably linked to a protein coding sequence and each of which is operably linked to a peptide acceptor at the 3' end of said protein coding sequence; (b) in vitro translating said protein coding sequences to produce a population of RNA-protein fusions; and (c) further incubating said population of RNA-protein fusions under high salt conditions, thereby producing a protein library. 2651

2,6,9-TRISUBSTITUTED PURINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR INHIBITION OF CYCLIN DEPENDENT KINASE 2 AND IKB-A 144675 תולדות פיורין מותמרות בעמדות 6,2 ו 9 ותכשירי רוקחות המכילים אותן לעכב קינאז 2 התלוי בציקלין ו a BkI [31] [87] 20.01.2000 09/241224 [32] 01.02.1999 [33] US Int. Cl.8 A01N 043/90, A61K 031/52, A61P 009/00, 013/10, 019/00, 025/00, 029/00, 031/10, 035/00, 037/00, C07D 473/00, 473/16 CV THERAPEUTICS, INC., U.S.A. WO/2000/044750 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] A 2, 6, 9-trisubstituted purine compound selected from the group consisting of: {2-[(2-aminoethyl) amino]-9-(methylethyl) purin-6-yl} [(4-chlorophenyl) methyl] amine; {2-[(aminopropyl) amino]-9- (methylethyl)purin-6-yl} [(4-chlorophenyl) methyl] amine; 2-[(2-aminoethyl) (6-{[(4-chlorophenyl) methyl] amino}-9-(methylethyl) purin-2- yl) amino] ethan-1-ol; 2652

and 2-[(2-hydroxyethyl) (6-{[(4-chlorophenyl) methyl] amino}-9-(methylethyl) purin-2- yl) amino] ethan-1-ol. METHOD AND DEVICE FOR EXECUTING METHOD STEPS 144681 התקן ושיטה לביצוע שלבים של שיטה [31] [72] 01.08.2001 10038772.1 [32] 09.08.2000 [33] DE Int. Cl.8 B41F 033/00, 033/16, G05B 019/04, G06F 011/34, G06K 015/02 HEIDELBERGER DRUCKMASCHINEN AG, GERMANY PETER SCHLEMM EITAN, PEARL, LATZER AND איתן, פרל, לצר וכהן צדק, COHEN ZEDEK, P.O.B. 12688, רחוב שנקר, 7 ת.ד. 12688, הרצליה HERZLIYA 46733 [57] Method of executing method steps, wherein an output signal is generated in a method step, characterized in that it is 2653 checked whether an output mode is switched on, and in that the output signal is output only if the output mode is switched on.

2654

USE OF FLUORINATED TRIAZOLES IN THE PREPARATION OF MEDICAMENTS FOR TREATING NEUROPATHIC PAIN 144852 שימוש בטריאזולים שעברו פלואורינציה להכנת תרופות לטיפול בכאב של מערכת העצבים [31] [87] 28.02.2000 09/259911 [32] 01.03.1999 [33] 09/259910 01.03.1999 Int. Cl.8 A61K 031/4192, 045/06, A61P 025/00 NOVARTIS AG, SWITZERLAND WO/2000/051577 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 US US לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] Use of a compound of the formula wherein Ph is o-fluorinated phenyl, which may be additionally substituted by 1 or 2 halogen atoms selected from the group consisting of fluorine and chlorine; R 1 is hydrogen, carbamoyl, N-(C 2 -C 5 ) alkanoylcarbamoyl or N,N-di (C 1 -C 4 ) alkylcarbamoyl; and R 2 is carbamoyl, N- (C 2 -C 5 ) alkanoylcarbamoyl or N,N-di(C 1 - C 4 ) alkylcarbamoyl, for the preparation of a pharmaceutical composition for the treatment of neuropathic pain. The applications for division from this application have not yet been published,189190 בקשות חלוקה מבקשה זו שטרם פורסמו. 2655

[72] PROCESS FOR PRODUCING APERTURES IN DRIPPER IRRIGATION PIPES AND DRIPPER UNITS FOR USE IN SAID PROCESS 14.08.2001 Int. Cl.8 B05B 001/20 D.R.T.S. ENTERPRISES LTD., U.S.A. RAMI HASHIMSHONY, TZADOK YEHIEL DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063 144891 תהליך ליצירת נקבים בצינורות השקיה בטפטוף ויחידות טפטוף לשימוש בתהליך האמור רמי השמשוני, צדוק יחיאל ד"ר יצחק הס ושותפיו, רחוב הירקון, 279 ת.ד. 6451, תל אביב [57] A dripper unit (430, 450) for use in a process for cutting holes in drip irrigation pipes, the dripper unit being characterized by having at least one outward protrusion (440) useful for forming a respective bulge in a drip irrigation pipe accommodating the dripper unit. 2656

145866 NUCLEIC ACID SEQUENCES ENCODING AN ORGANIC ANION TRANSPORT PROTEIN רציפויות חומצת גרעין המקודדים חלבונים המובילים אניון אורגני [31] [87] 19.05.2000 60/135081 [32] 20.05.1999 [33] US Int. Cl.8 A61K 038/17, C07K 014/435, 016/18, 019/00, C12N 015/12, 015/63, G01N 033/53, 033/567 BRISTOL-MYERS SQUIBB COMPANY, U.S.A. WO/2000/071566 WOLFF, BREGMAN AND GOLLER, וולף, ברגמן וגולר, P.O.B. 1352, JERUSALEM 91013, ת.ד. 1352, ירושלים [57] A purified and isolated nucleic acid sequence encoding all or a portion of an organic anion transport protein ("OATP"), said OATP comprising an amino acid sequence selected from the group consisting of SEQ ID NO:2 (OATP2), SEQ ID NO:4 (OATP-RP2), SEQ ID NO:6 (OATP-RP3), SEQ ID NO:8 (OATP-RP4), SEQ ID NO:10 (OATP- RP5), and SEQ ID NO:12 (OATP-RP1). METHOD AND SYSTEM FOR DOWN-CONVERTING AN ELECTROMAGNETIC SIGNAL AND TRANSFORMS FOR SAME 145908 שיטה ומערכת להמרה לתדר נמוך יותר שלאות אלקטרומגנטי, ומתמרים עבורה [31] [87] 14.04.2000 60/129839 [32] 16.04.1999 09/521878 09.03.2000 Int. Cl.8 H03D 007/00 PARKERVISION, INC., U.S.A. WO/2000/064042 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] US US וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] A method for down-converting an electromagnetic signal, comprising the steps of: (1) performing, using a switching module, a matched filtering/correlating operation, in which a duration of a sampling aperture 2657 is an approximate half cycle of a carrier signal, by convolving an approximate half cycle of the carrier signal with a representation of itself; (2) accumulating, via an integrating module, the result of the matched

filtering/correlating operation of step (1); and (3) repeating steps (1) and (2) for additional portions of the carrier signal, whereby the accumulation results form a down-converted signal, wherein if the carrier signal has an analog form, then the down-converted signal has the analog form and if the carrier signal has a digital form, then the down-converted signal has the digital form. STEP-BY-STEP ALKYLATION OF POLYMERIC AMINES 146208 אלקילציה בשלבים ואמינים פולימריים [31] [87] 02.05.2000 19919708.3 [32] 30.04.1999 [33] DE Int. Cl.8 B01D 071/68, C08G 065/48, C08L 081/06 THOMAS HARING, GERMANY WO/2000/066254 JMB, FACTOR & CO. LTD., ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים, ת.ד.,45087 PARK, HAR HOTZVIM HI-TECH P.O.B. 45087, ירושלים JERUSALEM 91450 [57] A polymer or polymer membrane formation of the tertiary amino group to containing secondary and/or tertiary amino form an electrophilically induced groups, and containing electrophilically functional group; wherein the electrophilic induced functional groups, which is agent comprises SO 2 Cl 2 or SO 2, and at obtained by the following: deprotonating a least one other agent selected from the primary amino group on a polymeric group consisting of SO 2, SO 3, SO 2 Cl 2, amine first with an organometallic base SOCl 2, CO 2, COCl 2, PCl 5, POCl 3, Cland then reacting with an alkyl halide to PO(OR) 2, aromatic ketones, aromatic give a secondary amino group; wherein an aldehydes, aromatic carboxylic esters, and electrophilic agent is introduced after aromatic carbonyl chlorides. 2658

MICROORGANISM HAVING AN ATTENUATING MUTATION WHICH DISRUPTS THE EXPRESSION OF THE SSAV GENE AND AN ATTENUATING MUTATION WHICH DISRUPTS THE EXPRESSION OF THE AROC GENE 146255 מיקרואורגניזם בעל מוטציה מחלישה המשבשת את הביטוי של הגן ssav ובעל מוטציה מחלישה המשבשת את הביטוי של הגן aroc [31] [87] 09.05.2000 9910812.8 [32] 10.05.1999 [33] GB Int. Cl.8 A61K 039/112, C07K 014/255, C12N 001/20 MICROSCIENCE LIMITED, UNITED KINGDOM WO/2000/068261 DR. YITZHAK HESS & PARTNERS, ד"ר יצחק הס ושותפיו, 279 HAYARKON ST., P.O.B. 6451, רחוב הירקון, 279 ת.ד. 6451, תל אביב TEL AVIV 61063 [57] A Salmonella microorganism having an attenuating mutation which disrupts the expression of the ssav gene and an attenuating mutation which disrupts the expression of the aroc gene. The applications for division from this application have not yet been published,186993 בקשות חלוקה מבקשה זו שטרם פורסמו. 2659

[31] [72] [87] PROCESS FOR PREPARING (1R,2S,4R) - (-) - 2 - [2(2' - {N,N - DIMETHYLAMINO} - ETHOXY)] - 2 - [PHENYL1 ] - 1,7,7 - TRI - [METHYL] - BICYCLO [2.2.1] HEPTANE 10.05.2000 P9901559 [32] 11.05.1999 Int. Cl.8 C07C 213/02, 217/00, 217/02 EGIS GYOGYSZERGYAR RT., HUNGARY GYULA LUKACS, GYULA SIMIG, TIBOR MEZEI, ZOLTAN BUDAI, MARTA PORCS-MAKKAY, GYORGEY KRASZNAI, KALMAN NAGY, GYORGYI DONATH VERECZKEY, TIBOR SZABO, NORBERT NEMETH, JANOS SZYLAGYI WO/2000/068181 DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 146421 תהליך הכנה של 2 )] ( ETHOXY DIMETHYLAMINO N, N) '2)2] 2 ( ) (4R, S2, R1) HEPTANE [2.2.1] BICYCLO [METHYL] TRI 1,7,7 [[1PHENYL [33] HU ד"ר מרק פרידמן בע"מ, מגדל משה אביב, ק. 54, רח ז'בוטינסקי 7, רמת- גן [57] A process for preparing (1R, 2S, 4R)-(-)-2-[(2'-{N,N-dimethylamino}- ethoxy)]-2- [phenyl]-1,7,7-tri-[methyl]- bicyclo [2, 2,1] heptane of the formula or a pharmaceutically acceptable acid addition salt thereof, which comprises converting (+)-1,7,7-tri-[methyl-[bicycle [2, 2,1] heptane-2-one {(+)-camphor} of the formula 2660

into (1R, 2S, 4R)-(-)-2-[phenyl]-1,7,7-tri- [methyl]-bicyclo [2,2,1] heptane-2-ol of the formula by reacting the former with a metalloorganic compound, if necessary carrying out a decomposition of the reaction product, and reacting the (1 R, 2S, 4R)-(-)- 2-[phenyl]- 1, 7,7-tri-[methyl]-bicyclo [2,2,1] heptane-2-ol of Formula III thus obtained with a (2-{halogeno}-ethyl)- dimethylamine in the presence of a basic salt forming agent in an organic solvent and, if desired, converting the base (1R, 2S, 4R)-(-)-2-[(2-{N, N-dimethylamino}- ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]- bicyclo [2,2,1] heptane of formula I thus obtained into a salt, wherein the reaction of (1R, 2S, 4R)-(-)-2-[phenyl]- 1, 7, 7-tri- [methyl]-bicyclo[2,2,1] heptane-2-ol of formula III and (2-{halogeno}-ethyl)- dimethylamine is carried out in a medium containing one or more compounds having a 5-or 6-membered saturated heterocyclic ring with 2 oxygen ring atoms as a solvent. 2661

METHOD OF IDENTIFYING A POLYNUCLEOTIDE OF A MICROBE THAT IS EXPRESSED IN VIVO 146544 שיטה לזיהוי פולינוקליאוטיד של חיידק שמבוע VIVO IN [31] [87] 04.08.2000 60/147551 [32] 06.08.1999 Int. Cl.8 C12Q 001/527, 001/68 ORAGENICS, INC., U.S.A. WO/2001/011081 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A method of identifying a polynucleotide of a microbe that is expressed in vivo comprising the steps of: (a) adsorbing antibodies against antigens that are expressed by the microbe in vivo and in vitro with cells or cellular extracts of the microbe that have been grown in vitro; (b) isolating unadsorbed antibodies; and (c) probing an expression library of the microbe's DNA or RNA with the antibodies of step (b); wherein a polynucleotide of the microbe that is expressed in vivo is isolated and identified. 2662

COMBINED MODALITIES FOR IMPROVED CANCER TREATMENT 147416 שילוב מנגנוני פעולה בטיפול משופר בסרטן [72] 31.12.2001 Int. Cl.8 A61K 031/517, 045/06, A61P 035/00, C07D 401/06 מדינת ישראל, משרד החקלאות, המכון STATE OF ISRAEL, MINISTRY OF AGRICULTURE, INSTITUTE OF לבעלי חיים, מינהל המחקר החקלאי, A NI MA L S CIEN CE, הדסית שרותי מחקר רפואי ופיתוח בע"מ, AGRICULTURAL RESEARCH ירושלים ORGANIZATION HADASIT MEDICAL RESEARCH קולגרד ביופרמסוטיקל בע"מ, הרצליה SERVICES & DEVELOPMENT LTD. COLLGARD BIOPHARMACEUTICALS LTD. ISRAEL VLODAVSKY, ARNON NAGLER, SHAI YARKONI, MARK PINES WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121 ישראל וולדבסקי, ארנון נגלר, שי ירקוני, מארק פינס ד"ר וב ושות', רח' פקריס, 2 ת.ד. 2189, רחובות [57] A pharmaceutical composition for improving the effectiveness of an antitumor treatment, containing as an active agent ingredient a quinazolinone derivative having the formula wherein: n=1-2; R 1 at each occurrence is independently selected from the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy; R 2 is a member of the group consisting of hydroxy, acetoxy and lower alkoxy; and R 3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl or pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable carrier or diluents, further comprising a known anti-tumor agent. 2663

147506 WATER SUPPLY SYSTEM מערכת אספקת מים 08.01.2002 Int. Cl.8 E03B 001/00, F16K 031/385, G05D 016/20 OPTIMUS WATER אופטימוס טכנולוגיות מים בע"מ TECHNOLOGIES LTD. REINHOLD COHN AND ריינהולד כהן ושותפיו, PARTNERS, 21 AHAD HA'AM ST.,, 21 ת.ד. 4060, תל אביב רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] A water supply system comprising a supply line (20) and a network of consumers (36, 40) one of which being a monitored consumer who receives the least amount of pressure, a pressure regulation system (30) comprising a pressure reducing valve (PRV) (26) associated with a pilot valve (86) present to a nominal output pressure; and a pressure control system comprising a differential control valve (DCV) (90); a pickup unit (100) for measuring a flow parameter indicative of the pressure at the monitored consumer and emitting a pressure signal to a controller (108); said controller generating a control signal (C5) responsive to the pressure signal to activate an actuator (92) of the DCV thereby governing the flow rate through the DCV, so as to obtain desired pressure at the monitored consumer, regardless of altering flow rate through the PRV. 2664

ISOXAZOLINE DERIVATIVE AND HERBICIDE CONTAINING THE SAME AS THE ACTIVE INGREDIENT 147651 נגזרת איסוקסאזולין וקוטל עשבים המכיל אותה כמרכיב פעיל [31] [87] 09.08.2000 11/225878 [32] 10.08.1999 Int. Cl.8 A01N 043/80, C07D 261/04 IHARA CHEMICAL INDUSTRY CO., LTD., JAPAN KUMIAI CHEMICAL INDUSTRY CO., LTD., JAPAN WO/2001/012613 SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013 [33] JP זליגסון גבריאלי ושות', רח' יבנה, 31 ת.ד. 1426, תל אביב [57] An isoxazoline derivative or a salt thereof of the formula wherein Q is a group represented by S(O) n (CR 5 R 6 ) m - (wherein n is 0 or an integer of 1 to 2, m is an integer of 1 to 3, and R 5 and R 6 are each independently a hydrogen atom, a cyano group, an alkoxycarbonyl group or a C 1 to C 6 alkyl group); and R 1, R 2, R 3, and R 4 are as defined in the specification, Y is a phenyl group substituted with 1 to 5 same or different R 7 ; each R 7 is a hydrogen atom, a C 1 to C 6 alkyl group [which may be substituted with 1 to 3 same or different halogen atoms, C 1 to C 6 alkoxy groups, hydroxyl groups, C 1 to C 6 alkylthio groups, C 1 to C 6 alkylsulfinyl groups, C 1 to C 6 alkylsufonyl groups, C 1 to C 6 alkylamino groups, di (C 1 to C 6 ) alkylamino groups, cyano groups or optionally substituted phenoxy groups], a C 1 to C 6 alkoxy group (which may be 2665 substituted with 1 to 3 same or different halogen atoms, C 1 to C 6 alkoxy groups, C 2 to C 6 alkenyl groups, C 2 to C 6 alkynyl groups, C 1 to C 6 alkoxycarbonyl groups, C 1 to C 6 alkylcarbonyl groups or C 3 to C 8 cycloalkyl groups), a C 2 to C 6 alkenyl group, a C 3 to C 8 cycloalkoxy group, a C 1 to C 6 alkylthio group (which may be substituted with 1 to 3 same or different halogen atoms or C 1 to C 6 alkoxy groups), a C 1 to C 6 alkylsulfinyl group (which may be substituted with 1 to 3 same or different halogen atoms or C 1 to C 6 alkoxy groups), a C 1 to C 6 alkylsulfonyl group (which may be substituted with 1 to 3 same or different halogen atoms or C 1 to C 6 alkoxy groups), an optionally substituted benzyloxy groups, an amino group [which may be substituted with C 1 to C 6 alkyl group, C 1 to C 6 alkylsulfonyl group, C 1 to C 6

alkylcarbonyl (C 1 to C 6 alkyl) group or C 1 to C 6 alkylsulfonyl (C 1 to C 6 alkyl) group], a di(c 1 to C 6 alkyl) amino group, a halogen atom, a cyano group, a nitro group, a C 1 to C 6 alkoxycarbonyl group, a C 3 to C 8 cycloalkyloxycarbonyl group, a carboxyl group, a C 2 to C 6 alkenyloxycarbonyl group, a C 2 to C 6 alkynyloxycarbonyl group, an optionally substituted benzyloxycarbonyl group, an optionally substituted phenoxycarbonyl group or a C 1 to C 6 alkylcarbonyloxy group; provided that compounds wherein R 1, R 2, R 3 and R 4 are hydrogen at the same time are excluded. [72] [87] METHOD AND APPARATUS FOR SIGNAL PROCESSING FOR ELECTROACOUSTIC TRANSDUCER 22.07.1999 Int. Cl.8 H04R 003/00 ADVANCE TECHNOLOGY AUDIO ORGANISATION (ATAO), LUXEMBOURG ANNIE CLAUDE PERRICHON, PATRICE MORCHAIN, MARC CHARBONNAUX, PIERRE PICCALUGA WO/2001/008446 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 147735 שיטה ומכשיר לעיבוד אותות עבור מתמר אלקטרו אקוסטי איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] Method in the sound reproduction frequency oscillating electric signal while field comprising the step of placing an not modifying the general aspect of the oscillator on the analog or digital electric original signal, said oscillator being selfpowered by the original signal which upon audio signal feed to at least one electroacoustic transducer, said oscillator passing through the oscillator, modifies the modifying the original electric signal to at original electric pulse into at least one least one very low amplitude and high electric micro-phase-shifted pulse. 2666

[31] [87] DERIVATIVES OF DICARBOXYLIC ACID HAVING PHARMACEUTICAL PROPERTIES 31.08.2000 19943635.5 [32] 13.09.1999 Int. Cl.8 C07C 229/00 BAYER AKTIENGESELLSCHAFT, GERMANY WO/2001/019780 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 148134 [33] תולדות של חומצה דיקרבוקסילית בעלות תכונות רוקחיות DE ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] Use of compounds capable of stimulating soluble guanylate cyclase independently of the haem group in the enzyme, for preparing medicaments for the treatment of cardiovascular disorders, such as angina pectoris, ischaemia and cardiac insufficiency. 148154 [31] [87] VACCINE AGAINST INTRA- CELLULAR PATHOGENS 18.08.2000 9919733.7 [32] 19.08.1999 Int. Cl.8 A61K 039/00, 039/385 IMMUNOBIOLOGY LIMITED, UNITED KINGDOM WO/2001/013943 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] GB חיסון כנגד פתוגניים תוך תאיים ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A method for producing a vaccine containing an immunogenic determinant, characterised in that it comprises the steps of: (a) subjecting cells infected with an intracellular bacterial, protozoan or parasitic pathogen to stress with heat or tumour necrosis factor; and 2667 (b) extracting the endogenous stressinduced products from the stressed cells; and (c) using the extracted products as the immunogenic determinant in the preparation of the vaccine composition.

COMPOSITIONS COMPRISING HALOFIGINONE DERIVATIVES FOR TREATING URETHRAL STRICTURE 148246 תכשירים המכילים תולדות הלופיגינון לטיפול בהצטלקות בדרכי השתן [72] [87] 09.09.1999 Int. Cl.8 A61K 031/505, A61P 013/00, 043/00, C07D 401/06 הדסית שרותי מחקר רפואי ופתוח בע"מ, HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT ירושלים LTD. מדינת ישראל, מנהל המחקר החקלאי, בית STATE OF ISRAEL, דגן AGRICULTURAL RESEARCH ORGANIZATION ישראל וולדבסקי, ארנון נגלר, מארק פינס ISRAEL VLODAVSKY, ARNON NAGLER, MARK PINES WO/2001/017531 WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121 ד"ר וב ושות', רח' פקריס, 2 ת.ד. 2189, רחובות [57] A composition for local administration, for treating a urethral stricture in a subject, comprising a pharmaceutically effective amount of a compound in combination with a pharmaceutically acceptable carrier, said compound having the formula: wherein: n=1-2; R 1 at each occurrence is independently selected from the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy; R 2 is a member of the group consisting of hydroxy, acetoxy and lower alkoxy; and R 3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl or pharmaceutically acceptable salts thereof. 2668

PROCESS TO SEPARATE 1,3- PROPANEDIOL OR GLYCEROL OR A MIXTURE THEREOF FROM A BIOLOGICAL MIXTURE 148371 הליך להפרדת פרופנדיול 1,3 או גליצרול, או תרכובת מהם מתרכובת ביולוגית [31] [87] 04.10.2000 60/157773 [32] 05.10.1999 [33] US 60/158204 07.10.1999 US Int. Cl.8 B01D 015/00, C07C 029/00, 029/76, C12P 007/18 E.I. DUPONT DE NEMOURS AND COMPANY, U.S.A. WO/2001/025178 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] A method for separating 1,3- (c) collecting the 1,3-propanediol and propanediol, glycerol or a mixture of 1,3- glycerol eluted from the zeolite in step (b); propanediol and glycerol selectively from (d) repeating steps (a) through (c) at least a mixture comprising the steps of: one time with the 1, 3-propanediol and (a) contacting a mixture containing a glycerol collected in step (c); and mixture of 1, 3-propanediol and glycerol (e) performing step (a)' by contacting the with a sufficient amount of a first zeolite mixture of 1, 3-propanediol and glycerol of selected from the group consisting of MFI, steps (c) or (d) with a second zeolite to MEL, BEA, MOR, FAU, LTL, GME, selectively adsorb 1, 3-propanediol or FER, MAZ, OFF, AFI, AEL, and AET, glycerol, (b)' contacting the second zeolite and materials with the same topology as of step (a)' with a desorbant of an ethanol: these zeolites, the zeolite selected on the water solution or of any C 1 -C 4 alcohol: basis of its selectivity to 1,3-propanediol water solution, (c)' collecting the 1,3- and glycerol approaching unity; propanediol or glycerol eluted from the (b) contacting the first zeolite of step (a) zeolite in step (b)', and (d)' repeating the with a desorbant of an ethanol; water series of steps (a)' through (c)' at least one solution or any C 1 -C 4 alcohol: water time to obtain a purified 1,3-propanediol or solution; glycerol. 2669

OPTICAL MEASUREMENTS OF PATTERNED STRUCTURES 04.03.2002 Int. Cl.8 G03B 027/54, G03F 007/20 NOVA MEASURING INSTRUMENTS LTD. NOVA MEASURING INSTRUMENTS LTD., WEIZMANN SCIENTIFIC PARK P.O.B 266 REHOVOT 76100 148484 מדידות אופטיות על מבנים בעלי צורה נובה מכשירי מדידה בע"מ, רחובות נובה מכשירי מדידה בע"מ, וייצמן פארק למדע, ת.ד. 266, רחובות [57] An optical measurement system for measuring in a structure (W) having a pattern in the form of spaced-apart parallel elongated regions of optical properties different from that of spaces between said regions, the system comprising a broadband illuminator (8) for generating incident radiation, a spectrophotometer arrangement (30) for detecting a spectral response of the structure to the incident radiation, and an optical arrangement for directing the incident light (13) to the structure and collecting the response of the structure, said optical arrangement comprising an elongated aperture stop (32) for mounting with respect to said structure such that providing different values of numerical aperture of at least one of an incident or collected light beams in directions along and perpendicular to longitudinal axes of said elongated regions of the pattern. 2670

CELL CYCLE CHECKPOINT GENES AND PROTEINS ENCODED THEREBY 148595 גנים נקודת בדיקה (צ'קפוינט) של מחזור התא וחלבונים המקודדים על ידם [31] [87] 14.09.2000 60/153836 [32] 14.09.1999 [33] US Int. Cl.8 A61K 038/17, C07K 014/47, 016/18, C12N 015/12, C12Q 001/68 JANSSEN PHARMACEUTICA N.V., BELGIUM THE SCRIPPS RESEARCH INSTITUTE, U.S.A. WO/2001/020038 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] An isolated nucleic acid encoding for a mammalian Mus81 protein. [31] [87] SURFACE MODIFIED PARTICULATE COMPOSITIONS OF BIOLOGICALLY ACTIVE SUBSTANCES 21.09.2000 60/154964 [32] 21.09.1999 Int. Cl.8 A61K 009/10 SKYEPHARMA CANADA INC., CANADA WO/2001/021154 PYERNIK RUTMAN, BEIT ETSION, 91 HERZL ST., P.O.B. 10012, BEER SHEVA 148685 [33] חומרים בעלי פעילות ביולוגית בצורת גרגרים מעם פני שטח ששינו US פיירניק רוטמן עו"פ, בית עציון, רח' הרצל, 91 ת.ד. 10012, באר שבע [57] A composition comprising stable, surface modified particles of a waterinsoluble biologically active substance, said particles of a mean particle size in the range of 0.01 to 10 micrometers, and dispersed in a non-aqueous carrier system comprising: 2671 (i) a non-aqueous medium in which said biologically active substance, selected from the group consisting of nifedipine, ursodiol, budesonide, paclitaxel, camptothecin, piroxicam, itraconazole, acyclovir, fenfibrate, cyclosporin, insulin

and derivatives thereof, is not soluble or is poorly soluble; (ii) a surfactant system consisting of at least one phospholipids surfactant which is soluble in said non-aqueous medium, wherein at least a portion of said phospholipid surfactant system adsorbs to the surface of said particles; and (iii) one or more hydrophilic substances that provide a self-dispersing property to said composition, said one or more hydrophilic substances being present in an amount of not more than 10% of the total weight of said composition; said carrier system allowing the composition to selfdisperse when added to a fluid aqueous medium to form a suspension comprising components of the non-aqueous carrier system and stable particles of the waterinsoluble, biologically active substance, said particles having a size in the range of 0.01 to 10 micrometer and having associated therewith on their surface, at least a portion of the phospholipid surfactant system. [31] [87] PREPARATION CONTAINING ACTIVE INGREDIENTS AND/OR AUXILIARY AGENTS WITH A CONTROLLED RELEASE OF THESE SUBSTANCES AND THE USE AND PRODUCTION OF THE SAME 16.09.2000 19946822.2 [32] 30.09.1999 Int. Cl.8 A61K 009/70 LTS LOHMANN THERAPIE- SYSTEME AG, GERMANY WO/2001/022947 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 148907 [33] תכשיר המכיל מרכיבים פעילים ו/או חומרי עזר בעלי שחרור מבוקר של חומרים אלה ושימוש וייצור שלהם DE לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] Preparation containing active and/or auxiliary substance(s), for the time and/or dose-controllable release of said substances, comprising a laminate made up of at least two layers in rolled or folded shape, characterized in that (a) the first layer contains at least one active or auxiliary substance, is continuous at least in sections thereof, that at least one of the parameters width and concentration of the active and/or auxiliary substance of this layer is not constant, and that (b) the second layer is continuous and possesses a lower moisture permeability than the first layer. 2672

PERMANENT AMNIOCYTE CELL LINE, THE PRODUCTION THEREOF AND ITS USE FOR PRODUCING GENE TRANSFER VECTORS 149291 קן תאים אמניוטים קבוע, הייצור שלו והשימוש בו לייצור וקטורים של מעבר גנים [31] [87] 07.11.2000 19955558.3 [32] 18.11.1999 [33] DE Int. Cl.8 C12N 005/10, 007/00, 015/00, 015/34, 015/861 CEVEC PHARMACEUTICALS GMBH, GERMANY WO/2001/036615 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A process for producing gene Also claimed is a permanent amniocytic transfer vectors and/or adenovirus mutants, cell line comprising at least one nucleic wherein a permanent amniocytic cell line acid which brings about expression of the in used. gene products of the adenovirus E1A and E1B regions. METHOD FOR PRODUCING THERAPEUTIC AGENTS FOR ULCERS 149358 שיטה ליצור חומרים לטיפול באולקוס [31] [87] 27.10.2000 19951960.9 [32] 28.10.1999 [33] DE Int. Cl.8 A61K 031/4439, A61P 001/04, C07B 045/04, C07D 401/12 GRUNENTHAL GMBH, GERMANY WO/2001/030765 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Process for the production of antiulceratives of the formula 2673

in which R 1, R 2 and R 3 are mutually independently selected from hydrogen, C1-C8 alkyl, C3-C8 cycloalkyl, C2-C8 fluoroalkyl and C1-C8 alkoxy, R 4 and R 5 are mutually independently selected from hydrogen, C1-C8 alkyl, C3-C8 cycloalkyl, CH 2 -C3-C8 cycloalkyl, C1-C8 alkoxycarbonyl, C1-C8 alkoxy, C1-C8 fluoroalkoxy, CF 3, C2-C8 fluoroalkyl and C(O)O-C1-C8 alkyl, and halogen, R 6 is selected from hydrogen and C1-C2 alkyl, in which process a compound of the formula is reacted with m-chloroperoxybenzoic acid in a solvent with a ph of 7.0, water is then optionally added, the solvent is optionally removed and then the crystals of the compound of the formula I are separated, characterised in that the stated solvent is an acetone/water mixture, wherein the ph of the solvent is maintained at a value of 7.0 by ph-static titration, preferably with NaOH, and/or by buffer substances dissolved in or added to the solvent, preferably mono or dibasic salts, in particular sodium or potassium carbonate and/or sodium or potassium bicarbonate and the temperature of the reaction mixture, in particular during the reaction between the compound of the formula II and m-chloroperoxybenzoic acid, is maintained between -20 o C and 30 o C, preferably between -5 o C and 5 o C. 2674

SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF HPPAR ALPHA DISEASE OR CONDITION 149582 תולדות אוקסאזול ותיאזול מותמרים, תכשירי רוקחות המכילים אותן והשימוש בהן לייצור תרופה לטיפול במחלות או מצבים הקשורים ל hppar אלפא [31] [87] 30.11.2000 9928561.1 [32] 02.12.1999 [33] GB 0003500.6 15.02.2000 GB Int. Cl.8 A61K 031/41, 031/44, A61P 003/00, 009/00, 029/00, 043/00, C07D 263/34, 277/56, 413/04, 417/04 GLAXO GROUP LIMITED, UNITED KINGDOM WO/2001/040207 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A compound of the formula and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof wherein; X represents O or S; R 1 and R 2 independently represent H, halogen, -CH 3 and OCH 3 ; n represents 1 or 2; X 2 represents NH, NHC 3 or O; one of Y and Z is N, and the other is O or S; R 3 represents phenyl or pyridyl (wherein the N is in position 2 or 3) and is optionally substituted by one or more halogen, NO 2, NH 2, CF 3, OCF 3, OC 1-6 straight or branched alkyl, C 1-6 straight or branched alkyl, alkenyl or alkynyl with the provision that when R 3 is pyridyl, the N is unsubsituted; R 4 represents CF 3 or CH 3. 2675

SYNTHESIS OF 2'-DEOXY -L- NUCLEOSIDES 149592 סינטזה של 2' דאוקסי L נוקלאוזידים [31] [87] 13.11.2000 60/165087 [32] 12.11.1999 [33] US Int. Cl.8 C07H 001/06, 019/00, 019/06, 019/16 PHARMASSET INC, U.S.A. WO/2001/034618 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A process for the preparation of a 2'- deoxy-l-nucleoside comprising the steps of: (a) preparing from a suitably protected and activated L-nucleoside a 2'-S-substituted- L-nucleoside of the formula: wherein B is a heterocyclic or heteroaromatic base, R 8 and R 9 are independently hydrogen or a suitable protecting group, R 6 is an alkyl or aryl, and m is 0 or 1; and (b) reducing the 2'-S-substituted-Lnucleoside to a 2'-deoxy-L-nucleoside. 2676

METHODS OF BLOCKING AN ETHYLENE RESPONSE IN PLANTS USING CYCLOPROPENE DERIVATIVES 149636 שיטות עיכוב של תגובת אתלין בצמחים ע"י שימוש בנגזרות של ציקלופרופן [31] [87] 22.11.2000 09/448523 [32] 23.11.1999 [33] US 60/193202 30.03.2000 US Int. Cl.8 A01N 003/02, 027/00, 031/04, 033/04, 033/12, 035/02, 035/10, 037/02, 037/06, 037/34, C07C 013/00, 013/04, 033/05, 043/188, 057/18, 069/007, 211/25, 211/62, 233/10, 251/38, 255/31 NORTH CAROLINA STATE UNIVERSITY, U.S.A. WO/2001/037663 DR. YITZHAK HESS & PARTNERS, ד"ר יצחק הס ושותפיו, 279 HAYARKON ST., P.O.B. 6451, רחוב הירקון, 279 ת.ד. 6451, תל אביב TEL AVIV 61063 [57] A method of inhibiting an ethylene response in a plant, comprising applying to the plant an effective ethylene responseinhibiting amount of a compound of the formula wherein: n is a number from 1 to 4; and each R is independently a saturated or unsaturated, linear or branched-chain, unsubsituted or substituted, C 6 to C 20 alkyl, alkenyl, or alkynyl. 2677

USE OF THYROMIMETIC COMPOUNDS IN THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF HAIR LOSS 149843 שימוש בתרכובות טירומימתיות להכנת תרופות לטיפול בנשירת שער [31] 23.05.2002 60/294962 [32] 31.05.2001 [33] US Int. Cl.8 A61K 000/842000 000/849000 031/395, A61P 017/14, C07C 235/70, 253/06, 311/15, 317/14, 323/18, C07D 249/10, 253/06, 257/04, 271/06, 277/20, 401/12, 403/12, 413/12, 491/02 PFIZER PRODUCTS, INC., U.S.A. LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] Use of a compound of the formula an isomer thereof, or a pharmaceutically acceptable salt of said compound or isomer; wherein the substituents are as defined in the specification, for the manufacture of a medicament for the treatment of hair loss in a mammal. The applications for division from this application have not yet been published,188110 בקשות חלוקה מבקשה זו שטרם פורסמו. 2678

149956 VIDEO PLAYER WITH CODE SENSOR מערכת וידאו עם חיישן להצפנה [31] [87] 27.11.2000 PQ4392 [32] 01.12.1999 [33] AU Int. Cl.8 B41J 003/42, 029/38, G06F 003/033, 017/30, G06K 007/00, H04M 001/00, H04N 001/00 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2001/040987 REINHOLD COHN AND ריינהולד כהן ושותפיו, PARTNERS, 21 AHAD HA'AM ST.,, 21 ת.ד. 4060, תל אביב רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] A video player including: a body; at least one sensor positioned in the body so that coded data printed on a substrate is sensed by positioning the video player body relative to the substrate, the sensor generating first data from the sensed coded data; a transmitter positioned in the body for transmitting, to a computer system, said first data or second data at least partially based on the first data; a receiver positioned in the body for receiving, from the computer system, video data associated with an identity derived from the first data; and at least one display device positioned in the body for outputting a visual display based at least partially on the video data. 2679

DI- OR OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS 150215 חלבון מאוחה רקומביננטי בצורת די או אוליגומר, דימר, טרימר, קווטרומר או פנטאמר [31] [87] 20.12.2000 19963859.4 [32] 30.12.1999 [33] DE Int. Cl.8 A61K 038/17, C07K 014/525, 019/00, C12N 015/11, 015/62 APOXIS S.A., SWITZERLAND WO/2001/049866 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A recombinant fusion protein having functional derivative thereof and at least one component A and at least one component B comprises a protein or a component B, wherein: component A protein segment selected from the group comprises a protein or a protein segment consisting of the family of C1q proteins with a biological function being a cytokine and the collectins, which oligomerizes the from the family of TNF cytokines, a recombinant fusion protein without the segment of such TNF cytokine or a effect of third molecules. 150371 NAVIGATION ניווט [31] [87] 22.12.2000 99403281.1 [32] 24.12.1999 [33] EP Int. Cl.8 G06F 000/303800 000/304800 003/033, H04N 005/445, 007/173 CANAL+SOCIETE ANONYME, FRANCE WO/2001/048586 EITAN, PEARL, LATZER AND איתן, פרל, לצר וכהן צדק, COHEN ZEDEK, P.O.B. 12688, רחוב שנקר, 7 ת.ד. 12688, הרצליה HERZLIYA 46733 [57] A method of assigning a navigation or descending a level of hierarchy between order to a plurality of objects to be these objects, the method being displayed at respective positions on a characterized in that a group of objects display, these objects being assigned to a may be traversed as a single entity at a first plurality of defined directions based on the level and individual objects or subgroups positions of the objects, said method may be traversed at a second level. comprising a step of including ascending 2680

150461 USE OF INTERLEUKIN-2 FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR PULMONARY DELIVERY שימוש באינטרלאוקין 2 רוקחי למתן לתוך הריאה להכנת תכשיר [31] [87] 27.12.2000 60/173922 [32] 30.12.1999 09/724810 28.11.2000 Int. Cl.8 A61K 009/08, 038/00, 047/18 NOVARTIS VACCINES AND DIAGNOSTICS, INC., U.S.A. WO/2001/049274 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] US US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] Use of IL-2 or biologically active variant thereof in the manufacture of a pharmaceutical composition comprising monomeric IL-2 or biologically active variant thereof for the treatment of a subject in need of Il-2 or variant thereof by 2681 administering said IL-2 or variant thereof via pulmonary inhalation, wherein said pharmaceutical composition is in a dry powder form consisting of particles having a mean diameter of less than 10 µm.

150866 [31] [87] VENTILATED ITEM OF CLOTHING 15.01.2001 PD2000A000026 [32] 31.01.2000 Int. Cl.8 A41D 027/28 GEOX S.P.A., ITALY WO/2001/056416 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 פריט לבוש מאוורר [33] IT לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] An item of clothing (10), such as a coat, jacket or overcoat, comprising: venting elements (16) for venting warm air, produced by the user's body, that has risen in an interspace (13), said venting elements being arranged at corresponding openings of the shoulders of said item of clothing, said venting elements being constituted by at least one mesh which is applied to said corresponding openings of the shoulders of said item of clothing;. characterized in that said item of clothing comprises spacer means which are arranged at least in an internal part of the shoulders of the item of clothing so as to generate said interspace between the shoulders of the user and the fabric which the item of clothing is made of, and to lift the item of clothing and in particular to lift said at least one mesh off the user's shoulders by way of said spacer means. 2682

2 PHENYL (SUBSTITUTED) AMINO PYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USE THEREOF AS MEDICAMENTS 150934 נגזרות 2 פניל (מותמר) אמינו פירימידין, תהליך להכנתן, תכשירי רוקחות המכילים אותן והשימוש בהן כתרופות [31] [87] 26.02.2001 0004886.8 [32] 01.03.2000 [33] GB Int. Cl.8 A61K 031/505, 031/506, A61P 035/00, C07D 239/47, 417/12 ASTRAZENECA AB, SWEDEN WO/2001/064653 S. HOROWITZ & CO., ש. הורוביץ ושות', ZION HOUSE, בית ציון, שדרות רוטשילד 41-45, תל 41-45 ROTHSCHILD BLVD., אביב TEL AVIV 65784 [57] A pyrimidine derivative of the formula having anti-cell proliferation activity, wherein: Q 1 and Q 2 are independently selected from aryl or carbon linked heteroaryl; and one of Q 1 and Q 2 or both of Q 1 and Q 2 is substituted on a ring carbon by one substituent of the formula: [provided that when Q 1 is substituted by (Ia) this substituent is not adjacent to the 2683 NH- link]; wherein:

X is O-; Y 1 is OH; Y 2 is H; Z is R c R d N-or a nitrogen linked heterocycle [wherein said heterocycle is optionally substituted on a ring carbon or a ring nitrogen by C 1-4 alkanoyl] wherein R c and R d are independently selected from hydrogen, C 1-4 alkyl, C 3-8 cycloalkyl; n is 1; m is 1; G is O- or S-; R 1 is selected from hydrogen, halo, hydroxy, nitro, amino, N-(C 1-3 alkyl) amino, N,N-di-(C 1-3 alkyl) amino, cyano, trifluoromethyl, trichloromethyl, C 1-3 alkyl [optionally substituted by 1 or 2 substituents independently selected from halo, cyano, amino, N-(C 1-3 alkyl) amino, N, N-di-(C 1-3 alkyl) amino, hydroxy and trifluoromethyl], C 3-5 alkenyl [optionally substituted by up to three halo substituents, or by one trifluoromethyl substituent], C 3-5 alkynyl, C 1-3 alkoxy, mercapto, C 1-3 alkylsulphanyl, carboxy and C 1-3 alkoxycarbonyl, Q is optionally substituted on a ring carbon by one to four substituents independently selected from halo, mercapto, nitro, formyl, formamido, carboxy, cyano, amino, ureido, carbamoyl, sulphamoyl, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl [wherein said C 1-4 alkyl, C 2-4 alkenyl and C 2-4 alkynyl are optionally substituted by one or more groups selected from R i ], C 1-4 alkanoyl, C 1-4 alkoxycarbonyl, heterocyclic group, C 1-4 alkyls(o), wherein a is 0 or 2 [optionally substituted by hydroxy], N-(C 1-4 alkyl) ureido, N', N'-di-(C 1-4 alkyl) ureido, N'-(C 1-4 alkyl)-n-(c 1-4 alkyl) ureido, N', N-di-(C 1-4 alkyl)-n-(c 1-4 alkyl) ureido, N-C 1-4 alkylamino, N,N-di-(C 1-4 alkyl) amino, N- (C 1-4 alkyl) sulphamoyl, N, N-di-(C 1-4 alkyl) amino, N-(C 1-4 alkyl) sulphamoyl, N, N-di-(C 1-4 alkyl) sulphamoyl, N-C 1-4 alkylcarbamoyl, N,N-di-(C 1-4 alkyl) carbamoyl and C 1-4 alkanoylamino; and also independently, or in addition to, the above substituents, Q 1 may be optionally substituted by one to two substituents independently selected from aryl, C 3-8 cycloalkyl and a heterocyclic group; wherein said aryl, C 3-8 cycloalkyl or heterocyclic group may be optionally substituted on a ring carbon by one or more groups selected from R j ; and wherein if said heterocyclic group contains an NH- moiety that nitrogen may be optionally substituted by a group selected from R k ; Q 2 is optionally substituted on a ring carbon by one to four substituents independently selected from halo, hydroxy, mercapto, nitro, formyl, formamido, carboxy, cyano, amino, ureido, carbamoyl, sulphamoyl, C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 1-4 alkoxy [wherein said C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl and C 1-4 alkoxy are optionally substituted by one or more groups selected from R 1 ], C 1-4 alkanoyl, C 1-4 alkoxycarbonyl, heterocyclic group, C 1-4 alkyls(o) a wherein a is 0 to 2 [optionally substituted by hydroxy], N'-(C 1-4 alkyl) ureido, N', N- di-(c 1-4 alkyl) ureido, N'-(C 1-4 alkyl)-n- (C 1-4 alkyl) ureido, N', N-di-(C 1-4 alkyl)-n- (C 1-4 alkyl) ureido, N-C 1-4 alkylamino, N,N-di-(C 1-4 alkyl) amino, N-(C 1-4 alkyl) sulphamoyl, N,N-di-(C 1-4 alkyl) sulphamoyl, N-C 1-4 alkylcarbamoyl, N-(C 1-4 alkyl) sulphamoyl, N-(C 1-4 alkyl) 2 sulphamoyl, N-(C 1-4 alkyl) carbamoyl, N- (C 1-4 alkyl) 2 carbamoyl, phenyl, phenylthio, phenoxy, C 3-8 cycloalkyl and a heterocyclic group; wherein said phenyl, phenylthio, phenoxy, C 3-8 cycloalkyl or heterocyclic group may be optionally substituted on a ring carbon by one or more groups selected from R o ; and wherein if said heterocyclic group contains an NH- moiety that nitrogen may be optionally substituted by a group selected from R p ; R j, R m and R o are independently selected from hydroxy, halo, amino, cyano, formyl, formamido, carboxy, nitro, mercapto, carbamoyl, sulphamoyl, C 1-4 2684

alkyl [optionally substituted by one or more groups selected from halo, cyano, amino, N-C 1-4 alkylamino, N, N-di-(C 1-4 alkyl) amino or hydroxy], C 2-4 alkenyl [optionally substituted by one or more groups selected from halo], C 2-4 alkynyl, N-C 1-4 alkylamino, N,N-di-(C 1-4 alkyl) amino, C 1-4 alkanoyl, C 1-4 alkanoyloxy, C 1-4 alkoxy [optionally substituted by one or more groups selected from halo], C 1-4 alkoxycarbonyl, N-C 1-4 alkylcarbamoyl, N,N-di-(C 1-4 alkyl) carbamoyl, C 1-4 alkanoylamino, C 1-4 alkyls(o) a wherein a is 0 to 2, C 1-4 alkylsulphonylamino, N-(C 1-4 alkyl) sulphamoyl, N-(C 1-4 alkyl) 2 sulphamoyl, phenyl, C 3-8 cycloalkyl and a heterocyclic group; and R k, R n and R p are independently selected from C 1-4 alkyl, C 1-4 alkanoyl, C 1-4 alkylsulphonyl, C 1-4 alkoxycarbonyl, carbamoyl, N-(C 1-4 alkyl) carbamoyl, N,N-(C 1-4 alkyl) carbamoyl, benzyl, benzyloxycarbonyl, benzoyl and phenylsulphonyl; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. 151343 PHOTOVOLTAIC DEVICE FORMING A GLAZING התקן פוטו-וולטי היוצר זיגוג [31] [87] 20.12.2001 00/16693 [32] 20.12.2000 Int. Cl.8 H01L 027/142 ENERGY SYSTEMS INTERNATIONAL BV, THE NETHERLANDS WO/2002/050913 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] FR סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] Photovoltaic device (1) comprising a plurality of photovoltaic cells (2) of the p- i-n type placed on a substrate (3), wherein said cells are positioned parallel to one another and wherein electrically conductive layers (7) connect the p-type layer (5) of every cell with the n-type layer of the adjacent cell on one side and connect the n-type layer (6) of said same cell with the p-type layer of the adjacent cell on the other side, except for cells located at the outer border of the device, so as to electrically connect all the consecutive cells of the device in series, characterised in that at least the p-type layer and the n-type layer of a photovoltaic cell of the photovoltaic device are both located in the same layer on the substrate, parallel to one another and on top of the electrically conductive layer. 2685

METHOD AND APPARATUS FOR MEASURING CHANNEL STATE INFORMATION 151397 שיטה והתקן למדידת מידע מצב ערוץ [31] [87] 20.03.2001 09/539224 [32] 30.03.2000 [33] US Int. Cl.8 H04B 001/69, 007/00, H04J 011/00, 015/00, H04Q 007/38 QUALCOMM INCORPORATED, U.S.A. WO/2001/076110 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] A method for measuring and reporting channel state information (CSI) in a multiple input/multiple output (MIMO) system, comprising the steps of: assigning a plurality of disjoint subchannel sets to a plurality of transmit antennas; transmitting a plurality of Orthogonal Frequency Division Multiplexed (OFDM) pilot signals from a transmitter unit to a plurality of receiver units, wherein each of the plurality of OFDM pilot signals is transmitted on at least one of the plurality of disjoint subchannel sets; demodulating the plurality of disjoint sub-channel sets, wherein the step of determining the CSI uses the demodulated plurality of OFDM pilot signals; transmitting the CSI of the plurality of disjoint sub-channel sets to the transmitter unit; and preconditioning a transmission symbol. 2686

The applications for division from this application have not yet been published,169251 בקשות חלוקה מבקשה זו שטרם פורסמו. AMINO ACID SEQUENCES FACILITATING PENETRATION OF A SUBSTANCE OF INTEREST INTO CELLS AND/OR CELL NUCLEI 151399 רצפי חומצות אמינו העוזרים לחדירת חומר בעל התענינות לתוך תאים ו/או לתוך גרעיני תאים [31] [87] 01.03.2001 00/02621 [32] 01.03.2000 [33] FR Int. Cl.8 A61K 048/00, C07K 005/11, 007/06, 007/08, 014/47, 017/14, C12N 001/19, 005/10, 015/87 DIATOS, FRANCE WO/2001/064738 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] Intracytoplasmic and/or intranuclear transfer vector for a substance of interest, 2687 characterised in that it comprises at least one amino acid sequence reacting in vivo

with aminoglycans and that is derived from human lipoprotein B coupled to at least one antibody fragment. The applications for division from this application have not yet been published,190542 בקשות חלוקה מבקשה זו שטרם פורסמו. DEVICE FOR TRANSFER OF DATA FROM EXTERNAL CARRIER TO HANDHELD ELECTRONIC DEVICE 151573 התקן להעברת נתונים ממנשא חיצוני למכשיר יד אלקטרוני [72] 02.09.2002 Int. Cl.8 G06F 003/00, 003/023, G06Q 002/00000 SPIRAL SOLUTIONS LTD ספירל סולושנס בע"מ, משגב דגלס יורק מלובסקי, עמיחי בן-דוד, אהוד MALAWSKY, DOUGLAS YORK AMIHAY BEN-DAVID, EHUD לוי LEVY NAOMI ASSIA & CO. LAW OFFICES, 32 HABARZEL ST. RAMAT HACHAYAL TEL AVIV 69710 נעמי אסיא ושות' משרד עורכי דין, רח' הברזל 32 רמת החייל, תל-אביב [57] A device for transferring data to a telephone, personal digital assistant or cellular telephone, said device comprising: (a) a reader comprising: a slot adapted to receive a card; a processor and dedicated hardware adapted to read data from a memory component of a card, and to transmit said data via a phone bridge to a telephone, personal digital assistant or a cellular telephone; (b) a card having at least one data substructure retained within a memory component of said card; said card comprising appropriate circuitry and hardware for allowing retrieval and transmission of said data to said reader; (c) a phone bridge connectable to said reader, wherein said phone bridge is adapted to transmit data from said reader to a telephone, personal digital assistant or a cellular telephone; wherein upon insertion of said card into said reader slot, a data substructure can be selected from said card and transmitted to a remote location via said reader and said phone bridge, by means of a telephone, personal digital assistant or cellular telephone. 2688

ALLOCATION OF RADIO RESOURCES IN A CDMA2000 CELLULAR SYSTEM 151644 הקצאת משאבי רדיו במערכת סלולרית CDMA2000 05.09.2002 Int. Cl.8 H04B 007/005, H04Q 007/20, 007/38 FAZAN COMMUNICATIONS LLC, U.S.A. קבוצת איתן מהולל, עורכי דין ועורכי GROUP, EITAN MEHULAL LAW 10 ABBA EBEN BLVD., פטנטים, P.O. B. 2081, שדרות אבא אבן, 10 ת.ד. 2081, הרצליה HERZLIYA 46120 [57] In a data transmission system for transmitting data from a transmitter to a plurality of subscriber units, wherein: fundamental channels (FCHs) are combined, in a hierarchical manner, into transmission channels of higher levels, 2689 each configured to carry data at a corresponding rate level, which is a correspondingly higher rate than the fundamental rate; and any unused channel, at any level, is periodically allocated to a corresponding one of the subscriber units,

in order to carry data to the subscriber unit from a buffer storage during a subsequent period; a method for periodically allocating channels to subscriber units, comprising, prior to the beginning of any period; (a) identifying all active subscriber units being in communication with the transmitter and for which there are data, exceeding a given minimal quantity, stored in the buffer storage; (b) calculating for each active subscriber unit one or more priority factors as a function of associated power levels; (c) on the basis of said priority factors, allocating at least one channel, to a corresponding active subscriber unit; (d) repeating the channel allocation with respect to any active subscriber units to which no channels have yet been allocated, subject to an availability of unallocated channels and subject to a limitation of maximum transmitter power. 2690

151903 DRIVING HEADS FOR FASTENERS ראשים מסתובבים למכשירי הידוק [31] [87] 30.03.2001 0008569.6 [32] 07.04.2000 [33] GB Int. Cl.8 B25B 015/00, F16B 023/00, 041/00 UNI-SCREW WORLDWIDE, INC., U.S.A. WO/2001/077538 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Fastener having a driving head which includes at least two superimposed non-circular recesses (11, 12, 13) for receiving the bit of a driver with which driver a torque can be applied to operate the fastener, at least one of said recesses having a different diameter to the other(s), wherein the diameter of a recess is its longest dimension parallel to the top surface of the fastener, characterised in that the fastener comprises a security feature whereby said torque needs to be applied to at least two of said recesses in order to operate the fastener. 2691

151954 [72] FIBRE OPTIC COUPLER 26.09.2002 Int. Cl.8 G02B 006/38 BIOSCAN LTD. ILAN GREENBERG, AVRAM MATCOVICH PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733 מחבר לכבל אופטי ביוסקאן בע"מ, יקנעם עילית אילן גרינברג, אברם מטקוביץ פרל כהן צדק לצר, מרכז גב- םי 1, רח' שנקר, 5 ת.ד. 12704, הרצליה [57] A fiber optic coupler assembly (16) for optically aligning a sectioned fibre optic cable, the cable having a first end (10) and a second end (12) and comprising one or more fibre optic cores, the assembly comprising a first holder for holding the first end; a second holder for holding the second end coupled to the first end; a retractor for retracting the second end; an aligning unit (40) comprising a resilient construction having a conduit passing through it, for linear alignment of the ends, and a rotor for rotating one end with respect to the other end; whereby the first and second ends are coupled by the respective holders and whereby the second end can be linearly aligned in the conduit of the aligning unit, retracted using the retractor, and rotated to obtain rotational alignment of the fiber cores of the ends. 2692

SUBSURFACE SOIL INJECTION APPARATUS AND METHOD 152120 התקן ושיטה להזרקה תת קרקעית של אדמה [31] [87] 10.01.2002 09/794062 [32] 28.02.2001 Int. Cl.8 A01C 023/00 ARYSTA LIFESCIENCE NORTH AMERICA CORPORATION, U.S.A. WO/2002/069692 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] US וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] An apparatus for introducing a discrete, predetermined amount of a material into soil at a plurality of predetermined points in the soil, characterised in that it includes: a container (50) for holding the material to be introduced into the soil; tubing (60) in fluid connection with the container at a first end thereof, the tubing having one distal end for introducing the material into the soil; at least one shank (20) for placing the distal end of the tubing at a predetermined depth in the soil during the introduction of the material into the soil, wherein the distal end of the tubing is attached to the at least one shank such that the distal end of the tubing on the shank is placed at the predetermined depth in the soil when the material is introduced into the soil, and a switch (90) for controlling the flow of the material through the tubing, the switch being operable between an open state for introducing the discrete, predetermined amount of the material into the soil at the predetermined points in the soil, and a closed state in which the shank is situated between the predetermined points in the soil. 2693

[31] [87] APPARATUS AND METHOD FOR MEASURING ALIGNMENT OF METERED DOSE INHALER VALVES 26.04.2001 561232 [32] 28.04.2000 Int. Cl.8 A61M 015/00, G01B 011/14 GLAXO GROUP LIMITED, UNITED KINGDOM WO/2001/083013 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 152172 [33] התקן ושיטה למדידת המערך של שסתומי משאף בעל מינונים מדודים US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A measuring apparatus comprising: (a) a housing (10) defining an inner chamber therein; (b) a transducer (80) mounted to the housing and including a probe extending into the inner chamber; and (c) a mounting platform disposed within the inner chamber of the housing and adapted for mounting an object thereon having opposing first and second end surfaces, the measuring apparatus being adapted for relative rotational movement between the mounting platform and the transducer probe so that the probe is caused to contact a portion of the first end surface of the object. The applications for division from this application have not yet been published,183570 בקשות חלוקה מבקשה זו שטרם פורסמו. 2694

152327 19-NORBUFALIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM נגזרות של 19 נורבופאלין, הכנתן ותכשירי רוקחות המכילים אותן [31] [87] 16.04.2001 135707 [32] 17.04.2000 [33] IL Int. Cl.8 A61K 031/56, A61P 043/00, C07J 017/00 YISSUM RESEARCH יישום חברה לפיתוח המחקר של DEVELOPMENT COMPANY OF האוניברסיטה העברית בירושלים, THE HEBREW UNIVERSITY OF ירושלים JERUSALEM WO/2001/079256 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] Compounds of the formula wherein R 1 is hydrogen or a hydroxy protecting group; R 2 is OH or hydrogen; R 3 is selected from one of the following groups: 2695

R 4 is hydrogen or OH; R 5 is hydrogen or OH; and the dashed line denotes an optional double bond; and isomers and pharmaceutically acceptable salts thereof. GIMBALED SCANNING SYSTEM AND METHOD 152364 מערכת ושיטה לסריקה על ז'ימבאלים [31] [87] 14.02.2002 09/785150 [32] 16.02.2001 Int. Cl.8 G02B 026/10 RAYTHEON COMPANY, U.S.A. WO/2002/067573 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A system (10) for scanning at least a portion of a field-of-regard, comprising: means for sensing (30) an image, and means for directing the image from the field-of-regard to the means for sensing, the means for directing including a reflecting surface (20) that is rotatable about a central axis (38), an adjustment axis (24) in a plane parallel to the central axis, and elevation axis transverse to the adjustment axis (24) and a flip axis (40) perpendicular to the central axis. 2696

PIPERIDINYL BENZAMIDINES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM 152431 פיפרידינים בנזאמינים ותכשירי רוקחות המכילים אותם [31] [87] 27.04.2001 60/200066 [32] 27.04.2000 [33] US 0018306.1 26.07.2000 GB 09/841417 24.04.2001 US Int. Cl.8 A61K 031/395, A61P 043/00, C07D 211/16, 211/70, 295/16, 401/04, 401/06, 401/10, 401/14, 405/10, 409/06, 409/10, 409/14, 417/10, 417/14, 471/04 AVENTIS PHARMACEUTICALS INC., U.S.A. WO/2001/081310 EITAN, PEARL, LATZER AND איתן, פרל, לצר וכהן צדק, COHEN ZEDEK, P.O.B. 12688, רחוב שנקר, 7 ת.ד. 12688, הרצליה HERZLIYA 46733 [57] A compound of the formula wherein Z is a carbon or nitrogen atom; Ar is an aryl group, a monocyclic is a 4 to 7-membered azaheterocyclyl or a 4 to 7-membered azaheterocyclenyl group; heteroaryl group, or a bicyclic azaheteroaryl group which includes a first proximal ring that is attached to the is a single or double bond, provided that when Z is a nitrogen atom, then is a single bond; 2697

moiety and a ring distal to said first ring said distal ring including at least one nitrogen atom; X a, X b, X c are independently selected from hydrogen, R 4 R 5 N-, (hydroxy)nh-, (alkoxy)nh-, R 6 O-, R 4 R 5 NCO-, R 4 R 5 NSO 2 -, -R 6 CO-, halo, R 4 R 5 NCO-, R 4 R 5 NSO 2 -, -R 6 CO-, halo, cyano, nitro R 7 (O)C(CH 2 ) q -and ;and when is a bicyclic heteroaryl group, then X c is a substituent that is at the and X c is selected from the group consisting of H, hydroxyl and H 2 N-, (optionally substituted lower alkyl) NH (hydroxyl) NH-, and (alkoxy) NH-; R 4 and R 5 are independently H or optionally substituted lower alkyl, or one of R 4 and R 5 is H and the other of R 4 and R 5 is R 7 (O)CCH 2 - or lower acyl; R 6 is H, optionally substituted lower alkyl, lower acyl or R 7 (O)CCH 2 -; R 7 is H, optionally substituted lower alkyl, alkoxy or hydroxyl; R 8 and R 9 taken together are =NR 10 ; R 10 is hydrogen, R 11 O 2 C-, R 11 O- HO-, cyano, R 11 CO-, NCO-, lower alkyl, nitro, or Y 1a Y 2a N-; R 11 is alkyl, aralkyl, or heteroaralkyl; R 12 is hydrogen, lower alkyl, aryl (lower alkyl), heteroaryl (lower alkyl), lower acyl, aroyl, or heteraroyl; R 13 is hydrogen, lower alkyl; a pharmaceutically acceptable salt thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof. 2698

152704 METHOD FOR PRODUCING 2- CHLORO-5-CHLOROMETHYL-1, 3-THIAZOLE שיטה לייצור 1,3 תיאזול 2 כלורו 5 כלורומתיל [31] [87] 26.04.2001 A895/2000 [32] 23.05.2000 Int. Cl.8 C07D 277/32 SYNGENTA PARTICIPATIONS AG, SWITZERLAND WO/2001/090089 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [33] AT לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] A process for the preparation of 2- chloro-5-chloromethyl-1,3-thiazole, which is characterized in that (a) alkyl isothiocyanate of the formula CH 2 =CH---CH 2 ---NCS is reacted at a temperature of from -40 o C. to 30 o C., in a solvent that is inert under the reaction conditions, optionally in an inert gas atmosphere, with from 1 to 2 mol of a chlorinating agent per mol of allyl isothiocyanate, said chlorinating agent being selected from the group consisting of Cl 2, SO 2, Cl 2, PCl 3, PCl 5 and POCl 3 ; (b) to the reaction mixture resulting from step (a), at a temperature of from 0 o C. to the boiling temperature of the reaction mixture, from 1 to 5 mol of an oxidizing agent per mol of allyl isothiocyanate are added, said oxidizing agent being selected from the group consisting of Br 2, an N- haloimide and a dihalodialkylhydantoin, optionally with the application of UV light and/or in the presence of a suitable initiator, optionally in an inert gas atmosphere; and (c) the 2-chloro-5-chloromethyl-l,3- thiazole is isolated from the reaction mixture resulting from step (b); and, if desired, (d) the isolated 2-chloro-5-chloromethyl- 1,3-thiazole resulting from step (c) is converted by crystallization into highpurity 2-chloro-5-chloromethyl-1,3- thiazole. 2699

CRYSTALLINE AND AMORPHOUS FORMS OF A TRIAZOLO (4,5-D) PYRIMIDINE COMPOUND 152777 צורה גבישית ואומורפית של תרכובת של טריאזולו (5,4 D) פירימידין [31] [72] [87] 31.05.2001 0013407.2 [32] 02.06.2000 [33] GB Int. Cl.8 A61K 031/519, A61P 009/10, C07D 487/04 ASTRAZENECA AB, SWEDEN MARTIN BOHLIN, STEVE COSGROVE, BO LASSEN WO/2001/092262 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A compound of the formula: in a substantially crystalline form selected from: a compound of formula (I) characterised by an X-ray powder diffraction pattern containing specific peaks of high intensity at 5.3 o (±0.1 o ), 20.1 o (±0.1 o ), 20.7 o (±0.1 o ), 21.0 o (±0.1 o ) and 21.3 o (±0.1 o )2Ө; a compound of formula (I) characterised by an X-ray powder diffraction pattern containing specific peaks of high intensity at 14.0 o (±0.1 o ), 17.4 o (±0.1 o ), 18.4 o (±0.1 o ), 21.4 o (±0.1 o ) and 24.1 o (±0.1 o ) 2Ө; and a compound of formula (I) characterised by an X-ray powder diffraction pattern containing specific peaks of high intensity at 4.9 o (±0.1 o ), 9.2 o (±0.1 o ), 11.6 o (±0.1 o ), 15.6 o (±0.1 o ) and 16.4 o (±0.1 o ) 2Ө. The applications for division from this application have not yet been published,187482 בקשות חלוקה מבקשה זו שטרם פורסמו. 2700

2-AMINOCARBONYL-9H-PURINE DERIVATIVES 152783 נגזרות של 2 אמינוקרבוניל H9 פורין [31] [87] 05.06.2001 0014048.3 [32] 06.06.2000 [33] GB 0018246.9 25.07.2000 GB 0024920.1 11.10.2000 GB Int. Cl.8 A61K 031/7076, A61P 001/04, 003/10, 009/00, 009/10, 009/12, 011/00, 011/02, 011/06, 015/08, 015/16, 017/00, 017/02, 017/04, 017/06, 019/02, 025/08, 025/18, 025/28, 029/00, 031/04, 037/08, 043/00, C07H 019/00, 019/16 PFIZER INC., U.S.A. WO/2001/094368 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A compound of the formula: or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is H, C 1 -C 6 alkyl or fluorenyl, said C 1 - C 6 alkyl being optionally substituted by 1 or 2 substituents each independently selected from phenyl and naphthyl, said phenyl and naphthyl being optionally substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halo or cyano; (A) R 2 is H or C 1 -C 6 alkyl, R 15 is H or C 1 - C 6 alkyl, and X is either (i) unbranched C 2 - C 3 alkylene optionally substituted by C 1 -C 6 alkyl or C 3 -C 8 cycloalkyl, or (ii) a group of the formula: -(CH 2 ) n -W-(CH 2 ) p - where W is C 5 -C 7 cycloalkylene optionally 2701 substituted by C 1 -C 6 alkyl, n is 0 or 1 and p is 0 or 1, or (B) R 15 is H or C 1 -C 6 alkyl, and R 2 and X, taken together with the nitrogen atom to which they are attached, represent azetidin-3-yl, pyrrolidin-3-yl, piperidin-3- yl, piperidin-4-yl, homopiperidin-3-yl or homopiperidin-4-yl, each being optionally substituted by C 1 -C 6 alkyl, or (C) R 2 is H or C 1 -C 6 alkyl, and R 15 and X, taken together with the nitrogen atom to which they are attached, represent azetidin-3-yl, pyrrolidin-3-yl, piperidin-3- yl, piperidin-4-yl, homopiperidin-3-yl or homopiperidin-4-yl, each being optionally substituted by C 1 -C 6 alkyl;

either, R 3 and R 4, taken together with the nitrogen atom to which they are attached, represent azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, homopiperidinyl or homopiperazinyl, each being optionally substituted on a ring nitrogen or carbon atom by C 1 -C 6 alkyl or C 3 -C 8 cycloalkyl and optionally substituted on a ring carbon atom not adjacent to a ring nitrogen atom by NR 6 R 7, or, R 3 is H, C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl or benzyl and R 4 is (a) azetidin-3-yl, pyrrolidin-3-yl, piperidin- 3-yl, piperidin-4-yl, homopiperidin-3-yl or homopiperidin-4-yl, each being optionally substituted by C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, phenyl, benzyl or het, or (b) (C 2 -C 6 alkylene)-r 8, (c) (C 1 -C 6 alkylene)-r 13, or (d) C 1 -C 6 alkyl or C 3 -C 8 cycloalkyl; R 5 is CH 2 OH or CONR 14 R 14 ; R 6 and R 7 are either each independently H or C 1 -C 6 alkyl or, taken together with the nitrogen atom to which they are attached, represent azetidinyl, pyrrolidinyl or piperidinyl, said azetidinyl, pyrrolidinyl and piperidinyl being optionally substituted by C 1 -C 6 alkyl; R 8 is (i) azetidin-1-yl, pyrrolidin-1-yl, piperidin-1-yl, morpholin-4-yl, piperazin- 1-yl, homopiperidin-1-yl, homopiperazin- 1-yl or tetrahydroisoquinolin-1-yl, each being optionally substituted on a ring carbon atom by C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, phenyl, C 1 -C 6 alkoxy-(c 1 -C 6 )- alkyl, R 9 R 9 N-(C 1 -C 6 )-alkyl, fluoro-(c 1 - C 6 )-alkyl, -CONR 9 R 9,-COOR 9 or C 2 -C 5 alkanoyl, and optionally substituted on a ring carbon atom not adjacent to a ring nitrogen atom by fluoro-(c 1 -C 6 )-alkoxy, halo, -OR 9, cyano,- S(O) m R 10, -NR 9 R 9, - SO 2 NR 9 R 9, -NR 9 COR 10 or NR 9 SO 2 R 10, and said piperazin-1-yl and homopiperazin-1-yl being optionally substituted on the ring nitrogen atom not attached to the C 2 -C 6 alkylene group by C 1 -C 6 alkyl, phenyl, C 1 -C 6 alkoxy (C 2 - C 6 )-alkyl, R 9 R 9 N-(C 2 -C 6 )-alkyl, fluoro-( C 1 -C 6 )-alkyl, C 2 -C 5 alkanoyl, -COOR 10, C 3 -C 8 cycloalkyl, -SO 2 R 10, -SO 2 NR 9 R 9 or CONR 9 R 9, or (ii) NR 11 R 12 ; R 9 is H, C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl or phenyl; R 10 is C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl or phenyl; R 11 is H, C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl or benzyl; R 12 is H, C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, phenyl, benzyl, fluoro-( C 1 -C 6 )-alkyl,- CONR 9 R 9, -COOR 10, C 2 -C 5 alkanoyl or SO 2 NR 9 R 9 ; R 13 is (a) phenyl, pyridin-2-yl, pyridin-3-yl or pyridin-4-yl, each being optionally substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, - (C 1 -C 3 alkylene)- (C 1 -C 6 alkoxy), halo, cyano, -(C 1 -C 3 alkylene)-cn, -CO 2 H, -(C 1 - C 3 alkylene)-co 2 H, -CO 2 (C 1 -C 6 alkyl), - (C 1 -C 3 alkylene)-co 2 (C 1 -C 6 alkyl), -(C 1 -C 3 alkylene)-nr 14 R 14, -CONR 14 R 14 OR (C 1 - C 3 alkylene)-conr 14 R 14, or (b) azetidin- 2-yl, azetidin-3-yl, pyrrolidin-2-yl, pyrrolidin-3-yl, piperidin-2-yl, piperidin-3- yl, piperidin-4-yl, homopiperidin-2-yl, homopiperidin-3-yl or homopiperidin-4-yl, each being optionally substituted by C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, phenyl, benzyl or het; R 14 is H or C 1 -C 6 alkyl optionally substituted by cyclopropyl; m is 0, 1 or 2; Y is CO, CS, SO 2 or C=N(CN); and "het", used in the definition or R 4 and R 13, is a C-linked, 4- to 6-membered ring, heterocycle having either from 1 to 4 ring nitrogen heteroatoms or 1 or 2 nitrogen ring heteroatoms and 1 oxygen or 1 sulphur ring heteroatom, optionally substituted by C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 alkoxy, C 3 -C 8 cycloalkoxy, hydroxy, oxo or halo. 2702

152834 LENS PRODUCTION METHOD AND PROCESS 14.11.2002 Int. Cl.8 G02B 003/00 SHAMIR SPECIAL OPTICAL PRODUCTS LTD PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733 התקן ושיטה לייצור עדשה שמיר מוצרים אופטיים מיוחדים בע"מ פרל כהן צדק לצר, מרכז גב- םי 1, רח' שנקר, 5 ת.ד. 12704, הרצליה [57] A method for processing a lens blank provided with a first surface and a second surface to be processed by a processing equipment for imparting the first and the second surface with required surface topography and obtaining a corresponding first optical face and a second optical face of a lens, said method comprising positioning the lens blank in a gripping device and gripping the lens blank by a gripping device while relying on reference datum indications enabling orientation of the lens blank to obtain the required surface topography of both optical faces of the lens, and wherein not more than one reference datum indication extends on the first optical face of the lens. The applications for division from this application have not yet been published,185718 בקשות חלוקה מבקשה זו שטרם פורסמו. 152844 TRANSGENIC ANIMAL IN WHICH GSK-38 PROTEIN IS OVER-EXPRESSED חיה טרנזגנטית אשר בה חלבון 38 GSK במצב בטוי יתר [31] [87] 2703 18.05.2001 0012056.8 [32] 18.05.2000 Int. Cl.8 A01K 067/00, C12N 009/12 CONSEJO SUPERIOR INVESTIGACIONES CIENTIFICAS, SPAIN UNIVERSIDAD AUTONOMA DE MADRID (UAM), SPAIN WO/2001/088109 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] GB וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים

[57] A transgenic non-human animal in the animal under the control of a wherein GSK-3β protein is over-expressed CamKIIa promoter. [31] [87] DRIP IRRIGATION HOSE AND METHOD OF MAKING SAME 13.08.2001 09/639768 [32] 21.08.2000 Int. Cl.8 B05B 001/20 AMIR COHEN WO/2002/015670 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15 TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 153049 צינור השקיה בטפטוף ושיטה ליצורו [33] US אמיר כהן ג'י.אי.ארליך (1995) בע"מ, מגדל אילון, קומה 15,רחוב מנחם בגין 11, רמת גן [57] A drip irrigation hose, comprising: a hose (2) conducting pressurized water through its interior and formed with a plurality of outlets for discharging the water at longitudinally-spaced locations along the length of the hose; and a plurality of emitter elements (4) secured to said hose at longitudinally-spaced locations along its length to define a plurality of turbulent flow passageways each in communication with the interior of the hose for discharging water from each hose outlet at a slow rate; characterized in that each of said turbulent flow passageways defined by said emitter elements includes a relatively elastic material coextruded with a relatively stiff material different from said elastic material, such that the relatively elastic material is pressure-deformable as compared to the relatively stiff material to change the turbulent flow through each emitter element in response to the pressure of the water in the hose at the respective emitter element. 2704

[31] [87] ENANTIOMER SEPARATION OF PIPERIDONE DERIVATIVES WITH SIMULTANEOUS IN SITU RACEMIZATION OF THE UNWANTED ENANTIOMER 09.06.2001 10029851.6 [32] 16.06.2000 Int. Cl.8 C07D 211/74 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, GERMANY WO/2001/096306 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 153085 [33] הפרדה אננטיומרית של תולדות פיפרידיון תוך רצמיזציה בו זמנית של האננטיומר הלא רצוי DE ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A process for dynamically separating the enantiomers of a piperidone derivative of the formula wherein: (b) adding a second solution containing the R 1 is aryl optionally mono-to piperidone derivative to the first solution polysubstituted, heteroaryl, which is linked to precipitate out the desired enantiomer of to the chiral center via at least one carbon the piperidone derivative as a salt of the atom belonging to the methylene bridge, or optically active acid while racemizing the straight-chain or branched C 1 -C 8 alkyl unwanted enantiomer of the piperidone optionally mono- to polysubstituted by derivative in solution and further halogen; R 2 and R 3, which are identical or precipitating the desired enantiomer of the different, are each straight-chain or piperidone derivative formed from the branched C 1 -C 6 -alkyl; and n is 0, 1, 2 or 3, racemization of the unwanted enantiomer the process comprising: of the piperidone derivative in solution; (a) dissolving an optically active acid and and optionally catalytic amounts of a sulfonic (c) separating the desired enantiomer of acid in a solvent to make a first solution the piperidone derivative as a salt of the maintained at a desired temperature; optically active acid. 2705

153128 [31] PRODUCTION METHOD OF A 2,6- DICHLOROPHENOL COMPOUND 27.11.2002 2001-387259 [32] 20.12.2001 Int. Cl.8 C07C 041/22, 043/00, 043/23 SUMITOMO CHEMICAL COMPANY, LIMITED, JAPAN DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063 [33] JP שיטת ייצור של תרכובת 2 6, דיכלורופנול ד"ר יצחק הס ושותפיו, רחוב הירקון, 279 ת.ד. 6451, תל אביב [57] A production method of a 2, 6- dichlorophenol compound of the formula wherein R represents a 3,3-dihalo-2- propenyl group, which comprises making a phenol compound of the formula wherein R has the same meaning mentioned above, react with sulfuryl chloride in the presence of a secondary amine. 2706

COMPUTER STORAGE APPARATUS AND METHOD FOR DATA MIRRORING 153163 התקן לאיחסון במחשב והליך לייצור תמונות ראי של נתונים [31] [72] [87] 02.06.2001 60/209469 [32] 05.06.2000 [33] US 60/223934 09.08.2000 US 60/262143 16.01.2001 US Int. Cl.8 G06F 003/06, 011/00, 011/20, 012/00 MIRALINK CORPORATION, U.S.A. RON MCCABE, TRACY CAMP, STUART CARD, DAVID J. SCHROEDER WO/2001/097030 JMB, FACTOR & CO. LTD., ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים, ת.ד.,45087 PARK, HAR HOTZVIM HI-TECH P.O.B. 45087, ירושלים JERUSALEM 91450 [57] A computer storage apparatus, comprising: means for receiving change data from a source, the change data received in a mirroring unit; and means for storing a changed logical block number indicating a logical block on the source corresponding to the change data, the means for storing the changed logical block number including a data structure including block checksums corresponding to the change data; and means for transmitting the block checksums across a journey link to a mirroring unit rather than transmitting change data across the journey link during a resynchronization of the mirroring unit and the computer storage apparatus. 2707

153221 METHOD FOR DETECTING ACTIVE INGREDIENTS OF MEDICAL VALUE שיטה לזיהוי מרכיבים פעילים בעלי ערך רפואי [31] [87] 30.05.2001 10028204.0 [32] 09.06.2000 Int. Cl.8 C12Q 001/37 SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY WO/2001/094612 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] DE איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] A method to determine whether a test substance inhibits or acts as a ligand of at least one binding domain of a protein, comprising: incubating said test substance with a mixture, wherein said mixture comprises: (a) the protein, (b) at least one marker substrate, and (c) at least one substrate; and determining whether the test substance inhibits or acts as a ligand of at least one binding domain of the protein by comparing the conversion of the marker substrate in the presence of the test substance with the corresponding conversion in control mixtures A and B, 2708

wherein the protein contains at least one catalytic domain and at least one binding domain, wherein the marker substrate is converted by said at least one catalytic domain of the protein, wherein the substrate is capable of binding to said at least one catalytic domain and to said at least one binding domain of the protein, wherein the control mixture A comprises the protein and the marker substrate; and the control mixture B comprises the protein, the substrate, and the marker substrate, and wherein the test substance is an inhibitor or ligand of said at least one binding domain of the protein if the conversion of the marker substrate in the presence of the test substance is between the values obtained with control mixtures A and B. 153503 POTENT IMMUNOSTIMULANTS FROM MICROALGAE ממריצים של המערכת החיסונית המופקים ממיקרו אצות [31] [87] 10.07.2001 60/217001 [32] 10.07.2000 [33] US Int. Cl.8 A61K 003/602000 031/715, 031/726, 031/736, 035/00, C07H 001/08 THE UNIVERSITY OF MISSISSIPPI, U.S.A. WO/2002/004000 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Immunostimulatory preparations isolated from microalgae comprising polysaccharides extractable by a solvent comprising water or a mixture of water and at least one lower alkyl alcohol where the alkyl portion is from 1 to 4 carbon atoms and where the active polysaccharides have apparent molecular weights above approximately 2 million Daltons. 2709

153655 POLYMERIC MICELLE COMPOSITIONS תכשירים בצורת מיצלות מפולימרים [31] [87] 28.06.2001 606398 [32] 29.06.2000 Int. Cl.8 A61K 009/00, 009/107, 009/51 LABOPHARM, INC., CANADA. WO/2002/000194 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] US.ד. 4060, תל אביב ריינהולד כהן ושותפיו, רחוב אחד העם 21 ת, [57] A micelle-forming composition, selected from the group consisting of poly comprised of: a hydrophobic core (glycolic acid), poly (lactic acid), poly (Dlactic acid), poly (D, L-lactic acid), surrounded by a hydrophilic shell; and a therapeutic agent physically entrapped lactide/glycolide copolymers or within said micelle; wherein the polycaprolactone and derivatives thereof; hydrophobic core is selected from the and the hydrophilic shell is poly (N-vinylgroup consisting of a polyorthoester, a 2-pyrrolidone); said composition being polyanhydride, a tyrosine derived pseudopoly (amino acid), a polyphosphazene or a following addition of an aqueous solution readily redispersed or redissolved poly (β-benzyl-l-aspartate) and to a freeze-dried form of the micelleforming composition. combinations thereof, or a polyester 153699 BONE GRAFT COMPOSITE 26.12.2002 Int. Cl.8 A61K 047/02 PROCHON LTD. WEBB & ASSOCIATES, 2 PEKERIS ST., P.O.B. 2189, REHOVOT 76121 הרכב להשתלה בעצם פרוכון בע"מ, נס-ציונה ד"ר וב ושות', רח' פקריס, 2 ת.ד. 2189, רחובות [57] A bone graft composite comprising a synthetic apatite, at least one amino acid in monomeric or polymeric form, a carbonate and at least one anti-resorptive agent, wherein the at least one anti-resorptive agent is introduced into the composite ab initio. 2710

APPARATUS AND PROCESSES FOR IODINE DISINFECTION OF WATER 153883 מתקנים ותהליכים לחיטוי של מים ע"י יוד [31] [87] 20.07.2001 PQ8916 [32] 21.07.2000 Int. Cl.8 C01B 007/14, C02F 001/50 IODINE TECHNOLOGIES AUSTRALIA PTY LTD., AUSTRALIA WO/2002/008126 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] AU סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] An apparatus for iodine decontamination and purification of a water stream, the apparatus comprising: a source of water for one or more water consuming applications and for providing a water stream; a delivery station intermediate said source of water and a treatment station; a source of iodine at the delivery station; means to enable release into said water stream of said iodine; a monitoring electrode associated with the delivery station which maintains the iodine in said water stream at a predetermined concentration to provide a predetermined level of purification of said water stream and/or objects in contact with said water stream in the treatment station; means for recovery from said water stream of said iodine and/or iodide and/or other iodine species derived from said iodine; and means for conversion of all said recovered iodine species derived from said iodine delivered to said stream to iodine as used in this system. SYSTEM AND METHOD FOR PULVERIZING STONES AND FOR SCAR REMOVAL IN SOFT TISSUES 24.01.2003 Int. Cl.8 A61B 017/22 SIALO-LITE LTD. REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 154120 מערכת ושיטה לריסוק אבנים והסרת צלקות ברקמות רכות סיאלו-לייט בע"מ, אשקלון ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב 2711

[57] A system for treatment of hard tissues present in a fluid-filled body cavity the cavity having a diameter of 3 mm or less, said system comprising: (a) an endoscope for visualizing the interior of said cavity; (b) an erbium laser device adapted to generate a laser beam configured to pulverize the hard tissue; and (c) an optic fiber (136) for delivering the laser beam to the hard tissue or to the vicinity of the hard tissue. 154134 VAGINAL DELIVERY OF BISPHOSPHONATES מתן וגינלי של ביספוספונטים [31] [87] 12.07.2001 09/626025 [32] 27.07.2000 [33] US Int. Cl.8 A61F 013/00, A61K 009/02, C07F 009/38 UMD, INC., U.S.A. WO/2002/009631 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] Use of a transmucosal vaginal to about 2000 mg of the bisphosphonate composition of bisphosphonates in the selected from the group consisting of preparation of a medicament for treatment alendronate, clodronate, etidronate, and prevention of osteoporosis and Paget's pamidronate, tiludronate, ibandronate, disease and for treatment of a metastatic neridronate, risedronate, zoledronate and bone disease in a human female patient, olpadronate; from about 40 to about 95% wherein a bisphosphonate is delivered into of a saturated mono-, di- or triglyceride of the systemic circulation through a vaginal fatty acids from 8 to 18 carbons or a mucosa from a vaginal device incorporated mixture thereof; from about 5 to about with a transmucosal vaginal composition, 25% of a mucoadhesive agent selected said use comprising steps of: providing the from the group consisting of alginate, transmucosal vaginal composition pectin and a cellulose derivative; and from consisting essentially of from about 0.001 about 5 to about 25% of 2712

ethoxydiglycol; wherein said composition microcapsules; and wherein said is formulated and incorporated into the composition is used via a vaginal tampon, device as a suppository, cream, gel, foam, vaginal ring, vaginal strip, vaginal capsule, ointment, capsule containing vaginal tablet, vaginal pessary, vaginal cup microparticles, microparticles or or vaginal sponge. 154236 [31] [87] ABRASIVE PRODUCT 31.07.2001 2000/3920 [32] 02.08.2000 2000/3919 02.08.2000 Int. Cl.8 B24D 003/04 ELEMENT SIX (PTY) LTD., SOUTH AFRICA WO/2002/009909 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [33] ZA ZA מוצר משפשף לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] An abrasive product comprising a plastic deformation of the abrasive polycrystalline mass of self-bonded ultrahard abrasive particles of irregular shape, least 0.3 percent, and having a porosity particles, such plastic deformation being at the product being substantially free of a which is greater than 10 percent by volume second phase, containing substantial and does not exceed 25 percent by volume. 2713

USE OF 5 METHYL 2- (2' CHLORO 6' FLUOROANILINO) PHENYLACETIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING CYCLOOXYGENASE 2 DEPENDENT DISORDER AND A MEDICAMENT PACKAGE COMPRISING THE SAME 154238 שימוש ב 5 מתיל 2 2') כלורו '6 פלואורואנילינו) חומצה פנילאצטית או מלח רוקחי מקובל שלו לייצור תרופה לטיפול באי סדר הקשור לציקלואוקסיגנז 2 ואריזה לתרופה המכילה אותם [31] [87] 10.09.2001 60/231655 [32] 11.09.2000 [33] US 60/232261 14.09.2000 US Int. Cl.8 A61K 031/196, A61P 029/00, 043/00, C07C 229/42 NOVARTIS AG, SWITZERLAND WO/2002/020090 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] Use of 5-methyl-2-(2'-chloro-6'- treating a cyclooxygenase-2 dependent fluoroanilino) phenylacetic acid or a disorder or condition wherein the pharmaceutically acceptable salt thereof in medicament is for once daily the manufacture of a medicament for administration. 2714

[31] [87] METHOD AND SYSTEM FOR REAL-TIME FLUORESCENT DETERMINATION OF TRACE ELEMENTS 29.08.2001 60/228673 [32] 29.08.2000 Int. Cl.8 G01N 023/00 GLAXO GROUP LIMITED, UNITED KINGDOM WO/2002/018921 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 154256 שיטה ומערכת למדידות פלורוסנציה של יסודות עקבות בזמן אמת [33] US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A system for use in in-situ analysis of pharmaceutical samples (14), said system comprising: means (10a, 10b) for holding a plurality of said samples, wherein said samples are present in the form of a Metered Dry Powder Inhaler formulation; means (50) for moving said plurality of samples along a sample path; means (26) for generating a plurality of incident radiation pulses of different wavelength; means (22) for illuminating at least a respective one of said samples with at least a respective one of said radiation pulses during said movement of said samples, said radiation pulse having a suitable range of radiation wavelengths capable of inducing a fluorescent response; means (20) for detecting a first resultant fluorescence emitted from each of said samples; first control means (24) in communication with said moving means and said incident radiation generating means for synchronizing said means for illuminating each of said samples with said moving means. 2715

154332 METHOD FOR PRODUCING β- KETOENOL ESTERS שיטה ליצור β קטואנול אסטרים [31] [87] 21.08.2001 10041044.8 [32] 22.08.2000 [33] DE Int. Cl.8 C07C 045/67, 067/00, 067/36, 069/76, C07D 261/04, 275/06 BASF AKTIENGESELLSCHAFT, GERMANY WO/2002/016305 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A process for preparing β-ketoenol esters of the formulae in which 5- or 6-membered saturated carbocycle, a R a, R b independently of one another are spiro-linked 3-, 4-, 5- or 6- or 7-membered C 1 -C 6 -alkyl or C 3 -C 8 -cycloalkyl, or R a and saturated carbocycle, a spiro-linked 3-, 4-, R b together are C 2 -C 4 -alkanediyl or C 5 -C 7-5-, 6- or 7-membered saturated heterocycle cycloalkanediyl, where the three groups having 1 or 2 chalkogen atoms, selected mentioned above may be substituted or from the group consisting of oxygen and unsubstituted and may have a fused 3-, 4-, sulfur and/or a carbonyl or thiocarbonyl 2716

group; Ar is phenyl or pyridyl, which may in each case have 1, 2, 3 or 4 substituents, it also being possible for two substituents attached to adjacent carbon atoms to form, together with these atoms, a 5- or 6- membered saturated or unsaturated carbocycle or a 5- or 6-membered saturated or unsaturated heterocycle which has 1, 2 or 3 hetero atoms selected from the group consisting of O, N and S and which for its part may be substituted or unsubstituted; which comprises reacting an aryl halide of the formula Ar-Hal in which Hal is bromine with a 1, 3- diketone or its tautomer of the formula in a carbon monoxide atmosphere in the presence of a base and a catalyst which comprises at least one transition metal of group VIII of the Periodic Table of the Elements. 154450 [31] [72] [87] 3D IMAGE PROCESSING ADEQUATE FOR SYSTEM WITHOUT HARDWARE SUPPORT 20.06.2002 2001-187619 [32] 21.06.2001 Int. Cl.8 G06T 003/00, 015/00 HI CORPORATION, JAPAN YASUHISA TANIOKA, JUNYA TSUTSUMI, KAZUO KAWABATA, KAZUTOSHI ODA WO/2003/001458 DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 [33] עיבוד הדמייה תלת מימדי מתאים למערכות ללא תמיכת חומרה JP ד"ר מרק פרידמן בע"מ, מגדל משה אביב, ק. 54, רח ז'בוטינסקי 7, רמת- גן [57] An information processing apparatus for, in conducting Rasterize processing of imaging of a three-dimensional image, calculating a quantity of a change of x coordinates 2717

to y coordinates of a straight line passing through a point P 1 (x 1, y 1 ) and a point P 2 (x 2, y 2 ) on a two-dimensional plane, characterized in that the apparatus comprises: a memory in which a constant µ representative of is stored in association with the quantity of the change of the y coordinates; and calculation means for, in calculating x, reading µ corresponding to the quantity of the change of said y coordinates from said memory, and calculating by means of multiplication, and calculating this result as x. 2718

[87] TIMING-SENSITIVE GLITCH- FREE LOGIC SYSTEM AND METHOD 14.08.2001 Int. Cl.8 G06F 009/455, 011/36, 017/50 VERISITY DESIGN, INC., U.S.A. WO/2003/017148 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 154480 מערכת ושיטה לוגית שאינה רגישת-זמן וחופשיה מהפרעה אקראית וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] A debug system for verifying the proper operation of a user design circuit, the user design containing logic devices and circuit paths, comprising: a computing system that generates a software model of the user design circuit; a reconfigurable hardware system that generates a hardware model of at least a portion of the user design circuit; and control means serving as a slave to the computing system and coupled to the computing system and the reconfigurable hardware system for controlling the operation of the hardware model in the reconfigurable hardware system. 2719

154551 [72] APPARATUS FOR CHECKING DEVIATION FROM CONCENTRICITY 20.02.2003 Int. Cl.8 B23B 049/00, G01B 005/20 TECHNOTOOL GOLDMAN ISRAEL LTD. ISRAEL GOLDMAN PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733 מתקן לבדיקת סטיה מקונצנטריות טוכנוטול גולדמן ישראל בע"מ, נהריה ישראל גולדמן פרל כהן צדק לצר, מרכז גב- םי 1, רח' שנקר, 5 ת.ד. 12704, הרצליה [57] An apparatus for checking deviation in the shape of a part (18) having a portion which has supposedly rotational symmetry about an axis and having a reference end face (20), comprising: a base (10); a support arrangement (14) mounted on said base for receiving said portion and comprising two V-blocks; a positioning arrangement (16) for positioning said part axially with respect to said reference end face; and a driving mechanism for driving said part in rotation about said axis, wherein said positioning arrangement comprises: a rectilinear portion with an end for providing an abutment for said reference end face, said rectilinear portion slidably mounted on said base, adjustable along three axes and rotatable about at least one of said three axes. 2720

[31] [87] SYSTEM AND METHOD FOR SECURED DUAL CHANNEL COMMUNICATION THROUGH A FIREWALL 05.09.2001 09/655256 [32] 05.09.2000 Int. Cl.8 G06F 002/100000 H04L 009/00 STERLING COMMERCE, INC., U.S.A. WO/2002/021772 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 154572 [33] שיטה ומערכת לתקשורת דו כיוונית מאובטחת באמצעות FIREWALL US לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] A method for establishing a data socket between a server and a client, comprising: encoding a port command including a client internal IP address and a client port number; generating a dual channel communication packet having a header and data payload, the header including a server external IP address, server port number, the client internal IP address and the client port number; the data payload including the encoded port command; transmitting the communication packet between the server and the client; decoding the port command; retrieving the client external IP address from the header; modifying the decoded port command by overriding the client internal IP address within the decoded port command with the client external IP address retrieved from the header; and establishing a data socket between the server and the client using the modified decoded port command. 2721

154652 PURINE RIBOSIDES AS ANTIARRHYTHMICS פורין ריבוסידים כחומרים נגד אי קצב [31] [87] 07.09.2001 60/231011 [32] 08.09.2000 [33] US 60/305328 13.07.2001 US Int. Cl.8 A61K 031/7076, A61P 009/06, C07H 019/167 CV THERAPEUTICS, INC., U.S.A. WO/2002/020024 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] Use of a therapeutically effective minimal dose of an adenosine A 1 receptor agonist of the formula wherein: said minimal dose is in the range of R 1 is an optionally substituted heterocyclic 0.0003-0.009 mg/kg, for the preparation of group; and a pharmaceutical composition for treating arrhythmia in a mammal. 2722

[31] [87] PHARMACEUTICAL HYDROPHILIC GEL FORMING MATRIX FORMULATION HAVING PROLONGED RELEASE AND METHOD FOR ITS PREPARATION 28.09.2001 1016295 [32] 29.09.2000 00203381.9 29.09.2000 Int. Cl.8 A61K 009/00, 009/22, 047/36 SOLVAY PHARMACEUTICALS B.V., THE NETHERLANDS WO/2002/026214 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 154731 הכנה רוקחית בצורת ג'ל הידרופילי יוצר מטריצה לשחרור מושהה ושיטה להכנתו [33] NL EP ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A pharmaceutical hydrophilic gel forming matrix formation comprising one or more active substances and having a prolonged release of said one or more active substances upon exposure to gastrointestinal fluids, characterized in that said pharmaceutical formulation comprises high or medium viscosity hydroxypropylmethylcellulose (HPMC) and a high or medium viscosity hydroxyethylcellulose (HEC), in a ratio HPMC/HEC = 1/0.85 1/1.2 and optionally a low viscosity HPMC in a ratio high or medium viscosity HPMC/low viscosity HPMC=1/0.01-1/0.2. 2723

USE OF DISTAMYCIN DERIVATIVES FOR THE PREPARATION OF MEDICAMENTS FOR TREATING TUMORS 154755 שימוש בתודות דיסטאמיצין להכנת תרופות לטיפול בגידולים ממאירים [31] [87] 21.09.2001 09/676770 [32] 02.10.2000 [33] US Int. Cl.8 A61K 031/40, 035/00, C07D 207/34, 403/14 PHARMACIA & UPJOHN COMPANY LLC, U.S.A. PFIZER ITALIA S.R.L., ITALY WO/2002/028389 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Use of an α-halogen-acryloyl distamycin derivative of the formula wherein: R is a bromine or chlorine atom; or a pharmaceutically acceptable salt thereof; in the preparation of a medicament for the treatment of tumors by a schedule comprising the intravenous infusion of the medicament as a single administration every three or four weeks in an amount of from 0.85 mg/m 2 to 20 mg/m 2 of body surface area, or weekly for three consecutive weeks every four or five weeks in an amount from 0.3 mg/m 2 /week to 7 mg/m 2 /week. 2724

COVER FOR DRAINS, PIPE ENDS AND THE LIKE 11.03.2003 Int. Cl.7 E03C 001/26, F16L 055/12 GILI PEERY REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 154866 מכסה לצינורות ניקוז, לקצוות צינורות ודומיהם גילי פארי, פרדסיה ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A closure device for a pipe end comprising: a ring member (30) adapted for press fitting within said pipe end and having a sealing surface (32); and a cover member (20) having a peripheral surface of a diameter larger than that of the pipe end, said cover member suited for abutment against a floor surface (90) and against at least one of said sealing surface and an end surface (37) of said pipe end; said cover member and said ring member comprising suitable rotatable engagement means (40) for enabling said cover member to be rotatably engaged with respect to said ring member. 2725

154896 TRANSFER OF DATA IN A TELECOMMUNICATIONS SYSTEM העברת נתונים במערכת טלקומוניקציה [31] [87] 23.07.2001 0023688.5 [32] 27.09.2000 [33] GB Int. Cl.8 H04B 007/26, H04J 013/00, H04L 001/00 AIRSPAN NETWORKS INC., U.S.A. WO/2002/028001 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] A method of operating a telecommunications system to route data messages between a network and subscriber terminals of the telecommunications system, the subscriber terminals being connectable to a central terminal of the telecommunications system via a transmission medium, the telecommunications system providing a number of communication channels arranged to utilize the transmission medium for transmission of data between the central terminal and the subscriber terminals, the method comprising the steps of: transmitting the data message destined for a particular subscriber terminal from the central terminal over at least one of the communication channels as a number of data blocks; and generating a number of frames to represent each data block to be transmitted, each frame having a header portion and a data portion, the header portion being arranged to be transmitted in a fixed format chosen to facilitate reception of the header portion by each subscriber terminal and being arranged to include a number of control fields for providing information about the data portion, said information comprising at least an indication of the subscriber terminal for which the corresponding data portion of the frame is destined, the data portion being arranged to be transmitted in a variable format selected based on predetermined criteria relevant to the particular subscriber terminal to which the data portion is destined; wherein the predetermined criteria comprises an indication of the signal-to-noise ratio (SNR) of signals received by the particular subscriber terminal from the central terminal, and if there are a plurality of formats selectable as the variable format given the indicated signal-to-noise ratio and the amount of data to be sent in the data block, then selecting in the frame generator from those plurality of formats the format requiring lowest transmission power. 2726

154905 PROCESS FOR PRODUCING FLUORINATED METHYL- BENZYL ALCOHOL תהליך ליצירת כוהל מתיל בנזיל מפלואור [31] [87] 26.09.2001 2000-293518 [32] 27.09.2000 60/256918 21.12.2000 Int. Cl.8 C07C 029/60, 031/00 SHOWA DENKO K.K., JAPAN WO/2002/026678 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] JP US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A process for producing a fluorinated methyl-benzyl alcohol of the formula (wherein m represents an integer of 0 to 3, n represents an integer of 1 to 4, and m+n is an integer of 1 to 4), which process comprises hydrogenolysis of one hydroxyl group in a fluorinated benzene dimethanol of the formula 2727

(wherein m and n are the same as above). DROPLET DEPOSITION APPARATUS, COMPONENT AND METHOD OF FORMING SAME 155047 התקן להגשת טיפונת, רכיב שלו ושיטה לייצורו [31] [87] 26.09.2001 0023544.0 [32] 26.09.2000 0117295.6 16.07.2001 Int. Cl.8 B41J 002/14, 002/16 XAAR TECHNOLOGY LIMITED, UNITED KINGDOM WO/2002/026501 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] GB GB איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] Method of forming a droplet deposition apparatus comprising the steps: forming a substrate having one or more electrically conductive tracks, forming a body of piezoelectric material having a top surface and a bottom surface, providing one or more electrically conductive points on the bottom surface of said piezoelectric material comprising forming one or more depressions in said bottom surface of said piezoelectric material, locating a coating of conductive material in said depressions and further comprising subsequently filling said one or more depressions with a nonconductive material; attaching said body of piezoelectric material to said substrate with said bottom surface overlying said tracks and said electrically conductive points establishing electrical connection with said tracks for actuation of the piezoelectric material, and subsequently forming in said attached piezoelectric material at least one droplet ejection chamber. 2728

PROCESS FOR PRODUCTION OF AN ABSORBING SANITARY ARTICLE COMPRISING LACTIC ACID PRODUCING BACTERIA 155150 תהליך להכנת מוצר סינטרי סופג המכיל חיידק המייצר חומצת חלב [31] [87] 19.09.2001 0003544-4 [32] 03.10.2000 Int. Cl.8 A61F 013/15, A61L 015/36 ELLEN AB, SWEDEN WO/2002/028446 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] SE איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] A process for the production of an absorbing sanitary article comprising lactic acid producing bacteria characterized in that it comprises the following steps: dispersion of viable lactic acid producing bacteria in an essentially hydrophobic carrier, resulting in a dispersion of bacteria, application of the dispersion of bacteria by continuous or discontinuous extrusion on and/or in at least one component that are to form part of the final article, providing at least one continuous and/or discontinuous string of dispersion of bacteria on and/or in the final sanitary article. 2729

PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF TACHYKININ MEDIATED CONDITIONS 155165 תולדות פיפרידין, תהליך להכנתן, תכשירי רוקחות המכילים אותן ושימושן בהכנת תרופות לטיפול בתנאים הקשורים לטקיקינין [31] [87] 12.10.2001 0025354.2 [32] 17.10.2000 [33] GB Int. Cl.8 A61K 031/495, A61P 025/00, 043/00, C07D 401/04 GLAXO GROUP LIMITED, UNITED KINGDOM WO/2002/032867 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A compound of the formula wherein R represents a halogen atom or a C 1-4 alkyl group; R 1 represents a C 1-4 alkyl group; R 2 represents hydrogen or a C 1-4 alkyl group; R 3 represents hydrogen or C 1-4 alkyl group; R 4 represents a trifluoromethyl group; R 5 represents hydrogen, a C 1-4 alkyl group or C 1-4 alkyl group or C(O)R 6 ; R 6 represents C 1-4 alkyl, C 3-7 cycloalkyl, NH(C 1-4 alkyl) or N(C 1-4 alkyl) 2 ; m is zero or an integer from 1 to 3; n is an integer from 1 to 3; and pharmaceutically acceptable salts and solvates thereof. The applications for division from this application have not yet been published,191486 בקשות חלוקה מבקשה זו שטרם פורסמו. 2730

[31] [87] PROCESS FOR THE MANUFACTURE OF THIAZOLE DERIVATIVES WITH PESTICIDAL ACTIVITY 25.10.2001 2105/00 [32] 27.10.2000 Int. Cl.8 C07D 277/32, 417/06 SYNGENTA PARTICIPATIONS AG, SWITZERLAND WO/2002/034734 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 155224 [33] תהליך לייצור נגזרות של תיאזול עם פעילות כקוטלי מזיקים CH לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] A process for the preparation of a compound of the formula and optionally its E/Z-isomers, E/Z-isomer mixtures and/or tautomers, in each case in free form or in salt form, in which Q is CH or N; Y is NO 2 or CN; Z is CHR 3, O, NR 3 or S; R 1 and R 2 are either, independently of one another, hydrogen, unsubstituted or R 4 - substituted C 1 -C 8 alkyl, or together are an alkylene bridge having two or three carbon atoms which optionally comprises a heteroatom chosen from the group consisting of NR 5, O and S, R 3 is H or unsubstituted or R 4 -substituted C 1 -C 12 alkyl, R 4 is unsubstituted or substituted aryl or heteroaryl, and R 5 is H or C 1 -C 12 alkyl; in which (a) a compound of the formula which is known or can be prepared by known methods, and in which X is a leaving group, is reacted with a chlorinating agent to give a compound of the formula 2731

or optionally a tautomer, in each case in free form or in salt form; and (b) the resulting compound of the formula (III) is reacted with a compound of the formula in which R 1, R 2, Y, Z and Q have the meanings given above for the compound of the formula (I); wherein the preparation of the compound of the formula (III) according to process stage (a) involves a purification step in which the crude product which has formed is treated with aqueous hydrochloric acid. PROCESS FOR THE HYDROCYANATION OF ORGANIC COMPOUNDS COMPRISING ETHYLENIC UNSATURATION 155226 תהליך להידרוציאנציה של תרכובות אורגניות המורכבות מאנסטורציה אתילנית [31] [87] 03.10.2001 00/13152 [32] 13.10.2000 [33] FR Int. Cl.8 C07C 253/10, 255/03, 255/04, 255/07 RHODIA POLYAMIDE INTERMEDIATES, FRANCE WO/2002/030854 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] Process for the hydrocyanation of organic compounds comprising at least one ethylenic bond by reaction with hydrogen cyanide in the presence of a catalytic system comprising a transition metal and an organophosphorus ligand, characterized in that the ligand is a phosphine of the formula 2732

in which: E represents O or S; n represents 0 or 1; R 1, R 4, R 5 and R 6, which are identical or different, represent a hydrogen atom; or else a T radical chosen from: a saturated or unsaturated, aliphatic hydrocarbonaceous radical comprising 1 to 40 carbon atoms, the hydrocarbonaceous chain of which is optionally interrupted by a heteroatom; a monocyclic or polycyclic, saturated, unsaturated or aromatic, carbocyclic or heterocyclic radical; or a saturated or unsaturated, aliphatic hydrocarbonaceous radical, the hydrocarbonaceous chain of which is optionally interrupted by a heteroatom and carries a carbocyclic or heterocyclic radical as defined above; or else R 4 and R 5 form, together with the carbon atoms which carry them, a saturated or unsaturated, carbocyclic monocycle preferably having from 5 to 7 carbon atoms; R 2 represents a hydrogen atom or the X radical; R 3 represents the X radical or the Y radical; it being understood that one and one alone of the R 2 and R 3 substituents represents the X radical; X being chosen from a monocyclic or bicyclic, aromatic carbocyclic or heterocyclic radical having from 2 to 20 carbon atoms; a 1-alkenyl radical optionally exhibiting one or more additional unsaturations in the hydrocarbonaceous chain and having from 2 to 12 carbon atoms; a 1-alkynyl radical optionally exhibiting one or more additional unsaturations in the hydrocarbonaceous chain and having from 2 to 12 carbon atoms; or a CN, [(C 1 -C 12 ) alkyl] carbonyl, [(C 3 -C 18 ) aryl] carbonyl, [(C 1 -C 12 ) alkoxy] carbonyl, [(C 6 -C 18 ) aryloxy] carbonyl, carbamoyl, [(C 1 -C 12 ) alkyl]] carbamoyl or [di(c 1 -C 12 ) alkyl] carbamoyl radical; and Y taking any one of the meanings of R 1, with the exception of a hydrogen atom; R 7 has the meaning of R 1, R 4, R 5 and R 6 or represents a hydrocarbonaceous radical comprising a carbonyl functional group or a radical of the formulae in which, A represents a hydrogen atom; (C 1 -C 10 ) alkyl; or (C 6 -C 10 ) aryl or (C 6 -C 10 ) aryl (C 1 - C 10 ) alkyl in which the aryl part is optionally substituted by one or more radicals chosen from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) 2733 alkoxy, trifluoromethyl, halogen, di (C 1 - C 6 ) alkylamino, (C 1 -C 6 ) alkoxycarbonyl, carbamoyl, (C 1 -C 6 ) alkylaminocarbonyl and di (C 1 -C 6 ) alkylaminocarbonyl; -Ar 1 -Ar 2 - represent: either the divalent radical of formula:

in which each of the phenyl nuclei is optionally substituted by one or more Z groups as defined below; or the divalent radical of formula: in which each of the phenyl nuclei is optionally substituted by one or more Z groups as defined below; Z represents (C 1 - C 6 ) alkyl, (C 1 -C 6 ) alkoxy, trifluoromethyl, halogen, (C 1 -C 6 ) alkoxycarbonyl, di (C 1 - C 6 ) alkylamino, (C 1 -C 6 ) alkylaminocarbonyl or di (C 1 -C 6 ) alkylaminocarbonyl; R 8 and R 9, which are identical or different, represent an aryl radical. 155477 FAN TYPE CHEMICAL DISPERSION EQUIPMENT ציוד דמוי מאוורר לדיספרסיה כימית [31] [87] 21.09.2001 2001-20234 [32] 29.01.2001 2001-20152 29.01.2001 2001-20188 29.01.2001 2001-184588 19.06.2001 Int. Cl.8 A01M 001/20 FUMAKILLA LIMITED, JAPAN WO/2002/060246 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 2734 [33] JP JP JP JP ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב

[57] A fan type chemical diffusing apparatus, characterized in that it comprises: a chemical receptacle (3) for accommodating a chemical impregnated body (10) therein that is impregnated with a chemical, the chemical receptacle having vent holes (9); a chemical receptacle retainer (4) for holding said chemical receptacle; a power supply housing (11) for receiving power supply therein, said power supply powering a motor (30); and an apparatus main body (1) including a fan (32) for producing an airflow, said motor for driving the fan, a switch for turning on and off current conduction to said motor, an inner airflow opening (24) and an outer air flow opening (28) disposed in a front face and a side face of said apparatus main body, respectively, for permitting the airflow produced by said fan to pass therethrough, a recessed portion formed in from a front side to a lower side of said apparatus main body, which can be loaded with said chemical receptacle retainer and said power supply housing, and an electric connector (36) which when said power supply housing is loaded into a lower portion of said recessed portion of said apparatus main body is brought into contact with said power supply received in said power supply housing to establish electric connection between said power supply and said switch; wherein said chemical receptacle retainer and said power supply housing are adapted to be detachably loaded in a front portion and the lower portion of said recessed portion of said apparatus main body, respectively and when loaded are each positioned therein so as to receive essentially no limitation in volume from the other. 2735

CIVIL AVIATION PASSIVE COHERENT LOCATION SYSTEM AND METHOD 155513 מערכת ושיטה לאיכון פסיבי בתעופה אזרחית [31] [72] [87] 22.10.2001 60/241738 [32] 20.10.2000 09/982948 22.10.2000 Int. Cl.8 G01S 005/12 LOCKHEED MARTIN CORPORATION, U.S.A. ROBERT BENNER, KEVIN W. BAUGH, RICHARD LODWIG WO/2002/035252 SOROKER-AGMON, 14 SHENKAR ST., HERZLIYA PITUAH 46725 [33] US US סורוקר-אגמון, בית נולטון, רחוב שנקר 14, הרצליה פיתוח [57] A system for enhancing object state awareness to track a plurality of approaching airborne objects, comprising: a receiver subsystem (220) to receive reference signals from an uncontrolled transmitter and scattered transmission originating from the uncontrolled transmitter and scattered by an object of approaching airborne objects; a front-end processing subsystem (230) to determine a radial velocity of the object based on the received transmissions and to buffer digitized transmission replicas of the received transmissions; and a backprocessing subsystem (240) to receive the digitized transmission replicas of the received transmissions and to determine object state estimates based on the determined radial velocity, wherein said front-end processing subsystem and said back-end processing subsystem are remotely located relative to one another. 2736

INHALATIVE SOLUTION FORMULATION CONTAINING A TIOTROPIUM SALT 155538 הרכב תמיסה להשאפה המכיל מלח טיאוטרופיום [31] [87] 24.10.2001 10054036.8 [32] 31.10.2000 [33] DE Int. Cl.8 A61K 009/00, 009/72, A61P 011/00, C07D 451/00 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG, GERMANY WO/2002/036104 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Propellant-free pharmaceutical preparation for administration by inhalation comprising a tiotropium salt as active substance, in a concentration based on tiotropium of between 0.0005 and 5% by weight, water on its own or water/ethanol mixture as solvent for the active substance, acid for achieving a ph between 2.0 and 3.1, a pharmacologically 2737 acceptable preservative, optionally editic acid or an editic acid salt in an amount of greater than 0 up to 25 mg/100 ml, optionally a pharmacologically acceptable complexing agent and/or stabilizer and/or a pharmacologically acceptable cosolvent and/or other pharmacologically acceptable adjuvants and additives in addition to the preservative.

PYRIMIDINE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF 155705 נגזרות של פירימידין ותוסף חומצת מלח רוקחי מתאים [31] [87] 13.11.2001 00125529.8 [32] 22.11.2000 [33] EP Int. Cl.8 A61K 031/495, 031/5377, 031/5395, C07D 239/46, 401/04, 401/12, 403/04, 413/04, 413/12 F. HOFFMANN-LA ROCHE AG, SWITZERLAND WO/2002/042280 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A compound of the formula: wherein R 1 is lower alkyl, lower alkoxy, pyridinyl, pyrimidinyl, phenyl, --S- lower alkyl -- S(O) 2 lower alkyl, --N(R a )--(CH 2 ) n -- N(R b ) 2, --O--(CH 2 ) n --N(R b ) 2, --O--(CH 2 ) n --N(R c ) 2, --N(R d ) 2, or a cyclic tertiary amine of the group having no or one additional heteroatom, connected to said pyrimidine ring of selected from N, O or S, said cyclic formula 1 via the linker - -O(CH 2 ) n --; tertiary amine being connected directly to R 2 is hydrogen, lower alkyl, lower alkoxy, a pyrimidine ring of formula 1 or halogen or trifluoromethyl; 2738

R 3 /R 3 ' are, independently from each other, hydrogen or lower alkyl; (R 4 ) m are, independently from each other in the case where m is not 0 or 1, halogen, trifluoromethyl or lower alkoxy; R 5 is hydrogen or lower alkyl; R, R a, R b, R c, R d, R e, R f are, independently from each other, hydrogen or lower alkyl; X is N(R f C(O)--; Y is --O--, --S--, --SO 2 --, - or --N(R)--; n is 1, 2, 3 or 4; and m is 0, 1 or 2; or a pharmaceutically acceptable acid addition salt thereof. MEDICAMENTS COMPRISING 5 (R) 2 (5, 6 DIETHYL INDEN 2 YLAMINO) 1 HYDROXY ETHYL] 8 HYDROXY 1H QUINOLIN 2 ONE AND CORTICOSTEROIDS FOR TREATING AIRWAY DISEASES 155709 תרופות המכילות 5 5] (6, 2 (R) דיאתיל אינדן 2 אילמינו) 1 הידרוקסיאתיל] 8 הידרוקסי H1 קווינולין 2 און וקורטיקוסטרואידים לטיפול במחלות בדרכי הנשימה [31] [87] 03.12.2001 0029562.6 [32] 04.12.2000 [33] GB Int. Cl.8 A61K 031/4704, 031/57, 031/573, 031/575, A61P 011/00, C07D 215/227, C07J 007/00, 009/00 NOVARTIS AG, SWITZERLAND WO/2002/045703 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] Medicament comprising, separately or together, (A) a compound of formula in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300. 2739

155734 ATORVASTATIN HEMI- CALCIUM FORM VII פורם 7 של אטורווסטטין המיקלציום [31] [87] 05.11.2001 60/245897 [32] 03.11.2000 [33] US Int. Cl.8 A61K 031/40, A61P 003/06, C07D 207/34 TEVA PHARMACEUTICAL טבע תעשיות פרמצבטיות בע"מ, פתח INDUSTRIES LTD. תקווה WO/2002/041834 TEVA PHARMACEUTICAL טבע תעשיות פרמצבטיות בע"מ, INDUSTRIES LTD., 5 BASEL ST., P.O.B. 3190,, 5 ת.ד. 3190, פתח תקוה בזל PETAH TIQVA 49131 [57] Atorvastatin hemi-calcium Form VII or a hydrate thereof characterized by a powder X-ray diffraction pattern having broad peaks in the range of 18.5-21.8 and 21.8-25.0 degrees two-theta. 155792 SINGLE USER DETECTION זיהוי משתמש יחיד [31] [87] 08.11.2001 60/246947 [32] 09.11.2000 [33] US Int. Cl.8 H04B 001/707, 007/216, H04Q 007/38 INTERDIGITAL TECHNOLOGY CORPORATION, U.S.A. WO/2002/039610 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A method for use in receiving a plurality of data signals transmitted from a transmitter site over a shared spectrum in a code division multiple access communication system, each transmitted data signal experiencing a similar channel response, the method comprising: receiving a combined signal of the transmitted data signals over the shared spectrum; sampling the combined signal at a multiple of a chip rate of the transmitted data signals; estimating a channel response for the combined signal at the multiple of the chip rate; determining a first element of a spread data vector using the combined signal samples and the estimated channel response; using a factor from the first element determination to determine remaining elements of the spread data vector; and estimating data of the data signals using the determined elements of the spread data vector. 2740

The applications for division from this application have not yet been published,192393 בקשות חלוקה מבקשה זו שטרם פורסמו. 155883 MODULATOR FOR ELECTROMAGNETIC SIGNALS TRANSMITTED BY A CONTACTLESS TRANSMISSION/RECEPTION SYSTEM מאפנן לאותות אלקטרומגנטיים המועברים על ידי מערכת קולטת/משדרת ללא מגע [31] [87] 13.09.2002 01/11917 [32] 14.09.2001 Int. Cl.8 H04L 027/00 ASK S.A., FRANCE WO/2003/025832 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] FR ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A transmission device using electromagnetic wave radiation (20) in a contactless transceiver system toward a contactless object, data bits transmitted corresponding to alternation of a first time interval during which electromagnetic waves are emitted at a predetermined carrier frequency and a second splitting time interval during which there is a split in transmission of the electromagnetic waves at said predetermined carrier frequency, further comprising generating means for generating, during said second splitting time interval, electromagnetic waves with a frequency greater than the fundamental frequency of the split resulting in an attenuation of the radiated field by the antenna greater than a predetermined value. 2741

SYSTEM AND METHOD OF DESKEW BUFFERING SIGNALS 155923 מערכת ושיטה של מנחת דיסקוו של סגנלים [31] [87] 16.11.2001 09/718275 [32] 21.11.2000 Int. Cl.8 H04B 001/707 QUALCOMM INCORPORATED, U.S.A. WO/2002/043267 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A method of deskew buffering a CDMA signal comprising: demodulating an earliest arriving signal to extract an earliest arriving symbol in a multirate system having a plurality of Walsh code lengths, aligning the earliest arriving symbol to a deskew buffer address using a PN count value; modifying the deskew buffer address; and writing the earliest arriving symbol into the modified deskew buffer address. 2742

METHOD AND SYSTEM FOR ONLINE PAYMENTS 156086 שיטה ומערכת לתשלומים בזמן אמת [31] [87] 26.11.2001 09/722174 [32] 25.11.2000 [33] US Int. Cl.8 G06F 003/033, G06Q 003/00000 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2002/042955 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A method of enabling payment of bills, the method including the steps of providing a person with a bill containing information relating to a requested payment, the bill including a plurality of coded tags, each coded tag encoding data indicative of an identity of the bill and a position of that tag on the bill; receiving, in a computer system indicating data from a sensing device, the sensing device, when placed in an operative position relative to the bill, sensing the coded tags and generating the indicating data to 2743 indicate the identity of the bill and a position of the sensing device relative to the sensed coded tags; and identifying, in the computer system and from the indicating data, at least one parameter relating to the requested payment from a digital description of the bill associated with the identify of the bill, the at least one parameter being associated in said digital description with the corresponding tag locations on the bill.

156091 METHOD AND SYSTEM FOR ONLINE PURCHASING שיטה ומערכת לקניה מקוונת [31] [87] 26.11.2001 09/721896 [32] 25.11.2000 [33] US Int. Cl.8 G06F 003/033, G06Q 003/00000 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2002/042954 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A method of enabling online purchasing via a form printed on a substrate, said form including graphical purchasing information and a plurality of tags, each tag comprising coded data identifying the form and its own location on the form, the method including the steps of: (a) determining a unique page identity for said form in a computer system before printing said form; (b) determining a page description for said form in said computer system before printing said form, said page description comprising a description of graphical information on said form, and a description of an interactive element including a zone of said interactive element on said form; (c) associating said page identity with said description of said interactive element; (d) printing, on demand, the form onto 2744

a substrate using a printer networked with the computer system, said graphical information and said tags being printed at the same time; (e) receiving, in said computer system, indicating data from a sensing device regarding the identity of the form and a position of the sensing device relative to the form, the sensing device, when placed in an operative position relative to the form, generating the indicating data using at least some of the coded data; and (f) identifying, in the computer system and from the indicating data, at least one paramteter relating to the purchasing transaction. METHODS OF ORGANIZING DATA AND PROCESSING QUERIES IN A DATABASE SYSTEM AND DATABASE SYSTEM AND SOFTWARE PRODUCT FOR IMPLEMENTING SUCH METHOD 156123 שיטות לארגון נתונים ולעיבוד שאלות במערכת מאגר נתונים, ומערכת מאגר נתונים ומצור תוכנה ליישומן של שיטותאלו [31] [87] 29.11.2001 00403330.4 [32] 29.11.2000 00403331.2 29.11.2000 00403332.0 29.11.2000 00403329.6 29.11.2000 Int. Cl.8 G06F 017/30 VIRTUAL KEY GRAPH, U.S.A WO/2002/044943 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] EP EP EP EP סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות 2745

[57] A method of organizing information in a database system, wherein a group of attributes is defined and words of a collection of data are assigned to said attributes, wherein the group of attributes is divided into a plurality of sub-groups each associated with a respective data table, each data table having a column for each attribute of the associated sub-group and rows for containing data table records comprising at least one word assigned to an attribute of the associated sub-group, wherein links are defined between the data tables records, each link having a target table and a corresponding source table having a link column containing link values each designating a record of said target table, whereby each of said link values represents a link between the record of the source table including said link value and the record of the target table designated by said link value, the method comprising the steps of: allocating respective identifiers to data graphs, wherein each data graph represents related attribute values respectively assigned to the attributes of said group, wherein each attribute value of a data graph is either a default value or a work of said collection of data, and wherein the words of each data graph are from linked data table records; storing a plurality of word thesauruses respectively associated with attributes of said group, wherein for each word assigned at least once to an attribute in the collection of data, the word thesaurus associated with said attribute has a respective entry containing said word; and storing data representing data graph identifier lists respectively associated with the word thesaurus entries, wherein the data graph identifier list associated with a thesaurus entry relating to a word assigned to an attribute includes any identifier allocated to a data graph having said word assigned to said attribute. The applications for division from this application have not yet been published,192443 בקשות חלוקה מבקשה זו שטרם פורסמו. 156212 FARNESYLTRANSFERASE INHIBITORS מעכבי טרנספרז של פרנזיל [31] [87] 30.11.2001 09/727230 [32] 30.11.2000 [33] US 09/912677 25.07.2001 US Int. Cl.8 A61K 031/4164, 031/426, A61P 035/00, 043/00, C07D 233/64, 277/20, 401/12, 403/12, 417/12, C07F 007/10 ABBOTT LABORATORIES, U.S.A. WO/2002/074747 DR. SHLOMO COHEN & CO., ד"ר שלמה כהן ושות', 124 IBN GABIROL ST., P.O.B. 11490, אבן גבירול, 124 ת.ד. 11490, תל אביב TEL AVIV 62038 2746

[57] A compound of the formula or a therapeutically acceptable salt thereof, wherein E is a five-, six-, or seven-membered aromatic or non-aromatic carbocyclic ring wherein from zero to three carbon atoms are replaced by nitrogen; F and G are independently selected from the group consisting of C and N; with the proviso that when one of F and G is N, the other is C; L 1 and L 2 are each independently selected from the group consisting of a bond, C 2 alkenylene, C 2 alkynylene, O, NR 9, C(O), S, S(O), SO 2, SO 2 NR 9, NR 9 SO 2, C(O)NR 9, NR 9 C(O), and CO 2 ; X is selected from the group consisting of S and NR 7 ; R 1 is selected from the group consisting of aryl, arylalkyl, heterocycle, and (heterocycle) alkyl; R 2 is selected from the group consisting of hydrogen, alkoxy, alkyl, amino, aminoalkyl, cyano, cyanoalkyl, cycloalkyl, cycloalkylalkyl, halo, haloalkyl, heterocycle, (heterocycle) alkyl, hydroxy, and hydroxyalkyl; R 3 is selected from the group consisting of aryl, heterocycle, and cycloalkyl; R 4-6 are each independently selected from the group consisting of hydrogen, NR 9 C(O), C(O)NR 9, alkanoyl, alkenyl, alkoxy, alkoxyalkyl, alkyl, alkylsulfonyl, alkynyl, amido, amino, aminoalkyl, aminosulfonyl, aryl, arylalkyl, aryloxy, arylsulfonyl, azido, carboxy, cyano, cyanoalkyl, cycloalkyl, cycloalkyalkyl, halo, haloalkoxy, haloalkyl, heterocycle, (heterocycle) alkyl, hydroxy, hydroxyalkyl, nitro, nitroalkyl, oxo, and thio (oxo); R 7 is selected from the group consisting of hydrogen, alkyl, aryl, cycloalkyl, cycloalkyalkyl, heterocycle, (heterocycle) alkyl, and trialkylsilyl; R 9 is selected from the group consisting of hydrogen, alkoxyalkyl, alkyl, amidoalkyl, aminoalkyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, carboxyalkyl, heterocycle, (heterocycle) alkyl, hydroxyalkyl, and a nitrogen protecting group; each R 12 is independently selected from the group consisting of hydrogen, alkoxy, alkyl, amino, halo, and hydroxy; m is 0, 1, 2, 3 or 4; n is 0, 1, 2, 3 or 4; p is 0, 1, 2, 3 or 4; and q is 0,1, 2, 3 or 4. 2747

SYSTEM AND METHOD FOR EFFECTING HIGH-POWER BEAM CONTROL WITH OUTGOING WAVEFRONT CORRECTION UTILIZING HOLOGRAPHIC SAMPLING AT PRIMARY MIRROR, PHASE CONJUGATION, AND ADAPTIVE OPTICS IN LOW POWER BEAM PATH 156226 מערכת ושיטה לביצוע בקרת קרן בעוצמה גבוהה בעלת תיקון חזית גל יוצא באמצעות דגימה הולוגרפית במראה הראשית, הצמדת מופעים ואופטיקה מסתגלת במסלול קרן בעוצמה נמוכה [31] [87] 26.09.2002 09/965929 [32] 28.09.2001 [33] US Int. Cl.8 G01J 009/00, G02B 023/02, 026/06, H01S 003/10 RAYTHEON COMPANY, U.S.A. WO/2003/027621 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] A beam control system (500) comprising: a telescope (510) for providing a first beam (503) of electromagnetic energy; a holographic element (518) for sampling said first beam and providing a second beam (505) in response thereto; a wavefront sensor (520) for detecting aberrations in said second beam and generating an error signal; and characterised by: an adaptive optical arrangement including; a source of a reference beam (552); a processor (580) responsive to said error signal to generate a correction signal for correcting aberrations in said first beam; an optical phased array (550) for modifying said reference beam in response to said correction signal; a first phase conjugate mirror (546); an aperture sharing element (540) disposed in alignment with said first phase conjugate mirror, wherein said modified reference beam is adapted to read a first surface of said aperture sharing element and provide a back side read beam in response thereto and said first phase conjugate mirror is adapted to conjugate the phase of said back side read beam and provide a conjugated back side read beam in response thereto; and a second phase conjugate mirror (550) adapted to conjugate the phase of said conjugated back side read beam thus cancelling the effect of the first phase conjugation process and provide said first beam in response thereto. 2748

156239 PEN-TYPE INJECTOR HAVING AN ELECTRONIC CONTROL UNIT מזרק מסוג עט עם יחידת בקרה אלקטרונית [31] [87] 21.12.2001 0031466.6 [32] 22.12.2000 Int. Cl.8 A61M 005/24 DCA DESIGN INTERNATIONAL LIMITED, UNITED KINGDOM WO/2002/051479 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] GB סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] An injection device having a drive mechanism (42) to expel selectively a dose of medicament from a medicament cartridge (40) through a needle unit (22), an electronic control unit to control the drive mechanism, and a dispense button (18) to generate a dispense button signal to the electronic control unit indicative of the dose to be expelled in which an arm button (16) causes a first arm button signal to be sent to the electronic control unit to permit the dose to be expelled, wherein the arm button is linked to a cover detection switch (28) such that the arm button will only function to arm an injector (2) when a cover (6) is not present. 2749

2750

[31] [87] ELECTRONIC COMPASS AND COMPENSATION OF LARGE MAGNETIC ERRORS FOR OPERATION OVER ALL ORIENTATIONS 28.11.2001 731177 [32] 06.12.2000 Int. Cl.8 G01N 021/00 HONEYWELL INTERNATIONAL INC., U.S.A. WO/2002/046693 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 156337 מצפן אלקטרוני ופיצוי על שגיאות מגנטיות גסות לשם תפעול בכל הכיוונים [33] US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A method of compensating an electronic compass to obtain accurate azimuth data for any orientation of the electronic compass despite the presence of perturbing magnetic effects, the method comprising: obtaining a measured magnetic field vector H MEAS representing magnetic field strength along three axes and a measured gravity vector G MEAS representing gravitational field strength along the same three axes; using a matrix compensation coefficient L E and a vector compensation coefficient H PE to correct measured magnetic field data by applying a formula of the form H EARTH= L E. H MEAS -H PE, where H EARTH is the compensated value for the Earth's true magnetic field; and calculating the azimuth data as a function of the corrected magnetic field data. 156474 METHOD FOR STORING ENCRYPTED DATA שיטה לאיחסון נתונים מוצפנים [31] [87] 15.01.2002 01/0061 [32] 16.01.2001 [33] CH Int. Cl.8 G06F 012/14, H04L 009/08, H04N 007/16, 007/167 NAGRACARD S.A., SWITZERLAND WO/2002/056592 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים 2751

[57] A storing method of data extracted from an encrypted data stream sent to a decoder (STB) connected to a security module (SM) and connected to a storing unit (DB), this method consisting in reencrypting, without previous decryption, in the decoder the encrypted data sent to the decoder before they are transferred to the storing unit by at least one specific key (K1, K2). 2752

BACKGROUND LIGHT INTENSITY ADAPTIVE ILLUMINATING LIGHT SYSTEM 156560 מקור תאורה עם אפשרות שליטה על העוצמה לפי תנאי הרקע [72] 19.06.2003 Int. Cl.8 F21V 007/00, F41G 001/34, G02B 023/10 MEPROLIGHT (1990) LTD. מפרולייט (1990) בע"מ GABRIEL NECHUSHTAN גבריאל נחושתן SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, REHOVOT 76122 שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A reflex sight comprising: an optical combiner operative to permit a scene to be viewed therethrough and to reflect light to a viewer; a light source arranged with respect to said optical combiner such that light from said source is reflected to said viewer as an aiming dot, said light source comprising an ambient light collector; and an attenuating compensator, compensating for variations in intensity of ambient light thereby to cause said aiming dot to have a generally uniform size. 2753

PHARMACEUTICAL COMPOSITIONS WITH ANTIBIOTIC ACTIVITY CONTAINING FOSFOMYCIN TROMETHAMOL AND A STABILIZER 156615 תכשירי רוקחות בעלי פעילות אנטיביוטית המכילים פוספומיצין טרומתאמול ומייצב [31] 24.06.2003 MI20020A001725 [32] 01.08.2002 [33] IT Int. Cl.8 A61K 009/16, 031/665, 033/00, A61P 031/00, C07F 009/00, 009/38 ZAMBON GROUP S.P.A., ITALY REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., רחוב אחד העם, 21 ת.ד. 4060, תל P.O.B. 4060, אביב TEL AVIV 61040 [57] A substance selected from: tribasic sodium or potassium citrate, monoacidic sodium or potassium citrate, tribasic sodium or potassium phosphate, monoacidic sodium or potassium phosphate, sodium or potassium carbonate, sodium or potassium bicarbonate, sodium or potassium tartrate, arginine, lysine or mixtures thereof, for use to stabilize Fosfomycin Tromethamol (FT). 156661 ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR I RECEPTOR נוגדנים לקולט גורם גידול דימוי אינסולין I [31] [87] 20.12.2001 60/259927 [32] 05.01.2001 [33] US Int. Cl.8 A61K 039/395, 048/00, A61P 035/00, C07K 016/28, C12N 015/13, C12P 021/08 PFIZER INC., U.S.A. AMGEN FREMONT INC., U.S.A. WO/2002/053596 WOLFF, BREGMAN AND GOLLER, וולף, ברגמן וגולר, P.O.B. 1352, JERUSALEM 91013, ת.ד. 1352, ירושלים [57] A human monoclonal antibody or antigen-binding portion thereof that specifically binds to insulin-like growth factor I receptor (IGF-IR), wherein said antibody or portion binds to IGF-IR with a K d of 8 x 10-9 M or less. 2754

METHOD AND SYSTEM FOR FORWARD LINK BEAM FORMING IN WIRELESS COMMUNICATIONS 156948 שיטה ומערכת עבור יצירת קרן חוליה קדמית בתקשורת אל חוטית [31] [87] 17.01.2002 09/771137 [32] 24.01.2001 Int. Cl.8 H04B 007/06, H04M 001/00 QUALCOMM INCORPORATED, U.S.A. WO/2002/060092 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A system (200) for forward link beam forming in a wireless communication system, comprising: an antenna configured to generate a plurality of antenna beam patterns (206), each of the antenna beam patterns having a corresponding signal transmission energy and being directed to a plurality of users of the wireless communication system; a control signal monitoring module (202) configured to receive a power control signal from a specific user among the plurality of users and to output a sequence of monitored signals; a signal statistic computation module (204) configured to determine a statistic for the specific user, said statistic comprising an average of the sequence of monitored signals from the control signal monitoring module over a specified time interval; an antenna beam pattern optimizing module (208) configured to narrow one of the antenna beam patterns based solely on the statistic of the specific user and focusing the signal transmission energy of said one antenna beam pattern on the specific user to obtain an optimizied antenna beam pattern for the specific user; and a base station using the optimized antenna beam pattern to transmit communication signals to the specific user. 2755

DOCUMENT AND METHOD FOR PERFORMING AN OPTICALLY- BASED DOCUMENT AUTHENTICATION 157021 מסמך ושיטה מבוססת אופטיקה לאימות מסמכים [31] [62] 31.03.1998 08/835655 [32] 10.04.1997 Int. Cl.8 G06K 009/74 DIVISION FROM 132309 BROWN UNIVERSITY RESEARCH FOUNDATION, U.S.A. EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] US איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] A method for authenticating a document, comprising the steps of: providing a document to be authenticated; illuminating at least a portion of the document with laser light that exceeds a threshold fluence; detecting a narrow band substantially non-saturable amplified spontaneous emission of at least one wavelength from the document in response to the step of illuminating; and declaring the document to be authentic only if the emission is detected. The parent application from which this application has been divided has not yet been published 132309 בקשת הורה לבקשה זו שטרם פורסמה 2756

157070 ISOXAZOLINE DERIVATIVE AND HERBICIDE CONTAINING THE SAME AS THE ACTIVE INGREDIENT נגזרת איסוקסאזולין וקוטל עשבים המכיל אותה כהרכב פעיל [31] [87] 07.02.2002 2001-031784 [32] 08.02.2001 [33] JP Int. Cl.8 A01N 043/80, C07D 261/00, 413/12, 417/12, 498/04, 513/04 IHARA CHEMICAL INDUSTRY CO., LTD., JAPAN KUMIAI CHEMICAL INDUSTRY CO., LTD., JAPAN WO/2002/062770 SELIGSOHN GABRIELI & CO., זליגסון גבריאלי ושות', 31 YAVNE ST., P.O.B. 1426, רח' יבנה, 31 ת.ד. 1426, תל אביב TEL AVIV 61013 [57] An isoxazoline derivative or a pharmaceutically acceptable salt thereof of the formula: wherein R 1 and R 2 may be the same or different and are each a hydrogen atom, a C1 to C10 alkyl group, a C3 to C8 cycloalkyl group or a C3 to C8 cycloalkyl C1 to C3 alkyl group; or R 1 and R 2 may be bonded to each other to form a C3 to C7 spiro ring together with the carbon atoms to which they bond, R 3 and R 4 may be the same or different and are each a hydrogen atom, a C1 to C10 alkyl group or a C3 to C8 cycloalkyl group; or R 3 and R 4 may be bonded to each other to form a C3 to C7 spiro ring together with the carbon atoms to which they bond; or R 1, R 2, R 3 and R 4 may form a 5- to 8- membered ring together with the carbon atoms to which they bond; R 5 and R 6 may be the same or different and are each a hydrogen atom or a C1 to C10 alkyl group; Y is a 5- to 6- membered aromatic heterocylic group or condensed aromatic heterocyclic group having one or more hetero atoms selected from a nitrogen atom, an oxygen atom and a sulfur atom; the heterocyclic group may be substituted with 0 to 6 same or different groups as defined in the specification. 2757

HETEROCARPINE, A PLANT PROTEIN BINDING HUMAN GHRH 157150 הטרוקרפין, חלבון צמחי הקושר GHRH של אדם [31] [87] 26.02.2002 01/02631 [32] 27.02.2001 [33] FR Int. Cl.8 A61K 038/16, A61P 005/04, 009/10, 035/00, C07K 001/14, 014/415, 016/16 SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.), FRANCE WO/2002/068461 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Isolated protein which can be obtained by extraction from the plant Pilocarpus heterophyllus, which is characterized in that it has a molecular mass of approximately 90.9 kda and comprises fragments of peptide sequences SEQ.ID.NO. 1, SEQ.ID NO.2 and SEQ.ID NO.3; said protein being able to be presented in a glycosylated or non-glycosylated form. [31] [87] IMPLANTS, DEVICE AND METHOD FOR JOINING TISSUE PARTS 04.03.2002 387/01 [32] 02.03.2001 Int. Cl.8 A61B 017/68 WOODWELDING AG, SWITZERLAND WO/2002/069817 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 157169 שתלים, התקן ושיטה לחיבור חלקי רקמה [33] CH ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] Implant for creating a positivefit connection to a tissue part for connecting the tissue part with a further tissue part or with an artificial element replacing or supporting a further tissue part or being a 2758

therapeutic auxiliary device, wherein the implant at least partly consists of a material which is liquefiable by mechanical energy, wherein the liquefiable material is arranged on the implant in a manner such that is can be brought into contact with the tissue part and can be excited by mechanical oscillation and simultaneously be pressed against the tissue part for liquefying at least part of the liquefiable material and for pressing it into openings of the tissue part. N - SUBSTITUTED NONARYL- HETEROCYCLIC ARYLS AND THEIR USE FOR PREPARING MEDICAMENTS FOR TREATING PAIN 157254 ארילים הטרוציקלים N מותמרים שאינם ארילים והשימוש בהם להכנת תרופות לטיפול בכאב [31] [87] 20.02.2002 60/271100 [32] 23.02.2001 [33] US Int. Cl.8 A61K 031/395, A61P 025/00, 043/00, C07D 401/00, 401/12, 401/14, 403/12, 403/14, 409/14, 413/12, 413/14, 417/12, 417/14, 471/02, 473/02, 475/02, 487/02, C07F 007/18 MERCK & CO., INC., U.S.A. WO/2002/068409 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A compound of the formula: 2759

or pharmaceutically acceptable salts thereof, wherein NonAr is a nonaromatic 6 membered ring containing 1 nitrogen ring atom; HetAr is a 6 membered heteroaromatic ring containing 2 nitrogen ring atoms; HetAr is optionally substituted with 1 or 2 substituents, each substituent independently is C 1-4 alkyl, C 1-4 alkoxy, C 2-4 alkynyl, trifluoromethyl, hydroxy, hydroxy C 1-4 alkyl, fluoro, chloro, bromo, iodo, cyano, methylsulfanyl, cyclopropylethynyl-, phenylethynyl-, heteroarylethynyl-, - N(C 0-4 alkyl) (C 0-4 alkyl), nitro, (C 1-2 alkyl) (C 1-2 alkyl) NHC 2 -, (C 1-2 alkyl) NHCH 2 -, Si(CH 3 ) 3 -C-, or NH 2 C(O)-; A is C 1-4 alkylene-; B is aryl (CH 2 ) 0-3 O-C(O)-, heteroaryl (CH 2 ) 1-3 -O-C(O)-, indanyl (CH 2 ) 0-3 -O-C(O)-, aryl (CH 2 ) 1-3 C(O)-, aryl-cyclopropyl-c(o_)-, heteroaryl-cyclopropyl-c(o)-, heteroaryl (CH 2 ) 1-3 C(O)-, heteroaryl (CH 2 ) 1-3 -, aryl (CH 2 ) 1-3 NH-C(O)-, aryl (CH 2 ) 1-3 NH-C(NCN)-, aryl (CH 2 ) 1-3 -SO 2 -, heteroaryl (CH 2 ) 1-3 - SO 2 -, wherein any of the aryl or heteroaryl is optionally substituted by 1-5 substituents, each substituent independently is C 1-4 alkyl, C 3-6 cycloalkyl, C 1-4 alkoxy, trifluoromethyl, bromo, fluoro, or chloro; and X is H, OH, F, C 1-4 alkyl, C 1-4 alkoxy, NH 2, or X taken with an adjacent bond is =O. SINGLE SOURCE MIXTURES OF METAL SILOXIDES 157559 תערובות של סילוקסידים מתכתיים ממקור יחיד [31] 25.08.2003 232052 [32] 30.08.2002 [33] US Int. Cl.8 C09D 001/00, C23C 016/40, H01L 021/316 AIR PRODUCTS AND CHEMICALS, INC., U.S.A. REINHOLD COHN AND ריינהולד כהן ושותפיו, PARTNERS, 21 AHAD HA'AM ST.,, 21 ת.ד. 4060, תל אביב רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] A metal siloxide precursor which is composed of a complex represented by the empirical formula: (R) m M (O SiR 1 R 2 R 3 ) n wherein M is a group 4 metal selected from the group consisting of zirconium and 2760

hafnium; R is (CH 3 CH 2 ) 2 N and R 1, R 2 and R 3 are ethyl; and m plus n is equal to a valence of the M metal (v). [31] [87] CIRCUIT ARRANGEMENT FOR A RESIDUAL-CURRENT CIRCUIT BREAKER 11.06.2002 A 909/2001 [32] 12.06.2001 Int. Cl.8 H02H 001/06 MOELLER GEBAUDEAUTOMATION GMBH, AUSTRIA WO/2002/101901 DR. YITZHAK HESS & PARTNERS, 279 HAYARKON ST., P.O.B. 6451, TEL AVIV 61063 157637 סידור מעגל עבור מפסיק מעגל ע"י זרם נותר [33] AT ד"ר יצחק הס ושותפיו, רחוב הירקון, 279 ת.ד. 6451, תל אביב [57] A circuit arrangement for a residual-current breaker, comprising a detection apparatus (10) for a residual current in a supply network, which detection apparatus is preferably provided, in outgoing circuit with a conditioning circuit (20) for the residual current; an energy storage circuit (30) which is charged in accordance with the detected residual current; a trigger (40) which monitors the charged state of the energy storage circuit, and a contact unit (50) for generating a tripping voltage pulse for a tripping element for an isolator of at least one consumer that is fed by the supply network, with the trigger causing the contact unit to generate a tripping voltage pulse for the tripping element (60) once the energy storage circuit has attained a predetermined charged state (set charged state), where a second trigger (40') is provided, characterized in that the second trigger blocks the contact unit reaching a further predetermined charged state (minimum charged state) of the energy storage circuit. 2761

[31] [87] METHOD FOR IDENTIFICATION BY A HOST COMPUTER AVOIDING COLLISION OF ELEMENTS 17.01.2003 02/00566 [32] 17.01.2002 Int. Cl.8 G06F 013/376, G06K 017/00 ASK S.A., FRANCE WO/2003/060734 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 157817 [33] שיטה לזיהוי באמצעות מחשב אורח ומניעת התנגשות חלקיקים FR ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] An anti-collision process by a host computer of elements matching a given relationship with said host computer enabling the identification of said elements by the latter, each of said elements having an identification number between 0 and a maximum value (MAX); said process being characterized by the following steps: (a) transmission by said host computer of a query instruction capable of being received and recognized by any element matching said given relationship with said host computer, (b) when at least one of said elements matches said given relationship with said host computer, transmission by the latter of an anti-collision signal including an identification attempt digital value, (c) response by any element matching said given relationship with said host computer and having an identification number less than or equal (or greater than or equal) to said digital identification attempt value, and (d) detection of collision between several elements when said host computer receives several responses and in this case, transmission of an anti-collision instruction made up of an identification attempt digital value defined according to a given algorithm, or selection of the element by its identification number when there is only one response. 2762

157873 DIHYDRO-BENZO [B] [1,4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II נגזרות של דיהידרו בנזו 4,1] [[b] דיאזפינ 2 ון כאנטגוניסטים II של MGLUR2 [31] [87] 02.04.2002 01109125.3 [32] 12.04.2001 [33] EP Int. Cl.8 A61K 031/5513, A61P 025/00, C07D 243/12, 401/04, 403/10, 403/14, 409/10, 413/10, 413/14, 417/10 F. HOFFMANN-LA ROCHE AG, SWITZERLAND WO/2002/083652 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] Compounds of the formula 2763

wherein X is a single bond or an ethynediyl group; wherein in case X is a single bond, R 1 is cyano, halogen, C 1 -C 7 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 7 -alkoxy, fluoro-c 1 -C 7 -alkoxy, fluoro-c 1 -C 7 -alkyl, or is pyrrol-1-yl, which is unsubstituted or substituted by one to three substituents selected from the group consisting of fluoro, chloro, cyano, -(CH 2 ) 1-4 -hydroxy, fluoro- C 1 - C 7 -alkyl, C 1 -C 7 -alkyl, -(CH 2 ) n -C 1 -C 7 - alkoxy, -(CH 2 ) n -C(O)O-R", -(CH 2 ) 1-4 NR'R", hydroxy-c 1 -C 7 -alkoxy, and (CH 2 ) n -CONR'R", or is phenyl, which is unsubstituted or substituted by one or two substituents selected from the group consisting of halogen, C 1 -C 7 - alkyl, fluoro- C 1 -C 7 -alkyl, C 1 -C 7 - alkoxy, fluoro- C 1 -C 7 -alkoxy and cyano; in case X is an ethynediyl group, R 1 is phenyl, which is unsubstituted or substituted by one to three substituents selected from the group consisting of halogen, C 1 -C 7 -alkyl, fluoro-c 1 -C 7 - alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 7 -alkoxy and fluoro- C 1 -C 7 -alkoxy; R 2 is NR'R", fluoro- C 1 -C 7 -alkoxy or 3-oxopiperazin-l-yl, pyrrolidin-l-yl or piperidin-l-yl, which rings are optionally substituted by R"; R' is hydrogen, C 1 -C 7 -alkyl, C 3 -C 6 - cycloalkyl, fluoro- C 1 -C 7 -alkyl or 2- C 1 -C 7 -alkoxy C 1 -C 7 -alkyl; R" is hydrogen, C 1 -C 7 -alkyl, C 3 -C 6 - cycloalkyl, fluoro- C 1 -C 7 -alkyl, 2-C 1 - C 7 -alkoxy C 1 -C 7 -alkyl, -(CH 2 ) 2-4 -di- C 1 -C 7 -alkylamino, (CH 2 ) 2-4 - morpholinyl, -(CH 2 ) 2-4 -pyrrolidinyl, - (CH 2 ) 2-4 -piperidinyl or 3-hydroxy- C 1 - C 7 -alkyl; Y is CH= or =N-; R 3 is halogen, C 1 - C 7 -alkyl, fluoro- C 1 -C 7 -alkyl, C 1 -C 7 - alkoxy, cyano, -(CH 2 ) n -C(O)-OR", - (CH 2 ) n -C(O)-NR'R", or is an optionally substituted five-membered aromatic heterocycle, which may be substituted by halogen, fluoro- C 1 -C 7 - alkyl, fluoro- C 1 -C 7 -alkoxy, cyano, - (CH 2 ) n -NR'R", -(CH 2 ) n -C(O)-OR", - (CH 2 ) n -C(O)-NR'R", -(CH 2 ) n -SO 2 - NR'R, -(CH 2 ) n -C(NH 2 )=NR", hydroxy, C 1 -C 7 -alkoxy, C 1 -C 7 - alkylthio, or by C 1 -C 7 -alkyl, which is optionally substituted by fluoro, hydroxy, C 1 -C 7 -alkoxy, cyano or carbamoyloxy; n is 0, 1, 2, 3 or 4; and their pharmaceutically acceptable addition salts. 2764

LIQUID FORMULATIONS FOR DERMAL APPLICATION TO CONTROL PARASITIC INSECTS IN ANIMALS 158068 תכשירים נוזליים לטיפול בעור המשמשים לטיפול נגד חרקים טפיליים בחיות [31] [87] 02.04.2002 1017676.7 [32] 09.04.2001 [33] DE Int. Cl.8 A01N 053/00, 053/06, C07D 213/00, 277/20 BAYER HEALTHCARE AG, GERMANY WO/2002/087338 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] Compositions, comprising (a) 35 60% by weight of the active compound permethrin (b) 2.5 12.5% by weight of imidacloprid or an imidacloprid analogue of the formula: in which R represents hydrogen, optionally substituted radicals of the group consisting of acyl, alkyl, aryl, aralkyl, heteroaryl and heteroarylalkyl; A represents a monofunctional group from the group consisting of hydrogen, acyl, alkyl, aryl, or represents a bifunctional group which is attached to the radical Z; E represents an electron-withdrawing radical; X represents the radicals CH= or =N-, where the radical CH= may be attached to the radical Z instead of an H-atom; Z represents a monofunctional group from the group consisting of alkyl, -O- R, -S-R, or represents a bifunctional group which is attached to the radical A or the radical X, where the substituents of the optionally substituted radicals listed above are selected from the group consisting of: alkyl having 1 to 2765 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkylthio having 1 to 4 carbon atoms, haloalkyl having 1 to 4 carbon atoms and 1 to 5 halogen atoms, where the halogen atoms are identical or different; hydroxyl;

halogen; cyano; nitro; amino; monoalkyl-and dialkylamino having 1 to 4 carbon atoms; carboxyl; carbalkoxy having 2 to 4 carbon atoms; sulfo (-SO 3 H); alkylsulphonyl having 1 to 4 carbon atoms; arlsulphonyl having 6 or 10 aryl carbon atoms and also heteroarylamino and heteroarylalkylamino; (c) 27.5-62.5% by weight of N- methylpyrrolidone (d) 0-5% by weight of water (e) 0-0/5% by weight of phenolic antioxidants and (f) 0-0/5% by weight of organic acids. REMOVABLE CRYPTOGRAPHIC IGNITION KEY SYSTEM AND METHOD 158183 מערכת ושיטה להסרת מפתח איתחול קריפטוגרפי [31] 30.09.2003 259866 [32] 30.09.2002 [33] US Int. Cl.8 G06F 001/00, 002/100000 H04L 029/06 HARRIS CORPORATION, U.S.A. REINHOLD COHN AND ריינהולד כהן ושותפיו, PARTNERS, 21 AHAD HA'AM ST.,, 21 ת.ד. 4060, תל אביב רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] A system for conducting secure operations, said system comprising: a removable cryptographic ignition key device; a processor configured to receive said removable cryptographic ignition key device; a proximity detector configured to determine if a distance between said removable cryptographic ignition key device and said processor is within a predetermined distance, a manual disable portion configured to disable secure operations regardless if a distance between said removable cryptographic ignition key device and said processor is within said predetermined distance, and a timer configured to determine an amount of time that said distance between said removable cryptographic ignition key device and said processor exceeds said predetermined distance, wherein said system is configured to: enable secure operations subsequent to said processor receiving said removable cryptographic ignition key device; conduct secure operations while said removable cryptographic ignition key device is within said predetermined distance of said processor; and disable secure operations if said amount of time that said distance between said removable cryptographic ignition key device and said processor exceeds said predetermined distance, as determined by said timer, is greater than a predetermined amount of time. 2766

APPARATUS AND METHOD FOR CONCURRENT CONVERSION OF MULTIPLE AUDIO AND VIDEO FORMATS 158196 מערכת ושיטה להמרה בו זמנית של פורמטים קוליים וחזותיים מרובים [87] 01.10.2003 Int. Cl.8 H04N 005/00, 007/16, 007/173, 007/24 OPTIBASE אופטיבייס, הרצליה WO/2002/093925 PEARL COHEN ZEDEK LATZER, פרל כהן צדק לצר, 5 SHENKAR ST., מרכז גב- םי 1, רח' שנקר, 5 ת.ד. 12704, P.O.B. 12704, הרצליה HERZLIYA 46733 [57] A modular, storage-less, realtime scalable video/audio streaming and switching system comprising a media format matrix, said media format matrix comprising: (a) at least one star topology packet switching fabric module, for managing network streaming inside said media format matrix; (b) one or more controller modules connected with said at least one switching fabric module and with an external management unit, for configuring and controlling said media format matrix; and at least one of a group consisting of: (c) one or more encoding modules 2767 connected with said switching fabric module, for receiving uncompressed video or audio and converting it into a predefined compressed format; (d) one or more decoding modules connected with said switching fabric module, for receiving compressed video or audio and converting it into a predefined uncompressed format; (e) one or more compressed stream interface modules connected with said switching fabric module, for transmitting compressed data between said switching fabric module and an external media interface; (f) one or more transcoding modules connected with said switching fabric

module, for receiving compressed streams from said switching fabric module, transcoding them into different compressed formats and sending said different compressed stream back to said switching fabric module; (g) one or more NIC modules connected with said switching fabric module, for connecting between said media format matrix and one or more distribution networks; and (h) one or more pre-processing modules connected with said switching fabric module, for processing uncompressed streams. 158446 METHOD AND DEVICE FOR IMPROVING THE EXTERNAL BALLISTICS OF AN ARTILLERY SHELL שיטה והתקן לשיפור הבליסטיות החיצונית של פגז ארטילרי [31] [72] [87] 11.04.2002 0101366-3 [32] 19.04.2001 Int. Cl.8 F42B 014/02 BAE SYSTEMS BOFORS AB, SWEDEN ULF HELLMAN WO/2002/086411 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] SE איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] An artillery shell comprising: a driving band groove (4) at a rear of the shell; a driving band (6) disposed within the driving band groove; a driving band groove filler (5) disposed within the driving band groove and comprising a plurality of springback filler elements; and an outer ring disposed between the driving band and the driving band groove filler. 2768

[31] [87] PIEZOELECTRIC TRANSDUCER ASSEMBLIES AND METHODS FOR THEIR USE 21.03.2002 870189 [32] 30.05.2001 Int. Cl.8 H01L 041/113 SENX TECHNOLOGY, U.S.A. WO/2002/099852 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 158816 [33] התקני מתמרים פיאזואלקטרי ושיטות השימוש בהם US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A piezoelectric transducer assembly (1) comprising: an insertable transducer retainer assembly (2) comprising a housing (3) having an outside surface (4), a front (5) and a back (6), said back (6) having centered therein, a hub (7), said centered hub having a centered opening (8) therethrough and said centered hub being integrally connected to said retainer assembly, said outside surface having a fastening means (12) thereon and a tapered front outside circumferential edge; said insertable transducer retainer assembly having a first circular opening (13) in the front, said first circular piezoelectric transducer 2769 disposed therein; said piezoelectric transducer having a bottom surface and a top surface, said piezoelectric transducer having electrical leads (31) connected to the bottom surface thereof; a second opening in the front, deeper than the first circular opening and having a lesser diameter than the diameter of the first circular opening; the centered opening in the centered hub continuing on through the transducer retainer assembly housing and opening into the second opening to provide a continuous channel through the transducer retainer assembly (11) that exits at the hub; a receiving transducer retainer assembly comprising a housing (27), said

receiving transducer retainer assembly housing having a front (28) and a back, the back having centered therein a hub (24) integrally mounted thereon, said receiving transducer retainer hub having a back (25) and a front and being lesser in diameter than the diameter of the receiving transducer retainer assembly housing, the front of said receiving transducer retainer assembly having located therein an opening (29), said receiving transducer retainer assembly opening having an interior surface and a bottom (19); the interior surface having disposed thereon, fastening means compatible with the fastening means of the insertable transducer retainer assembly, said opening having a tapered circumferential edge at the bottom; a saucer-like depression (30) below the bottom of the opening in the receiving transducer retainer assembly, said saucer-like depression having a bottom, the surface area of the top of the saucer-like depression being relative to the surface area of the top of the piezoelectric transducer, said surface area relationship having a ratio in the range of from zero to 1:1; a channeled opening from the bottom of the saucer-like depression through the center of the receiving transducer retainer hub, the interior of the receiving transducer retainer hub having an adapting means for adapting the receiving transducer retainer assembly to a pump, said pump being a gas pump. 158892 TAMPER-EVIDENT ADHESIVE TAPE 16.11.2003 Int. Cl.8 B32B 007/12 BSECURE LTD. EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 סרט אריזה דביק לעדות פריצה ביסקיור בע"מ איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה 2770

[57] A tamper-indicating adhesive tape (10) comprising a first top layer (12) of transparent polymer film substrate having an upper (14) and a lower (16) side, provided with an adhesive-release coating (18) on said upper side; a second layer (20) being printed first indicia comprising a portion of the total indicia to be seen, printed on said lower side of said first layer; a third layer (24) being transparent and containing a release varnish, said third layer being applied onto said second layer, comprises at least 80% transparent ink and up to 20% of a silicone-based release varnish, a fourth layer (26) being a transparent UV cured or heat cured adhesive applied onto said third layer; a fifth layer (22) being second indicia comprising the remaining portion of the total indicia, printed on said fourth layer to locate with and complete graphics of said first indicia; and a sixth bottom layer (28) of a pressuresensitive rubber based hot melt adhesive applied onto said fifth layer; whereby attempted removal of said tape after application to a solid surface causes tape delamination between said third layer and either adjacent layer, with additional conspicuous damage done to layers 1-6. (PYRIDO/THIENO)-[F]- OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTORS 158928 תולדות פירדו/תיאנו [ f ] אוקסזפין 5 און מודולטורים של רצפטורים AMPA חיוביים [31] [87] 10.06.2002 01202284.4 [32] 14.06.2001 [33] EP Int. Cl.8 A61K 031/553, A61P 025/28, C07D 498/12 N.V. ORGANON, THE NETHERLANDS WO/2002/102808 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 2771

[57] A (pyrido/thieno)-[f]-oxazepin- 5-one derivative of the formula wherein R 1, R 2 and R 3 are independently H or (C 1-4 ) alkyl; Ar represents a fused thiophene or pyridine ring optionally substituted with one or more substituents selected from (C 1-4 ) alkyl, (C 1-4 ) alkyloxy, (C 1-4) alkyloxy (C 1-4 )-alkyl, CF 3, halogen, nitro, cyano, NR 4 R 5, NR 4 COR 6, and CONR 4 R 5 ; R 4 and R 5 are independently H or (C 1-4 )alkyl; or R 4 and R 5 form together with the nitrogen atom to which they are bound a 5- or 6- membered saturated heterocyclic ring, optionally containing a further heteroatom selected from O, S or NR 6 ; R 6 is (C 1-4 ) alkyl; A represents the residue of a 4-7 membered saturated heterocyclic ring, optionally containing an oxygen atom, the ring being optionally substituted with 1-3 substituents selected from (C 1-4 ) alkyl, (C 1-4 ) alkyloxy, hydroxy, halogen and oxo; or a pharmaceutically acceptable salt thereof; with the proviso that the compound of formula I wherein Ar is a [3,2-f] fused pyridine ring; each of R 1 -R 3 is H, and A represents (CH 2 ) 3 ; is excluded. 158940 ELEMENTARY AND COMPLEX COUPLING DEVICES AND THEIR USE התקני הצמדה בסיסיים ומורכבים ושימושם [31] 18.11.2003 1022035 [32] 29.11.2002 Int. Cl.8 F16C 011/00 THALES NEDERLAND B.V., THE NETHERLANDS SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] NL סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] An elementary coupling device comprising: a means (1) for stiffening the elementary coupling device against torsion, two means (2', 2") for linking the means for stiffening to a second object (40) to be coupled, two first means (1/2', 1/2") for hinging each means for linking directly or indirectly on the second object to be coupled at two separate points, two second means (1/3', 1/3") for hinging the means for stiffening on each means for linking at two separate points, two third means (2/4', 2/4") hinging the means for stiffening directly or indirectly on a first object to be coupled at two separate points. 2772

[31] [72] METHOD AND DEVICE OF IMAGING WITH AN IMAGER HAVING A FIBER PLATE COVER 27.11.2003 60/429378 [32] 27.11.2002 Int. Cl.8 A61B 001/05, H01L 021/8238 GIVEN IMAGING LTD. GAVRIEL JOSEPH IDDAN PEARL COHEN ZEDEK LATZER, 5 SHENKAR ST., P.O.B. 12704, HERZLIYA 46733 159113 שיטה ומכשיר להדמייה כאשר למכשיר יש כיסוי עשוי מסיבים [33] US גיוון אימג'ינג בע"מ, יקנעם גבריאל יוסף עידן פרל כהן צדק לצר, מרכז גב- םי 1, רח' שנקר, 5 ת.ד. 12704, הרצליה [57] An autonomous in vivo device comprising: an imager; and a fiber plate cover disposed on sensor elements to said imager, said fiber plate cover to transfer to said sensor elements an image of an object in contact with said fiber plate cover while said in vivo device passes through a body lumen, said fiber plate cover configured to be contiguous with an outer wall surrounding said in vivo device. 2773

159261 MULTI-DETECTION OF HEARTBEAT TO REDUCE ERROR PROBABILITY איתור רב ערוצי של HB להורדת הסיכוי לטעות [31] [87] 13.06.2002 60/297925 [32] 13.06.2001 [33] US 60/297987 13.06.2001 US 997621 29.11.2001 US 60/378903 07.05.2002 US 171378 12.06.2002 US Int. Cl.8 H04B 001/707, 007/26, H04J 011/00, 013/00, H04L 027/26, H04Q 007/38 TANTIVY COMMUNICATIONS, INC., U.S.A. WO/2002/102098 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A method for use in a base station, the method comprising: booting a detection processor wherein the detection processor comprises a state machine and a hypothesis detector; receiving a signal from a wireless transmit/receive unit (WTRU) wherein the signal includes a maintenance channel, a plurality of traffic channels, an access channel, a heartbeat standby channel, and a heartbeat request active channel; processing the received signal and outputting a determined a heartbeat energy level and a request energy level to the hypothesis detector, wherein a heartbeat channel processor processes the heartbeat standby channel to determine the heartbeat energy level and a request channel processor processes the heartbeat request active channel to determine the request energy level; determining the signal type of the received signal in the hypothesis detector; processing the output of the hypothesis detector in the state machine and determining whether the received signal is a request to transmit data according to predetermined criteria; and allocating at least one traffic channel to the WTRU when the received signal is a request to transmit data. 2774

The applications for division from this application have not yet been published,193219 בקשות חלוקה מבקשה זו שטרם פורסמו. TRANSMITTAL OF HEARTBEAT SIGNAL AT A LOWER LEVEL THAN HEARTBEAT REQUEST 159262 העברה של אות HB בדרגה נמוכה יותר מאות HB מבקש [31] [87] 13.06.2002 60/297925 [32] 13.06.2001 [33] US 997621 29.11.2001 US 60/378697 07.05.2002 US 171080 12.06.2002 US Int. Cl.8 H04B 007/005, 007/208, 007/216, 007/26, H04J 003/00, 011/00, 013/00, H04L 001/16, 007/06, 027/26, H04Q 007/00, 007/20, 007/36 TANTIVY COMMUNICATIONS, INC., U.S.A. WO/2002/102095 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A code division multiple access (CDMA) user device comprising: a transceiver; and a controller configured to control the transceiver such that a connection with a base station is established, a signal is transmitted from the transceiver over a reverse link to indicate the presence of the CDMA user device to the base station, and at least one signal is transmitted from the transceiver to the base station over the reverse link to request that the base station reserve a reverse link traffic channel for the CDMA user device. 2775

The applications for division from this application have not yet been published,192394 בקשות חלוקה מבקשה זו שטרם פורסמו. 159593 ATMOSPHERIC OPTICAL DATA TRANSMISSION SYSTEM מערכת שידור נתונים אופטית אטמוספרית [31] [72] [87] 19.06.2002 892913 [32] 26.06.2001 [33] US Int. Cl.8 G02B 026/06, H04B 010/10, 010/105, 010/22 AOPTIX TECHNOLOGIES, INC., U.S.A. ELON J. GRAVES, MALCOLM J. NORTHCOTT WO/2003/003618 JMB, FACTOR & CO. LTD., ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים, ת.ד.,45087 PARK, HAR HOTZVIM HI-TECH P.O.B. 45087, ירושלים JERUSALEM 91450 [57] A free-space optical data determining characteristics of a transmission system, comprising: first wavefront of light transmitted from and second telescopes spaced from the second telescope across a second and aimed at each other, a light free-space optical path to the first transmitter operably coupled to the telescope and pre-correcting a first telescope for providing dataencoded wavefront of the data-encoded light in light to the first telescope response to said characteristics, which directs that data-encoded light wherein the second free-space optical across a first free-space optical path to path and the first free-space optical the second telescope, a light receiver path encounter substantially the same operably coupled to the second aberrations, and second adaptive telescope for receiving the dataencoded optics system provided with the light from the first telescope, second telescope for determining a first adaptive optics system provided characteristics of a wavefront of light with the first telescope for transmitted from the first telescope 2776

across the first free-space optical path to the second telescope across the first free-space optical path to the second telescope and correcting a wavefront of the data-encoded light in response to said characteristics. 159672 [31] [87] DISPERSITY CODING FOR INVERSE MULTIPLEXING 04.07.2002 1018463 [32] 04.07.2001 Int. Cl.8 H04L 012/56 NONEND INVENTIONS N.V., THE NETHERLANDS WO/2003/005661 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] NL קידוד מפוזר להיפוך ריבוב ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A method for digital inverse multiplexing digital data comprising: splitting a packet of digital data into: a first flow wherein the packet f digital data is sent from front to rear; a second flow wherein the packet of digital data is sent from rear to front; and a third flow, said third flow including a flow of data elements obtained from each time that a first data element from a rear part of a front sub-area of the packet of digital data and a second data element from a front part of a rear sub-area of the packet of digital data are reduced into a third data element by means of a reversible operation. 2777

159753 [31] [87] INDIVIDUAL PLANT WATERING DEVICE 01.07.2002 01/09450 [32] 16.07.2001 02/03432 20.03.2002 02/04848 18.04.2002 Int. Cl.8 A01G 027/00 AQUASOLO SYSTEMS, FRANCE WO/2003/007697 G.E. EHRLICH (1995) LTD., AYALON TOWER, 15 TH FLOOR, 11 MENACHEM BEGIN ST., RAMAT GAN 52521 מכשיר להשקיית צמח בודד [33] FR FR FR ג'י.אי.ארליך (1995) בע"מ, מגדל אילון, קומה 15,רחוב מנחם בגין 11, רמת גן [57] A fitting consisting of a piece of injected plastic material, permitting to interconnect a water reservoir and a hollow cone of porous ceramic material to provide a device allowing to individually dispense water to plants, especially potted plants, proximate of their roots, and in predetermined volume, comprising: an intermediate disk portion (4) having an aperture (5) at its center; a threadfree cylinder portion (A) arranged on one side of the intermediate disk portion and including one or two thread-free cylinders (7, 8) adapted to be permanently fixed to the cone; a threaded cylinder portion (B) arranged on the other side of the intermediate disk portion and including two threaded cylinders each having an internal threaded portion (13, 14); all in a coaxial relationship; the internal threaded portions of the two threaded cylinders being adapted to be threaded with a relatively large bottle and a relatively small bottle, respectively. 2778

159893 [72] METHOD OF TERRAIN FOLLOWING 15.01.2004 Int. Cl.8 G05D 001/04 RAFAEL ADVANCED DEFENSE SYSTEMS LTD. NITZAN SHARAV-SHAPIRO, GADI ZILBERMAN DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54 TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 שיטה לביצוע טיסה עוקבת קרקע רפאל מערכות לחימה מתקדמות בע"מ, חיפה ניצן שרב-שפירו, גדי זילברמן ד"ר מרק פרידמן בע"מ, מגדל משה אביב, ק. 54, רח ז'בוטינסקי 7, רמת- גן [57] An air vehicle comprising: (a) a memory for storing a map; (b) a processor for: (i) partitioning a flight corridor among a set of at least one frame, and (ii) as the air vehicle enters each of said at least one frame: (A) based on said map, providing a respective terrain profile for a respective portion of said flight corridor that lies within said each frame, and (B) transforming said respective terrain profile into a respective terrainfollowing flight profile for said each frame in accordance with at least one performance parameter of the air vehicle; and (C) a propulsion and guidance system for flying the air vehicle within said flight corridor in accordance with said at least one respective flight profile. 2779

AQUEOUS DISPERSION COMPRISING STABLE NANOPARTICLES OF A WATER- INSOLUBLE ACTIVE SUBSTANCE AND AN EXCIPIENT LIKE A MIDDLE CHAIN TRIGLYCERIDE (MCT) 160103 תפזיר מימי הכולל נאנו חלקיקים יציבים של חומר פעיל בלתי מסיס במים וחומר בלתי וחומר דוגמת טריגליצרידים בעלי שרשרת בינונית (MCT) [31] [72] [87] 01.08.2002 0119081.8 [32] 06.08.2001 0212463.4 30.05.2002 Int. Cl.8 A61K 009/00, 009/10, 009/16 ASTRAZENECA AB, SWEDEN PIA MARGARETHA CECILIA HEDBERG, TOMMY URBAN SKANTZE, LARS CHRISTIAN VON CORSWANT, ANNA ELIZABETH ZACKRISSON, PER LENNART LINDFORS, ULF OLSSON WO/2003/013472 S. HOROWITZ & CO., ZION HOUSE, 41-45 ROTHSCHILD BLVD., TEL AVIV 65784 [33] GB GB 41-45, תל ש. הורוביץ ושות', בית ציון, שדרות רוטשילד אביב [57] A process for the preparation of a stable dispersion of solid particles in an aqueous medium comprising: combining (a) a first solution comprising a pharmacologically active substance having a solubility in water at 25 o C of less than 0.5 mg/ml, a water-miscible organic solvent and an inhibitor, with (b) an aqueous phase comprising water and optionally a stabilizer, thereby precipitating solid particles comprising the inhibitor and the pharmacologically active substance; and optionally removing the water-miscible organic solvent; wherein: (i) the inhibitor is a non-polymeric hydrophobic organic compound; (ii) the inhibitor is less soluble in water than the pharmacologically active substance; (iii) the inhibitor is not a phospholipid and (iv) the inhibitor is sufficiently miscible with the pharmacologically active substance to form solid particles in the dispersion comprising a substantially single phase mixture of the substance and the inhibitor. 2780

160223 [72] DOUBLE-SIDED CUTTING INSERT AND MILLING CUTTER 04.02.2004 Int. Cl.8 B23C 005/16, 005/22 ISCAR LTD. CAROL SMILOVICI, ASSAF BALLAS ISCAR LTD., P.O.B. 11, TEFEN 24959 שימה דו צדדית וכרסום ישקר בע"מ, תפן קרול שמילוביץ', אסף בלס ישקר בע"מ,, ת.ד. 11, תפן [57] A double-sided cutting insert (10), for use in a milling cutter, comprising: two identical opposing end surfaces (12) and a peripheral side surface (14) extending therebetween, the peripheral side surface comprising two opposing identical major side surfaces (18); four spaced apart major cutting edges (34), each major cutting edge formed at the intersection of each major side surface with each end surface; and a primary relief surface adjacent each major cutting edge, wherein: in each cross section of the cutting insert taken in a plane generally perpendicular to the major side surfaces, a line tangent to the primary relief surface (50) extending from the major cutting edge adjacent each primary relief surface is inclined to a median plane (M) of the cutting insert at an acute interior angle; and each end surface has four corners, two diagonally opposed lowered corners (30) and two diagonally opposed raised corners (28), the lowered corners being closer to the median plane than the raised corners. 2781

[87] CONCATENATABLE POINT-TO- MULTIPOINT (PTMP) BROADCAST MESSAGES FOR DISPLAYING DISPLAY MESSAGES ON PERSONAL CELLULAR TELECOMMUNICATION DEVICES 16.08.2001 Int. Cl.8 H04L 012/18, H04Q 007/22 CELLTICK TECHNOLOGIES LTD. WO/2003/017701 SIMON KAY, PATENT ATTORNEY, P.O.B. 16044, NETANYA 42060 160309 הודעות שידור מנקודה אחת למספר נקודות (PTMP) הניתנות לשירשור לשם הצגת הודעות על מכשירי תקשורת סלולריים אישיים סלטיק טכנולוגיות בע"מ, הרצליה סיימון קיי, עו"פ,, ת.ד. 16044, נתניה [57] For use in a mobile cellular telecommunications network for displaying a display message on a personal cellular telecommunications device, the display message being transportable over an air interface by P 1 Point-To-MultiPoint (PTMP) broadcast messages each comprising (a) a header including (i) a macromessage identifier for identifying a macromessage; (ii) a macromessage page field for specifying a total number of pages I in a macromessage where K I 1 and K is a predetermined maximum number of PTMP broadcast messages in a macromessage; and (iii) a macromessage page counter for specifying a page number J=(1, 2,, I-1, I K) of a PTMP broadcast message in a macromessage, and (b) a payload including a reserved pseudoheader and a payload remainder for storing actual content, the pseudoheader having (i) a display message identifier for identifying a display message; and (ii) a PTMP broadcast message counter Q=(1, 2, P-1, P) for specifying the location of a PTMP broadcast message in a sequence of P PTMP broadcast messages. 2782

DEVICE FOR MEASURING ABERRATIONS IN AN EYE-TYPE SYSTEM 160347 מכשיר למדידת סטיות במערכת דמויית עין [31] [87] 12.08.2002 01/11112 [32] 12.08.2001 Int. Cl.8 A61B 003/103 IMAGINE EYES, FRANCE WO/2003/015622 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] FR איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] A device for measuring the aberrations in an eye-type system, comprising: an illumination path (VE) with notably means (SRC) for transmitting an illumination beam (FE) to form by backscattering on the retina of the eye a secondary light source; and a test path (VA) with notably test means (MA) in a given test plane (PA) of the phase of the wave emitted by said secondary 2783 source and emerging from the eye, characterised in that it comprises moreover; imaging means (L1) and eye-positioning means enabling in particular to position a predetermined plane of the eye in a focal plane of said imaging means, a stray reflection filtering element (FLT) where of the centre defines with the optical centre of the imaging means a measurement axis (z), substantially centred on the

pupil of the eye, optical separation means (LM1) placed on the measurement axis and defining the illumination path and the test path, on the illumination path, an illumination diaphragm (APT), of predetermined aperture, optical conjugation means (L2, L3) centred on the measurement axis and enabling optical conjugation between said predetermined plane of the eye, the plane of the illumination diaphragm and the test plane, and characterised in that the illumination beam converges substantially at the centre of the filtering element, in that the filtering element, the illumination path, the test path, the separation means and the conjugation means are interdependent, placed on a platform (PTF1) mobile relative to the imaging means along the optical axis of said means (z), enabling adjustment, with respect to the ametropia of the eye, of the optical conjugation by said means of the retina of the eye with the centre of the filtering element, and in that the illumination diaphragm is off-centre with respect to the measurement axis, so that the stray light flux reflected by the cornea of the eye, the imaging means as well as any diopter situated between the filtering element and the cornea, is deflected from the test path by the filtering element. [31] [87] FLEXIBLE THIN BATTERY AND METHOD OF MANUFACTURING SAME 20.09.2002 960079 [32] 21.09.2001 Int. Cl.8 H01M 002/02, 010/40 EVEREADY BATTERY COMPANY, INC., U.S.A. WO/2003/026039 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 160704 [33] סוללה דקה וגמישה והשיטה לייצורה US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב 2784

[57] A battery (1) comprising an anode electrode (3), a cathode electrode (5), electrolyte, at least one external electrode contact and a battery enclosure sealed about at least a portion of the perimeter (17) of the battery, said battery enclosure comprising electrically conductive material, said external electrode contact formed from said electrically conductive material, wherein the battery enclosure comprises a laminate comprising first, second and third layers, wherein the third layer comprises the electrically conductive material and is sandwiched between the first and second layers. ORAL DOSAGE COMPOSITION OF PROPIVERINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF PROVIDING PROLONGED RELEASE OF THE ACTIVE INGREDIENT 160977 תכשיר למתן פומי של פרופיוארין או מלח שלו המקובל ברוקחות עם שחרור מושהה של המרכיב הפעיל [31] [87] 08.10.2002 10149674.5 [32] 09.10.2001 [33] DE Int. Cl.8 A61K 009/00, 009/14, 009/20, 009/22, 009/28, 009/48, 009/52 APOGEPHA ARZNEIMITTEL GMBH, GERMANY WO/2003/030869 DR. YITZHAK HESS & PARTNERS, ד"ר יצחק הס ושותפיו, 279 HAYARKON ST., P.O.B. 6451, רחוב הירקון, 279 ת.ד. 6451, תל אביב TEL AVIV 61063 [57] A pharmaceutical composition for oral administration having prolonged release of the active agent, comprising propiverine and/or one or several pharmaceutically acceptable salts thereof in an amount of 4 mg to 60 mg of propiverine or the corresponding equivalent amount of a 2785 propiverine salts or a mixture thereof, being coated with one or more controlled releasing layers, said layer(s) comprising a retarding material insoluble in gastric fluid and insoluble in intestinal fluid and/or a retarding material insoluble in gastric fluid and soluble in intestinal fluid,

and/or being embedded in a controlled release matrix, which includes a swellable or insoluble material, wherein the composition has the following in vitro release, measured in 750 ml of 0.1 N hydrochloric acid during the first hour and subsequently measured in 750 ml USP buffer at ph = 5.8 using a Ph. Eur. Basket method at 100 rpm and 37 o C; 0-20% propiverine, released after 1 hour, 10-45% propiverine, released after 3 hours, 30-60% propiverine, released after 5 hours, 40-75% propiverine, releaed after 7 hours, 50-80% propiverine, released after 9 hours, 60-90% propiverine, released after 12 hours. [31] [87] FUNGICIDAL COMPOSITION BASED ON AT LEAST ONE PYRIDYLMETHYLBENZAMIDE DERIVATIVE AND AT LEAST ONE DITHIOCARBAMATE DERIVATIVE 21.10.2002 01/13688 [32] 23.10.2001 Int. Cl.8 A01N 043/40, C07D 213/24 BAYER CROPSCIENCE S.A., FRANCE WO/2003/034824 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 161008 הרכב קוטל פטריות מבוסס על נגזרת אחת לפחות של פירידילמתילבנזנאמיד ועל נגזרת אחת לפחות של דיתיאוקרבמאנט [33] FR לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] Fungicidal compositions comprising: (a) a pyridylmethylbenzamide derivative of the formula in which R 1 is chosen from a hydrogen atom, an optionally substituted alkyl radical and an optionally substituted acyl radical; R 2 is chosen from a hydrogen atom and an optionally substituted alkyl 2786

radical; R 3 and R 4, which are identical or different are independently chosen from a halogen atom, the hydroxyl radical, the cyano radical, the nitro radical, the radical SF 5, the trialkylsilyl radical, an optionally substituted amino radical, an acyl radical, and a group E, OE or SE, in which E is chosen from an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl and heterocyclyl radical, it being possible for each of them to be optionally substituted; c represents 0, 1, 2, 3 or 4; q represents 0, 1, 2, 3 or 4; and their agriculturally acceptable possible optical and/or geometric isomers, tautomers and addition salts with an acid or a base; and (b) a compound (II) chosen from dithiocarbamates, and their agriculturally acceptable isomers and addition salts with an acid; the compound (I)/compound (II) ratio ranging from 1/500 to 30/1. USE OF THYMULIN-LIKE PEPTIDES FOR MAKING PAIN- RELIEVING MEDICINES 161319 שימוש בפפטידים דמוי תימולין להכנת תרופות לשיכוך כאב [31] [87] 08.10.2002 01/12984 [32] 09.10.2001 [33] FR Int. Cl.8 A61K 038/08, 038/22, A61P 025/02, 025/06, 029/00, C07K 007/06, 014/575 INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), FRANCE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S), FRANCE NAYEF SAADE, LEBANON BARED SAFIEH-GARABEDIAN, LEBANON WO/2003/030927 REINHOLD COHN AND ריינהולד כהן ושותפיו, PARTNERS, 21 AHAD HA'AM ST.,, 21 ת.ד. 4060, תל אביב רחוב אחד העם P.O.B. 4060, TEL AVIV 61040 [57] Use of peptide analogues of thymulin, except thymulin, that are inactive relative to the immune system, and having anti-pain activity, for manufacturing a medicine for the treatment of pain. 2787

METHOD AND SYSTEM FOR SELECTING A BEST SERVING SECTOR IN A CDMA DATA COMMUNICATION SYSTEM 161396 שיטה ומערכת לבחירת סקטור המשרת באופן הטוב ביותר במערכת תקשורת נתונים CDMA [31] [87] 15.10.2002 09/982239 [32] 16.10.2001 [33] US Int. Cl.8 H04B 007/04, 007/26, H04J 013/00, H04L 012/56, H04Q 007/38 QUALCOMM INCORPORATED, U.S.A. WO/2003/034775 SANFORD T.COLB & CO., סנפורד ט. קולב ושות', P.O.B. 2273, שער הגיא 4, מרמורק, ת.ד. 2273, REHOVOT 76122 רחובות [57] A method for selecting a best serving sector in a CDMA communication system, said method comprising steps of: comparing a plurality of signal levels received from a plurality of active sectors with a signal level of a current serving sector to produce a difference; generating a delta credit for each of said plurality of active sectors based on said difference; accumulating a plurality of delta credits to produce an accumulated total credit; identifying said best serving sector from said accumulated total credit. 2788

[31] MULTIPLE WEAPON SYSTEM FOR AN ARMORED VEHICLE 19.04.2004 158338 [32] 09.10.2003 Int. Cl.8 F41A 023/34 ELBIT SYSTEMS LTD. BOROCHOV, KORAKH, ELIEZRI & CO., 15TH FLOOR, ATIDIM TOWER, KIRYAT ATIDIM, P.O.B. 58100, TEL AVIV 61580 161487 עמדת ירי מרובת נשקים לרכב משוריין [33] IL אלביט מערכות בע"מ, חיפה בורוכוב קורח אליעזרי ושות', מגדל כלל עתידים, ת.ד. 58100, תל- אביב [57] Land vehicle weapon system (100) comprising: a base mount (120) coupled with a land vehicle (102); a weapon mount; a plurality of different weapons (108) coupled with said weapon mount; a weapon moving mechanism coupled between said base mount and said weapon mount, said weapon moving mechanism being operable to move said different weapons to a combined configuration, between a transportation configuration and a static firing configuration; a plurality of moving actuator elements coupled with at least one of said base mount, said weapon mount, said different weapons, and with said weapon moving mechanism; a sensing mechanism coupled with a least one of said weapon mount, said different weapons and with said base mount; and at least one user interface coupled with said different weapons, said weapon moving mechanism, said moving elements, and with said sensing mechanism, said at least one user interface enabling a user to remotely operate said different weapons; wherein said weapon moving mechanism is in the form of a four bar linkage whose first link is fixed and is the same as said base mount, a second link of said four bar linkage being rotatably coupled with said first link, a third link of said four bar linkage being rotatably coupled with said second link and with a fourth link of said four bar linkage, said fourth link being rotatably coupled with said first link, at least one of said second link and said fourth link being slidably coupled with said first link, said weapon mount being coupled with at least one of said third link and said fourth link, said weapon moving mechanism being in said transportation configuration, when said second link, said third link, and said fourth link are substantially aligned along a substantially horizontal flat plane, said weapon moving mechanism being in said static firing configuration, when said four bar linkage is in a substantially triangular geometric form. 2789

161548 [31] METHOD OF REPLACING AN ABRADABLE PORTION ON THE CASING OF A TURBOJET FAN 21.04.2004 03/04906 [32] 22.04.2003 [33] Int. Cl.8 B23P 006/00, F01D 011/12, 025/28 SNECMA SERVICES, FRANCE EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 FR שיטה להחלפת רכיב בר שחיקה במעטפת של מניפת טורבו סילון איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] A method of replacing an characterized in that it comprises the abradable portion on the casing of a following operations: turbojet fan, the turbojet having a (a) removing the worn abradable rotary portion, this rotary portion itself portion; comprising a shaft having a fan stage (b) preparaing a new abradable attached to its front end, the fan stage portion; itself comprising a hub supporting a (c) applying adhesive to the bonding plurality of blades, the turbojet also surfaces of the abradable portion and comprising an annular fan casing (60) of the fan casing said bonding surfaces surrounding the fan stage, said fan having previously been cleaned; casing comprising an inside wall (70) (d) applying the abradable portion against which a likewise annular against the inside wall of the fan abradable portion (80) is bonded, the casing; bonding surfaces (82, 86) of the (e) putting an "inside" heating belt abradable portion and of the fan (100) into place against the sealing casing, the surface of the abradable surface of the abradable portion, the portion opposite from its bonding inside heating belt completely surface being referred to as its covering the abradable portion; "sealing" surface, the fan casing (f) putting holding sectors (110) into having a plurality of fixing points place against the inside heating belt (96), the fan stage having previously each holding sector including an been removed, the method being inflatable bladder (120), the abradable 2790

portion and the inside heating belt being sandwiched in full between the fan casing and the bladders, the holding sectors themselves being held in place by a plurality of straps (125) attached to the fan casing by the fixing points; (g) connecting the bladders to a common source (130) of air under pressure and connecting the inside heating belt to a regulated electrical power supply (140), pressurizing the bladders, and heating the adhesive in application of a cycle of temperature and pressure conditions that is adapted to the adhesive used and to the thermal conductivity of the fan casing; and (h) cooling and removing the holding sectors and the inside heating belt. 161870 [31] SUB-CALIBRE PENETRATOR PROJECTILE 06.05.2004 03/05659 [32] 09.05.2003 Int. Cl.8 F42B 014/06 GIAT INDUSTRIES, FRANCE REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] FR טיל תת קליבר חודר ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A sub-calibre penetrator projectile (1) incorporating a penetrator (2) and a sabot (3) formed of several segments, the penetrator and sabot incorporating profiles (D2, D3) that cooperate with one another so as to ensure the axial drive of the 2791 penetrator by the sabot when the projectile is being fired, such projectile wherein there is axial play (J) between the profile on the sabot and that on the penetrator so as to enable a limited relative axial displacement of the sabot with respect

to the penetrator, means being provided to ensure the radial locking of the sabot segments by the penetrator in the foremost position of the sabot with respect to the penetrator, this locking no longer being ensured in the rearmost position of the sabot with respect to the penetrator. [31] [87] PROJECTILE HAVING A HIGH PENETRATING ACTION AND LATERAL ACTION AND EQ U IP P ED WITH A N INTEGRATED FRACTURING DEVICE 21.11.2002 01127470.1 [32] 28.11.2001 Int. Cl.8 F42B 012/20 RHEINMETALL WAFFE MUNITION GMBH, GERMANY WO/2003/046470 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 161916 טיל בעל פעילות חדירה גבוהה ופעילות רוחבית המצויד במתקן שבירה משולב [33] EP לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] An active effective body (1), generating means (5) comprising one comprising: an effective body casing or more pressure-generating elements (2); a pyrotechnical pressure- (6); and an activatable initiating 2792

device (7) for initiating said pressuregenerating means, characterised by an inert pressure-transmitting medium (4) disposed within said effective body casing, as a separate component with respect to said pressure-generating means of said effective body, to which said pressure-generating means is adjacent or into which said pressuregenerating means is inserted, wherein the ratio of the pyrotechnical mass of said pressure-generating means to the mass of said inert pressuretransmitting medium is 0.5, and said pressure-transmitting medium is entirely or partially constituted of a material selected from the group comprising light metals or their alloys, plastically deformable metals or their alloys, duroplastic or thermoplastic synthetic materials, organic substances, liquid media, elastomeric materials, glass-like or pulverous materials, pressed members of glasslike or pulverous materials, and mixtures or combinations thereof. GPS EQUIPPED CELLULAR PHONE USING A SPDT MEMS SWITCH AND SINGLE SHARED ANTENNA 161987 טלפון סלולרי המצויד ב GPS המשתמש בממסר MEMS SPDT ומשושה יחידה משותפת [31] [87] 20.11.2002 09/995551 [32] 27.11.2001 Int. Cl.8 H01Q 021/28, H04B 001/38 QUALCOMM INCORPORATED, U.S.A. WO/2003/047035 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] An antenna sharing system (10) for use with an antenna (12) comprising: a first matching network (16) coupled to a first circuit (20); a 2793 second matching network (18) coupled to a second circuit (22); and a switch (14) having a first throw coupled to said first network, a second

throw coupled to said second network, and a pole coupled to said antenna. BILAYER HDP CVD/PE CVD CAP IN ADVANCED BEOL INTERCONNECT STRUCTURE AND METHOD THEREOF 162435 מכסה דו שכבתי לציפוי כימי של אדים לפלסמה רבת הבלטה/פלסמה מוגברת במבניחיבור מתקדמים בקדם ייצור ושיטה לנ"ל [31] [87] 22.11.2002 10/047964 [32] 15.01.2002 Int. Cl.8 H01L 021/44 IBM CORPORATION, U.S.A. WO/2003/060983 IBM LABORATORIES, HAIFA UNIVERSITY, HAIFA 31905 [33] US מעבדות יבמ מחלקת קנין רוחני, אוניברסיטת חיפה הר הכרמל, חיפה [57] A method for forming an interconnect structure on a substrate, the method comprising the steps of: depositing a dielectric material on the substrate, thereby forming a dielectric layer, depositing a hardmask material on said dielectric layer, thereby forming a hardmask layer, said hardmask layer having a top surface; forming at least one opening in said dielectric layer; filling said opening with a conductive material, thereby forming at least one conductor, said conductor having a surface coplanar with the top surface of said hardmask layer; depositing a first material on said conductor, thereby forming a first cap layer, wherein said first material is deposited by a high density plasma chemical vapor deposition (HDP CVD) process; and depositing a second material on said first cap layer, thereby forming a second cap layer, wherein said second material is deposited by a plasma-enhanced chemical vapor deposition (PE VCD) process. 2794

162450 [72] SCORCH PREVENTION IN FLEXIBLE POLYURETHANE FOAMS 10.06.2004 Int. Cl.8 C08G 018/02, C08J 009/04 BROMINE COMPOUNDS LTD. SAMUEL BRON, ARIEL SLUSZNY, DORIT PELED, DORIT PERLE LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 מניעת דהיה בקצפים פוליאורתניים גמישים תרכובות ברום בע"מ, באר שבע שמואל ברון, אריאל סלושני, דורית פלד, דורית פרלה לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] An anti-scorch composition for flame-retarded flexible polyurethane foams, comprising, in combination, one or more antioxidant agents, one or more metal salts of monocarboxylic or dicarboxylic acids, an epoxy compound, and at least one organic phosphite. 162561 [31] [72] [87] MILLING TOOL 13.12.2002 GM972/2001 [32] 21.12.2001 Int. Cl.8 B23C 005/20 CERATIZIT AUSTRIA GESELLSCHAFT M.B.H, AUSTRIA UWE SCHLEINKOFER, JUERGEN DUWE, WOLFGANG KOCH WO/2003/053618 EITAN MEHULAL LAW GROUP, 10 ABBA EBEN BLVD., P.O. B. 2081, HERZLIYA 46120 מכשיר שיבוב [33] AT קבוצת איתן מהולל, עורכי דין ועורכי פטנטים, שדרות אבא אבן, 10 ת.ד. 2081, הרצליה [57] A milling tool for milling workpiece surfaces, the milling tool having a rotational axis and comprising: one or more cutting segments, each with a cutting edge geometry including a main cutting edge, a cutting corner, and a secondary cutting edge; said cutting 2795 segments being formed such that a generatrix of an envelope curve described by a rotation of the milling tool includes a cutting corner portion, a first segment adjoining said cutting corner portion, and a second segment adjoining said first segment; said first segment having a projection length of

at least 1 mm, in a projection thereof onto the axis of rotation, lying nearest to the rotational axis at a beginning point bordering said cutting corner, and lying farthest from the rotational axis at an end point distal from said cutting corner, and wherein a tangent at each point within said first segment encloses an angle α 1 in a range of 0 o to 5 o with a parallel to the rotational axis; said second segment having a projection length of at least 1.5 mm, in a projection thereof onto the axis of rotation, lying, farthest from the rotational axis at a beginning point thereof bordering on said first segment, lying nearest to the axis of rotation at an end thereof, and wherein a tangent at each point of said second segment encloses an angle α 2 in a range from >0 o to 3 o with the parallel to the rotational axis and the angle α 2 increases progressively toward the end of said second segment; and said projection length of said second segment being at least 1.5 times greater than said projection length of said first segment. [31] [87] MATT POLYMERIC ADHESIVE 21.11.2003 10302416.6 [32] 21.01.2003 Int. Cl.8 C08K 007/10, C09J 011/04 ROHM GMBH & CO. KG, GERMANY WO/2004/065519 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 162753 [33] DE דבק פולימרי בעל מראה עמום ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A polymeric adhesive comprising the following additives: (a) silica powder having an average particle size of from 1 µm to 10 µm (matting agent); and (b) silica powder having an average particle size of more than 10 µm up to 200 µm (texturing agent). 2796

METHOD OF CREATING HIGH- QUALITY RELAXED SIGE-ON- INSULATOR FOR STRAINED SI CMOS APPLICATIONS 163124 שיטת יצור של מבדד על SiGe שהינו באיכות גבוהה ורפה לישומים CMOS עם Si הדוק [31] [87] 16.01.2003 055138 [32] 23.01.2002 Int. Cl.8 H01L 021/20 IBM CORPORATION, U.S.A. WO/2003/063229 IBM LABORATORIES, HAIFA UNIVERSITY, HAIFA 31905 [33] US מעבדות יבמ מחלקת קנין רוחני, אוניברסיטת חיפה הר הכרמל, חיפה [57] A substrate material comprising: a Si-containing substrate (10); an insulating region (12) that is resistant to Ge diffusion present atop said Sicontaining substrate; and a substantially relaxed SiGe layer present atop said insulating region, wherein said substantially relaxed SiGe layer has a thickness of about 2000 nm or less. WHEELCHAIR CAPABLE OF CLIMBING AND DESCENDING STAIRS 05.08.2004 Int. Cl.8 A61G 005/06, B62B 009/06 EFIM LAPATIN OLGA LAPATIN EFIM LAPATIN, 42/1 UZIEL ST., RAMAT GAN 163373 עגלת נכים בעלת יכולת לעלות ולרדת במדרגות יפים לפטין, רמת גן אולגה לפטין, רמת גן יפים לפטין, רח' עוזיאל 42 דירה 1, רמת גן [57] Wheelchair, able to climb and descend stairs comprising: a frame (1) having a seat (2) for an occupant (3); an axle (7) connected to the frame, 2797 transversely relative to wheelchair, spiders (8) set on the axle on the both sides of the frame with possibility of a turn relative to the axle, said driving

spiders each having at least three evenly spaced radial legs (13), bidirectional drive to rotate the axle with the spiders, main running wheels (4) linked with the radial legs of the spider and used for moving the wheelchair both over stairs and across a level bearing surface (6); a means for locking and unlocking the main running wheels relative to the spider, the said means comprising a brake unit and a projection (10) fixed on the axle, two stops (11, 12) fixed on the spider and interacting with the projection and a kinematic unit linking the spider with each main running wheel and providing for pressing of these wheels to the brake unit by rotating of the spider, ensuring a movement of the wheelchair over stairs during setting in motion the bidirectional drive, the said means ensuring a movement of the wheelchair on a level bearing surface during cutting out the bi-directional drive, under acting of the wheelchair's weight drawing to each main running wheel away from the brake unit of the spider turned by the wheels due to kinematic units, getting the wheels in contact with each other and drawing the stop away from the stopped projection, auxiliary running wheel (21) used for moving and turning the wheelchair on level bearing surface, said auxiliary running wheel linked with the frame and freely rotatable to the axis perpendicular to the seat. 2798

[31] [87] COMPONENT SUPPORT AND RADIOISOTOPE GENERATOR INCLUDING ONE OR MORE COMPONENT SUPPORTS 11.12.2002 0206550.6 [32] 20.03.2002 Int. Cl.8 F16B 021/06, G21F 005/00 GE HEALTHCARE LIMITED, UNITED KINGDOM WO/2003/081055 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 163438 [33] מערכת תמיכה לרכיב ומערכת יצור רדיואיזוטופים הכוללת מערכת תמיכה אחת או יותר לרכיבים GB ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A component support (29) for use in a radioisotope generator, the component support comprising a latching member (5) movable between an engaging position and an open position characterised by further including a bracing member (13) mechanically associated with the latching member and adapted to prevent movement of the latching member to the open position. 2799

163881 [31] [72] [87] AUTO-FOCUSING METHOD AND DEVICE 13.03.2003 148664 [32] 13.03.2002 Int. Cl.8 G02B 007/04 YEDA RESEARCH AND DEVELOPMENT CO. LTD. BENJAMIN GEIGER, ZVI KAM WO/2003/077008 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] IL שיטה והתקן למיקוד עצמי ידע חברה למחקר ופיתוח בע"מ, רחובות בנימין גייגר, צבי קם ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] An auto-focusing method for determining an in-focus position of a sample supported on one surface of a substrate plate made of a material transparent with respect to incident electromagnetic radiation, the method utilizing an optical system capable of directing incident electromagnetic radiation towards the sample and collecting reflections of the incident electromagnetic radiation which are to be detected, and comprising: (i) locating a focal plane of an objective lens arrangement at a predetermined distance from a surface of the substrate, which is opposite to said surface supporting the sample; (ii) providing continuous displacement of the focal plane relative to the substrate along the optical axis of the objective lens arrangement, while concurrently directing the incident radiation towards the sample through the objective lens arrangement to thereby focus the incident radiation to a location at the focal plane of the objective lens arrangement; and (iii) continuously detecting reflected components of the electromagnetic radiation collected through said objective lens arrangement, said detected reflected components being characterized by a first intensity peak corresponding to an in-focus position of said opposite surface of the substrate, and a second intensity peak spaced in time from the first intensity peak and corresponding to an in-focus position of said sample-supporting surface of the substrate, thereby enabling imaging of the sample when in the in-focus position of the samplesupporting surface of the substrate. 2800

163897 [31] [87] HYDRAULIC ROTARY- PERCUSSIVE HAMMER DRILL 18.03.2003 02/03402 [32] 19.03.2002 Int. Cl.8 B25D 017/24 MONTABERT S.A., FRANCE WO/2003/078107 LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER, P.O.B. 5352, BEER-SHEVA 84152 [33] מקדח פטיש נוקש סובב הידראולי FR לוצאטו את לוצאטו, גן תעשייה, עומר, ת.ד. 5352, באר שבע [57] A hydraulic rotary percussive hammer drill (1) comprising a body (2) containing a reciprocating percussion piston (4) sliding under the effect of a main hydraulic supply circuit, this main circuit also being intended to cause the sliding of a roughly annular abutment piston (5) housed in a cavity (3) of the body, and having, on the one hand, a front face (13) intended to position a shank (7) a predetermined distance away from the percussion piston and, on the other hand, a rear face (14) facing a rear wall of the cavity, wherein: an external hydraulic supply circuit (23) is able, when the main circuit (22) is shut down, to introduce fluid under pressure between the rear face of the abutment piston and the rear wall of the cavity so as to maintain a space between these items; and the external circuit opens into the rear end of the cavity and in that a sliding annular sleeve is placed around a rear part of the abutment piston and is able, on the one hand, to prevent the introduction of the fluid delivered by the external circuit when a pressure in a rear chamber (17) is above or equal to a predetermined value and, on the other hand, to allow this fluid to be introduced when the pressure in the rear chamber is below the determined value. 2801

DECANTER CENTRIFUGE WITH WEAR REINFORCEMENT INLET 164025 צנטריפוגת יציקה בעלת פתח כניסה עם חיזוק למניעת שחיקה [31] [87] 14.03.2003 PA 2002 [32] 14.03.2002 00398 Int. Cl.8 B04B 001/20 ALFA LAVAL COPENHAGEN A/S, DENMARK WO/2003/076078 SELIGSOHN GABRIELI & CO., 31 YAVNE ST., P.O.B. 1426, TEL AVIV 61013 [33] DK זליגסון גבריאלי ושות', רח' יבנה, 31 ת.ד. 1426, תל אביב [57] A decanter centrifuge with a hollow drum having a longitudinal axis of rotation and a direction of rotation, a screw conveyor in the drum comprising a core body (1) carrying at least one helical winding (2) wherein an inlet chamber (3) is provided in the core body, said inlet chamber having an inlet opening for inlet of material into the drum from the inlet chamber, a central inlet being provided in the inlet chamber as well as an end wall (13) in the inlet chamber opposite the central inlet, the inlet opening having a delimitation surface (7) which is rear relative to the direction of rotation and extending substantially axially, said delimitation surface being provided with a wear reinforcement (8) and a preferably substantially tangentially extending edge (13a), which is distal relative to the central inlet, characterized in that the wear reinforcement comprises a wear 2802

reinforcement member extending along the rear delimitation surface and, when viewed in section transverse to the direction of the axis of rotation, extending around the rear delimitation surface, the wear reinforcement member extending so far into the inlet chamber along its wall that a concave back surface of the wear reinforcement member facing the rear delimitation surface has an interior portion in the inlet chamber, said portion being positioned behind the foremost point of the rear delimitation surface viewed relative to the direction of rotation, that the wear reinforcement member is provided with an abutment surface with a component facing tangentially opposite the back surface in abutment against an abutment surface associated with the core body and which during operation prevents the wear reinforcement member from moving tangentially forwards in the direction of rotation, and an abutment surface with a radially outwards facing component in abutment against an abutment surface associated with the core body preventing the wear reinforcement member from moving radially out of the core body, that at least one of said abutment surfaces associated with the core body is constituted by a removable blocking member and that the wear reinforcement member and the inlet opening are designed in such a manner that the wear reinforcement member can be introduced to its operating position from the exterior side of the core body. [31] [87] 2803 AQUATIC ANIMAL FEED CONTAINING MICROALGAE CONTAINING ARACHIDONIC ACID 19.03.2003 60/365,182 [32] 19.03.2002 Int. Cl.8 A23K 001/00, 001/18 ADVANCED BIONUTRITION CORPORATION, U.S.A. WO/2003/079810 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 164123 [33] מאכל לחיות ים המכיל מיקרואצות המכילות חומצת אראחידונית US וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים

[57] A feed for an animal comprising one or more microalgae or portions thereof which comprise arachidonic acid, wherein the microalgal arachidonic acid comprises from about 1% to about 20% of the feed, and wherein the arachidonic acid is predominantly in a triglyceride form and wherein the microalgae is chosen from one or more of Euglena, Parietochloris, or snow algae. 164134 SHUTTER DEVICE WITH FLEXIBLE LATERAL EDGES התקן סגירה עם קצוות גמישים [31] [87] 17.03.2003 2002/0197 [32] 20.03.2002 Int. Cl.8 E06B 009/58 DYNACO INTERNATIONAL S.A., BELGIUM WO/2003/078783 EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733 [33] BE איתן, פרל, לצר וכהן צדק, רחוב שנקר, 7 ת.ד. 12688, הרצליה [57] Shutter device intended to close a bay or other opening, with flexible edges projecting with respect to the plane of the shutter and collaborating with guideways (4, 5), at least one reintroduction element (12) being provided, allowing the said edges to be reintroduced into the guideways when these edges become disengaged from the latter under the action of a force exerted on these edges in a direction transverse to the guideways, a contact area being formed during this reintroduction between the reintroduction element and the corresponding edge, characterized in that the lateral edges (2, 3) consist at least partially of an elastomeric material so that the said contact area increases as the said force increases, spreading this force over the contact area. 2804

164393 REVERSIBLE SPEED VARIATOR 04.10.2004 Int. Cl.8 F16H 009/26, 015/18 OLGA LAPATIN EFIM LAPATIN EFIM LAPATIN, 42/1 UZIEL ST., RAMAT GAN 52382 וריאטור המהירות עם מהלך אחורי אולגה לפטין, רמת גן יפים לפטין, רמת - גן יפים לפטין, עוזיאל 42 דירה 1, רמת - גן [57] A reversible speed variator comprising: a case (1), a driving (2) and driven (4) shaft, a differential fixed on a supporting shaft and having two driving conical gears (8, 9) and a driven axle (10) is perpendicular to the supporting shaft and having two driving conical gears (8, 9) and driven axle (10) is perpendicular to the supporting shaft and carrying two conical gears (11) engaged with driving conical gears, the driving conical gears linked with the driving shaft by an unregulable and regulable kinematic chain having odd and even quantity of external engagements, the supporting shaft linked kinematically with the driven shaft, a splined hollow shaft attached to the driving conical 2805 gear and having roller supports put in the case, a mobile wheel (14) put on splined hollow shaft (13) and mounted rotatably in a protective shroud linked with a longitudinal transference mechanism, a conical drum (35) with an inclined revolution axis having a lower forming line is parallel to the splined hollow shaft, the mobile wheel, having friction engagement with conical drum along the lower forming line, the mobile wheel, having an external diameter more than a small diameter and less than a big diameter of the conical drum, a conical drum put between a cardan and a tiltable support provided with a lifting mechanism, a means, providing a dry friction between the mobile

wheel and the conical drum, having the protective shroud and a folding shroud for the conical drum connected with the protective shroud. SEMI-SYNTHETIC PROCESS FOR THE PREPARATION OF N- DEBENZOYLPACLITAXEL 164486 תהליך סינטטי למחצה להכנת N דבנזואילפאקליטאקסל [31] [87] 24.03.2003 MI2002A000782 [32] 12.04.2002 [33] IT Int. Cl.8 C07D 305/00, 305/14, 405/12, 405/14, 407/12 INDENA S.P.A., ITALY WO/2003/087077 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., רחוב אחד העם, 21 ת.ד. 4060, תל P.O.B. 4060, אביב TEL AVIV 61040 [57] A process for the preparation of N-debenzoylpaclitaxel of the formula which comprises: (a) condensing a carboxylic acid, or a salt or an activated derivative thereof of the formula 2806

in which R1 is an aryl or heteroaryl group, with a baccatin derivative of the formula in which R2 is a hydroxy-protecting group removable by acid-catalyzed solvolysis, to give a compound of the formula in which R1 and R2 are as defined above; (b) removing the R2 group and opening the oxazolidine ring in the compound of formula (IV) by acid-catalyzed solvolysis. 2807

[31] [87] PESTICIDE COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING RESISTANCE TO A PESTICIDE OF A SUBSTRATE PEST 29.04.2003 0209749.1 [32] 29.04.2002 Int. Cl.8 A01N 025/00, 025/06, 053/08 ROTHAMSTED RESEARCH LIMITED, UNITED KINGDOM DEPARTMENT OF PRIMARY INDUSTRIES FOR AND ON BEHALF OF THE STATE OF NEW SOUTH WALES, AUSTRALIA WO/2003/092378 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 164768 תכשירים קוטלי חרקים ושיטות למניעת או הפחתת העמידות לקוטלי חרקים של מזיקי מצע [33] GB ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A method for preventing or reducing resistance to a pesticide of a substrate pest, which method comprises the administration to the substrate or the pest of a composition comprising: (a) a rapid-release formulation of an inhibitor of a factor causing or contributing to the resistance of the pest to the pesticide, the inhibitor being a metabolic enzyme inhibitor; and, substantially simultaneously, (b) a non-rapid release formulation of the pesticide. [31] [87] CHILD-RESISTANT BLISTER PACK 08.05.2003 10/141288 [32] 08.05.2002 Int. Cl.8 B65D 083/04 R.P. SCHERER TECHNOLOGIES, INC., U.S.A. WO/2003/095331 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 165045 [33] תפיסה של טבליות עמידה בפני ילדים US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב 2808

[57] A child-resistant blister pack that enables separating a plurality of dosage units (10) in a particular order, said pack comprising: (i) a blister film sheet (12) with depressions (16) therein; (ii) dosage forms within the depressions; (iii) a lidding sheet (14) which overlies the depressions and which is secured to the film sheet so as to seal the dosage forms within the depressions; and (iv) a network of lines of weakness (26) in the pack defining the plurality of dosage units, each dosage unit including (a) one of said dosage forms sealed in one of the depressions covered by the lidding sheet and (b) a peel region (40) where part of the lidding sheet is not secured to the blister film sheet, each peel region being disposed adjacent a respective one of the lines of weakness in the network; wherein said lines of weakness include; a first line of weakness (26) extending from a first access point (35) so that, when the first access point is exposed, the blister film sheet and the lidding sheet can be torn along the first line of weakness to expose a second access point (36) wherein the second access point enables access to only a second line of weakness (27) and also to enable access to the peel region of a first dosage unit (18) wherein the second line of weakness extending from the second access point so that, when the second access point is exposed, the blister film sheet and the lidding sheet can be torn along the second line of weakness to expose a third access point (56a) wherein the third access point enables access to only a third line of weakness and also to enable access to the peel region of a second dosage unit (19); and wherein the third line of weakness which is spaced from the first line of weakness and which extends from the third access point so that, when the third access point is exposed, the blister film sheet and the lidding sheet can be torn along the third line of weakness to enable access to the peel region of a third dosage unit. 2809

TARGETING SYSTEM COMPRISING UNIFORMLY- SIZED NANOPARTICLES WITH AT LEAST ONE POLYMER AND AT LEAST ONE POSITIVELY CHARGED POLYSACCHARIDE AND PREPARATION METHOD THEREOF 165830 מערכת העברה למטרה המכילה נאנו חלקיקים של גודל אחיד של לפחות פולימר אחד ושל לפחות פוליסככריד אחד מוטען באופן חיובי ושיטה להכנתה [31] [87] 20.06.2003 02/07668 [32] 20.06.2002 Int. Cl.8 A61K 009/00, 009/51 BIOALLIANCE PHARMA, FRANCE WO/2004/000028 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] FR סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] Vectorization and delivery system of nanoparticles present a homogeneous substances of therapeutic or diagnostic distribution of size and comprise (i) at least interest, of the type constituted by one polymer and (ii) at least one nontoxic nanoparticles, characterized in that said positively charged polysaccharide. PROCESS AND RIBBED TUBE FOR THERMALLY CLEAVING HYDROCARBONS 166229 תהליך וצינור מצולע לבקיעה תרמית של פחמימנים [31] [87] 08.05.2003 10233961.9 [32] 25.07.2002 Int. Cl.8 C10G 009/00, F28F 001/40 SCHMIDT +CLEMENS GMBH+CO. KG, GERMANY WO/2004/001502 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] DE וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] A finned tube for the thermal cracking of hydrocarbons in the presence of steam, in which the charge mixture is passed through externally heated tubes having a plurality of helically running inner fins, characterized in that the flank angle of the fins is 16 o to 25 o and the fins run at an angle of 20 o to 40 o with respect to the tube axis. 2810

166509 BIOMIMETIC MEMBRANES ממברנות ביומימטיות [31] [87] 28.07.2003 60/398784 [32] 29.07.2002 [33] US 60/438784 09.01.2003 US Int. Cl.8 A01N 001/00, B01D 053/84, 069/14, 071/80, C12N 001/00 MT TECHNOLOGIES, INC., U.S.A. WO/2004/011600 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A biomimetic membrane, comprising: a tri-block copolymer matrix simulating a natural biological membrane and natural protein environment; and membrane proteins incorporated into said matrix to form a membrane/protein composite. 2811

[31] [87] METHOD FOR PRODUCING AN AVOCADO UNSAPONIFIABLE MATERIAL RICH IN FURAN LIPIDS 28.07.2003 PCT/FR02/02715 [32] 29.07.2002 10/206792 29.07.2002 Int. Cl.8 A61K 003/600000 003/65400 LABORATOIRES EXPANSCIENCE, FRANCE WO/2004/012496 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 166567 [33] שיטה להכנת חומר עשיר בפוראן ליפידי שאינו הופך לסבון WO US ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] Process for obtaining a furan lipidrich unsaponifiable material from avocado, comprising: (I) controlling dehydration of fresh avocados or of avocados that have undergone a preliminary transformation, wherein the dehydration is performed at a temperature of between -50 o C and 75 o C, (II) extracting oil from dehydrated fruit, (III) alternatively, (a) heat treating the extracted oil at a temperature from 80 to 150 o C, and then concentrating the unsaponifiable fraction of the oil, or (b), concentrating the unsaponifiable fraction of the oil, followed by heat treating at a temperature from 80 to 150 o C, followed by (IV) saponificating and extracting of the unsaponifiable material wherein the concentrating of (III)a or (III)b is molecular distillation at a temperature of between 180 and 260 o C or cold crystallization. 166697 [31] [87] DISH ASSEMBLY 03.07.2003 2002950582 [32] 05.08.2002 Int. Cl.8 F24J 002/12 ROBERT EDGAR WHELAN, AUSTRALIA WO/2004/013547 DR. MARK FRIEDMAN LTD., MOSHE AVIV TOWER, 54TH FLOOR, 7 JABOTINSKY ST., RAMAT GAN 52520 [33] AU מכלול צלחת ד"ר מרק פרידמן בע"מ, מגדל משה אביב, ק. 54, רח ז'בוטינסקי 7, רמת- גן 2812

[57] A dish assembly (10) including:- a central hub (11); an outer rim member (12), and a plurality of concentric arcuate structural members (13) extending from the central hub to the outer rim member; the arcuate members being of box-section configuration and abutting along their inner and outer arcuate surfaces such that load can be transferred from an outer arcuate structural member to an inner arcuate structural member. 166744 [62] POLYURETHANE/UREA COMPOSITIONS 25.04.1999 Int. Cl.8 C08G 002/00, 018/32 Division from 129583 KENNETH I. SAWYER, U.S.A. REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 הרכבי פוליאורתאן/אוריאה ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A moisture curable, storage stable, single component polyurethane/urea composition comprising (i) polyaminobenzoates or polyaminobenzamides of the formula wherein at least one of the aromatic amino groups is blocked by reaction with aldehyde; n is 2813 an integer from 2 to 4; each k is one or two; each benzoyl nucleus is para, meta, or di-meta-aminosubstituted; each Z is O-or

NR-; G is a n-valent radical obtained by removal of hydroxy groups or amino groups from an n-valent polyol or polyamine having a molecular weight of from about 200 to about 6,000; and R is hydrogen or selected from the group consisting of C 1 -C 20 alkyl, [(C 1 -C 20 alkoxy) aryl] methyl and [(C 1 -C 20 alkyl) aryl] methyl; (ii) organic polyisocyanate or blocked organic polyisocyanate; and optionally (iii) a catalyst for accelerating curing, auxiliary agents and/or additives. CATHETER BALLOON HAVING IMPROVED BALLOON BONDING 166908 צנתר בלון בעל תקשיר בלון משופר [31] [87] 21.08.2003 10/255487 [32] 26.09.2002 Int. Cl.8 A61M 025/10 ADVANCED CARDIOVASCULAR SYSTEMS, INC., U.S.A. WO/2004/028614 WOLFF, BREGMAN AND GOLLER, P.O.B. 1352, JERUSALEM 91013 [33] US וולף, ברגמן וגולר,, ת.ד. 1352, ירושלים [57] A balloon catheter (10) comprising: (a) an elongated shaft (12) having a proximal end, a distal end, and an inflation lumen (22); and (b) a balloon (24) on a distal shaft section, having an interior in fluid communication with the inflation lumen of the shaft, and having a proximal (25) and a distal skirt (26) section bonded to the shaft and an inflatable section (32) therebetween, and a polymeric first layer (33) and a polymeric second layer (34) extending from the proximal skirt section to the distal skirt section, the first layer having an inner surface which has at least a section which is gas plasma-etched or chemical solutionetched and an outer surface which has at least a section which is gas plasma-etched or chemical solution-etched. 2814

167053 [31] [62] [87] PRINTER WITH A BINDING ASSEMBLY 24.05.2000 PQ0559 [32] 25.05.1999 PQ1313 30.06.1999 PQ5829 20.02.2000 Int. Cl.8 B41J 029/00 Division from 146639 SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA WO/2000/071355 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 [33] AU AU AU מדפסת עם מכלול קישור ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] A printer (601) which includes: a support structure that defines a print media feed path; a print media feed mechanism mounted on the support structure for feeding sheets of print media along the feed path; a printhead assembly (706) mounted on the support structure to carry out a printing operation on the sheets of print media; a binding assembly (605) mounted on the support structure downstream of the printhead assembly, the binding assembly including: a glue application means positioned downstream of the printhead assembly to apply glue to each sheet of print media; and a platen assembly that is positioned downstream of the glue application means, the platen assembly having a support platen that is positioned to receive and support each printed sheet and a binding platen that is reciprocally displaceable with respect to the support platen to displace a printed sheet (64) onto the support platen and to urge said sheet against a preceding sheet so that the sheets are glued together. 2815

PORTABLE ELECTRIC POOL CLEANER 168225 מנקה בריכה חשמלי הניתן להשאה [31] [87] 29.10.2003 10/282883 [32] 29.10.2002 Int. Cl.8 E04H 004/16 WATER TECH LLC, U.S.A. WO/2004/040083 SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT 76122 [33] US סנפורד ט. קולב ושות', שער הגיא 4, מרמורק, ת.ד. 2273, רחובות [57] A hand-held submersible electrically-powered pool cleaner (10) comprising: a nozzle (36); a toroidal body (16) having; a carrying handle (14) for carrying, manipulating, and directing the cleaner during use, with the carring handle being integrally formed from an upper portion of the toroidal body and an opening through the toroidal body; an impeller (82) and drive motor, and a filter (40); said body having an intake opening in fluid communication with the nozzle, wherein the impeller draws pool water through the nozzle and filter to remove dirt and debris from the pool water. 2816

[31] [87] PROCESS FOR THE RECYCLING OF SOLID PHASE BONDED CTC - RESIN 12.12.2003 02028744.7 [32] 20.12.2002 Int. Cl.8 C08F 002/00, 008/20 F. HOFFMANN-LA ROCHE AG, SWITZERLAND WO/2004/056883 REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040 168684 [33] תהליך למיחזור של שרף CTC הקשור למוצק EP ריינהולד כהן ושותפיו, רחוב אחד העם, 21 ת.ד. 4060, תל אביב [57] Process for the preparation of solid phase bonded 2-chlorotrityl chloride (2- CTC resin) of the formula wherein Ps is a polymeric support and n has the following meaning: 1 n 0 comprising the reaction of solid phase bonded 2-chlorotrityl of the formula I 2817

wherein R is OH or/and OC 1-4 -alkyl or/and NR'R" wherein R' and R" independently of each other represent C 1-4 -alkyl, or R' and R" together with the nitrogen to which they are bonded represent a 5 to 8 membered heterocyclic radical, in the presence of HCl and an organic solvent. CONNECTION BETWEEN THE REAR END WALL OF A COMBUSTION CHAMBER AND THE NOZZLE OF A ROCKET ENGINE 168861 קישור בין סופו של קיר אחורי של תא בעירה ופתחו של מנוע של טיל [31] [87] 01.12.2003 02/15158 [32] 02.12.2002 [33] FR Int. Cl.8 F02K 009/08, 009/34, F16J 015/08 SNECMA PROPULSION SOLIDE, FRANCE WO/2004/053320 LUZZATTO & LUZZATTO, לוצאטו את לוצאטו, INDUSTRIAL PARK, OMER, P.O.B. 5352, גן תעשייה, עומר, ת.ד. 5352, באר שבע BEER-SHEVA 84152 [57] A connection between the rear end wall (14) of a combustion chamber and a nozzle of a rocket engine, the connection comprising: mechanical connection means linking the nozzle to the end wall at least in an axial direction, together with a thermal barrier (40), and at least one sealing gasket (32) disposed in the interface (30) defined by the adjacent facing faces of the end wall and of the nozzle, the connection being characterized in that the thermal barrier comprises at least one refractory fiber fabric forming a cord (42) wound in the interface around the longitudinal axis (A) of the chamber, the cord(s) being made in such a manner as to ensure circumferential continuity of the thermal barrier. 2818

169680 LOCAL AREA NETWORK OF SERIAL INTELLIGENT CELLS LAN של תאים אינטיליגנטים סדרתיים [31] [62] [72] [87] 12.07.1999 09/123486 [32] 28.07.1998 [33] US Int. Cl.8 H04B 003/54, H04J 003/08, 004/00, H04L 005/14, 012/28, H04M 011/06 DIVISION FROM 140887 SERCONET LTD. סרקונט בע"מ, רעננה YEHUDA BINDER יהודה בינדר WO/2000/007322 REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., P.O.B. 4060,, 21 ת.ד. 4060, תל אביב רחוב אחד העם TEL AVIV 61040 [57] A network for remotely coupling a computer plug-in card to a computer over a wiring, said network comprising: wiring carrying bidirectional serial digital data; a first device housed, in a first enclosure, connected to said wiring and connectable to a computer via an interface, said first device being operative for coupling the serial digital data to the computer; and a second device, housed in a second enclosure, connected to said wiring, said second device comprising a bus slot and being operative for mechanically and electrically interfacing a computer bus plug-in card and coupling serial digital data to the plug-in card. The applications for division from this application have not yet been published,189508,189507 בקשות חלוקה מבקשה זו שטרם פורסמו. 2819

DEVICE FOR THE CONTINUOUS PRODUCTION OF A NONWOVEN WEB 169715 התקן לייצור רציף של רשת בלתי ארוגה [31] 18.07.2005 102004040645.6 [32] 20.08.2004 [33] DE 04028714.6 03.12.2004 EP Int. Cl.8 D01D 005/088, 005/098, D04H 003/16 REIFENHAUSER GMBH & CO. KG MASCHINENFABRIK REINHOLD COHN AND PARTNERS, ריינהולד כהן ושותפיו, 21 AHAD HA'AM ST., רחוב אחד העם, 21 ת.ד. 4060, תל P.O.B. 4060, אביב TEL AVIV 61040 [57] Device for the continuous production of a nonwoven web from filaments made from a thermoplastic synthetic, with a spinning nozzle (1), a cooling chamber (2), a stretching unit (4) and a depositing device for depositing filaments to the nonwoven web, whereby two or more different polymer fusions can be fed to the spinning nozzle and whereby a device is provided for merging the different polymer fusions such that bi-component filaments and multi-component filaments exit from the spinning nozzle openings of the spinning nozzle and whereby the cooling chamber is divided into the least two cooling chamber sections (2a, 2b) in which the bi-component filaments and multicomponent filaments respectively come into contact with process air with different convective heat discharge means. 2820

171405 CLEANABLE HAIR BRUSH 12.10.2005 Int. Cl.8 A46B 009/10 DAVID ABODREHAM DR. EYAL BRESSLER, 11 TUVAL ST., RAMAT GAN 52522 מברשת שיער ניתנת לניקוי דוד אבודרהם, הרצליה דר' אייל ברסלר עו"פ, תובל 11, רמת - גן [57] A cleansable hairbrush, comprising a basal surface from which a plurality of bristles are extending upwardly; and a rotatable cleansing sieve (30) wherein said sieve is rotatably mounted in a housing (20) located adjacent to said basal surface; said sieve comprising a plurality of apertures, each of which is accommodating at least one bristle; said sieve is adapted to rotate in a course providing a closed configuration, i.e., whereat the sieve is fastened parallel to the basal surface, and an open configuration i.e., whereat the sieve is tilted from said basal surface and provides for efficient removal of hair or litter from the said basal surface. 2821